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Abstract 
The incidence of oral cancer continues to rise in the UK and in Scotland, with a 
steady increase in oral cavity cancer rates and a rapid increase in oropharyngeal 
cancer rates in the last decade. These rates are projected to increase further 
over the next decade, so there is a pressing need to optimise oral cancer 
prevention strategies. Tobacco and alcohol use are recognised as the major 
modifiable risk factors for developing oral cancer (both oral cavity and 
oropharyngeal). In addition, there is a significant increased risk for oral cancer 
among lower socioeconomic groups, males, and older age groups. Recently there 
has been recognition of the role of human papillomavirus in the aetiology of 
oropharyngeal cancers. The major behavioural risk factors (tobacco and alcohol) 
implicated in oral cancer risk are also associated with a wide range of diseases 
affecting oral and general health and are thus termed ‘common risk factors’, 
increasing the public health benefit should they be tackled. 
Given the pivotal role in oral cancer and wider disease prevention of reducing 
tobacco and alcohol use, there is a clear need to optimise the role of primary 
care dental professionals in delivering behavioural interventions. However, there 
are uncertainties about the best evidence for particular strategies and 
approaches to assess risk factors, advise and/or refer in the dental practice 
setting, with a particular lack of clarity in terms of the specific form and 
content of such interventions (for example: duration, tailoring to need, who 
delivers). In addition, the barriers and facilitators to implementation in primary 
care dental practice - from both the dental professional and patient 
perspectives - is relatively under-explored. 
This thesis describes studies undertaken to address these gaps in the knowledge 
and evidence-base. First a systematic overview was undertaken of systematic 
reviews and published (international) clinical guidelines. This aimed to identify 
the evidence on the best practice for the assessment of the major behavioural 
risk factors associated with oral cancer and for delivering effective behaviour 
change preventive interventions (in relation to, for example: advice, 
counselling, signposting/referral to preventive services) by dental professionals 
in primary care dental practice setting. This evidence was then explored via a 
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study in primary care dental practices in Scotland utilising qualitative in-depth 
interviews with dental professionals, to identify barriers and facilitators to 
implementation, and to gather suggestions to inform the development of 
interventions to support dental professionals in delivering prevention. Finally, a 
small qualitative survey of patients attending primary care dental practice was 
conducted to explore barriers, facilitators, and acceptability of risk factor 
assessment and preventive interventions from the patients’ perspective. 
The overview shows a lack of direct evidence from the dental practice setting 
(one high-quality systematic review relating to tobacco prevention and none 
relating to alcohol). However, relatively strong evidence and recommendations 
from other primary care (medical/pharmacy) settings were identified and 
synthesised, which could potentially be adapted and adopted by dental 
professionals. Overall the findings show that robust risk factor assessment is an 
important first step in any prevention intervention. There is a clear indication of 
the effectiveness of a “brief”, in-person, motivational intervention for sustained 
tobacco abstinence and reduced alcohol consumption. The lack of detail 
particularly in relation to duration made it difficult to make a conclusion 
regarding precise specification of the duration of element of the “brief” 
interventions. For tobacco users, though longer (10-20 minutes) and intensive 
(more than 20 minutes, with follow-up visits) interventions have shown to be 
effective in increasing quit rates compared to no intervention, very brief (less 
than 5 minutes) interventions in a single session also showed comparable 
effectiveness to the longer brief or intensive interventions. While, for alcohol 
users, 10-15 minutes multi-contact interventions were most effective, compared 
to no intervention or very brief intervention or intensive intervention; brief 
interventions of 5 minutes duration were also reported to be equally effective. 
Thus, very brief or brief advice of up to 5 minutes, should be trialled for tobacco 
and alcohol respectively in a dental practice setting, tailored to patient 
motivational status. Exploring use of the dental team is supported, as 
effectiveness was generally independent of primary care provider (i.e. general 
practice physician or nurse). 
The qualitative studies on feasibility showed time and resources to be the major 
barriers from the dental professional perspective. Dental professionals also 
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reported social barriers for a) using cancer as a term to frame preventive 
consultations and b) in delivering alcohol advice which may not be welcome by 
patients. Professionals were willing to receive training to overcome confidence 
issues in approaching behavioural aspects of both main risk factors. Patients 
however generally supported explicit conversations on oral cancer, and were 
amenable to alcohol as well as smoking advice, provided their stage-of-change 
(motivational readiness) was incorporated. The use of formal risk assessment 
tools to frame discussions was broadly supported by patients and professionals 
alike.  
Recommendations are made for testing a model of preventive consultation that 
draws from this best available evidence and addresses barriers for professionals 
and patients alike to help shape practice and support this important area of 
public health going forward. 
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Chapter 1 Introduction 
“It is better to put out the fire while it is still small” (Stewart and Wild, 2014; 
Saracci and Wild, 2015). This saying from the “Kalenjin” tribe in Kenya has been 
used to greet patients arriving at the Tenwek Mission Hospital in the Western 
Highlands, and has been adopted as “an idiom for cancer prevention” by the 
World Health Organization’s International Agency for Research on Cancer (WHO 
IARC’s) World Cancer Report 2014 (Stewart and Wild, 2014). This phrase was 
further highlighted in the recent publication to mark the 50th anniversary of the 
establishment of IARC, and was featured as one of its missions/visions for the 
second 50 years of IARC to reduce the burden of cancer globally (Saracci and 
Wild, 2015). In order to address this mission, IARC is promoting international 
collaboration in research for cancer prevention in three important areas, which 
are: “describing the occurrence of cancer; identifying / understanding the 
causes of cancer; and evaluating preventive interventions and their 
implementation” (Stewart and Wild, 2014). Addressing each of these areas is 
described by the WHO IARC as “a vital contribution to the spectrum of cancer 
prevention” (Stewart and Wild, 2014). 
The understanding of underlying causes of a specific cancer, and the subsequent 
development of preventive strategies, is not complete without a description of 
the occurrence of the disease (i.e. incidence and mortality rates). According to 
the World Health Organisation’s Global Health Observatory data (WHO, 2016a), 
in 2016, of 56.9 million worldwide deaths, there were an estimated 40.5 million 
deaths due to all major non-communicable diseases (NCDs), including 
cardiovascular disease, diabetes, chronic respiratory disease, and cancer. 
Cancer is the second leading cause of death (after cardiovascular diseases), with 
22% (9.0 million) of all non-communicable disease deaths (Ferlay et al., 2015; 
WHO, 2016a). A global transition was witnessed between 1990 and 2010, where 
deaths from communicable diseases decreased by 17% and those from non-
communicable diseases increased by 30%. A large proportion (about 80%) of 
these non-communicable disease-related deaths occurred in low- and middle-
income countries, while the majority of those occurring in high-income countries 
were attributed to cancer (Bray and Soerjomataram, 2015; WHO, 2016a). 
Moreover, the World Cancer Report 2014 (WHO IARC) presents head and neck 
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cancers (oral cavity and oropharyngeal cancers combined) as the seventh most 
commonly occurring cancer, and as ninth-ranked in the world in terms of 
mortality for the year 2012 (Stewart and Wild, 2014). It has been estimated that 
more than half (50%) of all deaths due to cancer could be prevented by avoiding 
exposure to specific carcinogens, which follows from understanding the 
underlying causes. The idiom for cancer prevention reported above thus 
represents an “understandable desire to do better for patients by 
complementing the efforts to avoid the development of cancer in the first 
place”. 
This thesis focuses on evaluating the effective preventive interventions for oral 
cancer and understanding how best to support their implementation in a dental 
practice setting. This chapter provides background relevant to this thesis and 
context for the research undertaken. First, it sets out to identify and summarise 
the scientific literature related to this thesis, specifically the definitions, 
epidemiology, and aetiology of oral cancer. The chapter will then set the 
foundation to explore various behavioural preventive interventions that could be 
implemented in a primary care dental practice setting relevant to oral cancer. 
Lastly, it will identify uncertainties and gaps in the literature, and then provide 
the rationale for this thesis. 
1.1 Oral cancer: background 
1.1.1 Definition 
Oral cancer has been defined in various ways based on discussions about the 
coding of various anatomical sites for the classification of the disease. There has 
been debate among clinicians and researchers around the definitions of “the oral 
cavity”, “the mouth”, and “the oropharynx”, as their boundaries cannot be 
clearly defined (Moore et al., 2000; Tapia and Goldberg, 2011). One of the 
broadly accepted anatomical texts, Gray’s Anatomy (Bannister, 1995) describes 
these areas as follows: “the boundaries of the oral cavity (or mouth) extends 
from the mucosal surface of lips to the palatoglossal folds; covered superiorly by 
the hard palate; inferiorly by the floor of the mouth and the anterior two-thirds 
of the tongue; and the soft tissue mucosa in the oral cavity is described as 
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squamous cell epithelium”. Gray’s Anatomy describes the “oropharynx as being 
situated behind the oral cavity and extending from the posterior aspect of the 
soft palate to the superior border of the epiglottis (but not including the 
epiglottis itself)” (Bannister, 1995). Within the oropharynx, “the posterior third 
of the tongue and the isthmus of fauces are anterior, the oropharyngeal wall is 
posterior, and the palatopharyngeal arches and the tonsils are lateral” 
(Bannister, 1995). According to Gray’s Anatomy, “the palatoglossal folds” mark 
the boundary between the oral cavity and the oropharynx (Bannister, 1995). 
However, there is a variation in the defined boundaries between the oral cavity 
and the oropharynx among anatomical texts. Cunningham’s Textbook of 
Anatomy (Cunningham and Robinson, 1918) defines the isthmus of fauces as the 
boundary between the oral cavity and the oropharynx, while Hollinshead’s 
Textbook of Anatomy (Rosse and Gaddum-Rosse, 1997) has no clear depiction, 
describing the soft palate to be the posterior boundary. 
Conway and colleagues (2018), in their recently published narrative review, 
explored oral cancer definitions and stated that: “the debate over definitions is 
encapsulated and exemplified by the variation in routine publication of oral 
cancer statistics in the UK Cancer Registries” (Conway et al., 2018). The review 
further studied definitions from each of the UK Cancer Registries. It stated that, 
according to the Cancer Registration statistics for England (Statistics, 2018) and 
the Northern Ireland Cancer Registry (Registry, 2018a), the oral cancer has been 
defined as a single group “lip, oral cavity, and pharynx”, with the pharynx 
including oropharynx as well as nasopharynx and hypopharynx sites. The Cancer 
Registry for Wales (Unit, 2018), combines “oral and oropharynx cancer” together 
in their publication reporting cancer incidence, while the Scottish Cancer 
Registry (Registry, 2018b) reports several subgroupings of head and neck cancer 
including “oral cavity cancer” and “oropharyngeal cancer” (Conway et al., 
2018). 
More recently the differing aetiology, based on the role of human papilloma 
virus (HPV) infections which is mainly associated with oropharyngeal cancer, is 
driving the importance of defining “oral cavity” and “oropharyngeal” cancer 
distinctly (Chaturvedi et al., 2008; Conway et al., 2018). Oral cancer broadly 
includes oral cavity (mouth) and oropharyngeal (throat) cancers, and a 
Chapter 1  
 
20 
consensus on the definition is beginning to emerge (Chaturvedi et al., 2013). 
There are a number of International Classification of Diseases (ICD) codes 
included in both “oral cavity” and “oropharynx” definitions. Based on the World 
Health Organization’s (WHO) International Statistical Classification of Diseases 
and Related Health Problems 10th revision (ICD-10) and International 
Classification of Diseases for Oncology (ICD-O) coding: oral cavity cancer 
includes cancers of the lip (excluding external surface) (C00.3-C00.9), other and 
unspecified parts of the tongue (C02, excluding C02.4), the gum (C03), the floor 
of the mouth (C04), the palate (C05), other and unspecified parts of the mouth 
(C06), but not cancers of the salivary glands. Oropharyngeal cancer includes 
cancers of the base of the tongue (C01), the lingual tonsil (C02.4), the tonsils 
(C9.0-9.9), the oropharynx (C10.0-10.9), areas of the pharynx not otherwise 
specified (C14.0) and the Waldeyer ring (C14.2) (WHO, 2011; WHO, 2013). 
Despite being anatomically diverse, oral cavity and oropharyngeal cancers are 
mostly consistent with regards to clinical manifestations and descriptive 
epidemiology, and are often clinically managed and treated together. Moreover, 
the major etiologic factors (detailed in Section 1.2), i.e. tobacco and alcohol, 
still dominate oropharyngeal cancer risk besides human papilloma virus 
infections. Hence, most clinical guidelines have clinically combined/clustered 
these subsites together as “oral cancer”, or included them under a broader 
heading “head and neck cancers” (SIGN, 2006; NICE, 2015). However, they can 
be separable in terms of some aspects of early detection and prevention 
(Chaturvedi et al., 2013). For this thesis, both oral cavity and oropharyngeal 
cancers combined will be referred to as “oral cancer”. However, they will be 
discussed distinctly, where needed, to describe specific aspects of prevention. 
1.1.2 Incidence burden and trends 
1.1.2.1 Global burden and trends 
The World Cancer Report 2014 (WHO IARC) presents oral cavity and 
oropharyngeal cancers combined as the seventh most commonly occurring 
cancer, and as ninth-ranked in the world in terms of mortality for the year 2012 
(Stewart and Wild, 2014). It was reported that in 2012, there were 
approximately 529,000 new cases and 292,000 deaths from oral cavity and 
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pharyngeal cancers worldwide (Stewart and Wild, 2014). More recently, a report 
by Shield et al. (2017) provided the best peer-reviewed analyses of global data 
for new cases of lip, oral cavity, and pharyngeal cancers by subsite, country, 
sex, and age for the year 2012 based on data from the IARC’s Cancer Incidence 
in 5 Continents Volume X (2003 to 2007) and GLOBOCAN (Forman et al., 2013). 
For both sexes combined, Shield et al. (2017) reported that in 2012 (by subsite), 
cancer of the oral cavity presented the highest number of incidences (202,000 
cases), followed by oropharyngeal cancer (100,500 cases). Among other subsites, 
the newly diagnosed cases that year were: nasopharynx (86,700 cases); 
hypopharynx (60,800 cases); parotid gland and other and unspecified major 
salivary gland (40,100 cases); lip (23,700 cases); and other and ill-defined 
cancers of the lip, oral cavity, and pharynx (15,800 cases) (Shield et al., 2017). 
The WHO IARC’s global estimates identified considerable differences in the 
incidence of oral cavity and oropharyngeal cancer in different sex and age 
groups. In 2012, 70.8% of newly diagnosed cancer cases (375,000 cases) of the 
lip, oral cavity, and pharynx occurred in men, while only 29.2% (154,400 cases) 
of newly diagnosed cases occurred in women; with the majority of cases 
occurring among people aged 50 and above (Shield et al., 2017). The global 
estimated age-standardised rate for oral cavity cancer was 2.7 per 100,000, 
incidence being reliably higher in men than women (Male:Female rate ratio 
being 2:1); while for oropharyngeal cancer it was lower at 1.4 per 100,000, 
though with a considerably higher Male:Female rate ratio of 4.8:1 (Shield et al., 
2017). 
Conway and co-workers (2018) in their recent narrative review summarised the 
findings from a number of detailed peer-reviewed epidemiological studies on the 
worldwide trends (between 1975 and 2012) of oral cavity and oropharyngeal 
cancer incidence (Schottenfeld and Fraumeni Jr, 2006; Chaturvedi et al., 2011; 
Gillison et al., 2012; Chaturvedi et al., 2013; Simard et al., 2014; Gillison et al., 
2015; Shield et al., 2017). The authors reported that, in recent decades, 
oropharyngeal cancer has among the most rapidly increasing incidence rates in 
both men and women, and in younger age groups (people under 60 years of age) 
(Chaturvedi et al., 2013; Conway et al., 2018). The authors further showed that 
the trends of HPV-associated oropharyngeal cancer cases show a dramatic 
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increase, especially in high-income or developed countries (particularly in the 
North America and Europe), while patterns are still unclear in less developed 
countries (Gillison et al., 2012; Hashibe and Sturgis, 2013; Conway et al., 2018). 
On the other hand, the incidence rates for oral cavity cancer were reported to 
be “flat-lining” or marginally increasing in women and decreasing in men 
(Chaturvedi et al., 2013; Conway et al., 2018). The authors suggested that, 
“these changing trends are a global phenomenon and have been related to 
changing population risk factors” (Conway et al., 2018). Hashibe and Sturgis 
(2013) further depicts this changing tend as “controlling a tobacco epidemic 
while a human papillomavirus epidemic emerges”. 
1.1.2.2 UK burden and trends 
A recent study by Louie and co-workers (2015) used data from “population-based 
cancer registries in England”, and reported trends and burden of head and neck 
cancers (with specific subsites) between 1995 and 2011, and further projected 
trends from 2011 to 2025. The authors reported that between 1995 and 2011, 
there was an annual increase of oral cavity cancer cases by 2.8% for men and 
3.0% for women, while oropharyngeal cancer cases increased by 7.3% for men 
and 6.5% for women; and projected a further annual increase from 2011 to 2025 
(Louie et al., 2015).  
More recently, a detailed descriptive epidemiology study by Purkayastha and co-
workers (2016) analysed the Scottish Cancer Registry data and reported that 
between 2001 and 2012 there was a dramatic increase in oropharyngeal cancer 
cases (85%) in Scotland, while incidence rates remained relatively unchanged for 
oral cavity cancer (only 10% increase) (Purkayastha et al., 2016). The rates were 
again higher among men than women. The authors further examined the trends 
by socioeconomic status (deprivation) across all subsites, and reported a 
socioeconomic inequality in incidence rates, with rates being higher in people 
from more deprived backgrounds (Purkayastha et al., 2016). Moreover, 
oropharyngeal cancer rates are now markedly higher than those of cervical 
cancer, melanoma of the skin, and adenocarcinoma of the oesophagus in 
Scotland (Junor et al., 2010). The recent review by Conway and co-workers 
(2018) further explored the incidence burden and trends of oral cancer (oral 
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cavity and oropharyngeal) from region to region in the UK, and reported that 
Scotland, Wales, and Northern Ireland have higher oral cancer (oral cavity and 
oropharyngeal) incidence rates than England. 
1.1.2.3 Summary - incidence burden and trends 
In summary, similar to the studies reporting changing oral cancer trends globally 
(Shield et al., 2017; Conway et al., 2018), the studies in the UK show a rapid 
increase in oropharyngeal cancer incidence rates in all four countries in the last 
decade (Louie et al., 2015; Purkayastha et al., 2016; Conway et al., 2018). In 
comparison, oral cavity cancer incidence rates were relatively stable or steadily 
increasing over the period (Louie et al., 2015; Purkayastha et al., 2016; Shield et 
al., 2017; Conway et al., 2018). The rates are further projected to increase over 
the next decade for both oral cavity and oropharyngeal cancers (Louie et al., 
2015; Purkayastha et al., 2016; Shield et al., 2017; Conway et al., 2018). 
Therefore, this projected heavy burden warrants a need to take steps to devise 
more effective oral cancer prevention and control strategies. Gathering accurate 
global data on oral cancer incidence and mortality from population-based cancer 
registries (as discussed above) is a fundamental component to cancer prevention 
and control, as is the need to elucidate oral cancer causes. This will facilitate a 
better understanding of this important disease and help prioritize and plan 
appropriate prevention and control strategies (Stewart and Wild, 2014). 
1.2 Oral cancer: risk factors  
The most up to date and comprehensive data on oral cancer risk factors can be 
found from research by the International Head and Neck Cancer Epidemiology 
(INHANCE) consortium (INHANCE, 2018). INHANCE is a consortium of research 
groups which pools individual patient data from large epidemiological studies 
(mostly case-control studies) involving cases (patients) with head and neck 
cancer (including oral cavity and oropharyngeal cancers), and controls 
(comparisons) without head and neck cancers. To-date INHANCE includes over 35 
original analyses/studies from across the world (including United States, Europe, 
Brazil, Latin America, and Asia), and investigators of these studies have pooled 
data from 25,500 cases and 37,100 controls in order to expand the understanding 
of the aetiology of head and neck cancer (including cancers of oral cavity, 
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oropharynx, hypopharynx, and larynx), focusing on behavioural, social, 
environmental and genetic risk factors and interactions among these risk factors 
(Conway et al., 2009; Winn et al., 2015). The major strength of this large 
INHANCE dataset is that it provides more precise estimates (including individual 
patient data) of risk by controlling for potential confounding factors and 
examining factors that may interact with each other (Conway et al., 2009; Winn 
et al., 2015). However, currently the consortium does not include any studies 
reporting data from South-East Asia (including Bangladesh and India) and Africa, 
where there are many areas with very high head and neck cancer rates (Conway 
et al., 2009; Winn et al., 2015). 
The findings of these INHANCE studies have been reviewed, with a particular 
focus on the major behavioural risk factors (tobacco smoking and alcohol 
drinking) taking into consideration various sociodemographic factors. The other 
key and emerging risk factors have also been presented. The data from other 
published observational studies or systematic reviews have been reviewed, 
where there were gaps in the INHANCE analyses. 
1.2.1 Major risk factors 
1.2.1.1 Tobacco smoking and alcohol drinking 
There is explicit evidence establishing tobacco smoking (IARC, 2004) and alcohol 
drinking (IARC, 2007) as the major risk factors in oral cancer development. In 
the UK, over two-thirds of oral cancers in men and over half in women are linked 
to smoking, while over a third of oral cancers in men and around a sixth in 
women are associated with alcohol consumption (Cancer Research, 2014). The 
“population-attributable risks” of smoking and alcohol consumption combined 
have been estimated to be 80% for males, 61% for females, and 74% overall, i.e. 
approximately three-fourths of all oral and pharyngeal cancers (Blot et al., 1988; 
Petersen, 2009). 
Using INHANCE data, where there were sufficient numbers of study participants 
(oral cavity and oropharyngeal cases) who were never smokers or alcohol 
drinkers, the issue of confounding could be fully examined (Conway et al., 2009; 
INHANCE, 2018). Hashibe and colleagues (2007) provided a true and precise risk 
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estimate by projecting the effects of alcohol drinking in never users of tobacco, 
and the effects of cigarette smoking in never drinkers of alcohol (Hashibe et al., 
2007). They reported that cigarette smoking was associated with a two-fold 
increased risk of oral cancer among never alcohol drinkers, and the risk 
increased with frequency, duration, and pack-years of cigarette smoking. Heavy 
alcohol drinking (three or more drinks per day) among persons who never used 
tobacco was also linked to a similar two-fold increased risk (Hashibe et al., 
2007). 
Pooled data analysis from INHANCE found that the combined effects of tobacco 
and alcohol use are greater than the multiple of their individual effects on the 
risk of developing oral cancer, i.e. the risks are highest among individuals who 
both smoked tobacco and consumed alcohol heavily, showing a five-fold 
increased risk (Hashibe et al., 2009). The majority of oral cavity (64%), 
pharyngeal (72%), and laryngeal cancers (89%) are associated with these 
behaviours combined (Hashibe et al., 2009). 
The INHANCE analyses have also established a dose-response relationship; the 
risk of developing oral cancer increases with increased frequency (i.e. numbers 
of cigarettes or drinks per day or week) and duration (i.e. years of smoking or 
drinking) of tobacco and alcohol use (Lubin et al., 2009). This study found, as 
per the lung cancer risk (Peto, 2012), that smoking fewer cigarettes per day over 
a longer period of time is more harmful for oral cancer risk than smoking more 
cigarettes per day over a shorter period of time (i.e. duration more important 
than frequency) (Lubin et al., 2009). On the contrary, for alcohol-associated oral 
cancer risks, frequency is more important than duration, i.e. higher alcohol 
consumption (three or more drinks per day) for a shorter period of time led to 
greater harm than fewer drinks over a longer time period (Lubin et al., 2009). 
Furthermore, there are no safe low limits for either smoking or alcohol 
consumption, i.e. low intake of cigarettes and alcohol drinking increased the risk 
of oral cancer (Berthiller et al., 2015). Differences were also observed by 
anatomic sites for head and neck cancer; smoking risks were mostly greater for 
laryngeal cancer, and alcohol drinking for oral cavity and pharyngeal cancers 
(Lubin et al., 2009). 
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Similar results were obtained for different types of tobacco smoking products, 
i.e. increased risks of oral cancer for cigarettes, cigars, or pipes (Wyss et al., 
2013). Another INHANCE study investigated the independent associations with 
different measures of beverage consumption of beer, wine, and liquor (Purdue 
et al., 2008). Findings suggested the relative risks of oral cancer are equivalent 
for consumption of beer, liquor and, high consumption levels of wine. A 
comparatively weaker risk was observed at low consumption levels for wine, 
however, the authors were not able to rule out confounding from diet and other 
lifestyle factors (Purdue et al., 2008). 
INHANCE analyses further established that a beneficial effect on reducing oral 
cancer risk was observed following smoking cessation and quitting alcohol 
drinking. This study showed a benefit appearing within 1-4 years of smoking 
cessation, though the risk level of “never users” of tobacco may not be attained 
until 20 or more years post-cessation (Marron et al., 2010). In contrast, the 
benefit emerged much later, after 20 years of quitting alcohol drinking (Marron 
et al., 2010). 
1.2.1.2 Socioeconomic status 
Increased oral cancer risk is also observed in cases of lower socioeconomic status 
than controls, independent of tobacco smoking and alcohol drinking (Conway et 
al., 2008; Conway et al., 2015). According to a large INHANCE pooled data 
analysis (involving 31 studies in 27 countries), lower education status and lower 
income have been implicated as important oral cancer risk factors, showing 
more than a two-fold increased risk, even in a subgroup who neither smoked nor 
drank alcohol (Conway et al., 2015). This large data analyses by Conway and co-
workers (2015) further reported that the higher risk associated with lower 
socioeconomic status was not confined to men, nor to older people and was not 
fully explained by other behavioural risk factors (for example, diet or other 
tobacco use), although residual confounding could not be ruled out. 
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1.2.2 Other risk factors 
1.2.2.1 Smokeless tobacco 
In 2004, a Working Group at the IARC, established that smokeless tobacco is 
“carcinogenic to humans”, and evidenced that oral cancer risk (in particular oral 
cavity cancer) is increased by using smokeless tobacco (powdered snuff, chewing 
betel quid with or without tobacco) (Cogliano et al., 2004). The INHANCE 
analyses showed that the risk increases with the quantity consumed, duration of 
consumption, and consumption from an early age; with a nearly two-fold 
increased risk association, even among never cigarette smokers (Winn et al., 
2015; Wyss et al., 2016). 
A systematic review and meta-analysis of 15 case-control studies by Gupta and 
Johnson (2014) showed that betel quid (or “paan”) without tobacco has a near 
three-fold increased risk association with oral cancer. Various large case–control 
studies conducted in Asia further suggest that chewing tobacco and/or betel 
may have an increased risk for oral cavity cancer compared with smoked tobacco 
and alcohol. Women appeared to be more susceptible to the carcinogenic effect 
of betel than men, at the same level of consumption (Radoï and Luce, 2013). 
1.2.2.2 Marijuana 
Marijuana (Cannabis sativa) is the most widely used illegal drug worldwide, 
which is mainly consumed by smoking and is often smoked together with tobacco 
and/or used with alcohol (UN, 2007). Most of the carcinogens in the marijuana 
smoke are the same as in tobacco smoke, which raises concerns that marijuana 
smoking may be a risk factor for tobacco-related cancers (Hashibe et al., 2005; 
Radoï and Luce, 2013). However, it is difficult to exclude the possibility of 
residual confounding by tobacco and alcohol consumption (Radoï and Luce, 
2013). As tobacco and alcohol are major risk factors for oral cancer, the 
association of marijuana and oral cancer risk has been reviewed in some studies. 
One of the INHANCE studies by Berthiller and co-workers (2009) analysed the 
effects of marijuana use among never tobacco and alcohol users, and found no 
increased risks associated with the increase in frequency, duration or cumulative 
consumption of marijuana smoking. Several other studies also evaluated the 
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association of marijuana smoking and oral cancer. However, at present, 
sufficient evidence is not available to evaluate the influence of marijuana on 
oral cancer risk (Hashibe et al., 2005; Berthiller et al., 2009). 
1.2.2.3 Human papillomavirus 
Human papillomavirus (HPV) is mainly associated with increased risk of 
oropharyngeal (rather than oral cavity) cancer. Recent epidemiological studies 
(case-control studies) conducted in the United States show increased 
oropharyngeal cancer rates, which are thought to be partly attributable to the 
human papillomavirus and especially HPV16 (risks as high as 15 times greater), 
which is sexually transmitted (D'Souza et al., 2007; Gillison et al., 2015). 
INHANCE analyses found a slightly increased oropharyngeal cancer risk 
associated with certain sexual behaviours, i.e. history of having six or more 
lifetime sexual partners, four or more lifetime oral sex partners, an earlier age 
(<18 years) at sexual debut, and same-sex sexual contact (Heck et al., 2009). 
A review by Gillison and co-workers (2015), of recent data on the epidemiology 
of HPV-associated oropharyngeal cancer concluded that, despite the increased 
incidence rates or changing trends (Section 1.1.2), little is known about the 
natural history (i.e. prevalence, persistence, and determinants) and factors 
associated with oral human papillomavirus infections (Conway et al., 2018). A 
large cross-sectional survey by Gillison and co-workers (2012) investigated the 
prevalence of oral human papillomavirus infection among the United States 
population, and found an overall prevalence of 6.9% among men and women 
aged 14 to 69 years, with significantly higher prevalence among men than 
women (10.1% v/s 3.6%).The study identified some risk factors associated with 
oral human papillomavirus infections, which were: smoking, alcohol, number of 
sexual partners, number of oral sex partners, and open mouth (deep) kissing 
(Gillison et al., 2012). However, the authors recommended the need for further 
research to understand the effects of sexual behaviours on the incidence of oral 
human papillomavirus infections and their subsequent risk associations with  
oropharyngeal cancer, which are not well understood (Gillison et al., 2012). 
These prevalence findings were largely replicated in a small feasibility study in 
Scotland (Conway et al., 2016). 
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Furthermore, given the growing acceptance of the role of human papillomavirus 
in the aetiology (and HPV testing in the management) of oropharyngeal cancers, 
the implications for patient/social history taking in oral health assessment and 
for patient counselling needs to be considered (Chu et al., 2013). In theory, 
HPV-associated oropharyngeal cancer could be prevented through behavioural 
modification / safer sexual practices, i.e. use of condom or dental (rubber) dam 
during oral sex (NHS, 2018a). However, there is a lack of evidence on the 
effectiveness of sexual behaviour advice within the primary care setting and 
opportunities are being explored for the prevention of human papillomavirus 
infections through vaccinations (Kreimer, 2014). This latter approach, i.e. HPV-
related vaccine prevention is beyond the scope of this thesis. 
1.2.2.4 Age and gender 
Oral cancer is more common in males than in females, with two-thirds of oral 
cavity cancer cases occurring in men worldwide. There is also an increased risk 
for oral cancer among older age groups, with the majority of cases occurring in 
people aged 50 or over (Ferlay et al., 2015). A further INHANCE study compared 
the role of major oral cancer risk factors (tobacco smoking and alcohol drinking) 
in younger adults and older adults, and found similar major risk factors in young 
and in older groups, i.e. a positive association with oral cancer and these major 
risk factors independent of age (Toporcov et al., 2015). 
1.2.2.5 Diet 
Incidence of oral cancer among individuals who do not drink or smoke, indicates 
the involvement of other risk factors in oral cancer development. There is some 
evidence showing a positive relationship between inadequate fruit and vegetable 
intake and higher risk of oral cancer (Warnakulasuriya, 2009; Radoï and Luce, 
2013). Indeed, dietary intake of fresh fruits and vegetables, vitamin C, vitamin E 
and beta-carotene have been established as protective factors for oral cancer. 
Studies have shown a 50% lower oral cancer risk among those consuming 
approximately five or more fresh fruit and vegetable portions per day compared 
with those consuming low levels (Edefonti et al., 2011; Chuang et al., 2012). It is 
noteworthy that obesity was not linked with an increased oral cancer risk, unlike 
for many cancers (for example, cancer of the gallbladder, pancreas, liver, 
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breast) (Arnold et al., 2016). In contrast, there is some data to suggest that oral 
cancer may be more prone in those with low body mass index (Gaudet et al., 
2010).    
1.2.2.6 Genetics 
Genetic predispositions have also been identified as an aetiologic factor for the 
onset of oral cancer, however, at present their effects are likely to be 
underestimated (van Monsjou et al., 2013; Winn et al., 2015). There is some 
limited evidence showing associations of certain genetic loci associated with 
alcohol and nicotine metabolism, and DNA repair pathways - thus demonstrating 
the likely “genetic-environmental risk interactions” (Winn et al., 2015). Another 
INHANCE study demonstrated a relatively strong family history (hereditary) head 
and neck cancer risk. There was an increased risk associated with having a first 
degree relative with head and neck cancer (Negri et al., 2009). 
1.2.2.7 Oral health 
The INHANCE analyses further shows the links between poor oral health and 
increased oral cancer risk, independent of tobacco smoking and alcohol drinking. 
Good oral health indicated by few missing teeth and no gum disease, and good 
dental care indicated by annual dentist visits and daily tooth brushing, were 
found to modestly reduce the risk of oral cavity and oropharyngeal cancer 
(Ahrens et al., 2014; Hashim et al., 2016). Having two or less indicators of good 
oral health or dental care was found to add an estimated 8.9% of oral cavity 
cancers. There was no association observed for wearing dentures (Ahrens et al., 
2014; Hashim et al., 2016). 
A potential role for mouthwash use in the risk of oral cancer was suggested from 
the INHANCE research, given the alcohol content in many types of mouthwash. 
For example, 26.9% alcohol content in Listerine and around 22% alcohol in many 
of the mint flavoured mouthwashes. There was a modestly elevated risk 
associated with mouthwash use over a prolonged period (35 years or more) and 
for use greater than once per day; although it was not possible to completely 
assess risks in the non-users of tobacco and alcohol in this analysis (Boffetta et 
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al., 2016). A non-significant increased risk association for regular mouthwash use 
was also reported in an earlier systematic review (Gandini et al., 2012). 
1.2.3 Summary - oral cancer risk factors 
Oral cancer (oral cavity and oropharyngeal cancer) risk factor data analyses have 
established the clear role of tobacco smoking and alcohol drinking in its 
aetiology. Moreover, strengthening evidence on the benefits of quitting tobacco 
(smoking and other forms) and alcohol use, and the role of lower socioeconomic 
status, are crucial in planning and managing both individual and population risk 
reduction or preventive strategies. This understanding provides enhanced 
opportunities to help develop more effective tailored prevention strategies, 
including effective history taking, communication of risk, and adherence to 
advice given for oral cancer in a dental practice setting (detailed in following 
sections). For example, the more general risk associated with tobacco and 
alcohol means that risk prediction tools, available from other health contexts 
(for example, cardiovascular disease, lung cancer), might be of interest (Usher-
Smith et al., 2015). However, so far, they have been largely ignored in relation 
to oral cancer (Speight et al., 2006). 
The other key and emerging risk factors (for example, human papillomavirus 
infection) also need to be considered. However, the initial literature search 
showed a lack of evidence to demonstrate the effectiveness of sexual 
behavioural advice in a primary care setting, including the dental practice. This 
topic (sexual behavioural advice), was therefore considered beyond the remit of 
this thesis. 
The focus for this thesis, regarding delivering preventive interventions, was 
based on the two major risk factors, i.e. tobacco and alcohol, given the fact 
that tobacco and alcohol are the major etiologic factors that dominate both oral 
cavity and oropharyngeal cancer risk. 
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1.3 Oral cancer: prevention 
“Since the middle of the last century, enormous progress has been made in 
identifying the causes of cancer, so that more than 50% of cases could be 
prevented based on current knowledge” (Stewart and Wild, 2014). This 
important message emerging from the recent “WHO IARC’s World Cancer Report 
2014” (Stewart and Wild, 2014), and also from other global cancer control 
documents, including prevention module of the “Cancer Control: Knowledge into 
Action, WHO’s Guide for Effective Programs” (WHO, 2007a), emphasises that 
cancer prevention via risk assessment is an essential component for all cancer 
control policies. Moreover, the current successes in identifying cancer 
causes/risks necessitates an evaluation of the most effective preventive 
approaches, and consideration of how best to support their implementation into 
particular healthcare settings (Stewart and Wild, 2014). 
1.3.1 Prevention strategies 
The prevention of oral cancer may be applied using a primary, secondary or 
tertiary approach (Reichart, 2001; BDA, 2010). Primary prevention refers to 
strategies to prevent the onset of disease by removing causative risk factors (risk 
reduction), and thus aims to reduce the incidence of disease. Primary prevention 
has the potential to defeat the condition, as it involves interventions that are 
applied before there is any evidence of disease (for example, changes to 
behaviours such as tobacco smoking or alcohol drinking). However, it is also 
recognized that such lifestyles or behaviours are resistant to change, and thus 
secondary prevention through the early detection of malignant or potentially 
malignant lesions is essential (Brocklehurst et al., 2013a).  
The overall staging of cancer, based on TNM (tumour, node, metastasis) system, 
has four main stages which are defined as:  
Stage I – tumour less than two centimetres in size and not spread to the 
neighbouring tissues, lymph nodes, or organs; 
Stage II – tumours that are greater than two centimetres but less than four 
centimetres in size and have not spread to the neighbouring lymph nodes or 
organs; 
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Stage III - a) tumours that are greater than four centimetres but have not spread 
to the lymph nodes or other parts of the body, or b) cancers that are of any size 
but have spread to one lymph node on the same side of the neck (no bigger than 
three centimetres); 
Stage IV - is the advanced stage of cancer and is further divided into categories 
IVa, IVb, and IVc based on the extent of metastasis and the size of the lesion 
(IARC, 2017; Cancer Research, 2018). 
The five-year survival rate is projected to be 80% when oral cancer is detected 
early (or for localised disease). However, over 50% of cases are detected after 
metastasis and thus five year survival is less than 50% for certain types (Ragin et 
al., 2007; Goy et al., 2009; IARC, 2017). Rusthoven and colleagues (2010) 
reported that the survival rates of patients with advanced stage (III-IV) cancer 
was significantly lower than that of those with early stage (I-II) cancer. 
Moreover, as the stage of cancer advanced, the five-year survival rates 
decreased extensively (from 90% at Stage I to 60% at Stage III and 4% at Stage 
IVc) (Iro and Waldfahrer, 1998; Carvalho et al., 2005). 
This illustrates the important role of the General Dental Practitioner, as a 
primary healthcare professional, in early detection and prevention through 
regular patient contact and pre-symptomatic screening. Where oral cancer is 
suspected, the dental healthcare team plays a vital role in the early 
management of oral cancer through referral and sympathetic discussion, thus 
helping early diagnosis and definitive treatment (Conway et al., 2002). Tertiary 
prevention refers to preventing recurrence and further spread of disease in 
patients already treated for oral cancer and minimising morbidity (Reichart, 
2001; Joseph, 2002; BDA, 2010). 
Secondary and tertiary prevention are beyond the scope of this thesis, and the 
evidence has been considered to be much clearer in these area (Petersen, 2009). 
Moreover, a sister PhD project (in the University of Glasgow Dental School) is 
undertaking a study to assess best practice evidence for oral cancer early 
detection, screening and examination (Al Bulushi et al., 2016). The main focus 
of this thesis relates to primary prevention approaches, which are now 
discussed. 
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1.3.2 Upstream to downstream approaches 
The public health interventions for disease prevention and improving health 
often occur at multiple levels or metrics, leading to differences in individual-
level and population-level approaches (McKinlay, 1998; Brownson et al., 2010). 
Brownson and colleagues (2010) conducted a review to better understand the 
use of policy metrics that can affect these approaches at upstream, midstream, 
or downstream levels. The authors described that, upstream interventions 
involve “policy approaches that can affect large populations through regulation, 
increased access, or economic incentives”, i.e. changes happening at the macro 
policy level (national and international) in order to diminish the “causes-of-the-
causes” (Brownson et al., 2010). With midstream interventions, changes 
generally occur at the micro policy level (regional, local, community or 
organizational) and are about changing the causes (Brownson et al., 2010). 
Downstream interventions involve “individual-level behavioural approaches for 
prevention or disease management”, i.e. changes happening at the service or 
access to service level and are about changing the “effects of the causes” 
(Brownson et al., 2010). Figure 1.1 below presents a range of options for oral 
disease prevention – upstream to downstream approaches, as adapted from a 
review paper by Watt RG (2007). 
Figure 1.1: Upstream to downstream: options for oral disease prevention (adapted from 
(Watt, 2007)) 
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It is clear from these multiple level approaches that it is crucial to identify and 
understand the underlying root causes of the problem in order to develop an 
effective action to promote health (including oral health) and in turn tackle 
health inequalities (Watt, 2007; Brownson et al., 2010). Much of clinical and 
recent epidemiological research has concentrated on the “downstream” factors 
in disease aetiology, which involves behaviour change interventions targeted at 
the individual “lifestyle or behavioural” and biological risk factors (Pearce, 
1996; Sprod et al., 1996; Kay and Locker, 1998; Ostlin et al., 2005). It comprises 
of several actions or interventions for tobacco cessation or alcohol reduction 
delivered directly to individuals, such as counselling, tailored advice, health 
education, self-help programmes, and pharmacologic treatments. 
This downstream approach has guided the development of leading oral health 
preventive models. For example, Scotland’s Oral Health Improvement Plan 
focuses “to encourage a more prevention-based provision recognising the 
benefits of anticipatory care” (Scottish Government, 2018b). It recommends 
providing each patient with a “personalized care plan based on an assessment of 
the level of risk to their oral health”. In addition, some progress has been 
achieved in improving oral health via implementing the “Ottawa Charter” 20-
years since its first publication with a goal of “Health For All” (WHO, 1986). For 
example, significant success has been achieved in the field of tobacco control in 
many parts of the developed world, which in turn has led to oral health 
improvements (Watt, 2007). One of the good examples of coordinated global 
action is the “WHO Framework Convention on Tobacco Control (FCTC)” (WHO, 
2004). Various policies have been implemented linked to this framework, which 
are: banning tobacco advertising, sponsorship and promotion; health warnings; 
combatting illicit trade; plain packaging; taxation; smoke-free public places; 
and offering people help to end their addictions to tobacco (i.e. cessation) 
(WHO, 2004). Article 14 of the WHO FCTC states that the key cessation support 
could include various approaches such as telephone quit lines, brief advice from 
health workers, internet support, or even more intensive behavioural support 
delivered by trained specialists (WHO, 2004). Similar progress has been made via 
implementing “WHO’s Global strategy to reduce harmful use of alcohol” (WHO, 
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2010), which includes various policy actions such as: community action; drink-
driving policies and countermeasures; availability of alcohol; marketing of 
alcoholic beverages; pricing policies (including the Scottish Government’s 
Minimum Unit Pricing for alcohol); and health services’ response (which includes 
identification and brief advice programmes and referral to specialist services) 
(WHO, 2010; Scottish Government, 2018a). Indeed, delivering alcohol brief 
interventions was found to be among the most effective alcohol policies in a 
WHO review of 32 alcohol strategies and interventions (WHO, 2005a). 
The evidence for the effectiveness of tobacco cessation and alcohol reduction 
policies and interventions is extensive and comes from a large international body 
of research from a variety of health-care settings (WHO, 2004; WHO, 2010). 
Although more still needs to be known in many areas, notably in approaches to 
assess risk factors and effective components of preventive interventions (WHO, 
1986; Petersen, 2009). 
1.3.3 Common and multiple risk factors 
The risk factors implicated in oral cancer risk are also associated with a wide 
range of diseases (such as periodontal disease, cardiovascular disease, cancer, 
diabetes, stroke and other oral diseases); hence tobacco, alcohol and 
socioeconomic status in particular are known as common or shared risk factors 
(Sheiham and Watt, 2000). Therefore adopting a shared approach is more 
rational than a disease specific approach (Sheiham and Watt, 2000). The 
common risk factor approach is an important element to be considered in terms 
of preventing oral cancer, and has been presented in Figure 1.2, as described by 
Sheiham and Watt (2000). 
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Figure 1.2: Common risk factor approach (adapted from (Sheiham and Watt, 2000)) 
 
 
 
The associated common risk factor approach recognises that dental professionals 
can contribute to improve not only oral health but also general health. More 
recently, the WHO has supported this approach at a global level in their agenda 
“Global action plan for the prevention and control of non-communicable 
diseases (NCDs) 2013-2020” (WHO, 2016b), which includes nine global targets in 
order to address prevention and management of four major non-communicable 
diseases (including cardiovascular disease, diabetes, chronic respiratory disease, 
and cancer) and on four shared behavioural risk factors - tobacco use, unhealthy 
diet, physical inactivity and harmful use of alcohol (WHO, 2016b). Reducing 
these common or shared risk factors is a major strategic priority for the WHO 
going forward for the prevention and management of non-communicable 
diseases (WHO, 2016b). This action plan has a specific mention of oral diseases 
including oral cancer, and states that an effective oral cancer prevention 
strategy may have benefits that are not limited to this particular condition alone 
(Sheiham and Watt, 2000; Watt, 2005; WHO, 2016b). 
The World Health Organization (WHO) and the International Agency for 
Research on Cancer (IARC) are conducting further research in order to develop 
effective strategies for oral cancer prevention and control (Petersen, 2009; 
Stewart and Wild, 2014). These reports also highlight that primary preventive 
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approaches are the most cost effective long-term strategies for oral cancer 
control and are valuable as they can help in preventing various non-
communicable diseases that share the same risk factors (Petersen, 2009; WHO, 
2016b). In the recent World Congress on Preventive Dentistry (WCPD) (2017), 
which was organized jointly by the WHO and IADR, the WHO non-communicable 
disease global action plan was discussed extensively, and participants from 
different parts of the world debated the role of the oral health community in 
relation to this action plan (WHO, 2016b; WCPD, 2017). One of the key note 
speakers, Dr. Thamarangsi (Director, Department of Noncommunicable Diseases 
and Environmental Health, WHO Regional Office for South-East Asia), highlighted 
the importance of promoting oral health through controlling common risk factors 
for non-communicable diseases by using three key words: 
1) “Be connected - join the non-communicable disease movement and support 
WHO strategies and recommendations” 
2) “Be strategized - develop and implement oral health strategy integrated to 
non-communicable disease agenda towards Sustainable Development Goals”, 
and 
3) “Be strong - building comprehensive capacity at all levels” (Thamarangsi, 
2017). 
This common risk approach is now widely supported. However, there remains a 
challenge for many oral healthcare or dental professionals for changing from the 
isolated and individualistic pattern of working to this approach, due to many 
organizational and administrative constraints (Petersen, 2003). 
Consideration also needs to be given to focusing on the presence of multiple risk 
factors in individuals, i.e. clustering of unhealthy behaviours and socioeconomic 
factors. Research has shown that risk factors (for example, tobacco, alcohol, 
poor diet and physical inactivity) occur in combinations and show multiplicative 
interactions and are strongly associated with poorer socioeconomic 
environments (Lawder et al., 2010). This is particularly relevant to oral cancer 
prevention where there is a synergistic relationship between multiple risk 
factors, with tobacco and alcohol in combination magnifying the risk for oral 
cancer (Hashibe et al., 2009). 
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1.3.4 Risk communication 
Communicating risks associated with oral cancer is a key challenge for dental 
professionals and can help in changing behaviour and/or improving patient 
decision-making (Ahmed et al., 2012). One of the strategies for effective risk 
communication and to promote positive health behaviour change is to 
identify/create a “teachable moment”, which is an opportunity to implement 
preventive interventions (Lawson and Flocke, 2009). Moreover, the National 
Health Services (NHS) campaign “Making Every Contact Count (MECC)” states 
that all healthcare professionals are in the position to utilise and make the most 
of day-to-day interactions that they have with every patient in order to 
encourage and help people to make healthier choices to achieve positive long-
term behaviour change (Varley and Murfin, 2014). Here “risk” is the probability 
or chance that a disease will occur over a period of time. Risk communication 
can be defined as a two-way open exchange of views and information about 
harms and benefits, in order to promote patient involvement, improve the 
understanding of risks and lead to more informed decision-making about 
managing risks. If risk is communicated effectively, it can also trigger changes in 
patient’s beliefs and behaviours (French et al., 2017). 
There exists a good state of knowledge regarding non-personalised risk 
communication which is not specific to an individual, for example, general 
information on the harmful effects of smoking (Sheeran et al., 2014). A recent 
systematic review evaluating the effect sizes across 93 risk communication 
studies, found a mean increase of ‘d=0.23’ on subsequent behaviour change, 
where interventions produced a significant increase in risk 
appraisals/assessment relative to control participants (Sheeran et al., 2014). 
Additionally, in line with theory (Maddux and Rogers, 1983), effect sizes were 
much larger (d=0.45) on subsequent behaviour when “response-efficacy and self-
efficacy” were also increased (Sheeran et al., 2014). Response-efficacy refers to 
“a person’s belief that changing their behaviour (for example, smoking 
cessation) will reduce risk”, and self-efficacy refers to “a person’s belief that 
they are capable of changing the relevant behaviour” (Maddux and Rogers, 
1983). 
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Despite this current knowledge in terms of the most effective ways of non-
personalised risk communication for behaviour change, there is a lack of 
information regarding the extent to which response-efficacy and self-efficacy 
have been targeted in interventions involving personalised risk information 
(French et al., 2017). Moreover, there is a lack of clarity regarding behaviour 
change techniques used in such interventions to address risk assessments and 
efficacy assessments (Michie et al., 2013). More recently, a systematic review of 
systematic reviews by French and co-workers (2017) investigated a wide range of 
personalised approaches of assessing and communicating risk information, and 
found little evidence of strong or steady effects of personalised risk information 
on health-related behaviours. The quality of the included reviews was judged to 
be good, however, the quality of most of the primary studies was criticised. The 
reviews using imaging/visual techniques to provide risk feedback on smoking 
behaviours showed the most promising effects, although there were more null 
findings than significant ones and little evidence of sustained change (French et 
al., 2017). The effects of other methods of personalised risk communication for 
smoking cessation, for example, providing numerical risk information, were not 
promising (French et al., 2017). Overall, the authors showed that there is 
limited to no evidence from the existing reviews regarding stronger effects of 
personalised risk communications than non-personalised communications (French 
et al., 2017). One of the likely reasons is that personalised risk communications 
did not generally target response-efficacy and self-efficacy, which could 
increase the impact of risk communication on health-related behaviours (Peters 
et al., 2013; Sheeran et al., 2014). Moreover, work is required to compare 
various risk communication strategies to find out whether they promote uptake 
of evidence-based behaviour change programmes, because it seems unlikely that 
merely communicating personalised risk would bring about sustained behaviour 
change (French et al., 2017). 
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1.4 Oral cancer: primary prevention (behaviour 
change) approaches 
The primary prevention of oral cancers in or via dental practice setting is 
important (Watt, 2007). Again, the principles of prevention should reflect the 
evidence of major oral cancer risks. For example, there is reduction in oral 
cancer risk when behaviours stop (i.e. tobacco cessation and reduced alcohol 
consumption). Primary preventive interventions for the major behavioural oral 
cancer risk factors of tobacco and alcohol can be either non-pharmacologic/ 
behavioural, or pharmacologic, or a combination of these. The primary focus of 
this thesis is behavioural preventive interventions, with or without 
pharmacotherapy, or referral to specialist cessation services - that could be 
implemented in a primary care dental practice setting. 
1.4.1 Primary preventive interventions 
1.4.1.1 Behavioural interventions 
Behavioural science and strategies play an important role and inform, to a large 
extent, various approaches to behaviour change such as tobacco cessation and 
reducing alcohol consumption in patients in primary care practices. There are 
many theoretical approaches that could be used to deliver a behavioural 
preventive intervention, for example, “Motivational Interviewing (MI)” 
developed by Miller and Rollnick (Miller, 1983), the “Stages-of-Change or 
Transtheoretical Model of Change” by Prochaska and DiClemente (1983), and 
the “Cognitive Behavioural Technique” developed by Sanchez-Craig (1990). 
These models have been the basis for developing effective interventions to 
promote health behaviour change, by modifying a problem behaviour or 
acquiring a positive behaviour. Moreover, these models have been widely 
applied in behaviour modification techniques in various healthcare settings. 
Indeed, much of the core principles of behavioural science models that are 
effective for other health-related areas are equally relevant to and can 
complement the strategies to change behaviours associated with oral cancer. 
For example, Stages-of-Change in “Promoting nonpharmacologic interventions 
to treat elevated blood pressure” are relevant to the patients who attempt to 
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quit smoking and reduce alcohol consumption for oral cancer prevention as well 
(Stuart et al., 1993; Goldberg et al., 1994; Walsh and Sanson-Fisher, 2001). 
The first step in any behaviour modification intervention is the assessment of 
individual risk factors in clinical practice in order to inform decisions about risk 
factor management. This involves assessing a patient’s readiness to make 
changes in their lifestyle and also assessing their health literacy (Harris and 
Lloyd, 2012; Harris et al., 2017). The Stages-of-Change model by Prochaska and 
DiClemente (1983), which is “an integrative model of change to conceptualize 
the process of intended behaviour change”, describes essential stages of a 
patient’s readiness to make changes in their lifestyle or behaviours (Prochaska 
and DiClemente, 1983; Prochaska et al., 2008). These includes: 
1) Pre-contemplation (not ready to change) 
2) Contemplation (thinking of changing) 
3) Preparation (ready to change) 
4) Action (making change) 
5) Maintenance (staying on track) 
6) Relapse (fall from grace) 
Prochaska and DiClemente (1983) have provided a useful summary of these 
stages for smoking cessation interventions. They reported that the vast majority 
of smokers are in the pre-contemplation or contemplation stages. This model 
emphasizes the need to identify such patients and convince those who have 
never considered quitting smoking to do so effectively by advancing from one 
stage to the next (Prochaska and DiClemente, 1983; Walsh and Sanson-Fisher, 
2001). The Stages-of-Change model has also been applied successfully to assess 
a wide variety of behaviours beyond smoking cessation such as alcohol abuse, 
physical activity, diet, weight loss, chronic pain, safer sex, condom use and 
many other problem behaviours (O'Connell and Velicer, 1988; DiClemente and 
Hughes, 1990; Marcus et al., 1992; Prochaska et al., 1994; Greene et al., 1999; 
Kerns and Rosenberg, 2000). This approach allows healthcare professionals to 
tailor (personalise) their advice - which has been demonstrated to be effective 
in supporting behaviour change (Wanyonyi et al., 2011). 
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Subsequent to assessment of individual risk factors, Motivational Interviewing is 
the most commonly used approach for the behavioural management of disorders, 
and has been defined as “a collaborative conversation style for strengthening a 
person’s own motivation and commitment to change” (Miller, 1983; Miller and 
Rollnick, 2013). Motivational interviewing is a “patient-centred” 
psychotherapeutic approach that attempts to alter a patient’s harmful behaviour 
– by relying on personality or engaging style of a person. It may occur with an 
individual or in a group format and in a range of settings, gaining particular 
interest in healthcare settings (for example: general medical or dental practice, 
general hospital wards, and emergency departments) (Britt et al., 2004; Rollnick 
et al., 2008). A number of systematic reviews have shown over a period of time 
the effectiveness of motivational interviewing for alcohol abuse, drug addiction, 
diet, physical activity, diabetes, oral health, and smoking cessation (Miller, 
1983; Burke et al., 2003; Knight et al., 2006; Martins and McNeil, 2009; Lindson-
Hawley et al., 2015). 
In primary care, one of the key behaviour change frameworks for understanding 
the implementation of preventive interventions targeting behavioural risk 
factors (for example, tobacco and alcohol) is the “5A’s Behaviour Change Model” 
(Whitlock et al., 2002; Glasgow et al., 2003; Glasgow et al., 2004; Goldstein et 
al., 2004; Dosh et al., 2005). This approach has been widely accepted for 
addressing behavioural risk factors and includes the following behaviour change 
“techniques” delivered by healthcare professionals: 
1) Ask/Assess: systematic identification, assess behavioural risk factors, multiple 
risks, readiness to change, health literacy, inform decisions 
2) Advise: tailored information, motivational interviewing 
3) Agree: goal setting, shared decision making  
4) Assist: referral to intensive interventions 
5) Arrange: schedule follow up, maintenance (Glasgow et al., 2004; Goldstein et 
al., 2004; Dosh et al., 2005; Harris and Lloyd, 2012). 
This patient-centred model of care demonstrates that an increase in patient 
motivation and behaviour change are associated with the progress along the 
pathway from assessment and advice to goal setting, referral, and follow-up. 
The 5 A’s model has been used as a framework for understanding prevention and 
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for formulating recommendations in most of the current clinical guidelines in 
primary care medical practices (Fiore et al., 2008; RACGP, 2016), and has also 
been adapted in many dental practice guidelines (SDCEP, 2012; SDCEP, 2014). 
In addition to assessing readiness for change, it is important to assess patient’s 
health literacy in order to tailor appropriate messages and preventive 
approaches (Harris and Lloyd, 2012; Harris et al., 2017). Health literacy is 
defined as the “cognitive and social skills which determine the motivation and 
the ability of individuals to gain access to, understand, and use information in 
ways which promote and maintain good health” (Nutbeam, 2000). Studies have 
shown that patients with low health literacy are less likely to receive preventive 
interventions, as these patients are less likely to ask questions and leading to 
provider assumptions that these patients are not interested in preventive care 
(Beach et al., 2006). Patients with low health literacy could be supported by 
primary care professionals through provision, for example, of specific advice 
including 2-3 key points, repeating key points, demonstrating points using 
models or graphics, and at the end of the consultation confirming patients 
understand what they need to know (DeWalt et al., 2010; Harris and Lloyd, 
2012; Harris et al., 2017). 
The preventive advice (Advise/Agree) should then be tailored to a patient’s 
readiness to change and health literacy. Where patients are uncertain as to 
whether they want to take action to improve their health or change harmful 
behaviours, motivational interviewing should be offered to help them. The main 
current focus of preventive behavioural strategies is the delivery of a “Brief 
Intervention”, which involves “oral discussion, negotiation or encouragement, 
with or without written or other support; delivered by anyone who is trained in 
the necessary skills and knowledge; and are often carried out when the 
opportunity arises, typically taking no more than a few minutes for basic advice” 
(Bien et al., 1993; NICE, 2014). A brief intervention may also involve 
signposting/referral for further interventions, i.e. directing people to more 
intensive support, and follow-up visits (Assist/Arrange). Referrals to intensive 
preventive services could be delivered in a number of ways, for example, as 
group and individual programs, telephone and internet/web based interventions, 
or delivered by private provider or healthcare professional (including general 
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practitioner, practice nurse, psychologists, health educators) (Harris and Lloyd, 
2012; Harris et al., 2017). Primary care professionals, at an individual patient 
level, can influence tobacco use or alcohol drinking levels by systematically 
providing opportunistic advice and offering support to all tobacco users or 
alcohol drinkers who attend primary care practices. 
Despite the preponderance of guidelines, recommendations, and evidence on 
behavioural preventive interventions, it is difficult to establish precisely what 
they should involve and which components of interventions are most effective, 
particularly in primary care dental practice settings (Carr and Ebbert, 2012; 
Ramseier and Suvan, 2015). 
1.4.1.2 Pharmacotherapy 
Rigorous scientific research has shown that medical interventions or 
pharmacotherapies, delivered along with behavioural preventive interventions, 
are efficacious in promoting the cessation of major risk factors associated with 
oral cancer, in particular smoking cessation (Kottke et al., 1988; Cahill et al., 
2013). There is limited evidence relating to the impact of medications or 
pharmacotherapy in the treatment of non-dependent alcohol abuse (Johnson et 
al., 2011). However, effectiveness has been reported for the use of medications 
to treat alcohol dependence (Ernst et al., 2008). The main focus of this thesis is 
the primary prevention of risk factors and not the secondary/tertiary prevention 
of addiction or dependence treatment, which is beyond the scope of this thesis. 
Thus, these approaches have not been discussed, and only pharmacotherapy, as 
part of primary prevention, is detailed below. 
There are three standard smoking cessation medications which are licensed for 
this purpose in Europe and the Unites States - nicotine replacement therapy 
(NRT), bupropion and varenicline (Cahill et al., 2013). These medications have 
been shown to be more effective than placebo in helping patients to stop 
smoking (Kottke et al., 1988; Cahill et al., 2013). In addition, varenicline has 
been shown to be effective in helping people to stop using smokeless tobacco, 
while NRT and bupropion have not been shown to help smokeless tobacco users 
to quit (Ebbert et al., 2011). NRT has been a major element of programmes to 
stop smoking. Other critical components of treatment include proper assessment 
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of the patient, appropriate advice or counselling, and support and follow-up to 
ensure compliance (Kottke et al., 1988; Cahill et al., 2013). 
One of the evolving technologies to help smokers who want to reduce the risks 
of smoking is the use of “Electronic Cigarettes” (McRobbie et al., 2014). 
Electronic cigarettes are electronic devices that produce a vapour or smoke-like 
aerosol for inhalation, with or without nicotine (the total level of nicotine in 
vapor generated by 20 series of 15 puffs varied from 0.5 to 15.4 mg) (Goniewicz 
et al., 2012). Some electronic cigarettes look like regular cigarettes, cigars, or 
pipes; while others look like USB flash drives, pens, and other everyday items. 
They lack most of the toxins from cigarette smoke. A recent Cochrane review 
examined the effectiveness of electronic cigarettes to help smokers quit over 
the long-term (McRobbie et al., 2014). This review showed a reduction in 
cigarette consumption in electronic cigarette users compared with placebo 
(reported in 2 trials) and NRT or nicotine patches (reported in one trial). 
However, the small number of effectiveness trials limits the certainty of these 
findings. The electronic cigarette has been a topic of interest among smokers, 
healthcare professionals and policy makers to know if these devices could help 
in smoking harm reduction. Thus, further research is needed to confirm this 
(McRobbie et al., 2014). 
1.4.2 Role of primary care dental team in delivering behaviour 
change interventions 
A series of current narrative reviews, systematic reviews, and even randomised 
controlled trials have established that the dental team can play a potentially 
important role in disseminating oral health promotion advice (Conway et al., 
2002; Macpherson et al., 2003; Binnie et al., 2007; Watt et al., 2014; Ramseier 
and Suvan, 2015). In the UK, primary prevention aimed at changing behaviours 
(i.e. avoidance of tobacco use, controlled use of alcohol) is viewed as a priority 
by the Department of Health, National Institute for Health and Care Excellence 
(NICE), and the General Dental Council (GDC), and dental team members are 
encouraged to advise proactively against risky behaviour and are expected to 
deliver oral cancer prevention as appropriate (PHE, 2014a; NICE, 2015; GDC, 
2017). Moreover, the implementation of prevention and cessation counselling for 
tobacco and alcohol use in a dental practice has been recommended by the 
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WHO’s “Global Oral Health Programme” and “Oral health action plan” as one of 
the priority goals, and has also been recommended by many current clinical 
guidelines worldwide (WHO, 2007b; Petersen, 2008; SDCEP, 2014; SIGN, 2014; 
RACGP, 2016). 
It has been recommended that in order to contribute to the prevention of oral 
cancer effectively, dental professional roles may include: understanding the 
aetiology of oral cancer; recognising increased-risk patients as a result of 
lifestyle/behaviours; recording social and medical history; effectively 
communicating risks to patients to reduce risk levels; delivering appropriate 
prevention (providing motivational counselling, education, goal setting, 
arranging referral/signposting, and follow up), taking into account the patient’s 
sociodemographic context, and promoting behaviour change (Petersen, 2008; 
BDA, 2010). Research has shown that dental professionals are in a key position to 
identify the apparent first signs of tobacco and alcohol use, for example, tooth 
discoloration, bad breath, soft tissue changes and tooth wear, and thus provide 
an excellent platform for delivering tobacco cessation and alcohol reduction 
counselling to their patients (Petersen, 2008; Shepherd et al., 2010; Amemori et 
al., 2011; SDCEP, 2014). 
The General Dental Council has recently identified improved oral cancer 
detection as a recommended area for the Continuing Professional Development 
(CPD) of dental professionals. Moreover, the General Dental Council has an 
expectation that practitioners deliver oral cancer prevention, and it is now a 
professional duty that dental professionals provide up-to-date evidence-based 
preventive care to patients for behavioural risk factors in dental practice 
settings. In a recent hearing, a dentist was placed under supervision for failing 
to ensure that a patient with ulceration was urgently referred to a specialist, 
and was also cited on a charge that the dentist had “failed to ensure that 
Patient A [who smoked 10-15 cigarettes a day] was provided with smoking 
cessation advice” (GDC, 2017). However, it is still not quite defined or specified 
as to what this advice might involve or how this could/should be delivered in a 
primary care dental practice setting. 
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Moreover, it is crucial for all primary care professionals (medical and dental) to 
encourage patients to become aware of the harmful effects and benefits of 
tobacco cessation and reducing alcohol consumption, tailor advice to the needs 
of the patient, and thus aim to prevent oral diseases and promote general health 
(Watt et al., 2014). One study investigated the role of primary care health 
professionals in the prevention and detection of oral cancer by conducting a 
questionnaire and focus group interview study among medical and dental 
professionals in Scotland (Macpherson et al., 2003). The findings indicated that 
over half (58%) of dentists reported examining regularly for signs of oral cancer 
while for medical practitioners, examining the mouth was usually in response to 
symptoms being reported by patients. Although most general medical 
practitioners indicated they considered they should have a role in oral cancer 
detection, many felt that opportunistic screening should primarily be the remit 
of dental professionals (Macpherson et al., 2003). 
Most of the existing literature on preventive interventions in a dental practice 
setting has reported only a small proportion of dental professionals being 
involved routinely in enquiring about a patient’s tobacco and alcohol use 
(Conway et al., 2002; Macpherson et al., 2003). For example, in the study by 
Macpherson et al. (2003), only 19% of dental professionals reported asking about 
a patient’s smoking status, while only 3% asked about a patient’s alcohol use. 
However, a recent survey study in the UK, reported relatively higher proportion 
of dental professionals providing smoking cessation advice (76.7%) and alcohol 
advice (38%); though the dentists in this study reported a lack preventive 
knowledge, but showed positive attitudes towards delivering prevention (Yusuf 
et al., 2015). Moreover, these studies identified a need for further training for 
primary care dental professionals to strengthen their abilities to diagnose oral 
cancer and promote oral cancer prevention activities, i.e. advice on smoking and 
alcohol (Conway et al., 2002; Macpherson et al., 2003; Yusuf et al., 2015). 
Moreover, it was emphasised that members of the primary care dental team 
should receive information on various services or groups to which patients could 
be referred for counselling (Conway et al., 2002; Macpherson et al., 2003). 
Although, the current evidence and guidelines highlights the increased 
involvement of dental professionals in preventive activities (for example, advice 
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or counselling) (Watt et al., 2014; Yusuf et al., 2015), there is limited evidence 
for the effectiveness of these activities in a dental practice setting (Carr and 
Ebbert, 2012; Ramseier and Suvan, 2015). A key element of supporting behaviour 
change preventive interventions in a dental practice setting is to understand the 
process and barriers (and facilitators) involved in changing health-related 
behaviours (Watt et al., 2014). In addition, it is fundamental to recognise the 
assistance and support patients need to achieve sustained behaviour change 
(Watt et al., 2014). The various barriers reported in the literature to implement 
behaviour change interventions in a primary care dental practice setting are 
presented below. 
1.4.3 Evidence-based practice and implementation of behaviour 
change interventions in a primary care dental practice 
“Implementation Science” is a new and developing area which focuses effort on 
the factors (barriers and facilitators) than affect or promote the systematic 
uptake of evidence-based practice by healthcare professionals in routine clinical 
and organisational settings. This helps to improve the quality and effectiveness 
of healthcare services (Eccles and Mittman, 2006; Bauer et al., 2015). The field 
has developed due to known issues, involving staff, patient and organisational 
aspects, which affect the reliable adoption of evidence-based practices (Bauer 
et al., 2015). Exploring such issues is a vital and necessary step in supporting 
healthcare teams in implementation (Bauer et al., 2015). In order to understand 
the complex settings or contexts in which implementation efforts occur (due to 
the multiple interaction levels, for example, healthcare providers, teams, 
patients), this field needs a solid grounding in theory. That is, the 
implementation effort requires “clear, collective, consistent use of theory to 
build knowledge about what works, where, and why” (Grol and Grimshaw, 2003; 
Damschroder and Hagedorn, 2011; Bauer et al., 2015). 
Previous implementation attempts have usually taken the form of interventions 
or trials which seek to identify barriers and facilitators to adoption (rates and 
quality of use) of evidence-based practice by employing specific implementation 
strategies in controlled trials. For example, implementation trials to test a 
theory-driven implementation strategy for delivering smoking cessation advice 
by general practitioners, or to increase access to alcohol use disorder 
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pharmacotherapy in primary care settings (Michie et al., 2011; Bauer et al., 
2015). Other implementation studies enhance evidence-based practice adoption 
under naturalistic conditions. However, practice-based uptake remains variable 
and there are concerns about long-term sustainability and clinical effectiveness 
(Bauer et al., 2015). 
Despite dental practice being identified as an ideal setting to deliver health 
promotion activities to prevent oral cancer, i.e. tobacco cessation and alcohol 
reduction advice, there have been barriers identified in the successful 
implementation of these activities in a dental practice setting (Macpherson et 
al., 2003; Shepherd et al., 2010; Amemori et al., 2011; Watt et al., 2014). 
Research has shown that despite being aware of the harmful effects of tobacco 
and alcohol use, dental professionals report barriers in assisting patients to quit. 
Various barriers being reported are lack of knowledge, skills, confidence, and 
time, and even doubts about the effectiveness of counselling (Macpherson et al., 
2003; Shepherd et al., 2010; Amemori et al., 2011; Yusuf et al., 2015). These 
barriers have resulted in a widening gap between evidence-based clinical 
preventive care (including guideline recommendations) and their 
implementation. Thus, there is a need to design interventions to enhance the 
implementation of evidence-based preventive care in a dental practice setting 
(Amemori et al., 2011; Watt et al., 2014). 
1.5 Rationale and gaps identified  
There is a plethora of evidence and guidance available for dental professionals 
regarding the causes of oral cancer worldwide (WHO, 2007b; Petersen, 2009; 
Winn et al., 2015). The current evidence also shows the potential importance of 
dental professionals in delivering preventive interventions. However, this 
literature review has identified uncertainties within the dental setting 
environment about the best approaches or strategies to assess risk factors 
associated with oral cancer (Petersen, 2009), and the effective components of 
preventive interventions for behaviour change. This includes questions about 
what are the “active ingredients”/mechanisms (Petersen, 2009; Carr and 
Ebbert, 2012; Ramseier and Suvan, 2015) and implementation strategies (i.e. 
Chapter 1  
 
51 
“how to do” rather than “what to do”) (Grol and Grimshaw, 2003; Damschroder 
and Hagedorn, 2011; Bauer et al., 2015). 
The literature shows that specific preventive interventions are often absent or 
only cursorily described in oral cancer prevention/early detection clinical 
guidelines (SIGN, 2006; Petersen, 2009; NCC-C, 2016). There is much policy and 
guidance regarding tobacco and alcohol interventions more generally (WHO, 
2004; WHO, 2005b), however, practical detailed advice applicable to the dental 
practice setting is more limited. There is a need to determine the potential role 
of teachable moments related to oral cancer (which could be created, for 
example, through risk factor assessment or clinical examination) to facilitate 
dental professionals deliver more effective risk communication (Lawson and 
Flocke, 2009; Ahmed et al., 2012). It is often still hard to establish what these 
preventive interventions should involve, and which components of interventions 
are most effective, particularly in a primary care dental practice setting (Carr 
and Ebbert, 2012; Ramseier and Suvan, 2015). In addition, there are 
implementation gaps in relation to evidence-based preventive practice targeting 
the behavioural risk factors. These include gaps in: assessment, advice, referral, 
and maintenance (Amemori et al., 2011; Harris and Lloyd, 2012). 
Thus, there is a need to more clearly present details of evidence-based 
approaches for risk factor assessment and prevention for dental professionals for 
effective behaviour change to benefit those at risk of oral cancer (for example, 
tobacco cessation, reduced alcohol consumption). Thus, this thesis involves 
identifying and appraising evidence for the best practice in oral cancer risk 
factor assessment and the delivery of preventive interventions for effective 
behaviour change by conducting a systematic overview of systematic reviews 
and clinical guidelines. The barriers and facilitators to implementation of this 
synthesised evidence in primary care dental practices were then identified by 
conducting face-to-face interviews with dental professionals. In order to 
maximize the impact of the systematic overview and dental professional 
interviews, finally, interviews with patients attending primary care dental 
practices were conducted to gather their perceptions, compare them with 
dental professional views, and to make recommendations for the development of 
an oral cancer prevention intervention package. 
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The reason to focus on tobacco and alcohol (taking into consideration various 
sociodemographic factors) in this thesis was that these are the major oral cancer 
risk factors, with high population-attributable risks. Additionally, they are 
implicated in a wide range of diseases beyond oral cancer, thus integrating oral 
and the wider public health agenda by improving not only oral health but also 
general health (Sheiham and Watt, 2000; WHO, 2016b). The “WHO global action 
plan for the prevention and control of non-communicable diseases 2013-2020” 
calls on the need to focus on reducing these common or shared risk factors and 
this is a major strategic priority for the WHO going forward for the prevention 
and management of all leading non-communicable diseases (WHO, 2016b). 
The “dental professionals” in this thesis included: dentists, dental hygienists, 
dental therapists, dental nurses, and oral health educators in primary care 
dental practice setting. 
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Chapter 2 Aims and overview 
This chapter sets out the overarching aims and objectives of the research, and 
gives a brief overview of the thesis. 
2.1 Aims and objectives 
The overall aims of the research were: 
a) to synthesise best practice evidence (from current systematic reviews and 
clinical guidelines) in relation to undertaking assessment of behavioural risk 
factors for oral cancer and delivering preventive interventions (for example, 
advice, counselling, and/or referral) in the primary care dental practice setting, 
via a systematic overview (Chapter 3); 
b) to identify barriers and facilitators to implementation of the synthesised best 
practice evidence for behavioural risk factor assessment and subsequent 
preventive interventions for oral cancer, via interviews with dental professionals 
in Scotland (Chapter 4); 
c) to examine the views of patients attending primary care dental practices in 
Scotland on the acceptability of behavioural risk factor assessment and 
subsequent preventive interventions for oral cancer, via short patient 
interviews/survey (Chapter 5); and 
d) to make recommendations to inform the development of interventions to 
support evidence-based oral cancer prevention delivered by dental professionals 
in the primary care dental practice setting in Scotland and beyond (Chapter 6). 
Specific objectives included: 
a) identify data sources for systematic review evidence and clinical guidelines; 
determine scope of overview via inclusion and exclusion criteria; specify search 
terms for systematic review evidence and clinical guidelines; collate initial 
dataset; screen for inclusion, including cross-coding comparisons; appraise 
strength of evidence in systematic reviews and clinical guidelines via validated 
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appraisal tools (also including cross-coding); extract main findings; synthesise 
high-quality evidence/guidance; assess the applicability of high-quality findings 
from medical/pharmacy settings to dental practice setting; 
b) target dental professionals for recruitment, stratified by area-based 
deprivation codes; obtain university ethical approval for methods; develop and 
pilot in-depth interview schedules; contact practices and arrange interviews; 
obtain consent and conduct in-depth interviews; transcribe and analyse 
qualitative data; 
c) target dental practices for access to patient recruitment, stratified by area-
based deprivation codes; obtain NHS ethical approval for methods; develop and 
pilot short semi-structured interview schedules; contact practices and arrange 
times; obtain consent and conduct short interviews; transcribe and analyse 
qualitative data; collate quantitative (short survey) data; 
d) synthesise evidence-base and professional and patient views; make 
recommendations for intervention; discuss wider policy implications; set out 
future research directions. 
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2.2 Overview of the thesis 
Figure 2.1 gives an overview of the following Chapters 3-6. 
Figure 2.1: Overview of the chapters in this thesis 
 
It can be seen from Figure 2.1 that Chapter 3 proceeds via an overview of 
systematic reviews and clinical guidelines in parallel, then bringing these strands 
together in a narrative synthesis. This feeds (denoted by arrows) into the design 
of research questions for both Chapter 4 (dental professional perspective on 
evidence) and Chapter 5 (patient perspective, which builds also on the 
professional viewpoint). 
Integrated/combined synthesis
narrative (‘thematic’)
Study 1: Systematic Overview
(Chapter 3)
Synthesis of clinical 
guideline recommendations
Synthesis of systematic 
review evidence
Study 2: Dental 
professional interviews
(Chapter 4)
Study 3: Patient 
interviews/survey
(Chapter 5)
Overall discussion
(Chapter 6)
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Considering the aims and objectives stated above, it was decided that adoption 
of a pragmatic approach was appropriate for this research. The pragmatic 
approach links methods directly to the research questions, paying less attention 
to a philosophical commitment to a particular view of data (epistemology) or the 
world/reality (ontology); i.e. the design and methods are best suited to the 
purpose (Darlington and Scott, 2002; Creswell and Creswell, 2017). Rather than 
simple practicality, pragmatism has been seen as a philosophical paradigm in its 
own right (Teddlie and Tashakkori, 2009). Pragmatism is often adopted in 
applied health services research to guide researchers, as it avoids inherent bias 
in particular belief systems, such as constructivism (qualitative / inductive) or 
positivism (quantitative / deductive) (Teddlie and Tashakkori, 2009; Creswell 
and Creswell, 2017). Thus, here each method (i.e. systematic overview, 
qualitative interview, and qualitative survey) was chosen to fit particular 
research questions. A detailed description and justification for the specific 
methods chosen for each study in this thesis will be given in the respective 
chapter; however, a brief overview of the chosen methods for each 
study/chapter is outlined here. 
2.2.1 Study 1: Systematic overview study (Chapter 3) 
First, a ‘systematic overview’ of systematic reviews and clinical guidelines was 
conducted to establish best practice for addressing the major behavioural risk 
factors associated with oral cancer in primary care dental practice setting. 
Chapter 3 details the rationale for the search scope, which was across primary 
care more generally, and not restricted to oral cancer interventions. Firstly, the 
best practice, high-quality, evidence-base (reviews) and recommendations 
(guidelines) were synthesised in separate ‘streams’ using rigorous selection, 
screening and appraisal / risk of bias techniques; then a novel integrated 
comparison of both streams was provided. 
2.2.2 Study 2: Qualitative in-depth interview study (Chapter 4) 
Chapter 4 shows how qualitative in-depth interviews were conducted with dental 
professionals in Scotland, including dentists, dental hygienists, and dental 
therapists. Theory-based analysis aimed to describe the feasibility of translating 
the best practice evidence (from Chapter 3) into dental practice setting, and 
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examining potential oral cancer prevention interventions to support dental 
professionals in daily preventive care. 
2.2.3 Study 3: Qualitative survey study (Chapter 5) 
Then a small qualitative survey (individual interviews with a mixture of open-
ended and closed-ended (scale) questions) was conducted with patients (who are 
the target population of oral cancer prevention) attending primary care dental 
practices in Scotland. The aim was to assess patient views on the acceptability 
of the evidence-based preventive interventions (from Chapter 3) in the dental 
practice setting, and to compare/contrast the patient perspective with that of 
the dental professionals (from Chapter 4). 
2.2.4 Overall discussion of findings (Chapter 6) 
Finally, the three studies described above are then discussed in Chapter 6 in 
terms of potential future interventions to improve the entire ‘end-to-end’ 
preventive consultation in a primary care dental practice. A high-level discussion 
of findings from all these studies helped to make recommendations for the 
development of an oral cancer prevention intervention delivered by dental 
professionals, and for associated future research. Strengths and limitations of 
the work are also outlined in this final chapter. 
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Chapter 3 Systematic overview of systematic 
reviews and clinical guidelines: assessment 
and prevention of behavioural risk factors 
associated with oral cancer to inform dental 
professionals in primary care dental practices 
 
3.1 Introduction 
Oral cancer aetiology is multifactorial, and tobacco and alcohol are recognised 
as the major risk factors for both oral cavity and oropharyngeal cancers. Primary 
care dental professionals have a potential role in delivering preventive 
interventions (for example, tobacco cessation and reducing alcohol-related 
harm). In order to contribute to the prevention of oral cancer effectively, dental 
professionals need to assess patients in relation to the major risk factors 
(tobacco and alcohol), and deliver appropriate prevention, taking into account 
the patient’s sociodemographic background. However, there are uncertainties 
about the best approaches/strategies to assess risk factors associated with oral 
cancer, effective components of preventive interventions for behaviour change, 
and implementation strategies in primary care dental practices. Moreover, there 
is a raft of systematic review literature and international clinical guidelines, 
some focused in primary dental care, but the majority from across primary care 
settings. Thus, to address these research gaps and to distil this body of literature 
a systematic overview of both the systematic review literature and clinical 
guidelines was undertaken. This involved systematically searching, identifying 
and quality appraising the international literature (and grey literature for 
clinical guidelines), followed by synthesis of the evidence for best practice in 
delivering oral cancer preventive interventions (including risk factor assessment, 
behavioural advice, and/or signposting/referral) for effective behaviour change 
(for example, tobacco cessation and reduced alcohol consumption) to benefit 
those at risk of oral cancer. A systematic overview is the commonly used term 
used for systematic reviews of systematic reviews and systematic reviews of 
clinical guidelines (Koes et al., 2010; Silva et al., 2012; Lee et al., 2014; 
Alvarez-Bueno et al., 2015; Roque and Esteves, 2016). Silva et al. (2012) 
reported that “overviews of systematic reviews” are suited especially for 
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healthcare decision-makers, and are developed to provide a synthesis and 
incorporate information from multiple studies in order to reduce the 
uncertainties in decision-making; especially when the amount of “evidence” or 
studies has reached the stage where there are multiple systematic reviews 
covering either updates with recent randomised controlled trials, or in different 
contexts or settings. Overviews have a similar structure to intervention or trial 
reviews, but include systematic reviews (rather than primary studies); and are 
conducted in priority areas where a number of intervention systematic reviews 
already exist (Silva et al., 2012). More recently this methodology has also been 
applied to clinical guidelines to utilise these sources of evidence, where 
randomised controlled trials or systematic reviews perhaps do not exist, or cover 
areas of practice not suited to randomised trial methodology (Koes et al., 2010; 
Lee et al., 2014). Researchers have also reported that this new type of study 
(i.e. overviews) could generate a new hierarchy in the pyramid of evidence 
(Becker and Oxman, 2011). 
Hence, it was decided to conduct a systematic overview to identify the best 
practice in delivering oral cancer preventive interventions (including risk factor 
assessment, behavioural advice, and/or signposting/referral). 
3.2  Aims and research questions 
The main aim of this systematic overview was to collate, appraise, and 
synthesise evidence from systematic reviews and clinical guidelines on the best 
practice for a) undertaking an assessment of the major behavioural risk factors 
(tobacco smoking and alcohol drinking) associated with oral cancer, and b) 
delivering preventive interventions for major behavioural risk factors associated 
with oral cancer (for example, behavioural advice, signposting/referral to 
preventive services) by dental professionals in primary care dental practices. 
Specific objectives were to: 
§ identify data sources for systematic reviews and clinical guidelines; 
§ determine scope of overview via inclusion and exclusion criteria; 
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§ specify search terms for systematic reviews and clinical guidelines; 
collate initial dataset; and screen for inclusion including cross-coding 
comparisons; 
§ appraise strength of evidence in systematic reviews and clinical guidelines 
via validated appraisal tools (also including cross-coding);  
§ extract main findings; synthesise high quality evidence/guidance; assess 
the applicability of high-quality findings from medical/pharmacy settings 
to dental practice; 
§ compare and contrast between evidence synthesised from current 
systematic reviews and clinical guidelines; 
§ finally synthesise systematic reviews and clinical guidelines together. 
These objectives were set in order to address the following broad research 
questions for this study, developed in accordance with the PICOS (Population, 
Intervention, Comparator, Outcomes, and Setting) format (Moher et al., 2015; 
Shamseer et al., 2015): 
a) What methods are considered best practice for assessing the major 
behavioural risk factors associated with oral cancer delivered by dental 
professionals on patients visiting primary care dental practices? 
b) What methods are considered best practice for effective behaviour change in 
relation to delivering preventive interventions for major behavioural risk factors 
associated with oral cancer by dental professionals on patients visiting primary 
care dental practices? 
c) What is the commonality and/or divergence in recommended practice (on oral 
cancer risk factor assessment and delivering preventive interventions) between 
evidence synthesised from current systematic reviews and clinical guidelines 
currently available to primary care dental professionals, and to synthesise 
systematic reviews and clinical guidelines together? 
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3.3  Methods 
The methodology for this overview was registered with PROSPERO (registration 
number CRD42015025289). The protocol was published in the journal BMC 
Systematic Reviews (Mathur et al., 2015). The PRISMA-P 2015 statement and 
checklist for systematic review protocols was consulted for developing this 
protocol (Moher et al., 2015; Shamseer et al., 2015). The PRISMA-P 2015 
checklist is provided in Appendix 1. Other similar systematic reviews of reviews 
and/or guidelines were also referred to for convention, for example: Koes et al. 
(2010); Al-Ansary et al. (2013); Álvarez-Bueno et al. (2015); and Damery et al. 
(2015). 
Portions of this “Methods” section have been extracted from the following 
published protocol: (Mathur et al., 2015). 
Ethical approval was not required for this study as it reports a systematic 
overview that involved no primary data collection. 
3.3.1 Eligibility criteria 
3.3.1.1 Types of studies 
Systematic reviews or meta-analyses (of randomised and non-randomised 
studies) and clinical guidelines (published/e-learning) available worldwide were 
included in this systematic overview. The included systematic reviews comprised 
evidence for the effectiveness of interventions for addressing risk factors 
associated with oral cancer and/or for relevant preventive interventions 
delivered in a primary care setting. The included clinical guidelines were all 
recognized by a national, governmental or provider organization, and comprised 
of recommendations or best practice related to risk factors associated with oral 
cancer, history taking, delivery of preventive interventions in a primary care 
setting and/or referral to preventive services. 
3.3.1.2 Types of population  
The study population/ target groups included in the overview were: for risk 
factor assessment - all adult patients (18 years and above) attending primary 
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care practices (dental/medical/pharmacy); while for preventive interventions - 
adults who were at high risk of developing oral cancers, i.e. tobacco users, 
alcohol drinkers. 
3.3.1.3 Types of interventions 
The overview included primary preventive interventions to assess risk factors 
and/or promote behaviour change. Interventions included behavioural advice, 
counselling, brief interventions, motivational interviewing and 
signposting/referral to preventive services, or any combination of these. 
Secondary prevention screening interventions for the early detection of oral 
cancer (for example: visual screening, visual staining using toluidine blue, oral 
cytology using brush biopsies, fluorescence imaging and light-based techniques) 
were excluded from this overview. 
3.3.1.4 Types of outcome measures 
The main outcomes of interest were:  
1) The best practice (effective) evidence in oral cancer risk factor assessment 
(for example, how best to ask about behaviour / assess risk / communicate risk). 
2) The best practice (effective) evidence in preventive interventions: 
a) Effectiveness or significant effects of interventions, i.e. changes in behaviours 
(for example, decrease in tobacco consumption or smoking cessation, reduction 
in alcohol consumption - from baseline to follow-up) 
b) Description of evidence-based preventive interventions (for example, duration 
and content of preventive interventions, number of follow-up sessions, referral 
pathways) 
c) Role of specific aspects, such as combination interventions (addressing 
multiple risks). 
3.3.1.5 Types of setting 
A major decision in undertaking the overview was whether to restrict the setting 
to primary care dental practices (i.e. the first point of contact in the health care 
system, for example, general dental practice and the public dental service), or 
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to include interventions delivered in other primary care settings, such as, 
general medical practice and community pharmacy services. It was decided that 
evidence would only be restricted to the dental practice setting if literature of 
sufficient quality and quantity could be identified. After scoping the initial 
literature (Chapter 1), it was decided that all primary care settings (dental and 
medical/pharmacy) would be included, and best practice identified elsewhere 
would be separately appraised for its applicability/feasibility of implementation 
by dental professionals. Prevention interventions and guidelines for secondary or 
tertiary settings were excluded from this study. 
Professionals involved in reviewed studies or targeted by included guidelines 
were thus:  
§ dentists, dental therapists, dental hygienists, dental nurses, and oral 
health educators in primary care dental practices:  
§ primary care physicians, general practitioners, family physicians, and 
practice nurses in primary care medical practices;  
§ pharmacists, community pharmacists, and pharmacy assistants in primary 
care pharmacy practices. 
3.3.2 Search strategy 
A dedicated University Librarian (HW-A) helped develop the search strategy for 
identifying systematic reviews and clinical guidelines. The search terms were 
identified from scoping the initial literature and from MeSH subject headings. In 
order to find all relevant data, the search terms included were broad, drawing 
from across primary care (both dental and medical practice setting). In addition 
it was decided not to limit the search to “oral cancer”, because of not wanting 
to rule out good evidence and/or guidelines on how to assess risk and deliver 
oral cancer prevention that could be extracted from systematic reviews and/or 
clinical guidelines aimed at another clinical condition (for example, smoking 
cessation strategies targeting periodontal disease) (SDCEP, 2014). 
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3.3.3 Information sources 
The literature search for systematic reviews and clinical guidelines was carried 
out in August 2015 in the following health and psychological electronic 
databases: Cochrane Library, Ovid MEDLINE, EMBASE, Web of Science, 
PsychINFO, PubMed, TRIP, and Google Scholar. 
An internet search of the websites of health boards and relevant (professional, 
medical, dental, public health, scientific) organizations/agencies was also 
carried out in August 2015. A list of organizations/databases for searching 
clinical guidelines has been provided in Appendix 2. A dedicated University 
Librarian (HW-A) helped to develop a bespoke protocol to allow identification of 
clinical guidelines (published/e-learning) via websites of relevant 
organizations/agencies and an Internet Search Engine (Google). The 
bibliographies or reference lists of identified documents were also hand-
searched for additional references. Experts in the area were contacted to help 
locate any unpublished and ongoing research as the overview proceeded to 
minimise publication bias. 
3.3.4 Literature search  
The principal researcher or author (SM) conducted all of the literature searches 
(systematic reviews and clinical guidelines). The Ovid MEDLINE search strategy is 
provided in Appendix 3. The MEDLINE search strategy was finalised first and then 
it was adapted for other databases. 
Key terms were organised according to three subsets: 
§ Prevention (for example: advice, cessation, harm reduction, brief 
intervention, counselling); 
§ Primary care (for example: general dental practice, general medical 
practice, pharmacy);  
§ Risk factors (for example: tobacco, alcohol) 
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Various truncation symbols (for example:  *, ?, $) and Boolean operators (for 
example: AND, OR, proximity) were used to refine the search.  
The InterTASC Information Specialists' Sub-Group (ISSG) search filter resource 
provides easy access to published and unpublished search filters designed to 
retrieve records by study design or focus (ISSG, 2015). Thus, in order to retrieve 
systematic reviews in Ovid MEDLINE and EMBASE, the Scottish Intercollegiate 
Guidelines Network (SIGN) search filters were used; whereas to retrieve clinical 
guidelines in Ovid MEDLINE, the University of Texas School of Public Health 
search filters were used (ISSG, 2015). The search was limited to systematic 
reviews and clinical guidelines by using the filters provided in the databases: 
Cochrane Library, PsychINFO, PubMed and TRIP. In the Web of Science database, 
the search was limited to “Reviews” (including literature reviews and systematic 
reviews), as there was no filter for systematic review only. Using search filters 
helped to reduce the number of articles to be screened while identifying higher 
quality evidence and maximising specificity (Lee et al., 2012). The SIGN search 
filters and the University of Texas School of Public Health search filters have 
been provided in Appendix 4. 
No language restrictions were applied for identifying systematic reviews and 
clinical guidelines. The non-English papers were translated to English with the 
help of the Google Translate and private translation services. Clinical guidelines 
were limited to the last 10 years (2006 to 2015). There were no date restrictions 
for systematic reviews. Narrative/literature reviews and systematic review 
protocols were excluded. 
3.3.5 Data management  
In accordance with Cochrane review group guidance, all steps in data 
management (review of titles and abstracts, inclusion and exclusion decisions, 
data extraction, quality appraisal, assessing risk of bias, collating themes for 
final synthesis) were carried out independently by two members of the 
multidisciplinary review team (author (SM) + one of three supervisors 
(AJR/DIC/LMDM)), and discrepancies discussed with the wider team (Higgins and 
Green, 2008). It was decided if, after discussions between the review team, 
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uncertainties persisted, authors of the original studies would be contacted to 
resolve disagreements. However, this was not required as discrepancies were 
resolved by discussion between the author and supervisors. 
Records from all searches were combined, imported into EndNote X7 
bibliographic software (Reuters, 2013) and duplicate records were removed. 
3.3.6 Data screening 
Two investigators, the principal researcher (SM) and principal supervisor (AJR), 
independently reviewed the title and abstract of all records against the 
eligibility criteria (inclusion/exclusion criteria) to select for full text review. 
Disputed papers were included at this stage. Full text copies of selected 
systematic reviews and clinical guidelines were obtained and used to assess the 
eligibility of the records to be included in the final systematic overview. Reasons 
for exclusion were recorded and reported (Appendix 5). Where more than one 
eligible systematic review or clinical guideline of the same research data 
existed, the most recent publication was included. Discrepancies were discussed 
among the two reviewers (SM and AJR) and a few discrepancies were also 
discussed with the wider team (DIC and LMDM). 
To summarize, a PRISMA four-phase flow diagram was completed at the end of 
the study screening and selection process (Figures 3.1 and 3.3 in the Results 
section). 
The next steps were to extract data from the systematic review and clinical 
guidelines for separate systematic quality assessment / risk of bias exercises and 
synthesis, and finally to compare, contrast, and synthesise systematic reviews 
and clinical guidelines together. 
3.3.7 Data extraction 
Data were extracted independently by the author and checked for accuracy by 
one of the supervisors (AJR and DIC). The data extraction template was adapted 
from the Cochrane Collaboration (Higgins and Green, 2008) and the Centre for 
Reviews and Dissemination (CRD) at the University of York (CRD, 2009) data 
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extraction checklist. The data extraction form was pilot-tested on a small set of 
papers (three systematic reviews and three clinical guidelines) and refined to 
ensure the correct sensitivity and specificity. 
The following review or guideline characteristics were extracted: number and 
type of included studies, target population, setting or provider (for example: 
general practitioner, dentist, nurse, pharmacy), risk factors assessed, type of 
intervention (content, duration and number of sessions), type of 
control/comparison group, how professionals communicated risks or assessed 
risk factors, advice provided (whether tailored or not), training of providers, any 
referral to preventive services or any follow-up, main findings/outcomes for 
abstinence or behaviour change, and overall conclusion of study. 
All but one of the included clinical guidelines were published in English; one 
guideline was published in Czech (Kralikova et al., 2015). This guideline was 
translated to English with the help of the Google Translate and private 
translation services. 
3.3.8 Quality assessment and risk of bias 
3.3.8.1 Systematic reviews 
In order to assess the methodological quality of included systematic reviews, the 
AMSTAR (A MeaSurement Tool to Assess systematic Reviews) instrument was 
used (Shea et al., 2007). The AMSTAR checklist consisted of 11 key items 
designed to help systematically rate the quality of various methodological 
aspects (for example: an ‘a priori’ design, comprehensive literature search, data 
extraction by at least two independent reviewers, at least two electronic 
sources searched, duplicate study selection, list of included and excluded 
studies, quality of included studies assessed, quality considered while 
formulating conclusions, assessment of publication bias, conflict of interest 
stated) (Shea et al., 2007). AMSTAR categorizes quality as: 8-11 high quality, 4-7 
medium quality, and 0-3 as low quality, as per previous studies (Shea et al., 
2007; Sharif et al., 2013). 
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In addition, the ROBIS (Risk Of Bias In Systematic reviews) tool was used for 
assessing the risk of bias in included systematic reviews (Whiting et al., 2016). 
This is a new tool which is completed by assessing relevance, identifying 
concerns with the review process and finally judging risk of bias (high, low, or 
unclear). Both AMSTAR and ROBIS assessments of included systematic reviews 
were assessed independently by two reviewers (SM and AJR/DIC/LMDM). The 
final score was determined, if different between two reviewers, by discussion 
among the wider team. 
3.3.8.2 Clinical guidelines 
The quality of the included clinical guidelines was appraised using the AGREE II 
(Appraisal of Guidelines for REsearch & Evaluation II) instrument by two 
reviewers (SM and AJR/DIC/LMDM) (Consortium, 2009). The final score was 
determined, if different between two reviewers, by discussion among the wider 
team. The Conference on Guideline Standardization (COGS) checklist (Shiffman 
et al., 2003) to assess the validity of a clinical practice guideline was also 
consulted, but it was decided to proceed with AGREE II. As AGREE II is the better 
validated (and more recently updated and widely supported) measure and covers 
substantially the same ground (Bouwmeester et al., 2009; Sabharwal et al., 
2014). 
AGREE II consists of 23 key items in 6 domains, and was used to assess the 
methodological rigor and transparency in the development of the included 
clinical guidelines (Consortium, 2009). Each domain helped to appraise the 
quality of clinical guidelines in a unique dimension, i.e. scope and purpose, 
stakeholder involvement, rigour of development, clarity of presentation, 
applicability and editorial independence. This instrument also allows researchers 
to assign to each clinical guideline an overall quality rating between 1 (lowest 
possible quality) and 7 (highest possible quality), and to indicate whether the 
user would recommend the guideline for use in practice or not. 
Some researchers have been critical of AGREE II stating that it does not provide 
a clear distinction between high- and low-quality guidelines (Hoffmann-Eßer et 
al., 2017). Many researchers have therefore used a priori cut-offs to distinguish 
between high- and low-quality guidelines (Lee et al., 2014; Hoffmann-Eßer et 
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al., 2017). Thus, the principal researcher and the supervisors decided a priori 
that an overall AGREE II score of 6 or 7 would be considered a high-quality 
guideline and would be recommended for use in practice, guidelines that scored 
3 to 5 would be medium quality and recommended with modifications, and a 
score of 1 or 2 would be low-quality and not recommended for use in practice. 
Other similar texts were also referred to for convention (Lee et al., 2014). 
3.3.9 Data synthesis 
The general frameworks for conducting narrative (‘thematic’) synthesis 
developed by the Economic and Social Research Council (ESRC) Methods 
Programme (Popay et al., 2006), along with guidance from the Centre for 
Reviews and Dissemination (CRD, 2009), and Petticrew and Roberts (2008) text 
book were adopted for conducting a narrative synthesis in “systematic 
overviews”. A final “integrated/combined synthesis” then compared and 
contrasted evidence from the reviews and guidelines streams. 
The best practice evidence was assessed via a narrative synthesis of extracted 
data, taking quality and recency of evidence into account. Systematic reviews 
and clinical guidelines were initially kept as separate ‘streams’, and each was 
synthesised rigorously according to the guidance on conducting narrative 
synthesis in the context of systematic reviews (Popay et al., 2006; CRD, 2009). 
Popay and co-workers (2006) described this approach as the “Narrative Synthesis 
in Systematic Reviews (N.S.S.R.)”. These frameworks were developed for 
answering a wide a range of review questions. The guidance by Popay et al. 
(2006), for practical reasons, focuses on the conduct of mainly two types of 
systematic reviews which have particular salience for those who want their work 
to inform ‘policy and practice’; for example, systematic reviews addressing the 
effects of an intervention and implementation of an intervention in primary trial 
studies (Popay et al., 2006). As this overview aimed to assess the best practice 
evidence for an effective behaviour change intervention in the primary care 
practice, this framework was deemed appropriate and was thus adopted for 
conducting narrative synthesis in this study (for both the systematic reviews and 
clinical guidelines). Moreover, for narrative synthesis of clinical guidelines, 
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besides adapting these frameworks, other similar texts (reviews of guidelines) 
were also consulted (Koes et al., 2010; Polus et al., 2012). 
The main steps (as adapted from above frameworks) in synthesis involved 
initially keeping systematic reviews and clinical guidelines as separate ‘streams’ 
and included: 
a) Developing a theory: the implicit theory underlying most preventive 
interventions was that assessing risk factors associated with oral cancer (i.e. 
tobacco use status and alcohol consumption) and providing behavioural advice 
can increase knowledge of potential risks, change perceptions and lead to 
behaviour change (i.e. tobacco cessation and reduction in alcohol consumption). 
b) Developing a preliminary synthesis: extraction and organization of data in 
tabular form separately for systematic reviews and clinical guidelines. This was 
used to provide details of study design or type of guideline, quality assessment 
scores, outcome measures for effective intervention, and other findings / 
recommendations. 
c) Assessing the robustness of evidence-base and recommendations: the overall 
weight or strength of the evidence-base and recommendations was determined 
using validated tools to appraise each systematic review and clinical guideline 
(AMSTAR / ROBIS for reviews; AGREE II for guidelines). As an integral component 
of each narrative synthesis, data were related to the quality assessment in order 
to illustrate the strongest evidence among included systematic reviews and 
clinical guidelines. Thus, the synthesis included reviews and guidelines receiving 
an overall weighting of “high”; i.e. Low ROBIS, AMSTAR score of 8-11, and 
AGREE II score of 6 or 7 (Section 3.3.8). The levels of evidence within systematic 
reviews and clinical guidelines with same quality scores were further synthesised 
considering the recency of publication. The trials within both the systematic 
reviews and clinical guidelines were compared to check for and assess data 
duplication, this is conventional (or expected) in overviews, and thus needs to 
be considered to ensure that the syntheses add weight to findings based on trials 
being included in more than one review or guideline (Silva et al., 2012). 
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d) Exploring relationships in the data: analyses within and between reviews / 
guidelines, and within and between risk factors and professional groups/settings 
(dental and medical/pharmacy) were conducted. As stated above, the 
relationship was also explored considering the recency of the publication and 
data duplication. The relationships between characteristics and effectiveness of 
various components of preventive interventions (based on 5A’s model- as 
described in Chapter 1) were reported. The patterns across the results identified 
various factors that explained differences in direction and size of effect across 
the included reviews or guidelines (as separate streams). This further helped to 
understand “how and why interventions have or do not have an effect”. 
Exploring the influence of heterogeneity showed that there was much 
heterogeneity among the included systematic reviews and clinical guidelines in 
relation to the interventions covered, the target populations, and the methods 
employed. The synthesis therefore took a narrative ‘thematic’ approach to 
describing each stream, in line with study objectives. The heterogeneity or 
sources of variability among study populations, settings, or outcomes were 
explored as an integral part of data synthesis, but as this work was not meta-
analytic (decided a priori, considering heterogeneity based on initial literature 
search), the narrative synthesis approach was used to address the applicability 
of findings across: primary care setting, professional groups, and/or patient 
behaviours. 
The initial literature search revealed a much greater body of research in the 
primary care medical practice setting compared to that in the dental practice 
setting. Therefore, informed by the ADAPTE framework (Collaboration, 2009), 
which provides a systematic approach to adapting guidance developed in one 
setting for use in another setting, the high-quality evidence and 
recommendations in the primary care medical/pharmacy setting in this overview 
were adapted for use in the dental practice setting. 
The within-stream synthesis has been presented (Section 3.4) separately for 
dental and other primary care settings (medical/pharmacy), considering review 
quality, recency, and trial duplication. 
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Integrated / combined synthesis 
After this within-stream synthesis, the final integration of findings and 
comparison between evidence-base in systematic reviews and clinical guidelines 
(i.e. both ‘streams’ together) included systematic consideration to all the steps 
or elements in the framework discussed above (Popay et al., 2006). The patterns 
identified and analysed within the systematic reviews and clinical guidelines 
were compared and contrasted across both streams to give an overview of 
effective intervention. That is, the final synthesis included the analysis of 
relationships within and between evidence-base and guidelines, which lead to an 
overall assessment of the strength of the evidence available for drawing 
conclusions on the basis of a narrative synthesis. This helped to answer specific 
questions about whether evidence from reviews was reflected in current 
guidance or whether collated guidance showed areas where better evidence was 
required (i.e. highlighting gaps). 
Similar to ‘within-stream’ synthesis, the integral component of this ‘combined 
synthesis’ was to relate data to the quality assessment (high-quality systematic 
reviews and clinical guidelines), followed by recency of the publication, and 
data duplication, in order to illustrate the strongest evidence which could be 
reflected in a primary care dental practice. In other words, the overall hierarchy 
of integrated/combined synthesis considered in this overview was: high-quality 
evidence and recommendations from dental practice setting followed by other 
primary care settings (medical/pharmacy), recency of the publication, and data 
duplication. Thus, the final integrated synthesis examined carefully the link 
between the systematic review evidence and clinical guideline 
recommendations. This allowed recommendations to be made where a) gaps in 
guidance were identified or b) guidance showed areas where more evidence was 
required. 
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3.4 Results 
3.4.1 Systematic Reviews 
This section details the data/study selection, characteristics, quality 
assessment, and synthesis for the identified systematic reviews as a separate 
“stream”. 
3.4.1.1 Study selection 
The search strategy retrieved 1727 potentially relevant records. All included 
records were screened (title and abstract) independently by two reviewers (SM 
and AJR) and of these, 72 records were selected for full text review. 28 
systematic reviews were included after discussion among the two reviewers (SM 
and AJR) and a few discrepancies were discussed with the wider team (DIC and 
LMDM). Three additional systematic reviews were included through hand 
searching of the reference lists of the 28 included systematic reviews. Thus, 
finally 31 systematic reviews (nSR=31) were included in this overview (Figure 
3.1). 
A list of excluded studies (n=44) is presented with the reasons for exclusion in 
Appendix 5. 
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Figure 3.1: PRISMA four-phase flow diagram - for included systematic reviews 
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3.4.1.2 Trial duplication 
All systematic reviews included randomised control trials; one systematic review 
included before and after studies (non-RCTs) along with clinical trials 
(Blenkinsopp et al., 2003), while another included economic evaluations only 
(Angus et al., 2014). As might be expected there was trial duplication or overlap 
in the included systematic reviews, i.e. reviews included some trials in common. 
To address this, a list of all authors of all primary studies/trials referenced by all 
included systematic reviews was created, sorted, and labelled to identify 
publications which appeared two or more times on the list (Dijkers, 2018). The 
findings were synthesised considering the quality scores and recency of the 
systematic reviews. For example, there were seven systematic reviews (Kahan et 
al., 1995; Poikolainen, 1999; Blenkinsopp et al., 2003; Sinclair et al., 2004; 
Ballesteros et al., 2004; Hyman, 2006; Huibers et al., 2007) in which all included 
trials were found in more recent systematic reviews. The synthesis focused on 
the newer reviews in these cases, unless the older reviews were of higher 
quality. For example, trials in Sinclair et al. (2004) were found in Brown et al 
(2012), but findings from Sinclair et al. (2004) were included in the final 
synthesis as this review was of higher quality. In other systematic reviews 
(where not all trials were duplicate), synthesis focused on effects reported in 
the higher quality and recent publications, considering quality of the primary 
trials within systematic reviews, and even analysing the full text of each trial 
publication where findings were not clear. This avoided counting findings more 
than once if repeated in multiple systematic reviews, which would falsely inflate 
the effect or weight of findings. The steps have been detailed in the Section 
3.4.1.5 - best practice findings. 
There was a total of 171 original trials (after removing duplicates) included in all 
31 systematic reviews, which delivered face-to-face preventive interventions in 
a primary care setting. Appendix 6 provides a list of trials included in all 31 
systematic reviews. The included trials were labelled as T1-171; red coloured 
labels in Appendix 6 shows duplicate trials.  
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3.4.1.3 Study characteristics 
The main characteristics and findings of the included 31 systematic reviews are 
presented in Table 3.1 (for example: ID assigned to each systematic review, risk 
factors reviewed, included preventive interventions, intervention provider, 
study quality, type of synthesis and outcomes). Only the characteristics and 
findings of primary care, face-to-face interventions targeting adult populations 
(18 years and above) included in all 31 systematic reviews have been reported in 
Table 3.1. 
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Table 3.1: Characteristics and main findings from all included systematic reviews (n=31) 
 
Study ID 
 
(Author, year) 
Risk factors 
and number 
of primary 
care trials/ 
studies 
Intervention 
provider 
Preventive interventions 
(Ask/Assess/Advise/Referral) 
Type of synthesis 
and 
Main findings 
Quality score 
(AMSTAR/ 
ROBIS) 
SR1 
 
(Lindson-
Hawley et al., 
2015) 
Smoking  
(n=3 RCTs) 
 
General 
practitioners 
Motivational interviewing (MI)- 
1-6 sessions, duration of each session 
ranging from 10-60 minutes 
 
Training ranged from 2-40 hours 
(usually in the form of workshops) 
 
Follow-up telephone calls (1-4 calls) 
and around 10 minutes each, every 6 
months (n=2 RCTs) 
 
Meta-analysis 
 
Tobacco abstinence: 
MI > brief advice or usual care 
Shorter sessions (˂ 20 minutes) > longer 
sessions (˃ 20 minutes) 
Single sessions > multiple sessions  
Face-to-face MI = telephone MI 
1 or 2 follow-up calls > more than 2 follow-up 
calls 
General practitioner > nurses or counsellors 
(n=1) 
 
AMSTAR= 11 
 
ROBIS= Low 
 
SR2 
 
(Bully et al., 
2015) 
Smoking (n=7 
RCTs) 
 
 
Primary care- 
nurses, 
doctors, 
psychologists
, and 
nutritionists 
 
Brief motivational interview or 
counselling, self-help manuals, 
written prescriptions, emails, and 
financial incentives. 
Theoretical approaches: 
transtheoretical model (TTM), theory 
of planned behaviour (TPB), health 
belief model (HBM) 
Narrative synthesis 
 
Smoking cessation: 
Brief intervention (TTM based) > usual care 
HBM or TPB based = usual care 
 
Long term effectiveness of interventions (>12 
months follow-up)- (n=4 RCTs) 
AMSTAR= 8 
 
ROBIS= Low 
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Duration: few minutes to a number 
of months (not clearly reported) 
 
 
SR3 
 
(Morton et al., 
2015) 
 
Alcohol (n=11 
RCTs) 
 
Primary care 
practitioners 
 
Motivational interviewing (MI)- with 
or without additional intervention 
components. 
Face-to-face MI (n=8): 1-8 sessions, 
11 to 20 min. 
Both face-to-face and phone MI 
sessions (n=3) 
 
Narrative synthesis 
 
Alcohol reduction: 
MI > usual care or minimal intervention (n=6). 
‘Low’ intervention (one face-to-face session 
and 5 follow-up calls) > ‘High’ intervention 
group (6 face-to-face sessions) (n=1) 
 
AMSTAR= 6 
 
ROBIS= 
Unclear 
 
SR4 
 
(Angus et al., 
2014) 
Alcohol (n=22 
economic or 
modeling 
evaluations) 
 
General 
practitioner 
and practice 
nurse 
 
Screening and brief interventions 
(SBI), supportive written materials, 
follow-up telephone call (5 min.) or 
follow-up consultations with further 
advice (if necessary). 
 
BIs of 10 min or less (n=12); over 10 
min (maximum 45 min) (n=11). 
“stepped care”- 20 min. advice + 
referral to motivational enhancement 
therapy and/or specialist alcohol 
services. 
“minimal intervention”- 5 min. 
advice 
 
Cost-effectiveness (alcohol interventions): 
SBIs > no advice 
 
General practitioner (n=15) = nurse (n=5) 
interventions 
 
Shorter BIs (10 min or less) = longer BIs (over 
10 min) 
 
Longer BIs > shorter BIs (n=5) 
 
“stepped care” > “minimal intervention” 
(nurse-led) (n=2) 
 
AMSTAR= 7 
 
ROBIS= High 
 
SR5 
 
(Gebara et al., 
2013) 
Alcohol (n=1 
RCT) 
 
Primary care 
provider 
 
Brief intervention (BI) 
-face-to-face intervention in a single 
session, with the session length 
varying between 10 and 30 minutes. 
Thematic and structural content analysis 
 
Alcohol reduction: 
BI (single session, 10-30 min)- not effective 
AMSTAR= 3 
ROBIS= High 
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 (controls not reported) 
Males > Females 
(female consumption increasing following the 
BI, more defensive reactions- result being 
classified as negative) 
 
SR6 
 
(Rice et al., 
2013) 
Smoking 
(n=24 RCTs) 
 
Nurses  
 
High intensity intervention- more 
than 10 minutes, additional materials 
and/or strategies other than simple 
leaflets, follow-up visits (n=19). 
Low intensity intervention- advice 
provided (with or without a leaflet), 
10 minutes or less, with up to one 
follow-up visit (n=5). 
Use of NRT (n=2) 
Intervention was a core component 
of nurse’s role (n=4); other studies 
nurses trained (using the ’5 As’ 
framework). 
 
Meta-analysis (n=18) and narrative synthesis 
(n=6) 
 
Smoking cessation: 
Nursing intervention > no intervention or usual 
care (at 6 months or longer) 
 
High intensity intervention = low intensity 
intervention 
AMSTAR= 10 
 
ROBIS= Low 
 
SR7 
 
(VanBuskirk 
and Wetherell, 
2013) 
 
Smoking (n=3 
RCTs) 
 
Alcohol (n=3 
RCTs) 
 
Substance use 
(Marijuana) 
(n=1 RCT) 
 
Physicians, 
nurse 
practitioners, 
or other 
trained 
professionals 
(e.g. 
therapist, 
health 
educator, 
Motivational interviewing (MI)- in-
person MI sessions with phone calls 
as ‘‘booster’’ or follow-up sessions. 
MI-specific training: 8 hours to 4 
weeks (n=5) 
 
Use of AUDIT tool (n=1) 
 
Meta-analysis 
 
Smoking cessation: 
Three 20-min sessions > usual care (7 times 
more quitting) (n=1) 
In-person MI session plus follow-up phone 
calls (four 15-min calls) = in-person MI session 
only (n=1) 
 
Alcohol reduction: 
AMSTAR= 7 
 
ROBIS= Low 
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counsellor, 
interventionis
t, research 
assistant) 
 
2 MI sessions (20 min. each) or 1 MI session 
(45–60 min) > usual care; 12-month follow-up 
 
Substance use: 
One 15–20 min in-person MI session followed 
by one 10-min booster phone call > usual care 
 
SR8 
 
(Stead et al., 
2013a) 
 
Smoking 
(n=42 RCTs) 
 
Physicians, 
or physicians 
supported by 
another 
healthcare 
worker 
 
Minimal intervention: advice (with 
or without a leaflet), single 
consultation lasting less than 20 
minutes plus up to one follow-up 
visit. 
Intensive intervention: greater time 
at the initial consultation, additional 
materials other than a leaflet (e.g. 
demonstration of expired carbon 
monoxide or pulmonary function 
tests, self-help manuals), or more 
than one follow-up visit or referral to 
a cessation clinic. 
Follow-up: typically one year, the 
longest being three years. 
 
Meta-analysis 
 
Smoking cessation: 
Brief advice > no advice/ usual care (n=17) 
(RR 1.66, 95% CI 1.42 to 1.94; I2=31%). 
Intensive advice > no advice/ usual care (n=11) 
(RR 1.86, 95% CI 1.60 to 2.15; I2=50%). 
Intensive advice > minimal advice  
(small difference- RR 1.37, 95% CI 1.20 to 
1.56; I2=32%). 
Follow-up visits – more effective (n=5) 
Use of additional aids (n=10) = no additional 
aids (n=17) 
Combination of brief advice and computer-
generated tailored letters > advice or letter 
alone (n=1) 
 
AMSTAR= 10 
 
ROBIS= Low 
 
SR9 
 
(Noordman et 
al., 2012) 
 
Smoking (n=6) 
 
Alcohol (n=6) 
 
Combined 
lifestyle 
General 
practitioners 
(or 
physicians), 
nurses or 
both (in 
Face-to-face communication-related 
behaviour change techniques 
(BCTs)- behavioural counselling or 
motivational interviewing or 
education and advice. 
1 to 15 sessions, lasted from 30s to 
‘Best Evidence Synthesis’ 
 
Single or combined interventions significantly 
effective. 
Physicians = nurses or both or in combination 
with other providers - provide effective BCTs. 
AMSTAR= 5 
 
ROBIS= High 
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behaviours 
(n=25) 
 
combination 
with other 
health care 
providers) 
 
60 min. 
Most studies combined techniques 
such as advice and education or goal 
setting, self-monitoring and 
motivational interviewing. 
 
Simple advice > intensive advice (simple 
advice as effective as motivational 
interviewing). 
Feedback, risk-assessment, goal-setting, 
cognitive behaviour therapy and self-
monitoring- showed significant effects. 
 
SR10 
 
(Willis et al., 
2012) 
 
Smoking (n=5 
RCTs) 
 
Health care 
professional. 
Nurse-led 
(n=5), with 
behavioural 
scientists, 
nutritionists 
and health 
councillors 
providing 
care. 
 
Multifactorial (lifestyle) 
interventions- tailored intervention 
based on individual risk profile, goal 
setting, supporting materials. 
Duration- not reported. 
Follow-up: mean 3 years, ranging 
from 1 to 7 years. 
Screening: sessions to record 
smoking status (also cholesterol, 
blood glucose, activity level and 
dietary habits)- calculate 
cardiovascular disease risk scores. 
 
Narrative synthesis 
 
Smoking cessation: 
Multifactorial lifestyle interventions- strong 
evidence for the success of smoking cessation 
(no change in cardiovascular disease risk score) 
 
More intensive interventions > lower intensity 
interventions (n=2) 
 
AMSTAR= 7 
 
ROBIS= Low 
 
SR11 
 
(Jonas et al., 
2012) 
 
Alcohol (n=23 
RCTs) 
 
Primary care 
physician - 
alone or with 
a health 
educator, 
nurse, 
psychologist 
or researcher 
 
Behavioural counselling, with or 
without referral (brief advice, 
feedback, motivational interviews, or 
cognitive behavioural strategies). 
Very brief (≤ 5 minutes, single-
contact); brief (6 to 15 minutes, 
single-contact); extended (>15 
minutes, single-contact); brief multi-
contact (each contact ≤15 minutes); 
or extended multi-contact (some 
Meta-analyses (n=19) and qualitative synthesis 
(n=23) 
 
Alcohol reduction: 
Brief (10 to 15-minute) multicontact 
interventions- most effective (effect remains 
for several years). 
Brief multicontact interventions > extended 
multicontact interventions. 
Very brief interventions and brief interventions 
AMSTAR= 10 
 
ROBIS= Low 
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contacts >15 minutes). 
 
Screening assessments: multistep 
processes, interviews with research 
personnel up to 30 minutes. 
are less effective or ineffective. 
Men = women 
Delivered by primary care providers > research 
personnel 
 
SR12 
 
(Carr and 
Ebbert, 2012) 
Smoking  
(n=8 RCTs- 6 
RCTs involved 
adult 
smokers); 
 
Smokeless 
tobacco  
(n=6 RCTs) 
 
Dentists and 
dental 
hygienists 
Behavioural interventions involved 
either: 
1) brief advice plus quitline referral, 
brief advice plus motivational 
interviewing, brief advice plus video-
based cessation program with phone 
follow-up, or 
2) counselling using the 5 A’s plus 
NRT, 5 A’s plus NRT and 
population-specific printed material, 
3 A’s plus pharmacotherapy and 
referral as needed. 
Duration: 10-15-minute advice in 
single session (n=3). 
BIs also included combinations of an 
oral examination, feedback from the 
examination as to oral effects of 
tobacco use and involved team 
effort. 
Tobacco use status was determined 
from the patient’s chart and health 
questionnaire. 
 
Meta-analysis 
 
Tobacco abstinence: 
Behavioural interventions > usual care (n=14) 
(OR 1.71, 95% CI 1.44 to 2.03 - at 6 to 24 
months, I2=61%) 
(among both cigarette smokers and smokeless 
tobacco users) 
 
Subgroup of adult smokers (n=5), effect was 
stronger (OR=2.38, 95%CI 1.70, 3.35) 
 
Brief intervention > extended intervention 
(n=1) 
 
AMSTAR= 9 
 
ROBIS= Low 
 
SR13 
 
Smoking 
(n=16 RCTs) 
General 
practitioners, 
Counselling interventions- classified 
by intensity of contact with the 
Narrative synthesis 
 
AMSTAR= 5 
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(Taggart et al., 
2012) 
 
 
Alcohol (n=2 
RCTs) 
 
physician or 
nurse 
 
subjects (High ≥ 8 points of contact 
hours; Moderate >3 and <8; Low ≤ 3 
points of contact hours). 
 
Smoking cessation: 
Individual counselling and written materials > 
group education 
Low intensity interventions > high intensity 
interventions 
Primary health care settings > community 
settings 
 
Alcohol reduction: 
Interventions- not effective 
Health literacy: Low intensity interventions = 
high intensity interventions 
 
ROBIS= High 
 
SR14 
 
(Brown et al., 
2012) 
 
Smoking 
(n=35 RCTs); 
substance 
abuse 
including 
alcohol (n=25 
RCTs); sexual 
health (n=27 
RCTs) 
 
Community 
pharmacists 
 
Interventions promoting changes to a 
healthier lifestyle  
 
Structured interventions, using NRT 
& counselling 
Narrative synthesis 
 
Smoking cessation: 
Structured interventions > opportunistic 
intervention 
Pharmacists training > no training 
 
Substance abuse including alcohol and sexual 
health: 
Weak evidence for effectiveness 
 
AMSTAR= 5 
 
ROBIS= High 
 
SR15 
 
(Zbikowski et 
al., 2012) 
Smoking (n=4 
RCTs) 
 
Physicians, 
general 
practitioners 
and nurses 
 
Behavioural counselling- moderate 
level (2-5 sessions), tailored to older 
smokers or stage-based, with self-
help materials and follow-up advice 
or phone calls. 
11min advice followed by 2 phone 
Descriptive/ narrative synthesis 
 
Smoking cessation: 
Physician delivered interventions > no 
intervention (n=4) 
Physician/nurse counselling with 
AMSTAR= 2 
 
ROBIS= High 
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calls 7 min. each (n=1) 
 
pharmacotherapy and brief follow-up > no 
counselling (n=2) 
 
SR16 
 
(Cahill et al., 
2010) 
Smoking (n=2 
RCTs) 
 
 
Primary care 
physician  
Individual counselling or brief 
advice- 10-minute, tailored to the 
participant’s perceived stage of 
change, tailored self-help materials, 
one or more follow-up phone calls or 
letters, use NRT gum if appropriate. 
Training of physicians in the stages 
of change model; one trial used MI-
based counselling. 
 
Meta-analysis 
 
Smoking cessation: 
Evidence not clear for primary care staged 
intervention, and training of physicians. 
 
Advice + NRT = usual care (n=1) 
Training = no training (n=2) 
 
AMSTAR= 11 
 
ROBIS= Low 
 
SR17 
 
(Kaner et al., 
2009) 
 
Alcohol (n=24 
RCTs) 
 
General 
practitioners, 
nurse 
practitioners 
or 
psychologists 
 
Motivational interviews or cognitive 
behavioural therapy approaches. 
Brief intervention (BI): 1-5 sessions, 
1 to 50 minutes each. Treatment 
duration ranged from 5-10 minutes to 
60 minutes advice. 
Extended interventions: 2-7 sessions, 
initial and booster sessions ranged 
from 15 to 50 minutes. 
 
Screening- general health 
questionnaires, or alcohol screening 
tools such as CAGE, AUDIT or 
MAST, or variations on these. 
Administered by telephone or in the 
clinic (at registration). 
 
Meta-analysis 
 
Alcohol reduction: 
Brief intervention > control group (n=22), 
follow-up of one year or longer 
(mean difference: -38 grams/week, 95% CI: -
54 to -23, I2=57%) 
 
Men > Women (at one year of follow up) 
 
Extended interventions > Brief intervention 
(n=5) (non-significant) 
 
AMSTAR= 10 
 
ROBIS= Low 
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SR18 
 
(Halcomb et 
al., 2007) 
 
Smoking (n= 9 
RCTs) 
 
Alcohol (n= 3 
RCTs) 
 
General 
practice 
nurse- all 
trials 
 
Doctor (n=2) 
 
Individual or one-to-one 
interventions 
 
Multifaceted interventions- involved 
a range of individualised health 
assessment, lifestyle counselling, 
motivational interviewing, health 
education and protocol driven 
management of various risk factors. 
 
Targeted interventions- involved a 
baseline health check followed by 
the delivery of various forms of 
health education, focused on 
modification of a single lifestyle risk 
factor. 
 
Narrative synthesis 
 
Smoking cessation:  
Multifaceted interventions 
interventions > no interventions 
Nurse interventions = doctor interventions 
(n=1) 
 
Targeted interventions 
interventions > no interventions (n=1) 
interventions = no interventions (n=2) 
number of those who stopped smoking 
decreased with increasing age 
 
Alcohol reduction: 
Low intervention group (one appointment and 
five 15-min telephone follow ups and education 
manual) > control group (n=1) 
High intervention group (six 45-min 
appointments and education manual) = control 
group (n=1) 
High & low intervention group > control group 
(n=1) 
 
AMSTAR= 7 
 
ROBIS= 
Unclear 
 
SR19 
 
(Wilhelmsson 
and Lindberg, 
2007) 
 
Alcohol (n=1 
RCT and 1 
before-after 
study) 
 
Clinicians, 
physician- 
and nurse 
practitioners 
 
Brief intervention/ counselling 
 
Staff received training (2.5 hr. in 
RCT) in an alcohol preventive 
programme 
 
Narrative synthesis 
 
Alcohol reduction: 
Very short counselling or BI > usual care 
 
alcohol-related discussions were longer among 
AMSTAR= 4 
 
ROBIS= High 
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the clinicians who receivedtraining 
 
SR20 
 
(Huibers et al., 
2007) 
 
Smoking (n=2 
RCTs & 
CCTs) 
 
Alcohol (n=2 
RCTs & 
CCTs) 
 
General 
practitioners 
(or family 
physician or 
family 
doctor) 
 
Psychosocial interventions 
(including counselling, or more 
structured approaches, like cognitive 
behavioural interventions (CBI) or 
problem-solving therapy) 
 
Intervention consisted of a 
standardised number of at least 2 
face-to-face contacts between patient 
and general practitioner. 
 
Timing of interventions not reported  
Meta-analysis (results from smoking and 
alcohol studies were not pooled due to 
heterogeneity) 
 
Smoking cessation: 
1 high quality RCT: 
Five-session ’repeated counselling’ (RC) = 
one-session minimal intervention (MI) = 
RC+gum = RC+spirometry 
- overall cessation in all groups at 12 months 
 
Alcohol reduction: 
1 high quality RCT: 
Two-session CBI by research GP = CBI by 
nurse = one-session brief advice by regular GP 
- overall reduction in all groups at 12 months 
 
AMSTAR= 9 
 
ROBIS= Low 
 
SR21 
 
(Hyman, 2006) 
 
Alcohol (n=2 
RCTs) 
 
Staff or clinic 
nurse 
(1 trial 
compared 
nurse 
delivered to 
physician 
delivered BI) 
 
Brief interventions 
(Two 30 min. sessions included in 
one study, another study included 2 
or more consultation sessions over 
12 months) 
 
Review of clinical trials (summarized results 
from all included studies, no synthesis) 
 
Alcohol reduction: 
Limited evidence 
 
Nurse delivered BI > non-intervention or 
control group 
 
Equal effectiveness at 3, 6 and 12 months (no 
difference for follow-up) 
AMSTAR= 6 
 
ROBIS= High 
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SR22 
 
(Bertholet et 
al., 2005) 
 
Alcohol (n= 19 
RCTs) 
 
Primary care 
provider: GP 
(most 
studies), 
physician, 
nurse, trained 
interventionis
t or 
researchers  
 
Brief Alcohol Intervention (BAI)- 
advice, motivational interviewing or 
cognitive behavioural techniques, 
feedback regarding alcohol 
consumption levels and/or adverse 
effects of alcohol consumption. 
 
Length of intervention ranged from 5 
to 45 minutes, a booster session or 
follow-up visit. 
 
AUDIT or CAGE scores 
 
Qualitative synthesis and Meta-analysis 
 
Alcohol reduction: 
BI (5-15 min.) > no intervention/usual care/less 
than 5 min. of intervention 
 
BI accompanied by written material and 
repeated intervention (follow-up visits) - more 
effective (n=6) 
 
Men = women 
 
Follow-up: 6 months = 12 months 
 
AMSTAR= 7 
 
ROBIS= Low 
 
SR23 
 
(Gorin and 
Heck, 2004) 
Smoking (n= 
16 RCTs and 
quasi-
experimental 
studies) 
 
Primary care 
physicians, 
dentists, 
nurse or 
healthcare 
team 
 
In-person cessation advice or 
counselling 
 
Intensity ranged from brief (3-5 
min.) over single health visit, to 
structured behavioural change 
interventions lasting an hour 
delivered over multiple visits. 
 
Average duration of interventions 
was 76.5 days, no. of sessions was 4, 
with mean duration per session of 
22.7 min. 
 
Descriptive analyses and Metaregression 
(meta-analyses) 
 
Smoking cessation: 
Cessation effects: Physicians > multiprovider 
teams = dentists > nurses 
 
Cessation effects: More health care providers > 
fewer providers 
 
Measured clinical components- assess, assist, 
or arrange had no statistically significant 
influence on cessation. 
 
AMSTAR= 5 
 
ROBIS= High 
 
SR24 Smoking General Stages-of-change–based Qualitative (best-evidence synthesis) and AMSTAR= 6 
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(van Sluijs et 
al., 2004) 
 
(n=14 
RCTs/CTs) 
 
practitioner 
(GP) or 
primary care 
physician 
 
interventions; differed from a mailed 
letter to a possible six contact 
moments with individual 
counselling. 
 
Provider training- one study 
provided 1.5hr group session + 1/2hr 
individual session with role play; 
another study included manuals and 
training incorporated in a 10-week 
lecture series 
 
quantitative synthesis (odds ratios)  
 
Smoking cessation: 
Stages-of-change–based interventions > Usual 
care or brief standard advice or no provider 
training 
 
Personal advice from the primary care 
physician, with follow-up advice during 
subsequent visits (mostly not planned for 
smoking cessation) - most effective strategy 
 
Medium-term follow-up (limited evidence) > 
short and long-term follow-up (no evidence for 
effect) 
 
 
ROBIS= Low 
 
SR25 
 
(Whitlock et 
al., 2004) 
 
Alcohol (n= 11 
RCTs and 1 
CT) 
 
Primary care 
physicians 
 
(additionally, 
research staff 
or health 
educators, 
counsellors 
or clinic 
nurses 
delivered 
some or all of 
the 
intervention) 
Very brief interventions (n=2)- 1 
session, up to 5 minutes long 
 
Brief interventions (n=6)- 1 session, 
up to 15 minutes long 
 
Brief multicontact interventions 
(n=7)- an initial session up to 15 
minutes long, plus follow-up 
contacts 
 
Training: sessions, ranged from 15 
minutes to 2.5 hours (n=7) 
 
Qualitative or narrative synthesis 
 
Alcohol reduction: 
Brief multicontact interventions > usual care 
(13% to 34% reduction per week) 
 
Very BIs & BIs ≥ usual care (limited evidence, 
n=3) 
 
Effective interventions (any intensity) included 
at least 2 of 3 key elements- feedback, advice, 
and goal-setting. 
2 studies also reported tailoring intervention. 
 
AMSTAR= 7 
 
ROBIS= Low 
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 Screening: involved self-
administered questionnaires or brief 
interviews. Conducted outside the 
routine care encounter, approx. 30 
minutes. Many of the trials used 
CAGE and AUDIT instruments. 
 
Men = women (Brief multicontact 
interventions) 
 
Older adults ≥ younger adults (n=1) 
 
Outcomes- at least 12 months follow-up 
 
SR26 
 
(Ballesteros et 
al., 2004) 
 
Alcohol (n= 13 
RCTs) 
 
Primary care 
providers 
 
Brief interventions (BIs) lasting ~10–
15 minutes in one session, with 
reinforcing visits through follow-up 
of ~3–5 min each 
 
Minimal interventions (MI) lasting 
~3–5 minutes 
 
Extended brief interventions (EBI)- 
BI plus several specific 
reinforcement sessions through 
follow-up, ~10–15 min each.  
 
Meta-analysis 
 
Alcohol reduction: 
BIs > minimal interventions/usual care 
BIs to heavy drinkers > moderate drinkers 
 
EBI- limited evidence for effectiveness 
 
AMSTAR= 7 
 
ROBIS= 
Unclear 
 
SR27 
 
(Sinclair et al., 
2004) 
 
Smoking (n=2 
RCTs) 
 
Pharmacists 
and/or 
members of 
pharmacy 
staff 
 
Advice or more intensive 
behavioural therapy, with or without 
the use of any form of NRT or other 
pharmacotherapy. 
 
Involved training interventions 
which included the Stages of Change 
Model- 2-3-hour workshop for 
pharmacists and pharmacy assistants 
 
Narrative synthesis 
 
Smoking cessation: 
Pharmacist interventions > usual pharmacy 
support or any less intensive programme 
 
The strength of evidence is limited because 
only one of the trials showed a statistically 
significant effect. 
 
AMSTAR= 9 
 
ROBIS= Low 
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Follow-up points were not identical 
(3, 6 and 12 months in one, and 1, 4 
and 9 months in the other study). In 
both studies, follow- up was by 
postal questionnaire and depended 
on self-reported smoking status. 
 
SR28 
 
(Blenkinsopp 
et al., 2003) 
 
Smoking (n=2 
RCTs, 3 non-
RCTs) 
 
Community 
pharmacists 
and 
pharmacy 
assistants 
 
2 RCTs: Structured or tailored 
counselling, an information leaflet, 
weekly follow-up for the first 4 
weeks and monthly thereafter as 
needed up to 12 months. 
 
Training based on ‘stages of change’ 
model, which included self-study and 
attending a 3hr. workshop or one 
evening training session and 
subsequently supported by a 
researcher visit (n=2 RCTs). 
 
1 non-RCT: intervention included six 
1.5hr. meetings in each pharmacy. 2 
days intensive training (with lectures, 
role plays and discussions with other 
smoking cessation professional). 
 
Qualitative synthesis 
 
Smoking cessation: 
Advice/counselling > usual care (n=2 RCTs) 
 
Training > no training  
 
AMSTAR= 6 
 
ROBIS= High 
 
SR29 
 
(Poikolainen, 
1999) 
Alcohol (n=7) 
 
Family or 
general 
practitioners 
 
Very brief (5-20 min) interventions 
and extended (2-5 sessions or several 
visit) brief interventions (BIs) 
 
Meta-analysis 
 
Alcohol reduction: 
Extended BIs > Very BIs 
AMSTAR= 3 
 
ROBIS= High 
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 Women > men 
(Significant statistical heterogeneity) 
 
SR30 
 
(Ashenden et 
al., 1997) 
Smoking 
(n=23 RCTs) 
 
Alcohol (n=6 
RCTs) 
 
General 
practitioner, 
nurse or 
counsellor 
Lifestyle advice- verbal advice plus 
written materials 
Brief advice- single consultation; 
Intensive advice- more than a single 
consultation and follow-up by 
appointment, telephone or letter. 
Multifactorial advice (n=3) 
 
Meta-analysis 
 
Smoking cessation: 
Brief or intensive advice > no advice (n=16) 
Brief advice = intensive advice (n=7) 
 
Alcohol reduction: 
Brief or intensive advice > no advice (n=3) 
advice = no advice (n=3) 
men > women (n=2) 
 
AMSTAR= 6 
 
ROBIS= 
Unclear 
 
SR31 
 
(Kahan et al., 
1995) 
 
Alcohol (n=6 
RCTs) 
 
Primary care 
physicians 
 
Brief interventions, sessions with 
patients lasted 30 minutes or less 
 
Training sessions: 1 hour or less  
 
Narrative/ descriptive synthesis 
 
Alcohol reduction: 
Intervention group > control group (n=3) - 
among men 
Intervention group < control group (n=2) - 
among women (negative results) 
15-minute counselling session = 5-minutes of 
advice (n=2) 
 
AMSTAR= 4 
 
ROBIS= High 
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It can be seen from Table 3.1 that all included systematic reviews were 
published between 1995 and 2015, and included preventive interventions for 
tobacco and/or alcohol, in a primary care setting (medical, dental, or 
community pharmacy). Of 31 systematic reviews, 11 reviews provided 
quantitative or meta-analyses, 15 reviews provided qualitative or narrative 
analyses, while four included both narrative and meta-analyses, and one was a 
cost-effectiveness review. Study IDs (from Table 3.1) will now be used to 
represent/reference a particular systematic review in the following sections. 
As can be seen from Table 3.1, the included systematic reviews were relatively 
heterogeneous in that they covered different primary care settings 
(dental/medical/pharmacy), risk factors (tobacco/alcohol) and behavioural 
preventive interventions (motivational/stage-based). The systematic reviews 
varied in the types of preventive interventions in areas such as: duration of 
individual sessions, total number of sessions, follow-up visits and provider 
training (Table 3.1). All 31 systematic reviews included individual or face-to-face 
interventions, which provided behavioural advice focused on modification of a 
single or multiple lifestyle risk factor (tobacco or alcohol). The various 
behavioural preventive interventions included verbal advice from primary care 
providers in the form of: brief advice to quit, motivational interviewing, 
cognitive behavioural techniques, behavioural counselling, structured or tailored 
counselling programme and stages-of-change–based interventions. These 
approaches have been defined in Chapter 1 (Section 1.4.1.1). Most systematic 
reviews included “brief interventions” - advice or counselling, however 
definitions varied a lot among the included systematic reviews. 
3.4.1.3.1 Dental practice setting 
There were only two systematic reviews out of 31 which included preventive 
interventions (including risk factor assessment, behavioural advice, and/or 
signposting/referral) delivered in a primary care dental practice setting: one of 
these reviews (SR 23) included studies in both primary care medical and dental 
practices, interventions delivered by physicians, nurses, and/or dentists; while 
the other review (SR 12) focused exclusively in a primary care dental practice, 
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with interventions delivered by dental professionals only - dentists and/or dental 
hygienists. 
Both systematic reviews in the dental practice setting focused on providing 
advice for smoking (SR: 12, 23), one of these also included smokeless tobacco 
advice (SR 12). None of the dental reviews included advice for alcohol reduction. 
3.4.1.3.2 Medical or community pharmacy setting 
The majority, i.e. 29 out of the 31 systematic reviews, included studies which 
provided preventive interventions (including risk factor assessment, behavioural 
advice, and/or signposting/referral) in a primary care medical practice setting. 
Of these, 22 reviews (SR: 1, 2, 3, 4, 5, 7, 8, 9, 11, 13, 15, 16, 17, 19, 20, 22, 24, 
25, 26, 29, 30, 31) included interventions delivered by various primary care 
providers, for example: physicians or general practitioners, and non-physicians 
like nurses, counsellor, health educator, psychologists, nutritionists, trained 
interventionist, researchers or healthcare teams; four reviews (SR: 6, 10, 18, 21) 
included interventions delivered or led by primary care nurses only; while in 
three reviews (SR: 14, 27, 28) interventions were delivered by community 
pharmacists or pharmacy assistants/staff. 
Of these 29 systematic reviews: smoking cessation interventions or advice were 
included in ten reviews (SR: 1, 2, 6, 8, 10, 15, 16, 24, 27, 28); alcohol reduction 
interventions were included in 12 reviews (SR: 3, 4, 5, 11, 17, 19, 21, 22, 25, 26, 
29, 31); while seven systematic reviews (SR: 7, 9, 13, 14, 18, 20, 30) included 
interventions for both smoking and alcohol. All 29 reviews included 
single/isolated interventions for smoking and/or alcohol (unifactorial), none of 
the studies included combined interventions targeting both smoking and alcohol 
(multifactorial). 
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3.4.1.4 Quality assessment (AMSTAR) and Risk of Bias (ROBIS) 
The AMSTAR scores for all systematic reviews are included in Table 3.2; only two 
reviews met all 11 criteria in AMSTAR (SR: 1, 16). Included systematic reviews 
were considered high-quality if the AMSTAR score ranged from 8 to 11, medium 
quality if score ranged 4 to 7, and low-quality if score ranged 0 to 3 (as stated 
earlier in Section 3.3.8.1). Thus, this overview included ten high-quality 
systematic reviews, 18 mid-quality, and three low-quality reviews. The ROBIS 
scores for all systematic reviews are included in Table 3.3. Figure 3.2 depicts a 
graphical representation of both AMSTAR and ROBIS scores. Blue vertical bars in 
the figure represent the AMSTAR scores (which ranges from 1-11) and 
low/high/unclear written in boxes are ROBIS scores. It can be seen that all ten 
systematic reviews with high AMSTAR score had low risk of bias in ROBIS, three 
reviews with low AMSTAR score had high risk of bias, while risk of bias varied in 
reviews with mid AMSTAR score. Of 18 medium AMSTAR quality systematic 
reviews, nine had high risk of bias, five reviews had low risk of bias and four 
reviews were unclear. 
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Table 3.2: AMSTAR scores for included systematic reviews (n=31) (Shea et al., 2007) 
 
Study ID 
 
(Author, year) 
W
as
 a
n 
“
a 
pr
io
ri
”
 d
es
ig
n 
pr
ov
id
ed
?  
W
as
 th
er
e 
du
pl
ic
at
e 
st
ud
y 
se
le
ct
io
n 
an
d 
da
ta
 e
xt
ra
ct
io
n?
 
W
as
 a
 c
om
pr
eh
en
siv
e 
lit
er
at
ur
e 
se
ar
ch
 p
er
fo
rm
ed
? 
W
as
 th
e 
st
at
us
 o
f p
ub
lic
at
io
n 
(i.
e.
 
gr
ey
 li
te
ra
tu
re
) u
se
d 
as
 a
n 
in
cl
us
io
n 
cr
ite
ri
on
?  
W
as
 a
 li
st
 o
f s
tu
di
es
 (i
nc
lu
de
d 
an
d 
ex
cl
ud
ed
) p
ro
vi
de
d?
 
W
er
e 
th
e 
ch
ar
ac
te
ri
st
ic
s o
f t
he
 
in
cl
ud
ed
 st
ud
ie
s p
ro
vi
de
d?
 
W
as
 th
e 
sc
ie
nt
ifi
c 
qu
al
ity
 o
f t
he
 
in
cl
ud
ed
 st
ud
ie
s a
ss
es
se
d 
an
d 
do
cu
m
en
te
d?
 
W
as
 th
e 
sc
ie
nt
ifi
c 
qu
al
ity
 o
f t
he
 
in
cl
ud
ed
 st
ud
ie
s u
se
d 
ap
pr
op
ri
at
el
y 
in
 fo
rm
ul
at
in
g 
co
nc
lu
sio
ns
? 
W
er
e 
th
e 
m
et
ho
ds
 u
se
d 
to
 c
om
bi
ne
 
th
e 
fin
di
ng
s o
f s
tu
di
es
 a
pp
ro
pr
ia
te
?  
W
as
 th
e 
lik
el
ih
oo
d 
of
 p
ub
lic
at
io
n 
bi
as
 a
ss
es
se
d?
 
W
as
 th
e 
co
nf
lic
t o
f i
nt
er
es
t 
in
cl
ud
ed
? 
A
M
ST
A
R
 sc
or
e 
SR1 
(Lindson-Hawley 2015) P P P P P P P P P P P 11 
SR2 
(Bully 2015) P P P P O P P P P O O 8 
SR3 
(Morton 2015) P P O O O P P P P O O 6 
SR4 
(Angus 2014) P O P P O P P P P O O 7 
SR5 
(Gebara 2013) O P O O O P O O P O O 3 
SR6 
(Rice 2013) P P P P P P P P P P O 10 
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SR7 
(VanBuskirk 2013) O O P P O P P P P P O 7 
SR8 
(Stead 2013) P P P P P P P P P P O 10 
SR9 
(Noordman 2012) O P O O O P P P P O O 5 
SR10 
(Willis 2012) O P P P O P P P P O O 7 
SR11 
(Jonas 2012) P P P P P P P P P O P 10 
SR12 
(Carr 2012) P P P P P P P P P O O 9 
SR13 
(Taggart 2012) O P P O O P P P O O O 5 
SR14 
(Brown 2012) P O P P O P P O O O O 5 
SR15 
(Zbikowski 2012) O O P O O P O O O O O 2 
SR16 
(Cahill 2010) P P P P P P P P P P P 11 
SR17 
(Kaner 2009) P P P P P P P P P P O 10 
SR18 
(Halcomb 2007) O P P P P P P O P O O 7 
SR19 
(Wilhelmsson 2007) O P O O O P P P O O O 4 
SR20 
(Huibers 2007) P P P P P P P P P O O 9 
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SR21 
(Hyman 2006) O O P P O P P P P O O 6 
SR22 
(Bertholet 2005) O P P O O P P P P P O 7 
SR23 
(Gorin 2004) O O P P O O O P P P O 5 
SR24 
(van Sluijs 2004) O P P O O P P P P O O 6 
SR25 
(Whitlock 2004) O P P P P P P P O O O 7 
SR26 
(Ballesteros 2004) ? O P O P P P P P P O 7 
SR27 
(Sinclair 2004) P P P P P P P P P O O 9 
SR28 
(Blenkinsopp 2003) P O P P O P P P O O O 6 
SR29 
(Poikolainen 1999) O O P O O P O O P O O 3 
SR30 
(Ashenden 1997) O O P O O P P P P P O 6 
SR31 
(Kahan 1995) O O P O O P P P O O O 4 
P = Yes;  O = No;  ? = Can’t answer  
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Table 3.3: ROBIS scores (notation as per (Whiting et al., 2016)) 
 
Phase 2 Phase 3 
Study ID 
(Author, year) 
1. Study eligibility 
criteria 
2. Identification and 
selection of studies 
3. Data collection and 
study appraisal 
4. Synthesis and 
findings 
Risk of bias in the 
review 
SR1 
(Lindson-Hawley 2015) J J J J J 
SR2 
(Bully 2015) ? J J ? J 
SR3 
(Morton 2015) ? ? J ? ? 
SR4 
(Angus 2014) J ? L ? L 
SR5 
(Gebara 2013) L L L L L 
SR6 
(Rice 2013) J J J J J 
SR7 
(VanBuskirk 2013) ? ? J J J 
SR8 
(Stead 2013) ? J J J J 
SR9 
(Noordman 2012) J J L L L 
SR10 
(Willis 2012) J J J J J 
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SR11 
(Jonas 2012) J J J J J 
SR12 
(Carr 2012) J J J J J 
SR13 
(Taggart 2012) ? ? ? ? L 
SR14 
(Brown 2012) ? L L ? L 
SR15 
(Zbikowski 2012) L L ? L L 
SR16 
(Cahill 2010) J J J J J 
SR17 
(Kaner 2009) J J J J J 
SR18 
(Halcomb 2007) J J J L ? 
SR19 
(Wilhelmsson 2007) L ? L L L 
SR20 
(Huibers 2007) ? J J J J 
SR21 
(Hyman 2006) ? L L J L 
SR22 
(Bertholet 2005) J J J J J 
SR23 
(Gorin 2004) L L L L L 
SR24 
(van Sluijs 2004) J ? J J J 
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SR25 
(Whitlock 2004) J J J L J 
SR26 
(Ballesteros 2004) J ? ? J ? 
SR27 
(Sinclair 2004) ? J J J J 
SR28 
(Blenkinsopp 2003) L J ? L L 
SR29 
(Poikolainen 1999) L L L J L 
SR30 
(Ashenden 1997) J ? J J ? 
SR31 
(Kahan 1995) ? ? ? ? L 
J = low risk;    L = high risk;   ? = unclear risk (use of characters- suggested tabular presentation for ROBIS results) (Whiting et al., 2016) 
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Figure 3.2: Graphical representation of both AMSTAR and ROBIS scores 
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3.4.1.5 Best practice (high-quality) systematic review evidence 
The high-quality evidence/findings were presented from all low risk of bias (low 
ROBIS) reviews, giving priority in the narrative data synthesis to: firstly, high-
quality AMSTAR scores with low risk of bias in ROBIS (n=10); and secondly to mid-
quality AMSTAR scores but with low risk of bias in ROBIS (n=5). 
Trial data duplication assessment identified that in the ten reviews with high 
AMSTAR and low ROBIS: one of the reviews (SR 20) had all trials duplicate with 
more recent reviews (SR: 8, 17) which were also of higher quality, thus findings 
from SR 20 were not included in this synthesis; while for another review (SR 27), 
which also had duplicate trials with a more recent review (SR 14), findings were 
included in the synthesis, as it was of higher quality. For the remaining high-
quality reviews, some of the included trials were duplicate (Appendix 6), which 
are discussed while synthesising findings. 
Thus, the findings synthesised in this overview were from 14 systematic reviews 
which had: 
1) High AMSTAR and low ROBIS (n=9) (SR: 1, 2, 6, 8, 11, 12, 16, 17, 27) 
2) Mid AMSTAR and low ROBIS (n=5) (SR: 7, 10, 22, 24, 25) 
The details of the other main findings from these high-quality reviews and all 
remaining systematic reviews with lower quality scores (i.e. mid AMSTAR with 
high/unclear ROBIS, and low AMSTAR with high ROBIS) were recorded in Table 
3.1. 
As this is a systematic overview, the synthesis focused on the results of the 
included systematic reviews and not results of individual trials/studies within 
these systematic reviews. However, the results from individual trials/studies 
have been presented where the included systematic reviews had not reported 
combined results for all primary care studies in that review. The number of the 
included trials/studies and other features (such as, effect sizes) have also been 
mentioned in order to depict the nature and strength of the evidence. The 
results have now been presented separately for dental and other primary care 
settings (medical/pharmacy), considering review quality, recency, and trial 
duplication. Furthermore, as all high-quality reviews focused on interventions / 
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outcomes in terms of tobacco and/or alcohol, the results have been organised 
under these two headings. 
3.4.1.5.1 Dental practice setting 
Of the 14 high-quality systematic reviews, there was only one review (SR 12) 
which investigated behavioural preventive interventions (including risk factor 
assessment, behavioural advice and/or referral) delivered exclusively in a 
primary care dental practice setting. This high-quality Cochrane review (SR 12) 
included preventive interventions for smoking and smokeless tobacco. This 
review (SR 12) included 14 randomised controlled trials, and the interventions 
were delivered by dentists and/or dental hygienists to smokers or tobacco users 
of any age exclusively in a dental practice setting. Eight trials targeted smokers 
and six trials targeted smokeless tobacco users. 
Risk factor assessment (Ask/ Assess) 
There was limited description of risk factors assessment of smoking behaviour in 
this dental review (SR 12). Most of the included trials did not provide 
information on how they assessed a patient’s smoking or tobacco use status. 
Only one of the trials reported that patient charts, medical records or health 
questionnaires were used to determine tobacco use status and to identify at risk 
groups. All the other studies simply mentioned determining tobacco use status 
but provided no details.  
A significant component of behavioural preventive interventions in all included 
trials was to identify and record findings from the patient’s oral examination, 
and then incorporating it as an integral part of advice/counselling by relating it 
to the patient’s tobacco use. 
Behavioural preventive intervention (Advise/ Arrange) 
This high-quality Cochrane review (SR 12) investigated the effectiveness of 
smoking and smokeless tobacco cessation interventions in a dental practice 
setting. Following meta-analyses, it found that, in general, tobacco cessation 
interventions delivered by dental professionals are likely to be effective at 
increasing tobacco abstinence for at least 6 months (OR=1.71, 95%CI 1.44, 2.03; 
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n=14 trials). In the subgroup of adult smokers (n=5 trials), the effect was 
stronger (OR=2.38, 95%CI 1.70, 3.35). The review concluded that: “Differences 
between the studies limit the ability to make conclusive recommendations 
regarding the intervention components that should be incorporated into clinical 
practice, however, behavioural counselling (typically brief) in conjunction with 
an oral examination was a consistent intervention component that was also 
provided in some control groups”. The review further stated that results need to 
be viewed with caution due to a lack of biochemical validation of self-reported 
tobacco abstinence (only two trials reported it). 
Exploring the interventions employed in the trials further, there was high 
heterogeneity, including: brief tailored advice, or motivational interviewing 
using printed educational materials or self-help aids, or counselling using the 5 
A’s (brief) or 3 A’s (very brief), or quit-line referral (as needed). All trials 
employed brief behavioural interventions (advice or counselling) and only one 
needed pharmacotherapy as part of the intervention. All trials included an oral 
examination as an interventional component, and provided personalized 
(tailored) feedback to patients from the examination as to the oral effects of 
tobacco use. The trials further incorporated a training component for dental 
professionals to deliver effective interventions (brief or intensive), however the 
details of training (duration, number of sessions) were not reported. In addition, 
the effects were not reported to compare interventions delivered by 
professionals ‘with’ versus ‘without’ training. 
There were differences in the definition of ‘brief’ intervention amongst the 14 
trials. Most of the trials did not report the duration and number of sessions of 
tobacco cessation interventions. Two of the trials with smokeless tobacco users 
reported effectiveness of 3-5-minutes very brief advice to stop, following an oral 
examination, and an offer of 10-15-minutes brief motivational counselling 
session and pharmacotherapy (if needed - in the case of addiction). Another trial 
included ‘intensive’ interventions for smokers including eight 40-minute 
counselling sessions over four months, while ‘brief’ interventions in this trial 
included one 30-minute counselling session to explain an 8-week self-help 
programme. Thus, there was wide inconsistency in the reporting of the duration 
and definition of brief behavioural interventions. 
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The other trials (which did not report duration) considered an intervention as 
brief or very brief if it included an advice or message to quit, plus educational 
materials or self-help guide, and an offer of quit-line referrals. On the other 
hand, intensive interventions were described as: brief intervention plus 
motivational counselling (or video), setting a quit date (within 2 weeks or more), 
including a follow-up appointment to see if the patient has quit, and developing 
a plan or training to prevent relapse. Where compared, one trial found benefit 
of intensive intervention over brief intervention for smokeless tobacco users. 
Other trials reported similar quit rates for ‘brief’ and ‘intensive’ interventions 
for smokers (or smokeless tobacco users), showing no additional benefit of 
intensive intervention (gauged by number of personal contact) over brief 
intervention. One of the trials reported 3.3% quit rates (27/817) for both brief 
and intensive interventions. The results for intensive interventions were not 
included in the meta-analysis in this review (SR 12), as results were similar. 
Overall, the review reported that interventions in all included trials were a team 
effort involving brief dental encounters and behavioural interventions which 
differed in intensity “as measured by number of planned contacts but there was 
no clear indication of a dose-response relationship” (SR 12). 
Referral to cessation services (Assist) 
Most of the included trials reported brief interventions as tailored advice plus an 
offer of quit-line referral, as needed. However, outcomes for referral were not 
reported in the majority trials. Only one trial reported that a brief advice plus 
quit-line referral resulted in a 3.3% quit rate compared to usual care (simple 
advice). Largely, in most other trials, it was not clear whether the effective 
adult brief interventions included additional support from signposting/referral to 
smoking cessation services. 
Summary 
Table 3.4 summarises the reviewed best practice evidence for tobacco cessation 
interventions in a primary care dental practice setting. Overall this dental 
review (SR 12) demonstrated an effectiveness of brief (or very brief) 
interventions delivered by trained dental professionals incorporating an oral 
examination component, compared to no intervention or usual care in increasing 
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tobacco abstinence rates for at least 6 months (OR=1.71, 95%CI 1.44, 2.03; n=14 
trials) among cigarette smokers and smokeless tobacco users. The effect was 
stronger (OR=2.38, 95%CI 1.70, 3.35) in the subgroup of adult smokers (n=5 
trials). Though the review showed no additional benefit of intensive intervention 
(gauged by number of personal contact) over brief intervention, the results were 
not synthesised here due to lack of reporting of effect sizes comparing both. 
The dental review (SR 12) concluded that: “Differences between the studies 
limit the ability to make conclusive recommendations regarding the intervention 
components that should be incorporated into clinical practice, however, 
behavioural counselling (typically brief) in conjunction with an oral examination 
was a consistent intervention component that was also provided in some control 
groups.” 
Table 3.4: Dental practice - best practice (high-quality) evidence for smoking cessation 
interventions in the systematic review (SR) 
 
Preventive interventions for smoking 
Strength of 
evidence 
(based on 
effect size) 
SR supporting 
evidence 
 
Ask/ 
Assess 
 
Use patient’s charts, medical records or 
health questionnaires to determine tobacco 
use status and at-risk groups 
 
Record findings from oral examination 
and relate to patient’s tobacco use 
Weak 
 
 
 
Strong 
 
 
SR 12 
 
 
Advise/ 
Arrange 
Brief (or very brief) behavioural advice > 
No intervention 
 
Personalised (tailored) feedback from the 
oral examination as to the oral effects of 
tobacco use 
 
Intensive intervention > brief intervention 
 
Effectiveness of interventions delivered 
by trained professionals (effect sizes not 
reported) 
Strong 
 
 
Strong 
 
 
 
Weak 
 
None 
 
 
SR 12 
 
Assist/ 
Referral 
 
Brief advice plus quit-line referral > 
simple brief advice to quit  
(only one trial reported 3.3% quit rate) 
 
Weak 
 
SR 12 
“>” greater-than sign – used to show greater effects 
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As reported previously (Section 3.4.1.3.1), there were no systematic reviews of 
alcohol interventions in the dental practice setting. 
In the next section, the evidence from the primary care medical or community 
pharmacy setting will be synthesised, which constitutes the majority of evidence 
found in this overview study. 
3.4.1.5.2 Medical or community pharmacy setting 
While there was only one systematic review in the dental practice setting (SR 
12), the remaining 13 high-quality reviews (SR: 1, 2, 6, 7, 8, 10, 11, 16, 17, 22, 
24, 25, 27) investigated tobacco cessation interventions delivered in a primary 
care medical or community pharmacy setting (Table 3.1). Of these, eight 
systematic reviews included trials/studies with preventive interventions solely 
for smoking (SR: 1, 2, 6, 8, 10, 16, 24, 27), four reviews included studies with 
preventive interventions for alcohol only (SR: 11, 17, 22, 25), while one review 
(SR 7) included studies delivering preventive interventions for both smoking and 
alcohol (as separate interventions). Thus, there were nine systematic reviews 
with smoking interventions (SR: 1, 2, 6, 7, 8, 10, 16, 24, 27), and five reviews 
with alcohol interventions (SR: 7, 11, 17, 22, 25). 
The results have now been organised in relation to the two major risk factors – 
smoking and alcohol. As mentioned earlier, the main findings from these high-
quality systematic reviews (and other reviews with lower quality) has been 
summarised in Table 3.1. 
SMOKING 
Risk factor assessment (Ask/ Assess) 
The majority of the included trials in the nine systematic reviews with smoking 
cessation interventions reported providing personalised feedback or tailored 
advice based on assessment of patient’s smoking status (effectiveness detailed 
in next section). However, trials did not provide information on how they 
assessed people at risk or how a patient’s smoking status was determined. Only 
one review (SR 10) reported that included trials involved screening sessions to 
record smoking status along with cholesterol, blood glucose, activity level, and 
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dietary habits - to calculate cardiovascular disease risk scores. The results from 
these screening sessions informed the treatment given, i.e. patients were 
provided tailored interventions based on individual risk profiles. However, none 
of the trials/studies reported how a patient’s self-reported smoking status was 
confirmed - in terms of duration, frequency, or type (cigarette, cigar, pipe). 
Behavioural preventive interventions (Advise/ Arrange) 
The nine high-quality systematic reviews (SR: 1, 2, 6, 7, 8, 10, 16, 24, 27) 
included smoking cessation interventions delivered by primary care professionals 
to adult smokers, and all reported cessation interventions (advice or counselling) 
to be more effective in helping smokers to quit compared to no intervention or 
usual care. These reviews reported strong strength of evidence for the 
effectiveness of smoking cessation interventions in a primary care setting (for 
example, effect sizes ranged from (RR 1.66, 95% CI 1.42 to 1.94) to (OR 6.91, 
95% CI 1.98–24.15) – detailed below. 
Type of interventions 
The behavioural preventive interventions included in these nine high-quality 
reviews were heterogeneous and comprised of various treatment approaches. 
There was quite a lot variation in the definitions, terminologies, and 
characteristics of behavioural interventions among these reviews. The most 
commonly used theoretical techniques for delivering smoking interventions 
were: motivational interviewing (SR: 1, 7, 8) and stages-of-change-based 
interventions (SR: 2, 16, 24, 27), which were included in most trials/studies 
within seven of the high-quality reviews. The other two reviews (SR: 6, 10) did 
not describe any theoretical model underpinning smoking cessation interventions 
- interventions were simply referred as structured advice/counselling (some 
based on 5A’s), with varying intensities (brief or intensive). The control groups 
in all included reviews consisted of either no intervention or simple (non-
structured) advice or interventions of lower intensities. The specific theory-
based interventions, for example, motivational interviewing and stages-of-
change-based interventions (explained in Chapter 1; Section 1.4.1.1), reported 
higher quit rates than simple advice or usual care (SR: 1, 2, 7, 8, 16, 24, 27). 
The findings from these reviews, with effect sizes (where reported), are now 
discussed.  
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The three most recent reviews (SR: 1, 7, 8) included trials/studies delivering a 
smoking cessation intervention involving Motivational Interviewing techniques, 
describing it as an approach in which smokers were given personalised feedback 
to help them build commitment and reach a decision to change in a non-
threatening manner (Miller and Rollnick, 2013). The majority of trials in these 
recent reviews described ‘brief’ motivational interventions as a tailored advice 
lasting 5-20 minutes, delivered by a primary care professional, with up to one 
follow-up visit. The ‘intensive’ motivational interventions, on the other hand, 
were described as tailored advice of more than 20 minutes in a single 
consultation (in-person), with more than one follow-up sessions (in-person or 
telephone). In the one high-quality Cochrane systematic review (SR 8), 
investigating the effectiveness of smoking cessation interventions delivered by 
primary care physicians (or medical practitioners), 42 trials were included. 
Following meta-analyses (effect sizes reported as relative risks (RR)), it found 
that amongst 17 trials comparing brief or very brief advice (which included face-
to-face advice plus printed materials) versus no advice (or usual care) there was 
a significant increase in the rate of quitting (RR 1.66, 95% CI 1.42 to 1.94) – 
additional 1 to 3% quit rates than control group. The duration of brief or very 
brief interventions were not reported in all included trials - one trial reported it 
as 2 minutes, while another reported 10 minutes advice. The estimated effects 
were detected to be higher (RR 1.84, 95% CI 1.60 to 2.13) amongst 11 trials 
where the interventions were more intensive (face-to-face advice plus self-help 
manuals and offering additional follow-up visits), however, there was no 
statistical difference between the intensive and brief (or very brief) subgroups. 
Direct comparison between brief and intensive smoking cessation interventions 
amongst 15 trials showed that, overall, there was a small but significant 
advantage of more intensive advice (RR 1.37, 95% CI 1.20 to 1.56), with a small 
benefit of follow-up visits. Overall, the Cochrane review (SR 8) concluded / 
indicated: “the potential benefit from brief simple advice given by physicians to 
their smoking patients. The challenge as to whether or not this benefit will be 
realised depends on the extent to which physicians are prepared to 
systematically identify their smoking patients and offer them advice as a matter 
of routine. Providing follow-up, if possible, is likely to produce additional 
benefit. However, the marginal benefits of more intensive interventions, 
including use of aids, are small, and cannot be justified as a routine intervention 
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in unselected smokers. They may, however, be of benefit for individual, 
motivated smokers.” 
The other two systematic reviews (SR 1, 7) lend support to these findings, where 
brief motivational interventions were effective in shorter duration and over one 
or two sessions. The Cochrane review (SR 1) amongst these two reviews, 
investigated whether motivational interviewing interventions help people to quit 
more than simple advice or usual care in a range of settings, including primary 
care, outpatient clinics and hospital settings. Only the findings from primary 
care trials have been synthesized here. The review reported that the effect size 
associated with brief motivational interventions (mostly 10-20 minutes, but also 
included some trials with less than 5-minutes advice) seem to be higher than 
that for intensive interventions (more than 20 minutes advice). The effect for 
brief intervention versus control was - RR of 1.69 (95% CI 1.34 to 2.12; 9 trials; N 
= 3651). This review further detected an increased probability of quitting with 
single brief sessions over multiple sessions – with both treatments (single and 
multiple sessions) producing positive outcomes. However, the review (SR 1) 
concluded that: “the results should be interpreted with caution, due to 
variations in study quality, treatment fidelity, between-study heterogeneity and 
the possibility of publication or selective reporting bias.” Two smoking cessation 
trials in the other high-quality review (SR 7) reported that intensive motivational 
interventions were more likely to increase quit rates compared to control groups 
(which received either simple advice or self-help didactic materials). Patients in 
one of these trials showed seven times greater odds of quitting in the 
motivational interviewing group, involving three in-person 20 minutes session, 
after 12 months (OR 6.91, 95 % CI 1.98–24.15); than in the control group which 
involved simple anti-smoking advice. The review (SR 7) however, concluded 
that: “as few as one motivational interviewing session may be effective in 
enhancing readiness to change and action directed towards reaching health 
behaviour-change goals.” 
The smoking cessation interventions based on Stages-of-Change (SR: 2, 16, 24, 
27) showed weaker evidence (limited to no evidence for effectiveness) 
compared to motivational interviewing interventions in a primary care setting. 
Not all the included trials/studies reported duration and number of sessions of 
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interventions which utilized a stages-of-change-based approach. The trials in 
one of the recent reviews (SR 2) established superiority of interventions based 
on stages-of-change in promoting smoking cessation in primary care over the 
long-term, compared to interventions based on other theories (for example, 
social cognitive theory or theory of planned behaviour). None of the trials, 
however, compared stages-of-change with motivational interviewing 
interventions. Only two trials in the review (SR 2) reported duration of the 
stage-based interventions, which ranged from 10-20 minutes each plus 2-3 
follow-up sessions and found positive results in the long-term (outcomes 
measured one year or longer post-intervention). However, effect sizes were not 
reported. 
Another Cochrane review included in this overview (SR 16), which had the 
highest quality score (AMSTAR=11), investigated the effectiveness of stages-of-
change-based interventions in helping smokers to quit in a range of healthcare 
settings. The review included three primary care trials of which one trial was a 
duplicate with the more recent review described above (SR 2). The evidence was 
not clear in this older review (SR 16) for primary care interventions, where two 
trials found no advantage for the stage-based smoking cessation interventions 
(face-to-face advice and/or tailored materials, pharmacotherapy for 
dependence) against usual care (simple advice or self-help materials). The 
effect sizes for primary care trials were not synthesised separately. Overall the 
review (SR 16) concluded that: “based on four trials using direct comparisons, 
stage-based self-help interventions (expert systems and/or tailored materials) 
and individual counselling were neither more nor less effective than their non-
stage-based equivalents. Thirty-one trials of stage-based self-help or counselling 
interventions versus any control condition demonstrated levels of effectiveness 
which were comparable with their non-stage-based counterparts. Providing 
these forms of practical support to those trying to quit appears to be more 
productive than not intervening. However, the additional value of adapting the 
intervention to the smoker’s stage of change is uncertain”. The findings were 
further supported by another high-quality systematic review (SR 24) which 
included ten primary care trials, of which six trials were duplicates with those in 
the more recent reviews (SR 1, 2, 6, 16). The remaining four trials (which were 
not duplicate) found limited to no evidence for an effect at short and long-term 
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follow-up on stages-of-change for smoking and smoking quit rates, based on the 
strength of the evidence (a rating system developed based on previously used 
best-evidence syntheses and odds ratios). However, the odds ratios for quitting 
smoking showed a positive trend at all follow-up measurements. The duration 
and number of sessions (dose response / intensity data) was not reported in any 
of these trials. 
The other high-quality systematic review (SR 10), which did not describe 
incorporating any theoretical model in the smoking cessation interventions, 
demonstrated the potential of a multifactorial lifestyle intervention, including 
five primary care trials. The smoking cessation advice was included as part of a 
healthy lifestyle advice intervention (along with dietary and physical activity 
advice), which aimed to lower cardiovascular disease risk and mortality. 
However, none of these trials included alcohol advice along with smoking 
cessation advice. The main outcome measures used in the included trials were 
changes in the validated cardiovascular disease risk score and mortality. A meta-
analysis was not conducted in this review (SR 10) due to a lack of homogeneity in 
outcomes and risk scores used. The review found strong evidence for the success 
of smoking cessation following multifactorial interventions; one of the trials 
even reported significant differences in smoking cessation at a 7-year follow-up. 
The significant benefits were associated with an intensive intervention, 
however, details of the nature of the intensive interventions were not provided 
by all included trials. Only one of the trials described intensive interventions as: 
two initial screening sessions for high risk individuals (cardiovascular risk); 
assessment of smoking status (along with blood pressure, dietary assessment and 
lipid profiling) at 4 and 8 months; and 10 weekly group sessions. Although there 
were significant benefits associated with smoking cessation, the trials did not 
report statistically significant change in cardiovascular disease risk score, 
compared to the control group. 
In the majority of trials/studies in all high-quality reviews, the behavioural 
advice was reinforced by providing or involving one or more of the following 
supportive strategies: written materials, self-help manuals or videos, or tailored 
feedback letters (SR: 1, 2, 6, 7, 8, 10, 16, 24, 27). However, none of these trials 
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assessed the effectiveness of interventions ‘with’ versus ‘without’ supporting 
materials or strategies. 
Intervention providers and training to deliver preventive interventions 
The smoking cessation interventions were effective irrespective of the 
intervention provider, for example, interventions delivered by a primary care 
physician, nurse or pharmacist resulted in positive results (increased quit rates). 
However, one of the reviews (SR 1) reported that motivational interviewing 
interventions, delivered by general medical practitioners, confer greater benefit 
(RR 3.49; 95% CI 1.53 to 7.94: 2 trials, N = 736) than those delivered by nurses 
(RR 1.24; 95%CI 0.91 to 1.68; 5 trials, N= 2256) or counsellors (RR 1.25; 95% CI 
1.15 to 1.36; 22 trials, N = 13,593). The review (SR 1), however, stated that this 
evidence should not be “overstated”, as it was based on findings from only two 
small trials. The nurse-delivered interventions had a non-significant effect on 
quit rates, which was supported by findings from another systematic review (SR 
6), where weaker evidence was found for an effect of smoking cessation 
interventions delivered by nurses when health promotion or smoking cessation 
was not a core component of their role. The other high-quality systematic 
reviews did not compare effects of interventions delivered by different primary 
care providers, the interventions were reported to be effective if delivered by 
any member of the primary care team, who received training on how to deliver 
behavioural preventive interventions (irrespective of care provider). However, 
the effects were not reported to compare interventions delivered by 
professionals ‘with’ versus ‘without’ training. The evidence was not clear in one 
high-quality Cochrane review (SR 16), where two of the primary care trials found 
no advantage for the training of physicians to deliver stage-based smoking 
cessation advice against usual care. 
The training characteristics were not reported in all trials/studies. Where 
reported, provider training involved workshops based on motivational 
interviewing or stages-of-change-based interventions. However, heterogeneity 
between training duration and number of sessions limit the ability to make 
recommendations in a primary care setting. Trials in one review (SR 1) reported 
motivational interviewing specific training, with training time ranging from 2 to 
40 hours workshop; another review (SR 7) reported training time ranging from 8 
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hours to 4 weeks; while trials in a further review (SR 24) reported 1.5-hour group 
session with role play to 1 or 2 half day trainings, or a 10-week lecture series. 
However, the longest training reported (10-week lecture series) was from a low-
quality trial and reported non-significant results, thus the findings need to be 
considered with caution. The provider training was reinforced by inclusion of 
manuals or booklets and discussions with other professionals. 
There was only one high-quality systematic review which reported smoking 
cessation interventions delivered by community pharmacists (SR 27). Both trials 
in this review included a large number of pharmacies in the UK: 51 pharmacies 
in one trial and 60 in the other, with a total of 976 smokers. The trials recruited 
pharmacy customers who expressed a wish to stop smoking. The interventions 
involved stages-of-change based training interventions (2-3 hours workshops) for 
pharmacists and pharmacy assistants, followed by a support programme 
involving counselling and record keeping, which were compared with the usual 
pharmacy support. One of the trials showed a statistically significant difference 
in self-reported cessation rates at 12 months: 14.3% versus 2.7% (p < 0.001); 
while the other trial showed a positive trend (not statistically significant) at 
each follow-up, with 12.0% versus 7.4% (p = 0.09) at nine months. Moreover, at 
the end of the intervention in both trials, a significant proportion of participants 
started using nicotine replacement therapy (87% and 98%). The review, however, 
concluded that: “the strength of evidence is limited because only one of the 
trials showed a statistically significant effect.” 
Referral to cessation services (Assist) 
Two reviews (SR 1, 8) included trials/studies which included referral to more 
intensive interventions/therapy, or local cessation services, or quit-lines as part 
of the smoking cessation interventions. The results were quite variable in the 
trials included in both these high-quality reviews regarding effectiveness of 
referral. One of the trials in one review (SR 1) had a control group where 
smokers were provided with simple advice based on the 5A’s (duration not 
reported) and referral to a state quit-line. The findings were compared to an 
additional 45-minute motivational counselling session with a health educator and 
two follow-up telephone calls. The intensive motivational interventions were 
more effective compared to the control group, however, controls also showed a 
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significant benefit. One of the trials in the other review (SR 8) found structured 
physician advice of 3-5 minutes plus referral to group therapy to be more 
effective than structured advice only. The effect sizes for these trials were not 
reported in these reviews (showing a weaker evidence), thus making it difficult 
to make comparisons with other intervention components. 
Summary 
Table 3.5 summarises the reviewed best practice evidence for smoking cessation 
interventions in a primary care medical practice setting. Overall nine high-
quality medical practice reviews demonstrated an effectiveness of theory-based 
‘brief’ interventions (motivational interviewing in particular) delivered by 
primary care professionals in a single session, following an assessment of a 
patient’s smoking status, compared to no intervention or simple advice in 
increasing smoking cessation rates. The lack of precise reporting of intervention 
duration and number of sessions (brief intervention described as 5-20 minutes; 
wide range), somewhat limited the inferences (regarding duration of sessions) 
that can be drawn from the review findings. It was reported that although longer 
interventions (10-20 minutes) were more effective in increasing quit rates, even 
very brief interventions of as little as 2 minutes have also been shown to be 
effective (RR 1.66, 95% CI 1.42 to 1.94). There was a small additional benefit of 
more intensive interventions (more than 20 minutes, and more than one follow-
up visits) compared to brief (or very) interventions (RR 1.37, 95% CI 1.20 to 
1.56). Interventions were reported to be effective if delivered by a primary care 
professional with minimal training in theory-based approaches, however, effect 
sizes were not reported to compare interventions delivered by professionals 
without training. Moreover, the exact training characteristics to deliver the 
intervention require better reporting and clarification by future researchers. 
Additional components (i.e. written materials, self-help aids) were reported to 
support behavioural advice, however, again, effect sizes were not reported to 
compare interventions ‘with’ versus ‘without’ supporting materials. 
Furthermore, this overview showed a lack of trials reporting effect sizes for 
referral pathway compared with behavioural advice for smoking cessation in 
primary care settings. 
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Table 3.5: Medical practice - best practice (high-quality) evidence for smoking cessation 
interventions in the systematic reviews (SRs) 
 
Preventive interventions for smoking 
Strength of 
evidence 
(based on 
effect size) 
SRs supporting 
evidence 
 
Ask/ 
Assess 
 
Assess and record patient’s smoking 
status 
 
Details of smoking assessment, for 
example, duration, frequency, or type 
(cigarette, cigar, pipe). 
 
Strong 
 
 
None 
SR: 1, 2, 6, 7, 8, 10, 
16, 24, 27 
 
 
 
Advise/ 
Arrange 
Theory-based or structured 
interventions > Simple advice or 
message to quit 
 
Brief (or very brief) motivational 
interventions > No intervention 
 
Intensive interventions (more than 20 
minutes) > Brief interventions 
(small but significant benefit) 
 
Single sessions > multiple sessions 
 
Physician > nurses or counsellors 
(reported in only two small trials) 
 
Training received by providers > no 
training (effects not reported) 
 
Effectiveness of additional 
components: written materials or self-
help aids (effect sizes not reported) 
 
Strong 
 
 
 
Strong 
 
 
Moderate 
 
 
 
Strong 
 
Weak 
 
 
None 
 
 
None 
 
SR: 1, 2, 7, 8, 16, 
24, 27 
 
 
SR: 1, 2, 6, 7, 8, 10, 
16, 24, 27 
 
SR: 1, 6, 7, 8 
 
 
 
SR: 1, 7, 8 
 
SR: 1 
 
 
 
 
 
 
 
Assist 
(Referral) 
Brief advice (3-5minutes) plus 
referral to cessation services > Brief 
advice only 
(effect sizes not reported) 
 
Weak 
 
 
SR 8 
“>” greater-than sign – used to show greater effects 
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ALCOHOL 
Risk factor assessment (Ask/ Assess) 
All five high-quality systematic reviews which included alcohol interventions (SR: 
7, 11, 17, 22, 25), reported the use of alcohol screening tools such as AUDIT, 
CAGE or another screening questionnaire to establish the level of alcohol 
consumption (low, moderate, or heavy drinkers). These questionnaires were 
either self-administered, or administered by research personnel in a clinic, or 
over the telephone before a patient’s appointment. The preventive 
interventions were later determined based on different levels of alcohol 
consumption. For example, patients with heavy alcohol consumption or 
dependence were more likely to need referral to specialist services or 
treatment, while for at-risk or moderate drinker, behavioural preventive 
interventions in primary care may be effective. The time taken to administer 
these screening tools in a primary care practice was not reported in these 
reviews. 
Two of the reviews (SR: 11, 25) included studies which used a multistep process 
for screening assessments, involving up to 30-minute interviews with research 
staff in order to assess whether individuals had heavy alcohol consumption or 
dependence (and should probably be referred for specialized treatment) as 
opposed to risky or moderate drinking (provided with behavioural interventions). 
Behavioural preventive interventions (Advise/ Arrange)  
Five high-quality systematic reviews (SR: 7, 11, 17, 22, 25) included behavioural 
preventive interventions to adult drinkers or alcohol users delivered by primary 
care providers. All these reviews reported behavioural advice or counselling to 
be more effective in reducing alcohol consumption compared to no intervention 
or usual care. There was strong evidence for effectiveness of alcohol 
interventions in the primary care settings for improving drinking behaviour 
outcomes, such as alcohol consumption, heavy drinking episodes, and drinking 
above recommended levels – effect sizes detailed below. 
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Type of interventions 
The most commonly used approaches for delivering a behavioural preventive 
intervention for reducing alcohol consumption were: simple advice/counselling 
to reduce consumption, motivational interviewing or cognitive behavioural 
therapy, with or without referral to specialist services. These interventions 
included various strategies to reinforce behavioural advice, such as: self-
completed action plans, written materials or educational leaflets specifically on 
alcohol or general health issues, written personalised feedback about alcohol 
consumption levels and adverse effects of alcohol consumption, follow-up visits 
or telephone counselling, drinking diaries, problem-solving exercises to complete 
at home, or goal setting. 
The most recent alcohol review (SR 7) included three trials which included 
individuals with at-risk (moderate) drinking. The effect sizes of meta-analyses of 
primary care alcohol trials were not synthesised separately, therefore the 
findings from individual trials are reported here. One of these trials was a 
smaller study (26 individuals) and included one 45-60 minutes in-person 
motivational interviewing session delivered by a nurse practitioner to hazardous 
alcohol drinkers. This trial resulted in a significant reduction in daily alcohol use 
at 6-weeks and a significant reduction in gamma-glutamyltransferase levels in 
the blood (a marker of alcohol consumption), versus no treatment (no advice) 
group. Another trial in this review (SR 7) supported these findings, however, 
instead of one long session, this trial included two motivational interviewing 
sessions of 20 minutes each. The third large trial (897 individuals) in this review 
(SR 7) included six motivational interviewing sessions delivered entirely over the 
telephone, with no face-to-face behavioural session. The trial showed 
significantly lower drinking days and amounts compared to control groups who 
received a mailed pamphlet (which also showed some positive effects). 
The second high-quality alcohol review (SR 11) included 23 trials, of which only 
one trial was duplicate with the more recent review (SR 7). The remaining 22 
trials in the review (SR 11) included behavioural counselling interventions of 
varying duration and number. The ‘brief’ interventions included in this review 
consisted of single or multiple sessions of motivational discussions without any 
underpinning theory (for example, advice, counselling, feedback); while 
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‘intensive’ interventions included various theoretical approaches (for example, 
motivational interviewing or cognitive behavioural strategies). The review (SR 
11) concluded that the evidence for the effectiveness in adult drinkers is 
strongest for brief (10-15-minutes) multi-contact interventions, compared to no 
intervention or very brief intervention (less than 5 minutes) or intensive 
interventions (more than 20 minutes). Among adults receiving interventions, the 
consumption decreased by 3.6 drinks per week from baseline (95% CI, 2.4 to 4.8 
drinks/wk; 10 trials; 4332 participants). The overall strength of evidence was 
judged to be moderate. The review showed that very brief interventions (less 
than 5 minutes) compared with brief interventions (5-20 minutes) were less 
effective in reducing alcohol consumption (5-8% increased abstinence in very 
brief versus 7-12% in brief intervention); however, based on only one head-to-
head study, it concluded that there was “insufficient evidence to determine how 
very brief and brief intensity interventions compare for improving intermediate 
outcomes”. The review (SR 11) also provided comparison between brief multi-
contact and intensive multi-contact interventions and found both to be effective 
in reducing alcohol consumption. However, brief multi-contact interventions 
were found to be the most effective and their effect lasted for several years. 
The reported benefits were similar for men and women in a subgroup analysis.  
The third high-quality alcohol review (a Cochrane review) (SR 17) included in 
total 24 trials, of which 11 trials were duplicates of those in the more recent 
review (SR 11) and the results of which have been discussed in the previous 
paragraph. Of the remaining 13 trials, six trials were excluded in the more 
recent review (SR 11), the main reasons reported for exclusions being poor 
quality and wrong PICOTS (Populations, Interventions, Comparators, Outcomes, 
Timing, Settings). Thus, the findings of these poor-quality trials had not been 
synthesised in this overview study, as the target was to get the best quality 
evidence. The remaining seven trials (not duplicate with recent reviews) 
compared a brief intervention with a control intervention (no intervention or 
usual care or simple advice), and showed that individuals receiving a brief 
intervention drank less alcohol per week than those receiving a control 
intervention after follow-up of one year or longer (mean difference: -38 
grams/week, 95% CI: -54 to -23). However, there was considerable 
heterogeneity between the findings of the trials. The duration of effective brief 
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interventions ranged from 5-10 minutes, with 2-5 visits over a year; and the 
advice was supported by written materials or self-help manuals. However, the 
evidence needs to be considered with caution as five of these seven trials were 
reported in this review to have unclear or inadequate risk of bias (concealment 
of allocation). While only two trials had adequate risk of bias. Where compared, 
intensive interventions (more than 20 minutes) showed a little evidence (non-
significant) of greater reduction in alcohol consumption than brief intervention 
(mean difference = -28, 95%CI: -62 to 6 grams/week). The review (SR 17) 
concluded that future trials should focus on defining the most effective 
components of interventions. 
The review (SR 22) had in total 18 alcohol trials (face-to-face interventions), of 
which the majority (15 trials) were duplicate with those in recent reviews (SR 
11, 17): six trials duplicate with SR 11; and ten trials duplicate with SR 17 (one 
trial common in both SR 11 and 17). The remaining three trials had 
methodological quality assessed in the review (SR 22) as: two trials with low 
quality and the other trial with a high-quality score. The high-quality trial 
included a brief intervention of 10-15-minutes duration in the first session, 
followed by a booster session of 90-minutes with no written materials provided 
to the patients. The two low-quality trials included a brief intervention of 5 
minutes duration in the first session, followed by a booster session of 15-20 
minutes, with written materials provided to patients at both visits. The 
interventions were delivered by psychologists, social workers, and advanced 
medical students in one trial, and by nurses in another trial. All three trials 
reported no positive/significant effects of the alcohol brief interventions 
compared to usual care or no interventions. 
The final high-quality alcohol review (SR 25) had in total 12 trials, of which 11 
trials were duplicate with those in the more recent reviews (SR 11 and 17), and 
the remaining trial was excluded from the recent reviews (SR 11 and 17) as it 
had wrong PICOTS, no pre-specified outcomes and quality of this trial was 
judged to be fair. The findings from this trial showed that brief multi-contact 
interventions significantly reduced average daily alcohol consumption compared 
with no intervention. However, the details of the intervention were not clearly 
reported, for example, duration, number of sessions, and intervention provider. 
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Intervention provider and training to deliver preventive interventions 
Overall, the alcohol preventive interventions were found to be effective 
irrespective of the intervention provider in a primary care setting (physician or 
non-physician). The interventions were delivered by a general practitioner, 
nurse practitioner, health educator, or counsellor; there were no pharmacist 
delivered alcohol interventions. One of the reviews (SR 11) compared 
interventions delivered by a primary care provider and research personnel, and 
found greater reduction for interventions delivered by primary care providers 
(WMD, -4.0 drinks per week, 95% CI, -5.4 to -2.6) compared to those delivered 
primarily by research personnel (WMD, -3.0, 95% CI, -5.0 to -1.0). 
Alcohol interventions were more effective when primary care providers received 
training on how to deliver behavioural preventive interventions; however, effect 
sizes were not reported to compare interventions delivered by a professional 
‘with’ versus ‘without’ training. Again, not all the included trials/studies 
reported details of the training received by healthcare professionals (for 
example, duration and number of training sessions). There was only one high-
quality review (SR 11) in which most of the included trials/studies reported 
details of training a primary care provider to deliver effective screening and 
behavioural interventions for alcohol misuse. Where reported, training duration 
ranged from as little as 15 minutes to as long as 6 to 8 hours, full-day workshops, 
or a 4-week training in motivational interviewing principles. One of the trials in 
another review (SR 7) reported that intensive interventions included training 
primary care providers in motivational interviewing or cognitive-behavioural 
skills. 
Referral to specialist services (Assist) 
Referral to more intensive interventions/therapy or specialized treatment 
services was mentioned in only one alcohol review (SR 11). Some of the 
trials/studies in this review reported assessing patients at the screening stage as 
to whether they had alcohol abuse or dependence, in which case they referred 
them for specialized treatment. However, none of these trials reported 
outcomes for referral, i.e. evaluating the number/proportion of individuals who 
followed up with referrals and whether it worked when individuals got there.  
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Summary 
Table 3.6 summarises the reviewed best practice evidence for alcohol 
interventions in a primary care medical practice. Overall, it could be concluded 
from all high-quality systematic reviews for reducing alcohol consumption that 
brief (10-15 minutes) multi-contact (two or more follow-up visits over a year) 
motivational interventions were most effective (consumption decreased by 3.6 
drinks per week from baseline; 95% CI, 2.4 to 4.8 drinks/wk) (SR 11); 
interventions of 5 minutes duration were also reported to be effective in equally 
higher quality review (mean difference: -38 grams/week, 95% CI: -54 to -23) (SR 
17). Intensive interventions were also reported to be effective, however, where 
compared, the reported effect rates were smaller for intensive compared to 
brief interventions (non-significant) (SR 11). There was little or insufficient 
evidence for the effectiveness of very brief (less than 5 minutes) interventions in 
reducing alcohol consumption (5-8% increased abstinence in very brief versus 7-
12% in brief intervention) (SR 11). The effective brief advice was further 
supported by written materials or self-help manuals, however, effect sizes were 
not reported to compare intervention ‘with’ and ‘without’ supporting materials. 
This overview showed an overall lack of studies reporting local referral pathway 
for reducing alcohol consumption and its effectiveness compared to brief 
interventions or usual care. 
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Table 3.6: Medical practice - best practice (high-quality) evidence for alcohol reduction 
interventions in the systematic reviews (SRs) 
 
Preventive interventions for alcohol 
Strength of 
evidence 
(based on 
effect size) 
SRs supporting 
evidence 
 
Ask/ 
Assess 
Assess and record patient’s alcohol 
consumption levels (moderate or 
dependence), using validated 
screening tools – to determine 
treatment options 
 
Strong  SR: 7, 11, 17, 22, 
25 
 
 
 
 
Advise/ 
Arrange 
 
Behavioural interventions (face-to-
face tailored advice/counselling) > No 
intervention or usual care 
 
Brief (5-20 minutes) interventions > 
no intervention or very brief or 
intensive intervention 
 
Multiple sessions > single sessions 
 
Intensive (more than 20 minutes) > 
brief intervention 
 
Very brief (less than 5-minutes) > 
brief intervention 
 
Primary care providers (physician, 
nurses, health educator) > research 
personnel  
 
Training received by providers > no 
training (effects not reported) 
 
Additional components to support: 
written materials or self-help manuals 
(effects not reported) 
 
Strong 
 
 
 
Strong 
 
 
 
Strong 
 
Weak 
 
 
Weak 
 
 
Strong 
 
 
 
None 
 
 
None 
 
SR: 7, 11, 17, 22, 
25 
 
 
SR: 11, 17, 22 
 
 
 
SR: 11, 17 
 
SR 11 
 
 
SR 11 
 
 
SR: 11 
 
 
 
 
 
 
Assist 
(Referral) 
Referral to specialized treatment 
services 
(outcomes for effectiveness not 
reported) 
 
None  
“>” greater-than sign – used to show greater effects 
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3.4.1.6 Summary of systematic overview of systematic reviews 
This overview study aimed to identify best practice evidence emerging from all 
primary care settings (dental/medical/pharmacy), primarily from the dental 
perspective, i.e. giving higher weighting to dental review findings, and 
considering higher quality and more recent medical/pharmacy findings 
applicable in a dental practice setting. The key findings from high-quality 
systematic reviews that constitute this systematic overview had been presented 
in respective tables at the end of each section (Tables: 3.4, 3.5 and 3.6). 
There was only one high-quality systematic review in the dental practice setting 
relating to smoking cessation and no high-quality reviews on alcohol reduction 
(not even mid- or low-quality reviews) in a dental practice setting were 
available. However, best practice has been developed from synthesising and 
drawing from the best evidence from other primary care (medical/pharmacy) 
settings, which could be adapted / adopted to dental practice, along with 
synthesising with the recommendations (evidence) within dental clinical 
guidelines (Section 3.4.2). 
Overall, for smoking cessation interventions this systematic overview showed 
strong evidence for the effectiveness of brief, in-person, motivational 
interventions in a single session, delivered by primary care professionals 
(irrespective of provider type – physician, nurse, or pharmacist), following an 
assessment of a patient’s smoking status, in comparison with no intervention or 
usual care in a primary care setting for adults. Though, longer brief 
interventions (10-20 minutes) and intensive interventions (more than 20 
minutes, with follow-up visits) have shown to be effective in increasing quit 
rates (marginal additional benefit over shorter duration), very brief 
interventions (less than 5 minutes) have also shown a significant and comparable 
effect, and thus should be trialled in a dental practice setting. The lack of detail 
particularly in relation to duration made it difficult to make a conclusion 
regarding precise specification of the duration of element of the “brief” 
interventions. The effect sizes showing the effectiveness of training primary 
care providers, including referral to the smoking cessation services, and 
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supporting materials along with brief intervention were not reported, thus 
showing a weaker evidence. 
For reducing alcohol consumption, overall it could be concluded that: after 
assessing/recording patient’s alcohol consumption levels, a ‘brief’ in-person 
motivational intervention delivered by primary care professional (physician or 
nurse) with one or more follow-up visits over a year are likely to have a greater 
effect for sustained alcohol reduction compared to no intervention or very brief 
intervention or intensive interventions. Though, 10-15 minutes multi-contact 
interventions were reported most effective, brief interventions of 5 minutes 
duration were also reported to be equally effective, and thus should be trialled 
in a dental practice setting. Again, the duration of the effective ‘brief’ 
intervention ranged from 5-20 minutes (wide range) in the high-quality reviews, 
thus making it difficult to make a conclusion regarding precise specification of 
the duration of element of the “brief” interventions. Referral to specialist 
services was suggested in cases of alcohol dependence, however, again, 
outcomes for effectiveness of referral were not reported. Similarly, the effect 
sizes showing the effectiveness of training primary care providers and including 
supporting materials along with brief intervention were not reported, thus 
showing a weaker evidence. 
Lastly, this overview showed a lack of combined interventions for smoking and 
alcohol (only isolated interventions were reported). 
  
Chapter 3  
 
 
126 
3.4.2 Clinical Guidelines 
The recommendations from the high-quality clinical guidelines regarding 
assessment of major oral cancer risk factors and various components of 
behavioural preventive interventions (advice, signposting/referral) that could be 
delivered in a primary care practice setting (dental/medical/pharmacy) will now 
be reviewed in this section. The section outlines the clinical guideline selection, 
characteristics, quality assessment and synthesis of the identified clinical 
guidelines as a separate ‘stream’. 
3.4.2.1 Guideline selection 
The search strategy retrieved 2477 potentially relevant records through 
database searches and 12 additional records were identified through 
organization or health board website searches. All included records were 
screened (title and abstract) and of these, 59 records were selected for full text 
review. Finally, 27 clinical guidelines were included in this overview. One of the 
included guidelines (MQIC, 2015) was presented as a summary document and was 
based on another large/detailed guideline document (Fiore et al., 2008). Thus, 
both guidelines were considered as a single document in this overview, and 
referred to as CG 23 (Table 3.7). Thus, in total, there were 26 clinical guidelines 
(nCG= 26) included in this overview (Figure 3.3). 
The reference lists of the included clinical guidelines were hand searched for 
any relevant clinical guidelines (and systematic reviews) to be included in this 
overview. Some of the referenced systematic reviews (which met our inclusion 
criteria) in the included guidelines were already included in this overview (SR: 1, 
6, 8, 12, 16, 27). Thus, showing that a comprehensive search strategy was 
followed in this overview to promote inclusion of all relevant systematic reviews 
and clinical guidelines. 
A list of excluded guidelines (n=32) is presented, with the reasons for exclusion, 
in Appendix 5. 
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Figure 3.3: PRISMA four-phase flow diagram - for included clinical guidelines 
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3.4.2.2 Guideline characteristics 
This overview included clinical guidelines from different countries/regions across 
the world: Australia, Europe, India, New Zealand, United Kingdom, and United 
States. As mentioned in Section 3.3.3, the clinical guideline search was limited 
to the last ten years, thus all included clinical guidelines were published 
between 2006 and 2015 (guideline search was carried out in August 2015). During 
data extraction, published updates of three included guidelines were found. 
Thus, it was decided to include the updated versions of these clinical guidelines 
in this overview, which were CG: 1, 2, 3 (Kottke et al., 2016; Piepoli et al., 
2016; RACGP, 2016). 
The 26 clinical guidelines included recommendations based, or drawn from, the 
other existing (older) guidelines, relevant systematic reviews, research/trial 
evidence, and the opinion of experts and experienced practitioners. The 
majority of the guidelines provided details of the strategy used to search for the 
evidence-base to develop the guideline, e.g. search terms used, sources 
consulted, and dates of the literature covered, thus showing rigour in the 
development of the guideline (which was reflected in their quality scores – high 
AGREE II scores). However, a few guidelines did not provide details of the 
strategy used to search for the evidence-base to develop the guideline, and thus 
scored low on AGREE II (Section 3.4.2.3). 
The various guideline characteristics have now been presented for dental and 
medical (or pharmacy) settings as separate sub-sections. 
3.4.2.2.1 Dental practice setting 
Of the 26 clinical guidelines, five included recommendations exclusively for a 
primary care dental practice (CG: 6, 8, 9, 11, 16); while of the other 21 clinical 
guidelines (medical/pharmacy), some included dental professionals along with a 
range of primary care medical professionals as their target users (see Table 3.7 
at the end of section 3.4.2.2.2). The dental clinical guidelines (CG: 6, 8, 9, 11, 
16) were designed for use by the whole primary care dental team, including 
dentists, dental therapists, dental hygienists, dental nurses, and oral health 
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educators. Directors of public health, dental public health consultants and 
strategic leads who plan local dental services were also reported as target users 
of these dental clinical guidelines (CG: 6, 8, 9, 11, 16).  
All five dental guidelines mentioned oral cancer as one of the target health 
conditions together with other oral health conditions (for example, periodontal 
diseases, tooth loss, tooth wear, halitosis, stained teeth). Four guidelines 
included recommendations for delivering preventive interventions (including risk 
factor assessment, behavioural advice and/or referral) for smoking, smokeless 
tobacco, and/or alcohol, along with advice on diet, oral hygiene practices, and 
the use of fluoride (CG: 6, 8, 11, 16). One dental guideline included advice for 
tobacco use only (smoking and smokeless tobacco) (CG 9). 
3.4.2.2.2 Medical or community pharmacy setting 
The majority, 21 out of the 26 clinical guidelines, included recommendations for 
delivering preventive interventions (including risk factor assessment, 
behavioural advice and/or referral) in a primary care medical or pharmacy 
setting. The clinical guidelines aimed to help tackle a range of major behaviours 
including smoking, smokeless tobacco, and alcohol misuse. Similar to the 
systematic reviews (Section 3.4.1), the main risk factors discussed were smoking 
and alcohol in all included guidelines. These behaviours were linked to a range 
of health problems and chronic diseases, such as cardiovascular disease, type 2 
diabetes, and cancer. The medical guidelines were designed for use by the 
whole primary care medical (or pharmacy) team and included a range of health 
care professionals (target users) who could deliver a preventive intervention, 
targeting various health conditions. Some of the guidelines also reported dental 
professionals as their target users (Table 3.7). Three of the primary care medical 
guidelines mentioned preventing oral cancer along with other chronic diseases 
(CG: 3, 17, 23). 
A summary of the type of interventions within the 21 medical guidelines is 
shown below: 
Chapter 3  
 
 
130 
§ Smoking cessation interventions were included in the majority of the 
guidelines - 17 guidelines (CG: 1, 2, 3, 4, 5, 7, 12, 13, 14, 18, 19, 20, 22, 
23, 24, 25, 26); 
§ Smokeless tobacco interventions were included in three guidelines (CG: 
17, 19, 23), one of these guidelines (CG 17) included advice exclusively 
for smokeless tobacco use; 
§ Alcohol reduction interventions were included in nine guidelines (CG: 1, 
2, 3, 4, 10, 14, 15, 21, 25). 
Table 3.7 presents the various recommendations made about the assessment of 
major risk factors and delivering behavioural preventive interventions for each 
of the included clinical guidelines (n=26), along with target risk factors, and 
target users for these guidelines. 
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Table 3.7: Recommendations from all included clinical guidelines (n=26) about oral cancer risk factor assessment and delivering preventive interventions 
 
Clinical 
Guideline 
(CG) ID 
Target 
users 
Risk 
factors (target 
population) 
Ask/ 
Assess Advise/ Arrange Assist/ Referral 
CG1 
 
(Kottke et al., 
2016) 
Health care 
professionals- all 
clinicians, clinics 
and health care 
delivery systems, 
and other expert 
audiences 
 
Tobacco and 
alcohol 
(Adults aged 18 
years or more) 
 
 
Tobacco: 
All adults to be screened for 
tobacco use. 
Record a patient's smoking 
status as a vital sign or list 
tobacco use or exposure as a 
specific problem in the 
medical records. 
 
Alcohol: 
Screen individuals using 
validated tool for 
risky/hazardous drinking. Ask 
a single question about heavy 
drinking, or administer a 
written self-report instrument 
(AUDIT, AUDIT-C). 
 
Tobacco: 
Clinicians should advise patients 
who smoke to quit. Offer 
behavioural (motivational) or 
pharmacologic interventions. 
Agree upon one or more 
SMART goals. 
 
Alcohol: 
Offer a brief behavioural 
intervention for individuals who 
screen positive; 10-15 minutes, 
multi-contacts. Agree upon one 
or more SMART goals. 
 
Tobacco: 
Offer more intensive 
counselling or referrals 
 
Alcohol: 
For alcohol dependence 
refer to chemical 
dependency counsellor or 
program 
 
CG2 
 
(Piepoli et al., 
2016) 
Healthcare 
professionals in 
their clinical 
practice: primary 
Smoking 
 
Alcohol- as part of 
recommendations 
Smoking: (5A’s) 
Ask: Systematically inquire 
about smoking status at every 
opportunity. 
Smoking: 
Advise: Unequivocally urge all 
smokers to quit. 
Arrange: Arrange a schedule of 
Smoking: 
Assist: Agree on a 
smoking cessation 
strategy, including setting 
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care, acute hospital 
settings and cardiac 
rehabilitation 
centre 
 
on nutrition 
 
Assess: Determine the 
person’s degree of addiction 
and readiness to quit. 
 
Alcohol: 
not reported 
 
follow-up.  
 
Alcohol: 
Consumption of alcoholic 
beverages should be limited to 2 
glasses per day (20 g/d of 
alcohol) for men and 1 glass per 
day (10 g/d of alcohol) for 
women. 
 
a quit date, behavioural 
counselling, and 
pharmacological support. 
 
Alcohol: 
not reported 
 
CG3 
 
(RACGP, 
2016) 
General 
practitioner, 
clinicians and 
practice nurses 
 
Smoking, alcohol 
and sexual 
behaviours 
Smoking: 
Ask about patient’s interest in 
quitting. 
Assess nicotine dependence 
 
Alcohol: 
All patients should be asked 
about the quantity and 
frequency of alcohol intake 
from age 15 years. 
 
Smoking: 
Advise to stop smoking, agree 
on quit goals and offer 
pharmacotherapy if appropriate. 
Follow-up to support 
maintenance and prevent relapse 
using self-help or 
pharmacotherapy. 
 
Alcohol: 
Those with at-risk patterns of 
alcohol consumption should be 
offered brief advice to reduce 
their intake. Provide 
interventions using brief 
motivational interviewing 
targeted at high-risk use; 5-15 
minute advice. Training for 
clinicians and practice nurses. 
 
Smoking: 
Offer referral to a 
proactive telephone call-
back cessation service (e.g. 
the Quitline 13 7848), or 
motivational interviewing. 
 
Alcohol: 
not reported 
 
Chapter 3  
 
 
133 
 
CG4 
 
(RACGP, 
2015) 
General 
practitioners (GPs) 
and practice staff 
(the GP practice 
team) 
 
Lifestyle risk 
factors of smoking, 
nutrition, alcohol 
and physical 
activity (SNAP) 
Smoking: (5 A’s) 
Ask- identify patients with 
smoking 
Assess: Amount smoked, 
dependence, readiness to 
change. Smoking status 
should be assessed for every 
patient aged 10 years and 
older. 
 
Alcohol: 
All patients aged 15 years and 
older should be asked about 
the quantity and frequency of 
their alcohol intake. 
Assess: Alcohol intake and 
readiness to change; AUDIT 
and AUDIT-C 
 
Smoking: 
Advise/agree: Brief advice and 
motivational interviewing, set a 
quit date (quit-plan). 
Arrange: Quit-line, follow-up 
visit 
 
Alcohol: 
Advise/agree: Information and 
motivational interviewing 
Arrange: Drug and alcohol 
services, follow-up visit 
 
Smoking: 
Assist: Quit-line, consider 
pharmacotherapy 
 
Alcohol: 
Assist: Drug and alcohol 
services, pharmacotherapy 
 
 
CG5 
 
(Siu, 2015) 
 
Primary care 
providers, 
including 
clinicians, 
physicians, nurses, 
psychologists, 
social workers, and 
cessation 
counsellors 
 
Tobacco smoking Smoking: (5 A’s) 
Asking every patient (all 
adults) about tobacco use 
 
Assessing the willingness of 
all tobacco users to make an 
attempt to quit 
Smoking: 
Behavioural interventions alone 
(in-person behavioural support 
and counselling, telephone 
counselling, and self-help 
materials) or combined with 
pharmacotherapy substantially 
improve achievement of tobacco 
cessation. 
Brief sessions (<10 min) 
Smoking: 
Assist all tobacco users 
with their attempt to quit 
Arrange follow-up 
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effectively increase the 
proportion of adults who 
successfully quit smoking and 
remain abstinent for 1 year. 
Although less effective than 
longer interventions, even 
minimal interventions (<3 min) 
have been found to increase 
cessation rates in 
some studies 
 
CG6 
 
(NICE, 2015) 
Dental care 
professionals, e.g. 
dental hygienists, 
dental nurses, 
dental therapists, 
dental technicians 
and orthodontic 
therapists. 
Directors of public 
health, dental 
public health 
consultants, 
educators 
 
Smoking and 
alcohol 
Smoking: 
Ask and record whether the 
person uses tobacco.  
 
Alcohol: 
Consider asking people about 
their alcohol use 
 
 
Smoking: 
Offer brief advice and  
follow recommendations from 
CG 22 (NICE ph10 guideline). 
 
Alcohol: 
Follow recommendations from 
CG 21. 
 
Consider delivering oral health 
improvement messages in a 
variety of formats and using 
different media to meet the 
needs of different groups. 
Trained professionals 
 
Smoking: 
Offer to refer them to the 
local stop smoking service 
CG7 
 
(Kralikova et 
All professions in 
clinical medicine – 
as recommended 
Tobacco 
 
Document for each patient 
identified and selected as 
smoker; and encourage to 
From brief intervention (10-
minute) at each clinical contact 
with patients up to intensive 
Not reported 
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al., 2015) 
 
by WHO mainly 
doctors, nurses, 
pharmacists and 
dentists 
 
stop treatment. It includes psycho-
socio-behavioural support and 
pharmacotherapy. 
CG8 
 
(PHE, 2014a) 
 
Primary dental care 
teams  
 
Smoking (or 
tobacco use) 
Alcohol 
 
Smoking (or tobacco): 
Ask – establish and record 
smoking status  
 
Alcohol: 
Ask – establish and record if 
the patient is drinking above 
low risk (recommended) 
levels 
 
Smoking (or tobacco): 
Advise – advise on benefits of 
stopping and that evidence 
shows the best way is with a 
combination of support and 
treatment 
 
Alcohol: 
Advise – offer brief advice to 
those drinking above 
recommended levels  
 
Training: in undergraduate or 
dental setting; in line with 
national training standards. The 
minimum standard that every 
dental practice member should 
achieve is ‘Very brief advice, 
just 30 seconds to ask, advise 
and act’. 
 
Smoking (or tobacco): 
Act – offer help referring 
to local stop smoking 
services 
 
Alcohol: 
Act – refer or signpost 
high risk drinkers to their 
GP or local alcohol 
support services 
 
CG9 
 
(PHE, 2014b) 
Dental 
professionals or 
dental teams, 
commissioners and 
Tobacco 
(refers to PHE 
2014a, and NICE 
guidelines) 
Establish and record smoking 
status (ASK)- at least once a 
year. Is the patient a smoker, 
ex-smoker or a non-smoker? 
Very brief advice 
Advise on the personal benefits 
of quitting (ADVISE) 
 
Offer help (ACT) 
Refer to local stop 
smoking services 
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educators   
CG10 
 
(CDC, 2014) 
 
For alcohol 
screening: 
receptionists, 
medical assistants, 
nurses 
To deliver the brief 
interventions: 
primary care 
practitioners/physic
ians, physician 
assistants, nurse 
practitioners, 
nurses, health 
educators, or other 
allied health 
professionals  
 
Alcohol use Patients should be screened at 
least annually 
 
The ‘Single Question Alcohol 
Screen’ or AUDIT (1–3) 
 
Ask if they would like your 
medical advice  
 
Patients who screen positive for 
risky drinking need a brief 
intervention (5-15 minutes). 
Tailoring the plan for alcohol 
brief interventions to your 
practice; establish a goal and 
develop an action plan. 
Provide feedback about 
screening results. 
Establish a follow-up system to 
monitor patients’ drinking, 
provide encouragement and 
support. 
Determine who needs training- 
since every primary care practice 
is different. 
 
For dependence:  
Offer the patient a referral 
to further treatment 
 
A qualified clinician in the 
practice to manage 
dependent patients. 
 
Offering medications for 
alcohol dependence, 
particularly if patients 
refuse to go to traditional 
alcohol treatment. 
 
CG11 
 
(SDCEP, 
2014) 
 
Clinicians who are 
involved in the 
prevention and 
treatment of 
periodontal 
diseases 
e.g. dentists, dental 
therapists, dental 
hygienists and oral 
health educators 
 
Smoking and 
Alcohol 
 
(patients both at 
risk of and with 
periodontal 
diseases)  
 
Smoking: 
Ask the patient if he/she 
(still) smokes (or uses 
smokeless tobacco) and 
record the response. Ask if 
the patient is interested in 
stopping smoking. 
 
Alcohol: 
Assess patient’s alcohol 
consumption. Ask about 
his/her daily/weekly alcohol 
Smoking: 
Discuss effect smoking has on 
his/her oral health and general 
health and the benefits of 
stopping. Inform the patient that 
stopping smoking is the single 
most important thing he/she can 
do to improve not only oral 
health but general health as well. 
Offer relevant health promotion 
material (e.g. ‘Aspire’ 
magazine) 
Smoking: 
Refer to smoking cessation 
services if necessary 
 
Alcohol: 
Advise the patient to see 
his/ her general medical 
practitioner for further 
advice and help. 
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consumption and convert into 
units. Ask patient’s 
willingness to discuss this. 
 
 
Alcohol: 
Outline the possible harmful 
effects of excessive alcohol 
consumption. Advise them to 
visit the Alcohol Focus Scotland 
website (www.alcohol-focus-
scotland.org.uk) for further 
advice and help. 
 
CG12 
 
(New Zealand 
Health, 2014) 
 
All health care 
workers, managers 
of health care 
services, 
practitioners in 
stop-smoking 
services 
 
Smoking (or 
tobacco) 
The ABC pathway 
Ask about and document 
every person’s smoking 
status. 
Give brief advice (face-to-face) 
to stop to all patients who smoke 
at every opportunity. Can give 
this advice in 30 seconds. 
Tailored brief advice and self-
help materials. 
Seek appropriate training 
 
Strongly encourage every 
person who smokes to use 
Cessation support (a 
combination of 
behavioural support and 
stop-smoking medicine 
works best) and offer them 
help to access it. Refer to, 
or provide, cessation 
support to everyone who 
accepts the offer. 
 
CG13 
 
(Zwar et al., 
2014) 
 
General practice 
team (GP or 
practice nurse) 
 
Smoking 
 
5As approach 
Ask- regularly ask all patients 
if they smoke and record the 
information in the medical 
record. 
Assess- interest in quitting, to 
help tailor advice to each 
smoker’s needs and stage of 
Advise- all smokers to quit in a 
clear, unambiguous way such as 
‘the best thing you can do for 
your health is to stop smoking’. 
 
Arrange: follow-up visits to 
increase the likelihood of long-
term abstinence. 
Assist: all smokers should 
be offered help to quit. 
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change. Nicotine dependence 
should also be assessed as 
this helps to guide treatment. 
Assessment of other relevant 
problems, such as mental 
health conditions, other drug 
dependencies and 
comorbidities. 
 
 
When time is short, use the 
approach of ‘very brief advice’- 
Ask, Advise and Refer. 
 
CG14 
 
(NICE, 2014) 
 
Practitioners, 
policy makers, 
researchers, 
individuals, health 
and social care 
organisations and 
other service 
providers 
 
Range of 
behaviours 
including smoking, 
alcohol misuse 
 
Assess participants' health in 
relation to the behaviour and 
the type of actions needed 
 
Use a very brief or brief 
intervention to motivate people 
to change behaviours that may 
damage their health. The 
interventions should also be 
used to inform people about 
services or interventions that can 
help them improve their general 
health and wellbeing. 
Tailor interventions to meet 
participants' needs. 
Train professionals 
 
Direct and refer people to 
specialist support 
services 
 
CG15 
 
(Moyer and 
Preventive 
Services Task, 
2013) 
 
Primary care 
practices or 
primary care 
clinicians  
 
Alcohol misuse 
 
Clinicians should screen 
adults aged 18 years or older 
for alcohol misuse 
 
AUDIT, AUDIT-C, or 
Single-question screening, 
such as asking, “How many 
times in the past year have 
Provide persons engaged in 
risky or hazardous drinking with 
brief behavioural counselling 
interventions to reduce alcohol 
misuse. 
Interventions may be delivered 
by face-to-face sessions, written 
self-help materials, computer- or 
Not reported 
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you had 5 (for men) or 4 (for 
women and all adults older 
than 65 y) or more drinks in a 
day?” 
 
Web-based programs, or 
telephone counselling. Brief 
multi-contact (each contact is 6 
to 15 minutes) behavioural 
counselling seems to have the 
best evidence of effectiveness; 
very brief (≤ 5 minutes) 
behavioural counselling has 
limited effect. 
 
CG16 
 
(SDCEP, 
2012) 
 
Primary care dental 
team 
Tobacco and 
alcohol 
 
Tobacco: 
Assess the patient’s smoking 
habits: follow the ‘ask’ and 
‘assess’ elements of the 5 ‘A’ 
protocol 
 
Alcohol: 
Ask each patient about their 
weekly alcohol consumption 
in units and the largest 
number of units consumed in 
the past week. Consider using 
a validated alcohol screening 
tool to gain an objective 
measure of alcohol 
consumption. 
 
Tobacco: 
After ‘ask’ and ‘assess’, either 
‘refer’ the patient or carry out 
the remaining ‘advise’, ‘assist’ 
and ‘arrange follow-up’ 
elements of the 5 ‘A’ protocol. 
 
Alcohol: 
Advise high-risk drinkers about 
possible harmful effects of 
excessive alcohol consumption 
Tobacco: 
After ‘ask’ and ‘assess’, 
refer the patient to a 
smoking cessation service 
 
Alcohol: 
Advise to see their general 
medical practitioner and/or 
to visit the Alcohol Focus 
Scotland website if they 
have concerns. 
 
CG17 
 
(NICE, 2012) 
Primary healthcare 
teams: GPs, nurses, 
dentists, dental 
Smokeless tobacco 
(people of South 
Asian origin are the 
Ask people if they use 
smokeless tobacco, using the 
names that the various 
Ensure smokeless tobacco users 
are aware of the health risks. 
Use a brief intervention to 
In addition to delivering a 
brief intervention, refer 
people who want to quit to 
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 nurses, dental 
hygienists, 
community 
pharmacists 
 
focus of this 
guidance as they 
are the 
predominant users 
of smokeless 
tobacco products in 
England) 
 
products are known by 
locally. If necessary, show 
them a picture of what the 
products look like, using 
visual aids. (This may be 
necessary if the person does 
not speak English well or 
does not understand the terms 
being used.) Record the 
outcome in the patient notes. 
 
advise them to stop.  
Record the response to any 
attempts to encourage or help 
them to stop using smokeless 
tobacco in the patient notes (as 
well as recording whether they 
smoke).  
Training for practitioners 
 
local specialist tobacco 
cessation services (see 
NICE guidance ph10). 
This includes services 
specifically for South 
Asian groups, where they 
are available. 
 
CG18 
 
(RACGP, 
2011) 
All health 
professionals, 
including dental 
professionals 
 
 
Smoking 
 
A system for identifying all 
smokers and documenting 
tobacco use should be used in 
every practice or healthcare 
service. 
Assessment of readiness to 
quit is a valuable step in 
planning treatment 
 
All smokers should be offered 
brief advice to quit. 
Offer brief cessation advice in 
routine consultations and 
appointments whenever possible 
(at least annually). 
All smokers attempting to quit 
should be offered follow-up. 
Pharmacotherapy should be 
offered in case of nicotine 
dependence 
Telephone call-back 
counselling services are 
effective in assisting 
cessation for smokers who 
are ready to quit. Referral 
to such services should be 
considered for this group 
of smokers. 
CG19 
 
(NTCP, 2011) 
 
Physician 
or other health care 
providers 
 
Tobacco 
 
(5 A’s) 
Systematically identify all 
tobacco users at every visit. It 
should be an essential part of 
evaluation that for every 
tobacco user at every 
consultation, tobacco-use 
status be queried and 
All tobacco users should be 
firmly advised to quit in a way 
that is supportive and 
nonconfrontational. Tell them 
about benefits of quitting. 
Brief advice (few minutes) 
should have a clear, strong, and 
personalized message. 
Not reported 
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documented. Determine 
willingness to make a quit 
attempt. Assess nicotine 
dependence 
 
Pharmacotherapy where needed. 
Schedule a follow-up contact. 
 
CG20 
(NHG, 2011) 
 
Primary care 
professionals, 
general practitioner 
 
Smoking 
 
A risk questionnaire is 
completed (calculate risk 
score) before the Prevention 
Consultation, which can be 
used to deduce whether there 
is an increased risk of the 
listed cardiometabolic 
conditions. 
 
Individuals with a score on 
the questionnaire below the 
threshold value but with risk 
factors (smoking, etc.) 
receive targeted lifestyle 
advice. 
 
Tailored or targeted lifestyle 
advice, and patients are 
informed of the option to make 
an appointment with the GP or 
the practice support employee 
for risk communication and 
targeted lifestyle advice 
according to the NHG 
Guidelines on Smoking 
Cessation (only summary 
document available online) – 
which recommends that it is 
important to offer smokers, who 
are motivated to stop, intensive 
support at the right moment. 
Medicinal support in the way of 
nicotine replacement therapy, 
nortriptyline or bupropion is, if 
possible, recommended in 
motivated smokers who smoke 
at least 10 cigarettes daily. 
 
Not reported 
 
CG21 
 
(NICE, 2010) 
Trained primary 
healthcare; other 
healthcare services 
Alcohol  
(Adult drinkers- 
hazardous or 
Complete a validated alcohol 
questionnaire, e.g. AUDIT, or 
abbreviated version (such as 
Offer a session of structured 
brief advice on alcohol for 5–15 
minutes, based on FRAMES 
Referral to a specialist 
alcohol treatment service 
for alcohol dependence or 
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 (outpatient 
departments, sexual 
health, pharmacies, 
dental surgeries)  
 
harmful amount of 
alcohol) 
AUDIT-C, AUDIT-PC, or 
FAST) 
principles (feedback, 
responsibility, advice, menu, 
empathy, self-efficacy). Offer an 
extended intervention 
(motivational interviewing or 
motivational-enhancement 
therapy), from 20 to 30 minutes. 
Follow up or offer up to four 
additional sessions (if needed). 
 
have failed to benefit from 
structured brief advice and 
an extended brief 
intervention. 
 
CG22 
(NICE, 2008) 
 
NHS and other 
professionals 
responsible for 
smoking cessation 
services. e.g. 
Doctors, nurses, 
pharmacists, 
dentists, quit-line 
counsellors 
 
Smoking or 
tobacco use 
(everyone who 
smokes or uses 
tobacco in any 
other form) 
 
Identify and record the 
smoking and/or tobacco use 
status of all their patients 
Healthcare professionals should 
be trained to give brief advice 
(less than 10 minutes) on 
stopping tobacco use. Remind at 
every suitable opportunity of the 
health benefits of stopping. 
Pharmacotherapy as appropriate. 
Train all healthcare staff to offer 
brief advice and to make 
referrals 
 
Offer referral to the NHS 
Stop Smoking Service, to 
help people in their 
attempt to quit 
CG23 
 
(Fiore et al., 
2008) 
Physician or other 
clinician (e.g., 
nurse, 
psychologist, 
dentist, or 
counsellor) 
 
Smoker or tobacco 
user 
Identify and document 
tobacco use status for every 
patient at every visit as a 
‘vital sign’. Assess 
willingness to make a quit 
attempt. 
Advise in a clear, strong, and 
personalized manner, urge every 
tobacco user to quit (3-10-
minutes). Or offer intense 
counselling of four or more 
sessions that are 10 minutes or 
more in length. Arrange follow-
up contacts, self-help material, 
or offer medication. 
Provide or refer for 
counselling or additional 
treatment to help the 
patient quit. E.g. Quit-
lines, smoking cessation 
program, or patient's 
health plan program. 
Alternative programs such 
as acupuncture or 
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 hypnotism. 
CG24 
 
(IPCRG, 2008) 
 
Primary care health 
professionals or 
clinicians including 
doctors, GPs, 
nurses and other 
health workers 
 
Smoking 
 
Ask smokers and ex-smokers 
about smoking status on at 
least an annual basis: All 
members of the practice team 
should ask about smoking 
status at all opportunities. 
- Assess desire to quit, 
dependence and barriers to 
quitting 
 
a) Brief intervention: 
opportunistic advice in less than 
a minute- ask, assess, provide 
self- help materials, and refer. 
b) Moderate intervention: advice 
in 2-5-minutes- ask, assess, 
advise on strategies to overcome 
barriers, provide self-help 
materials, set a quit date, assist 
by offering pharmacotherapy, 
arrange follow-up (or refer). 
c) Intense intervention: advice if 
more than 5 minutes available- 
ask, assess, advise, assist, 
arrange follow-up consultation 
(or refer), and address issues of 
dependence, habit, triggers, 
negative emotions. Brainstorm 
solutions and develop a quit 
plan. 
 
Refer to available smoking 
cessation services. 
 
Promote self-help 
materials, leaflets, quitline 
numbers in the waiting 
room, display no smoking 
posters. 
CG25 
 
(RACGP, 
2006) 
 
General 
practitioners, 
general practice 
nurses and other 
practice staff, and 
divisions of general 
practice 
 
Smoking 
 
Hazardous alcohol 
drinking 
 
One-minute interventions 
using the 5A framework 
Smoking: 
Ask- Do you smoke?  
Assess- Interest in quitting; 
Barriers to quitting; Nicotine 
dependence 
 
Smoking: 
Advise- Provide brief, non-
judgmental personalised and 
clear advice to aid quitting 
 
Alcohol: 
Advise- Provide brief, 
personalised and non- 
Smoking: 
Assist- Offer relevant 
pamphlets 
Arrange- Follow up or 
referral 
 
Alcohol: 
Assist- Enlist support  
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Alcohol: 
Ask- Do you drink? How 
much on a typical day? How 
many days a week?  
Assess- Concern about 
drinking; Interest in cutting 
down; Barriers to cutting 
down 
 
judgmental clear advice to cut 
down; Highlight other benefits 
of cutting down 
 
Arrange- Offer relevant 
pamphlets on safe drinking 
levels and ideas to help 
reduce intake; Follow up 
soon after 
 
 
CG26 
 
(NICE, 2006a) 
GPs, nurses in 
primary and 
community care, 
other health 
professionals, such 
as hospital 
clinicians, 
pharmacists and 
dentists 
 
Smoking 
 
Ask people who smoke how 
interested they are in quitting, 
i.e. an assessment of the 
patient's commitment to quit 
 
 
Brief intervention, 5-10-minutes; 
involving simple opportunistic 
advice to stop, an offer of 
pharmacotherapy and/or 
behavioural support, provision 
of self-help material 
If they want to stop, refer 
them to an intensive 
support service such as 
NHS Stop Smoking 
Services.  
If they are unwilling or 
unable to accept a referral, 
offer a stop smoking aid 
(pharmacotherapy). 
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3.4.2.3 Quality assessment (AGREE II) 
The quality of all included clinical guidelines was assessed using the AGREE II 
instrument. The AGREE II scores of all the clinical guidelines are included in 
Table 3.8. Figure 3.4 depicts a graphical representation of AGREE II scores. Blue 
vertical bars in the figure represent the AGREE II scores (which range from 0-7). 
The guidelines were considered high-quality if the AGREE II score was 6 or 7; 
medium or mid-quality if the score ranged from 3 to 5; and a score of 1 or 2 
indicated a low-quality guideline (Section 3.3.8.2). It can be seen from Table 3.8 
that this overview included 11 high-quality guidelines and 15 mid-quality 
guidelines; there were no low-quality guidelines. The 11 clinical guidelines with 
high quality score were: CG 1, 2, 5, 11, 12, 14, 17, 18, 21, 22, 23; and two of 
these high quality guidelines met all the criteria in AGREE II and scored 7 (CG: 1, 
11) (SDCEP, 2014; Kottke et al., 2016). 
 
Chapter 3  
 
 
146 
Table 3.8: Quality scores of clinical guidelines for the six domains of the AGREE II Instrument (D 1–D 6) and the overall quality 
 
Clinical 
Guideline (CG) 
ID 
D 1 D 2 D 3 D 4 D 5 D 6 
Overall 
quality 
of CG 
Recommend 
CG for use 
 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23   
CG1 
(Kottke 2016) 6 6 6 6 2 6 6 5 7 6 7 7 6 7 7 6 7 6 6 4 1 7 7 7 Yes 
CG2 
(Piepoli 2016) 7 7 7 7 2 7 2 3 7 7 6 7 7 4 7 7 7 6 7 5 2 2 7 6 Yes 
CG3 
(RACGP 2016) 6 6 6 7 4 7 2 2 6 4 5 6 6 5 6 6 6 6 6 5 2 2 2 5 
Yes, with 
modifications 
CG4 
(RACGP 2015)  6 6 6 6 4 7 2 2 7 2 6 7 6 3 7 7 7 7 7 6 6 2 2 5 
Yes, with 
modifications 
CG5 
(Siu 2015) 7 7 7 6 5 6 7 7 7 4 7 7 5 2 3 6 6 7 6 6 2 6 7 6 Yes 
CG6 
(NICE 2015) 6 6 6 6 6 6 6 6 4 5 5 4 6 6 4 4 5 3 4 3 2 6 4 5 
Yes, with 
modifications 
CG7 
(Kralikova 2015) 3 4 3 4 2 4 3 3 3 2 3 3 2 2 3 4 4 5 4 5 2 3 2 3 No 
CG8 
(PHE 2014a) 6 6 6 5 1 6 3 3 6 6 5 6 5 3 6 6 6 4 5 1 1 1 1 5 
Yes, with 
modifications 
CG9 
(PHE 2014b) 6 6 6 6 1 7 1 1 1 1 3 4 2 2 4 5 6 6 6 1 1 1 1 4 
Yes, with 
modifications 
CG10 
(CDC 2014) 6 6 6 2 2 6 2 1 2 2 2 2 2 2 6 6 6 6 7 4 5 1 2 4 
Yes, with 
modifications 
CG11 
(SDCEP 2014) 7 7 7 7 6 7 7 6 7 7 6 7 7 7 7 7 7 6 7 1 4 2 4 7 Yes 
CG12 
(NZHealth 2014) 6 7 5 7 2 7 7 7 7 7 7 7 5 6 7 6 7 7 7 4 6 2 7 6 Yes 
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CG13 
(Zwar 2014) 6 6 7 2 1 5 1 1 1 1 4 4 4 1 6 6 6 4 4 1 1 1 6 3 No 
CG14 
(NICE 2014) 6 6 6 6 6 6 6 6 4 5 5 4 6 6 5 6 5 4 5 4 3 6 5 6 Yes 
CG15 
(Moyer 2013) 5 6 5 5 4 5 6 6 6 3 5 6 4 2 3 5 5 6 5 5 2 5 6 5 
Yes, with 
modifications 
CG16 
(SDCEP 2012) 6 7 7 7 1 5 2 2 1 5 5 2 6 5 4 6 5 5 5 2 6 2 4 5 
Yes, with 
modifications 
CG17 
(NICE 2012) 6 7 7 6 3 5 4 4 3 6 6 4 6 6 5 6 6 5 5 4 6 5 5 6 Yes 
CG18 
(RACGP 2011) 7 7 6 6 2 7 2 2 7 3 6 7 6 5 7 7 7 6 7 2 2 4 7 6 Yes 
CG19 
(NTCP 2011) 5 5 6 5 2 4 2 2 2 2 6 3 4 2 5 6 4 5 3 2 2 2 2 3 No 
CG20 
(NHG 2011) 5 6 6 5 2 3 3 4 4 5 5 3 5 6 5 6 5 5 5 3 5 3 4 5 
Yes, with 
modifications 
CG21 
(NICE 2010) 6 5 6 6 2 7 5 5 6 7 6 7 6 5 7 6 5 6 6 6 4 2 2 6 Yes 
CG22 
(NICE 2008) 6 6 6 6 6 6 6 6 6 6 5 6 6 6 5 5 5 5 5 5 6 5 4 6 Yes 
CG23 
(Fiore 2008) 6 6 6 5 4 6 6 7 7 7 6 7 6 6 5 6 6 5 6 5 5 5 6 6 Yes 
CG24 
(IPCRG 2008) 3 4 4 4 2 4 3 3 3 2 3 3 2 2 5 5 5 5 5 5 2 3 2 3 No 
CG25 
(RACGP 2006) 6 7 5 5 3 7 2 2 3 2 5 4 3 2 5 6 4 6 7 5 6 3 2 4 
Yes, with 
modifications 
CG26 
(NICE 2006a) 6 6 6 5 5 6 5 5 5 5 6 6 6 6 5 5 5 4 4 5 6 6 4 5 
Yes, with 
modifications 
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Figure 3.4: Graphical representation of AGREE II scores 
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3.4.2.4 Best practice (high-quality) recommendations 
Table 3.7 presents the main recommendations reported in all included clinical 
guidelines (n=26) for risk factor assessment and delivering a preventive 
intervention for smoking cessation and reducing alcohol use (for example, risk 
factors, recommended interventions, target users and population). The 
recommendations for a face-to-face behavioural preventive intervention, 
targeting adult populations (18 years and above) and in a primary care setting, 
(dental/medical/pharmacy) were reported. 
Similar to the systematic review synthesis (Section 3.4.1.5), the best practice, 
high-quality, guideline recommendations were synthesised here. Thus, the 
recommendations presented and discussed in this overview are for the 11 
clinical guidelines with high AGREE II scores (CG: 1, 2, 5, 11, 12, 14, 17, 18, 21, 
22, 23) (Section 3.4.2.3).  
To deal with levels of recommendation quality within the "high-quality" clinical 
guidelines, so that all statements within the guidelines were not all given the 
same weight, the preference for synthesis within the high-quality guidelines was 
given to the higher quality (AGREE II) score, recency of publication, and the 
level of evidence for particular recommendations within high-quality guidelines. 
Data duplication, i.e. previous guidelines or systematic reviews (used for 
developing guidelines) was also considered while presenting recommendations 
from all high-quality guidelines. The main recommendations from all remaining 
guidelines are summarised in Table 3.7. 
The guideline recommendations have been presented separately for dental and 
for other primary care settings (medical/pharmacy). Furthermore, as all high-
quality guidelines focused on preventive interventions in terms of smoking 
and/or alcohol, the recommendations have been organised under these two 
major headings. 
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3.4.2.4.1 Dental practice setting 
Of the 11 high-quality guidelines, there was only one guideline (CG 11) which 
provided recommendations for delivering behavioural preventive interventions 
(including risk factor assessment, behavioural advice and/or referral) delivered 
exclusively in a primary care dental setting. This guideline was developed by the 
Scottish Dental Clinical Effectiveness Programme (SDCEP), and met all criteria 
in AGREE II. The guideline included recommendations on best practice for the 
prevention and treatment of periodontal diseases in a primary care setting. This 
guidance presented clear and consistent advice to support dental professionals 
to deliver preventive interventions for both smoking (or smokeless tobacco) and 
alcohol. The guidance emphasised that these risk factors (tobacco and alcohol) 
are not only associated with periodontal diseases, but also cancers of the mouth, 
other oral diseases, and many other chronic diseases (i.e. common risk factors). 
The guideline reported that it was based on existing guidelines (for example, 
British Society of Periodontology), relevant systematic reviews, research 
evidence and the opinion of experts and experienced practitioners (discussed in 
detail later under relevant sections - for smoking and alcohol). 
TOBACCO 
The smoking cessation interventions in this dental guideline (CG 11) were based 
on another existing guideline: the NHS Health Scotland publication “A Guide to 
Smoking Cessation in Scotland 2010” (NHS, 2017), which in turn included 
recommendations drawn from the National Institute for Health and Care 
Excellence (NICE) Public Health Guidance on smoking cessation (NICE, 2006a; 
NICE, 2008) which were also included in this overview study under medical 
practice guidelines (CG: 22, 26) (Table 3.7). 
It was stated that dental practices were well placed to provide smoking 
cessation support given the large proportion of the population who visit a dentist 
(or dental care professionals) for regular check-ups, including teenagers and 
pregnant women who are entitled to free dental care (NHS, 2017). Many of the 
recommendations for smoking cessation in this guideline were based on the 
research evidence reported in a Cochrane review (Carr and Ebbert, 2012), which 
reported the effectiveness of smoking cessation interventions in a dental 
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practice setting, and was the only dental review included in this overview study 
under systematic review evidence (SR 12) (Section 3.4.1.5.1). 
The main recommendation regarding smoking cessation stated that (CG 11): 
“All health and health-related staff should raise the issue of stopping smoking in 
their day-to-day work with patients and clients and, where appropriate, refer 
them on to local services to help them stop”. 
Risk factor assessment (Ask/Assess) 
The high-quality dental guideline (CG 11) recommended to ask a patient if they 
smoked (or used smokeless tobacco) and to record the response (i.e. patient’s 
smoking/tobacco use status) as part of a social history. It was also recommended 
to ask if the patient had considered the effect smoking (or smokeless tobacco) 
had on their oral health and general health and the benefits of stopping, and to 
ask if the patient was interested in stopping smoking (or tobacco use), and then 
deliver a preventive intervention accordingly. This recommendation was in line 
with the only high-quality dental systematic review (SR 12) included in this 
overview, also referenced in this guideline. 
Behavioural preventive interventions (Advise/ Arrange)  
The guideline (CG 11) recommended providing a ‘brief’ intervention to 
encourage smoking cessation, which was defined as “opportunistic discussions 
where healthcare professionals deliver advice, encouragement, and referral to 
more intensive treatment where appropriate”. It was recommended to offer a 
brief or very brief advice to stop smoking, tailored or adapted to suit the 
circumstances of each individual (i.e. patient’s preferences and needs). It was 
mentioned that spending a few minutes to raise the issue of smoking (or tobacco 
use) with patients might trigger a successful attempt at quitting, i.e. very brief 
advice in a single visit was effective in increasing smoking cessation rates. This 
recommendation reflects the evidence from the dental Cochrane review (SR 12) 
included in this overview (Section 3.4.1.5.1), suggesting strong strength of 
recommendation. 
It was further recommended that dental professionals were not expected to 
provide comprehensive specialist support, i.e. intensive or structured (theory-
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based) interventions, as this could be best delivered by trained smoking 
cessation counsellors. The guideline highlighted that the dental professionals 
should: “Ask if the patient has considered the effect smoking has on his/her oral 
health and general health and the benefits of stopping and inform the patient 
that stopping smoking is the single most important thing he/she can do to 
improve not only their oral health but their general health as well”. It was also 
recommended that dental professionals should provide patients with various 
smoking cessation resources, for example: relevant educational or health 
promotion materials, and online support (strength of recommendation not 
supported with research evidence). 
Referral to specialist services (Assist) 
With a very brief intervention, dental professionals were required to direct 
patients who expressed an interest in stopping smoking to local smoking 
cessation services or provide ‘Smokeline’ numbers (if necessary), in order to 
increase their chances of a successful quit attempt. The guideline (CG 11) 
further mentioned that smoking cessation services were available from every 
community pharmacy in Scotland and specialist services were also offered by 
smoking cessation advisors (trained) throughout Scottish health board areas. 
However, there was no review or research evidence reported in this guideline to 
support smoking referrals. 
Summary 
Table 3.9 summarises recommendations from the high-quality guideline on 
smoking cessation interventions in a primary care dental practice. Overall, it 
was recommended to record a patient’s smoking (or tobacco use) status as part 
of social history, assess patient’s risk levels, and offer a very brief opportunistic 
advice (for few minutes) to stop smoking (or tobacco use). It was further 
recommended to offer information on referrals to quit-line or local stop smoking 
services. However, not all recommendations made were supported by research 
evidence. 
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Table 3.9: Dental practice - best practice (high-quality) recommendations for smoking 
cessation interventions in the clinical guideline (CG) 
 
Preventive interventions for smoking 
Strength of 
recommendations 
(based on supported 
evidence) 
CG supporting 
recommendations 
 
Ask/ 
Assess 
 
Ask and record patient’s smoking 
(or tobacco use) status as part of 
social history 
 
Assess patient’s risk levels, and 
their interest in stopping smoking 
 
Strong 
 
 
 
Strong 
 
 
CG 11 
 
Advise/ 
Arrange 
Offer brief or very brief 
opportunistic interventions 
 
Brief interventions should be 
tailored to meet individual needs 
 
Advice supported with 
educational materials or online 
support 
 
Strong 
 
 
Strong 
 
 
Weak 
 
 
CG 11 
 
Assist/ 
Referral 
Offer smokers (or tobacco users) 
‘Smokeline’ numbers or 
information on local smoking 
cessation services 
 
Weak 
 
 
 
CG 11 
 
ALCOHOL 
The interventions for reducing alcohol consumption in this dental guideline (CG 
11) were based on two existing guidelines: the Scottish Intercollegiate 
Guidelines Network Guideline 74 (SIGN, 2003) and a brief guidance by NHS 
Health Scotland on the link between alcohol and oral health (NHS, 2012). The 
NHS guidance in turn included recommendations drawn from the other SDCEP 
guidance “Oral Health Assessment and Review” document (SDCEP, 2012) and the 
NICE Public Health Guidance on behaviour change (NICE, 2014). Both of these 
guidelines were already included in this overview study (CG: 14, 16) (Table 3.7); 
the recommendations from CG 16 were not synthesised here as it had a lower 
quality score, while CG 14 is synthesised under medical practice guidelines. 
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Similar to providing smoking cessation support in a dental practice, it was 
recommended to include preventive interventions to reduce alcohol 
consumption in a dental practice setting, given the large proportion of the 
population who visit a dentist (or dental care professionals) for regular check-
ups, including teenagers (NHS, 2017). The research evidence reported in these 
guidelines also suggested that raising the issue of alcohol with patients in a 
dental practice was feasible and quite acceptable to patients (McAuley et al., 
2011). The evidence for the effectiveness of alcohol reduction interventions in 
this dental guideline were adapted from the review of trial evidence in the 
medical practice settings. There was no dental research evidence referenced in 
this guideline – which was reflected in the systematic review synthesis in this 
overview study, where there were no dental reviews identified. 
Risk factor assessment (Ask/Assess) 
The high-quality dental guideline (CG 11) recommended assessment of a 
patient’s alcohol consumption by asking about average weekly alcohol 
consumption and maximum daily consumption in the last week and to convert 
this into units. The guideline stated: “The recommended limit for men is 21 
units of alcohol per week, with no more than 4 units in any one day; the 
recommended limit for women is 14 units of alcohol per week, with no more 
than 3 units in any one day.” 
The guideline recommended that a patient’s alcohol consumption should be 
recorded as part of a social history, and that the dental professional should then 
ask and assess if the patient is interested in reducing alcohol consumption and in 
seeking further help. It was further recommended to use various screening tools 
to assess a patient’s alcohol consumption, for example AUDIT-PC (Alcohol Use 
Disorders Identification Test – Primary Care) and FAST (Fast Alcohol Screening 
Test) – which are shorter versions (taking only a couple of minutes to administer 
the tool) of other alcohol screening tools (for example, AUDIT) to identify risky 
drinkers in primary care settings. 
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Behavioural preventive interventions and referral to specialist services 
(Advise/ Arrange/ Assist) 
The dental guideline (CG 11) recommended that: “If a patient is drinking alcohol 
excessively and is willing to discuss this with you, outline the possible harmful 
effects of excessive alcohol consumption and advise the patient to see his/ her 
general medical practitioner and/or to visit the Alcohol Focus Scotland website 
(www.alcohol-focus-scotland.org.uk) for further advice and help.” It stated that 
the alcohol issue must be addressed with sensitivity and that it might be useful 
to deliver advice in the context of improving a patient’s oral tissues (or oral 
health) as a result of changes to their alcohol consumption. No further details 
were provided in this dental guideline (CG 11) regarding delivering behavioural 
preventive interventions for alcohol reduction, for example, exact duration of 
advice, follow-up visits, or training of dental professionals. However, similar to 
smoking interventions, it was mentioned that spending a few minutes i.e. very 
brief advice in a single visit was effective in reducing alcohol consumption. 
However, there was no research evidence to support this recommendation. 
There were no details provided in this dental guideline regarding making 
referrals for specialist alcohol treatment services. 
Summary 
Table 3.10 summarises recommendations from the high-quality guideline on 
alcohol reduction interventions in a primary care dental practice. Overall, it was 
recommended to assess a patient’s alcohol consumption (using screening tools), 
followed by very brief advice/discussion to outline and discuss the possible 
harmful effects of excessive alcohol consumption, and then recommend that 
patients visit their general medical practitioner for further advice and help. 
However, there were no research evidence reported to support these 
recommendations. Thus, further guidance is required (with evidence to support 
recommendations) regarding delivering effective behavioural alcohol 
intervention in a dental practice setting. 
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Table 3.10: Dental practice - best practice (high-quality) recommendations for alcohol 
reduction interventions in the clinical guideline (CG) 
 
Preventive interventions for alcohol 
Strength of 
recommendations 
(based on supported 
evidence) 
CG supporting 
recommendations 
 
Ask/ 
Assess 
 
Ask, assess and record patient’s 
average daily/weekly alcohol 
consumption as part of social 
history 
 
Use shorter versions of validated 
screening tools (AUDIT-PC, 
FAST) 
 
Weak 
 
 
 
 
Weak 
 
 
 
 
 
CG 11 
 
Advise/ 
Arrange 
Very brief advice - outline the 
possible harmful effects of 
excessive alcohol consumption  
 
(no details provided, e.g. duration, 
number of sessions, training) 
 
Weak  
CG 11 
 
 
 
Assist/ 
Referral 
Refer patients to general medical 
practitioner for further advice and 
help 
 
Provide online support (e.g. visit 
“Alcohol Focus Scotland” 
website) 
 
Weak 
 
 
 
Weak 
 
CG 11 
 
3.4.2.4.2 Medical or community pharmacy setting 
As reported in the previous section, there was only one high-quality guideline 
(CG 11) in the dental practice setting. The remaining 10 high-quality guidelines 
(CG: 1, 2, 5, 12, 14, 17, 18, 21, 22, 23) related to interventions delivered in a 
primary care medical or community pharmacy setting (Table 3.7). There were no 
separate recommendations provided to be delivered particularly in a pharmacy 
setting; recommendations were in general for all primary care practices 
including pharmacy. Five guidelines (CG: 17, 18, 21, 22, 23) also included dental 
professionals as their target users. 
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It can be seen from Table 3.7 that, of these 10 high-quality guidelines, nine 
guidelines included recommendations for smoking (or smokeless tobacco) 
cessation (CG: 1, 2, 5, 12, 14, 17, 18, 22, 23), while alcohol reduction 
interventions were included in four guidelines (CG: 1, 2, 14, 21). The 
recommendations have now been organised under two major risk factors - 
tobacco and alcohol. The main recommendations from these high-quality 
guidelines (and other guidelines with lower quality) has been summarised in 
Table 3.7. 
TOBACCO 
Risk factor assessment (Ask/Assess) 
In line with the systematic reviews, all nine high-quality clinical guidelines which 
included smoking (or smokeless tobacco) interventions (CG: 1, 2, 5, 12, 14, 17, 
18, 22, 23) recommended that clinicians should ask and document/record every 
patient's smoking (or tobacco use) status: i.e., ask all individuals if they (still) 
smoke (or use smokeless tobacco), ask if the patient is interested in stopping 
smoking (or tobacco use) and record the response, even those who are not ready 
to stop and review with the individual once a year, where possible. The strength 
of these recommendations was evaluated as strong in these guidelines, as 
evaluated by various evaluation/grading methods in these guidelines; for 
example, CG 1 used the “Grading of Recommendations Assessment, 
Development and Evaluation (GRADE)” methodology system (Guyatt et al., 
2008). 
One of the guidelines (CG 17; a NICE guideline) included recommendations 
exclusively for reducing smokeless tobacco use. It was recommended in this 
guideline to ask individuals at their regular patient visits if they used smokeless 
tobacco (for example, ghukta, paan, betel quid with tobacco, areca nut). If the 
person did not understand the terms used or did not understand English, it was 
suggested to use local names of the various smokeless tobacco products or show 
the product image (CG 17). 
It was further recommended in all high-quality guidelines that records should be 
updated regularly at every admission to hospital and at least annually in primary 
care (CG: 1, 2, 5, 12, 14, 17, 18, 22, 23). Two of the high-quality guidelines (CG: 
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1, 12) even recommended that a patient’s smoking status should be recorded as 
a “vital sign” or as a specific medical problem in the patient’s clinical records, 
in order to remind healthcare professionals to ask about and record smoking 
status. Recording a patient's smoking (or tobacco use) status this way might 
increase rates of referral for smoking cessation counselling (CG: 1, 12). 
Three of the high-quality guidelines (CG: 12, 18, 23) recommended assessing the 
nicotine dependence by asking about the time to first cigarette and the number 
of cigarettes smoked a day: for example, ask patients, “How soon after you 
wake up do you usually have your first cigarette?” or “Number of cigarettes per 
day?” These guidelines mentioned that there was a high likelihood of nicotine 
dependence if the person smokes within 30 to 60 minutes of waking, and smokes 
more than ten cigarettes a day. If the patient had previously attempted to quit, 
it was recommended to investigate whether the patient had withdrawal 
symptoms (CG: 12, 18, 23). The strength of this recommendation (assessing 
nicotine dependence) was judged to be strong, however, there was no research 
evidence reported to support this. 
Thus, this first step in the smoking (or tobacco) cessation intervention, i.e. 
asking, identifying, and assessing tobacco use status helped to divide patients 
into three treatment categories: (1) those who are willing to quit should receive 
interventions to help in their quit attempt; (2) those who are unwilling to quit 
should receive motivational interventions to encourage them to quit; and (3) 
those who recently quit using tobacco should be provided relapse prevention 
treatment (Fiore et al., 2008). 
Behavioural preventive interventions (Advise/ Arrange)  
The smoking (or tobacco use) cessation recommendations included in the most 
recent guideline (CG 1) were based on another older guideline included in this 
overview (CG 5), which in turn included recommendations based on a large 
document/guideline developed by the Department of Health and Human Services 
in the United States (CG 23). These three guidelines were all developed in the 
United States. Another high-quality guideline (CG 18) which was developed by 
the “Royal Australian College of General Practitioners (RACGP), included 
recommendations based on two recent guidelines included in this overview: the 
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U.S. Department of Health and Human Services guideline (CG 23), and the New 
Zealand Smoking Cessation Guideline (CG 12). 
The recommendations from these high-quality guidelines (CG: 1, 5, 12, 18, 23) 
have been presented together, considering higher AGREE II score, recency, and 
duplication. The recommendations were evidence based: produced from a 
review of good quality systematic reviews, and a literature search or systematic 
review of randomized controlled trials conducted by the guideline development 
team. Some of the referenced systematic reviews in these guidelines (on which 
recommendations were based) were also included in this overview study, for 
example, SR: 1, 6, 8, 12, 16, 27 (Section 3.4.1.5.2); thus, showing strength of 
the evidence in this overview study. 
The recommendations in these guidelines (CG: 1, 5, 12, 18, 23) were organised 
around the “5A’s behaviour change model” for delivering smoking cessation 
interventions in a primary care setting. After asking and assessing a patient’s 
smoking (or tobacco use) status and their willingness to quit, these high-quality 
guidelines recommended offering face-to-face behavioural interventions to 
patients if acceptable to them. It was recommended to offer smoking cessation 
advice to all patients who smoke, regardless of the amount they smoke, in 
routine consultations and appointments whenever possible (at least annually). 
The guidelines also recommended that all smokers should also be offered follow-
up interventions, as it further increases the quit rates. The strength of these 
recommendations was strong, as they were based on evidence obtained from 
systematic reviews of relevant randomized controlled trials. 
In line with the systematic reviews, either brief (5-20 minutes) or intensive 
(more than 20 minutes) interventions were recommended to increase the quit 
rates; a small dose response relationship was reported to be effective to 
improve quit rates (i.e., longer sessions or more follow-up support). The 
strength of the recommendation was graded as strong for providing ‘brief’ 
advice to all smokers at every opportunity and recording this in patient records. 
It was reported that although longer interventions were more effective in 
increasing quit rates, even very brief interventions (less than 3-minutes) have 
been found to be effective. Overall, it was emphasised in these guidelines (CG: 
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1, 5, 12, 18, 23) that every smoker (or tobacco user) should first be offered at 
least a very brief intervention; that is, firstly advised in a clear, strong and 
personalized manner to quit. If patients were unwilling to quit after this very 
brief advice, primary care professionals should provide motivational 
interventions designed to increase future quit attempts. 
Three of the remaining high-quality smoking (or smokeless tobacco) guidelines 
were developed by the “National Institute for Health and Care Excellence 
(NICE)” in England (CG: 14, 17, 22), and had similar quality (AGREE II) scores. 
The more recent NICE guideline (CG 14) on “Individual approaches for Behaviour 
Change” aimed to help tackle a range of behaviours including smoking, alcohol 
misuse, poor eating patterns, lack of physical activity, and unsafe sexual 
behaviour. The recommendations for smoking cessation in this recent NICE 
guideline (CG 14) were based on another older NICE guideline exclusively on 
“Smoking Cessation Services” (CG 22). The third NICE guideline (CG 17) included 
recommendations exclusively for reducing smokeless tobacco use, and people of 
South Asian origin were the main target population for this guidance, as they 
were the predominant users of smokeless tobacco products in England. 
The recommendations in these NICE guidelines (CG: 14, 17, 22) were similar to 
the guidelines reported above (CG: 1, 5, 12, 18, 23), i.e. for patients who smoke 
(or use smokeless tobacco), primary care professionals were recommended to 
consider offering a brief behavioural intervention in routine consultations and 
appointments whenever possible (at least annually). The brief interventions 
should involve: opportunistic advice, encouragement, and referral. Additionally, 
these NICE guidelines defined a measure of success as “not having smoked in the 
third and fourth week after the quit date” (CG 22). Furthermore, the success 
should be validated by carbon monoxide monitoring, with a reading of less than 
10 ppm at the 4-week point. 
Based on an expert paper, the recent NICE guideline (CG 14) also recommended 
offering a very brief intervention, which involved 30 seconds to a couple of 
minutes advice following an “ask, advise, assist” structure. For example, very 
brief advice on smoking would involve recording the individual's smoking status 
and advising them that stop smoking services offer effective help to quit. If the 
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patient agrees, the patient could be directed to these services for additional 
support. However, the strength of the evidence for the effectiveness of such a 
very brief (30 seconds advice) intervention for smoking cessation was weak; the 
recommendation was based on an expert paper and descriptive studies; 
however, no systematic reviews or randomized controlled trials were reported 
supporting this evidence. Thus, the main recommendation, with higher strength 
of evidence, was to offer brief, rather than very brief advice (CG 14). 
A similar approach of providing a very brief intervention was recommended by 
the other high-quality guideline, which was the New Zealand guideline for 
“Helping People to Stop Smoking” (CG 12). This updated version of the guideline 
replaced the “5A’s advice” with the simpler “ABC pathway”. This pathway 
includes ‘Asking’ about and documenting every patient’s smoking status; 
providing ‘Brief advice’ to stop smoking; and finally referring to services, or 
providing, ‘Cessation support’ to smokers who are willing to stop smoking. It was 
recommended that such advice could be delivered in 30 seconds and the “ABC 
pathway” should take less than two-minutes. The recommendation (30 seconds 
advice) was based on a consensus statement by Jackson and colleagues (2001) 
with special reference to primary care, and considering various studies reporting 
lack of time as a major barrier by most professionals in providing such 
interventions (New Zealand Health, 2014). Thus, presenting moderate or weak 
strength of recommendation (a grading system developed by the Australian 
National Health and Medical Research Council (NHMRC, 2009)). 
The majority of these high-quality guidelines recommended that clinicians 
should tailor or personalize brief advice to the individual patient to meet their 
needs by assessing and then addressing them. In addition, they stated that 
consideration needs to be given to personal, cultural, social, environmental and 
economic barriers to an individual’s health. For an intensive intervention (if 
required), professionals should agree on quit goals (SMART goals, i.e. Specific, 
Measurable, Attainable, Relevant, and Timely) and targets with their patients by 
developing action plans to prioritise actions and coping plans to prevent and 
manage relapses. Patients should be encouraged and supported to self-monitor 
behaviour and its outcomes and be provided with regular feedback on behaviour 
and its outcomes. 
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Intervention providers and training to deliver preventive interventions 
It was recommended that smoking (or tobacco use) cessation interventions were 
effective if delivered by any member of the primary care team, including 
physicians, nurses, psychologists, social workers, cessation counsellors, 
pharmacists, or dental professionals (CG: 17, 18, 22, 23)  - who were trained to 
offer advice. It was strongly recommended for healthcare professionals to 
receive appropriate training to provide brief (or very brief) advice effectively. 
Training should include how to support people to quit smoking by providing brief 
advice and also on how to make referrals, where needed. In addition, it was 
recommended in one of the NICE guidelines (CG 22) that training to provide 
smoking cessation interventions should be included as part of the core 
curriculum for healthcare undergraduates and postgraduates. 
However, the guidelines reported a lack of evidence reporting effect size 
between practitioner training, subsequent competencies and behaviour change 
interventions (CG 14). It was further recommended to have future research to 
determine: “what characteristics of behaviour change training influence the 
effectiveness of behaviour change practitioners?” 
Additional support 
Providing educational or self-help materials, tailored to the individual patient, 
also had a small effect in improving smoking abstinence rates (CG: 1, 5, 12, 18, 
23). An offer of pharmacotherapy, including nicotine replacement therapy 
(NRT), where appropriate (for dependence), was also recommended to increase 
the smoking (or tobacco) abstinence rates. Moreover, a combination of brief 
behavioural intervention and pharmacotherapy was recommended to work best 
(CG: 1, 5, 12, 18, 23). A similar combined approach was strongly recommended 
in another high-quality guideline (CG 2) which was a “European Guideline on 
cardiovascular disease prevention”. This guideline, along with offering repeated 
5 A’s advice, recommended offering pharmacological support (including nicotine 
replacement therapies, varenicline, and/or bupropion) to increase quit rates. 
The level of evidence was strong as it was derived from multiple randomized 
clinical trials or meta-analyses (Cahill et al., 2012; Cahill et al., 2013). 
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Referral to specialist services (Assist) 
Besides offering brief behavioural support within the practice, it was 
recommended to refer individuals who agree to quit to more intensive external 
support such as quit-lines or telephone counselling, an accredited tobacco 
treatment specialist, or other local cessation programmes or services (CG: 1, 2, 
5, 12, 14, 17, 18, 22, 23). It was reported that more people will make a quit 
attempt if the very brief advice is followed by an offer of cessation support (lack 
of evidence reported in the systematic reviews; Table 3.5). Moreover, referral 
was reported to be most effective when it included a brief description of the 
recommended service or treatment. The strength of the recommendations was 
graded as strong to moderate in most guidelines, i.e. “body of evidence can be 
trusted to guide practice in most situations”, as it was based on one or two 
randomised controlled trials or on expert opinions. One of the high-quality 
guidelines (CG: 12) also reported evidence based on one systematic review of 
trials from the four Cochrane reviews (one of these Cochrane reviews included 
this overview study - SR 8; Section 3.4.1.5.2; other reviews were not included in 
this overview study as they had the wrong setting or had no face-to-face 
intervention, see Appendix 5). 
Telephone call-back counselling services, also known as “quit-lines”, were 
reported in most high-quality guidelines to be effective in assisting cessation for 
smokers who were ready to quit. It was reported that quit-lines have broad 
reach and thus are effective in diverse populations. Thus, it was strongly 
recommended that referral to such services should be considered for smokers 
who are willing to quit or who have recently quit. The strength of the 
recommendation was graded as strong in three of the high-quality guidelines 
(CG: 12, 18, 23), as it was based on Cochrane reviews, randomized controlled 
trials, cost-effectiveness studies, and expert opinions; these studies reported 
that adding quit-line counselling to brief intervention and pharmacotherapy 
increases abstinence rates (RR 1.29; 95% CI: 1.20–1.38) (Shearer and Shanahan, 
2006; Borland et al., 2008; Stead et al., 2013b). Moreover, it was recommended 
in these guidelines to have a proactive form of support from these quit-line 
services, as it was reported that most smokers (or tobacco users) do not 
make/initiate the calls to a quit-line to get the full benefit. However, they 
readily accept proactive calls from these services (CG: 12, 18, 23).   
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Furthermore, the NICE guideline on “Smokeless tobacco cessation for South 
Asian communities” (CG 17) and the New Zealand guideline for “Helping People 
to Stop Smoking” (CG 12) recommended referring Asian people to services 
specifically for their groups, where available. It was recommended that the 
stop-smoking practitioners who provide support to Asian people should obtain 
training so that they are technically and culturally skilled in this role. However, 
the strength of this recommendation was not strong, as there was limited 
evidence available for effectiveness, and it was based mostly on clinical 
experience and expert opinions. 
Summary 
Table 3.11 now summarises the recommendations from all nine high-quality 
clinical guidelines on smoking cessation interventions in primary care practices. 
It was recommended to ask, assess, and record a patient’s tobacco use status in 
the clinical records, and offer an opportunistic ‘brief’ tailored intervention to all 
smokers (or tobacco users) by a trained primary care provider (although no 
evidence to support effectiveness of training), to increase abstinence rates; with 
some guidelines recommending very brief intervention – but this had little 
evidence base. Intensive interventions (more than 20 minutes) were likely to 
have a small additional effect on quit rates (in line with systematic review 
evidence in this study; Table 3.5). Again, the duration of effective interventions 
recommended ranged from as little as 3 minutes to 20 minutes or even more, 
thus making it difficult to determine a precise specification of the intervention 
duration. It was further recommended, if the patient is willing to quit, to make 
referral to quit-line services (proactive support) for further help which were 
reported to be effective along with brief intervention and pharmacotherapy to 
increase abstinence rates (RR 1.29; 95% CI: 1.20–1.38). The recommendations 
seem to be much strong from clinical guidelines regarding referral to cessation 
services than came through from systematic reviews in medical practice setting 
in this overview study. In addition, it was recommended for primary care 
providers to support advice with feedback, written materials, and follow-up 
support, however, no evidence to support its effectiveness.  
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Table 3.11: Medical practice - best practice (high-quality) recommendations for smoking 
cessation interventions in the clinical guidelines (CGs) 
 
Preventive interventions for smoking 
Strength of 
recommendations 
(based on 
supported evidence) 
CGs supporting 
recommendations 
 
Ask/ 
Assess 
 
Ask and record every patient’s 
smoking (or tobacco use) status, 
and update regularly (at every 
visit or at least annually) 
 
Assess nicotine dependence (by 
asking amount smoked) 
 
Assess readiness to change and 
their interest in receiving further 
help 
 
Strong 
 
 
 
 
Weak 
 
 
Strong 
 
CG: 1, 2, 5, 12, 14, 
17, 18, 22, 23 
 
 
 
CG: 12, 18, 23 
 
 
CG: 1, 2, 5, 12, 14, 
17, 18, 22, 23 
 
 
Advise/ 
Arrange 
Offer brief or very brief tailored 
intervention to increase tobacco 
abstinence rates 
 
Intensive interventions (over 
multiple sessions) more effective 
than brief intervention  
(small additional effect) 
 
Educational materials to support 
advice 
 
Intervention delivered by any 
member of the primary care team 
 
Training received by providers to 
deliver effective intervention 
 
Behavioural advice plus 
pharmacotherapy effective to 
increase abstinence rates 
 
Strong 
 
 
 
Moderate 
 
 
 
 
Weak 
 
 
Strong 
 
 
Weak 
 
 
Strong 
 
CG: 1, 5, 12, 14, 
17, 18, 22, 23 
 
 
CG: 1, 5, 12, 18, 
23 
 
 
 
CG: 1, 5, 12, 18, 
23 
 
CG: 1, 2, 5, 12, 14, 
17, 18, 22, 23 
 
CG: 14, 17, 18, 22, 
23 
 
CG: 1, 5, 12, 18, 
23 
 
 
Assist/ 
Referral 
Make referral to quit-line 
services (proactive support), as 
part of brief intervention 
 
Strong 
 
CG: 12, 18, 23 
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ALCOHOL 
Risk factor assessment (Ask/Assess) 
Again, in line with the systematic reviews, three of the high-quality clinical 
guidelines comprising alcohol interventions (CG: 1, 14, 21) recommended that 
clinicians should screen adult patients aged 18 years or older for excessive 
alcohol use by asking questions about heavy drinking. For example, asking a 
single question as: for men - “How many times in the past year have you had five 
or more drinks in a day?”; for women - “How many times in the past year have 
you had four or more drinks in a day?” If the patient reports one or more heavy 
drinking days, they screen positive for alcohol misuse. In addition, it was 
recommended administering a written self-report instrument or validated 
screening tool (for example, AUDIT, AUDIT-C, AUDIT-PC, CAGE, or FAST) for 
assessing alcohol risk levels. These high-quality guidelines (CG: 1, 14, 21) 
suggested using validated screening tools to decide whether to offer patients a 
brief intervention (for moderate drinkers) or whether to make a referral for 
specialist treatment (if patient is dependent on alcohol). It was further 
recommended to record/document the patient’s alcohol use and any diagnosis 
of alcohol dependence in clinical records, and to update records regularly at 
every admission to hospital and at least annually in primary care. The strength 
of recommendations graded in these guidelines was strong (CG: 1, 14, 21), as 
they were based on relevant systematic reviews, randomised controlled trials, 
and expert papers/opinions. 
Behavioural preventive interventions (Advise/ Arrange)  
There were four high-quality guidelines which included alcohol reduction 
interventions in a primary care setting (CG: 1, 2, 14, 21). Of these, the 
recommendations in the most recent and higher quality guideline (CG 1), which 
was developed by the Institute for Clinical Systems Improvement (ICSI) in the 
United States, were based on another older mid-quality guideline (which was 
also included in this overview study - CG 15; Table 3.7). The other two high-
quality guidelines were developed by the “National Institute for Health and Care 
Excellence (NICE)” in England (CG: 14, 21). The more recent NICE guideline (CG 
14) on “Individual approaches for Behaviour Change” included recommendations 
for alcohol reduction based on another older NICE guideline (CG 21) which 
included recommendations exclusively on “Alcohol-use disorders”. While the 
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fourth high-quality guideline (CG 2), which was “European Guideline on 
cardiovascular disease prevention (ESC)”, included alcohol reduction 
interventions as part of recommendations on nutrition. This guideline also 
included some recommendations based on the NICE guideline on “Alcohol-use 
disorders” (CG 21). However, the guideline (CG 2) did not provide any details on 
the components of the behavioural intervention for alcohol reduction (for 
example, duration and number of sessions). 
The recommendations from these high-quality alcohol guidelines (CG: 1, 2, 14, 
21) have been presented together, considering higher quality (AGREE II) score, 
recency, and duplication. The recommendations were evidence based: produced 
from a review of good quality systematic reviews, and a literature search or 
systematic review of randomized controlled trials conducted by the guideline 
development team. Some of the referenced systematic reviews in these 
guidelines (on which recommendations were based) were also included in this 
overview study, SR: 11, 17, 22 (Section 3.4.1.5.2); thus, showing strength of the 
evidence in this overview study. 
All four high-quality guidelines recommended providing face-to-face behavioural 
interventions (structured advice) to help address a patient’s alcohol use after 
assessing their alcohol consumption (CG: 1, 2, 14, 21). It was recommended that 
the behavioural intervention should be tailored or personalized to the individual 
patient to meet their needs by assessing and then addressing them (for example, 
based on severity of alcohol use, comorbidities) (CG: 1, 14, 21). It was further 
recommended in the NICE guidelines (CG: 14, 21) that the intervention should 
aim to reduce the amount an individual drinks to low-risk levels, reduce risk-
taking behaviours as a result of drinking alcohol, or to consider moderation. Like 
smoking interventions, recommendations in the most recent high-quality 
guideline - ICSI guideline (CG 1) were based on the “5A’s behaviour change 
model” for delivering alcohol interventions in a primary care setting. Clinicians 
were recommended to consider offering a brief behavioural intervention for 
individuals who screen positive on a validated tool for risky/hazardous drinking. 
Interventions could be delivered in the form of brief advice or motivational 
interviewing (including action plans, drinking diaries, stress management, or 
problem solving). The duration of the brief intervention was recommended as 
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10-15 minutes for effective behaviour change in this guideline (CG 1). It was 
further recommended to deliver intervention in two or more sessions, i.e. multi-
contact interventions. The strength of recommendations was strong, as 
evaluated by the GRADE system (Guyatt et al., 2008). Very brief (less than five 
minutes) and single-contact interventions were reported to be ineffective or less 
effective than multi-contact interventions; there was a weak evidence to 
support this (CG 1). These recommendations were in line with the systematic 
review evidence identified in this overview study (Section 3.4.1.5.2; Table 3.6). 
The NICE guideline on “Alcohol-use disorders” (CG 21), instead of using the 5 A’s 
approach, recommended using an evidence-based resource based on the 
“FRAMES principles (i.e. feedback, responsibility, advice, menu, empathy, self-
efficacy)” for delivering a brief intervention. It was recommended that the 
intervention should last from 5–15 minutes and include: “feedback (on the 
client's risk of having alcohol problems), responsibility (change is the client's 
responsibility), advice (provision of clear advice when requested), menu (what 
are the options for change?), empathy (an approach that is warm, reflective and 
understanding) and self-efficacy (optimism about the behaviour change)”. It was 
further recommended to routinely monitor a patient’s progress in reducing their 
alcohol consumption to a low-risk level and to offer an additional session of 
structured brief advice (where required). If the patient does not respond to the 
brief advice, offer an intensive intervention (in the form of motivational 
interviewing or motivational-enhancement therapy) to motivate them to address 
their alcohol misuse. An intensive intervention could last from 20-30 minutes, 
and it was recommended to set up a follow-up appointment in order to support 
the behaviour change and re-evaluate drinking behaviours. The other NICE 
guideline (CG 14), besides offering a brief intervention as mentioned in the 
guideline (CG 21), recommended offering a very brief intervention, which 
involved 30 seconds to a couple of minutes of advice following an “ask, advise, 
assist” structure. However, the strength of the evidence for the effectiveness of 
a very brief intervention for alcohol reduction was weak; the recommendation 
was based on expert papers and descriptive studies, however no systematic 
reviews or randomized controlled trials were reported supporting this evidence. 
Thus, the main recommendation, with higher strength of evidence, was to offer 
brief, rather than very brief advice (CG 14). 
Chapter 3  
 
 
169 
Similar to smoking interventions, alcohol reduction interventions were 
recommended to be effective if delivered by any member of the primary care 
team, including physicians, nurses, psychologists, social workers, cessation 
counsellors, pharmacists, or dental professional (CG: 21)  - who were trained to 
offer advice (CG: 1, 2, 14, 21). It was strongly recommended for healthcare 
professionals to receive appropriate training to provide brief advice effectively. 
However, the duration of training was not reported in any high-quality alcohol 
guideline, and research evidence supporting effectiveness were not reported. 
It was further recommended that brief advice should be supported by providing 
written information or self-help materials (CG: 1, 2, 14, 21). However, again, 
there was no research evidence to support this. 
Referral to specialist services (Assist) 
It was recommended in three of the high-quality alcohol guidelines (CG: 1, 14, 
21) that healthcare professionals should consider making a referral for specialist 
alcohol treatment services under these circumstances:  
a) if the patient is diagnosed with alcohol dependence;  
b) if the patient fails to benefit from the structured advice (brief and intensive 
interventions); and 
c) if the patient is willing to receive further help for his/her alcohol problem. 
However, the strength of this recommendation was not reported in these 
guidelines, due to lack of supporting evidence.  
Summary 
Table 3.12 summarises the recommendations from all four high-quality clinical 
guidelines on alcohol reduction interventions in a primary care medical practice. 
It was recommended to ask, assess, and record an adult patient’s alcohol use in 
the clinical records. Use of validated screening tools (for example, AUDIT, 
AUDIT-C, CAGE) was recommended for assessing alcohol risk levels. Following 
alcohol risk assessment, a brief (10-15 minutes) multi-contact intervention (two 
or more sessions) delivered by a trained provider was recommended to be the 
most effective in a primary care setting. Very brief interventions of less than 5 
minutes were also recommended, but the evidence reported was weaker 
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compared to the longer interventions to support this recommendation. Where 
needed, for example if patient is dependent on alcohol, it was recommended to 
make a referral to specialist alcohol treatment services. In addition, it was 
recommended to support advice with written materials, self-help materials, 
and/or goal-setting. However, research evidence was not reported to support 
the recommendations for referral and supporting materials. 
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Table 3.12: Medical practice - best practice (high-quality) recommendations for alcohol 
reduction interventions in the clinical guidelines (CGs) 
 
Preventive interventions for alcohol 
Strength of 
recommendations 
(based on supported 
evidence) 
CGs supporting 
recommendations 
 
Ask/ 
Assess 
 
Ask, assess, and record patient’s 
alcohol consumption levels 
(moderate or dependence), using 
validated screening tools – to 
determine treatment options 
 
Strong 
 
CG: 1, 14, 21 
 
 
Advise/ 
Arrange 
Offer behavioural (face-to-face) 
structured interventions to all 
patients with excessive alcohol 
consumption 
 
Brief (10-15-minutes) multi-
contact (two or more sessions) 
interventions were recommended 
to be most effective 
 
Very brief intervention (less than 
5 minutes) or intensive 
interventions (more than 20 
minutes)  
 
Additional components to 
support advice: written 
information or self-help 
materials, goal-setting 
 
Intervention delivered by any 
member of the primary care team 
 
Training received by primary 
care providers (evidence not 
reported to support effectiveness) 
 
Strong 
 
 
 
 
Strong 
 
 
 
 
Weak 
 
 
 
 
Weak 
 
 
 
 
Strong 
 
 
Weak 
CG: 1, 2, 14, 21 
 
 
 
 
CG: 1, 14, 21 
 
 
 
 
CG: 1, 14 
 
 
 
 
CG: 1, 2, 14, 21 
 
 
 
 
CG: 1, 2, 14, 21 
 
 
CG: 1, 2, 14, 21 
 
Assist/ 
Referral 
Make referral to specialist 
alcohol treatment services (for 
alcohol dependence) 
 
Weak 
 
CG: 1, 14, 21 
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3.4.2.5 Summary of systematic overview of clinical guidelines 
Similar to the systematic review synthesis, this clinical guideline synthesis aimed 
to identify best practice recommendations emerging from all primary care 
practices (dental/medical/pharmacy), primarily from the dental perspective, 
i.e. giving higher weighting to dental guideline recommendations and 
considering higher quality and more recent medical recommendations applicable 
in a dental practice setting. The key recommendations from the high-quality 
clinical guidelines in a primary care setting that constitute this systematic 
overview have been presented in respective tables at the end of each section 
(Tables: 3.9, 3.10, 3.11, and 3.12). 
There was only one high-quality clinical guideline relating to smoking cessation 
and alcohol reduction in a dental practice setting. However, best practice was 
developed from synthesising and drawing from the recommendations from other 
primary care (medical/pharmacy) settings, which could be adapted / adopted to 
dental practice. 
Overall recommended intervention for smoking cessation included: ask, assess, 
and record a patient’s smoking (or tobacco use) status in the clinical records 
(along with other “vital signs”); offer a brief or very brief smoking cessation 
advice (tailored based on individual needs) to all smokers, regardless of the 
amount they smoke, in routine consultations whenever possible; if the patient is 
willing to quit, make referral to quit-line services (proactive support) for further 
help. Interventions to be delivered by any member of the primary care team 
(physician, nurse, pharmacist, or dental professional). It was further 
recommended that intensive (or longer) interventions were likely to have a 
greater (but marginal) effect on quit rates compared to brief interventions. 
Overall, guidelines recommended to start with brief advice (plus quit-line 
referral) and then offer intensive advice depending on patient needs or 
addiction. 
For reducing alcohol consumption, it was recommended to assess patient’s 
alcohol consumption (using validated screening tools), followed by a brief 
tailored intervention with one or more follow-up visits, delivered by primary 
care professional (physician, nurse, pharmacist, or dental professional) to 
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outline the possible harmful effects of excessive alcohol consumption. A brief 
(10-15-minutes) intervention was best recommended in medical practice 
guidelines for helping alcohol users to reduce consumption, though 5 minutes 
advice was also reported to be effective (supported with research evidence). 
Referral to specialist services was suggested in cases of alcohol dependence, 
however, again, outcomes for effectiveness of referral were not reported. 
Again, similar to systematic reviews, none of the clinical guidelines 
recommended offering combined interventions for tobacco and alcohol. 
3.4.3 Integrated or combined synthesis (systematic review 
evidence and clinical guideline recommendations) 
The results from Section 3.4.1.5 (high-quality systematic review evidence 
synthesis) and Section 3.4.2.4 (high-quality clinical guideline recommendation 
synthesis) helped to answer research questions 1 and 2 (Section 3.2), which were 
to identify the evidence-based best practice for assessing major behavioural risk 
factors associated with oral cancer and associated behaviour change preventive 
interventions delivered by dental professionals in primary care dental practices. 
In order to answer research question 3 (Section 3.2), the results from current 
systematic review evidence and clinical guideline recommendations were 
compared and contrasted to provide an integrated/combined overview that is 
relevant to primary care dental professionals. As mentioned in the data synthesis 
section (Section 3.3.9), after the within-stream synthesis (Section 3.4.1.5 and 
3.4.2.4) an integrated synthesis was conducted in order to answer specific 
questions about whether evidence from reviews were reflected in current 
guidance or whether collated guidance showed areas where better evidence was 
required. 
The behavioural preventive interventions included in all high-quality systematic 
reviews and clinical guidelines were heterogeneous and comprised of various 
treatment approaches. There was quite a lot variation in the definitions, 
terminologies, and characteristics of behavioural interventions among these 
reviews. After detailed analysis of all included interventions within high-quality 
reviews and guidelines (even primary studies or trials within them), it was 
decided that the following definitions would be used: a “very brief” intervention 
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would last for less than 5-minutes (including as little as 30 seconds to a couple 
of minutes advice), involving a message to highlight benefits of 
quitting/moderating and providing information for further help; a “brief” 
intervention would last 5-20 minutes, usually involving theory-based advice to 
motivate individuals for behaviour change and could involve 1 or 2 follow-up 
visits; while an “intensive” intervention is similar in content to a brief 
intervention, but would last more than 20-minutes and involve multiple sessions 
(NICE, 2014). All these interventions involve (within that duration) other 
components such as: asking, assessing, and recording an individual’s 
tobacco/alcohol use status; providing supporting materials; or referral to local 
support services – as discussed previously in the overview findings. The relative 
effectiveness of each intervention for tobacco cessation and alcohol reduction 
has been reported earlier in the within-stream synthesis (Section 3.4.1.5 and 
3.4.2.4); the effect sizes are further reported below to give a combined 
synthesis of both systematic review evidence and clinical guideline 
recommendations. 
3.4.3.1 Areas where evidence-base and guidance match (strong strength of 
evidence / recommendations) 
Most of the high-quality systematic review evidence and clinical guideline 
recommendations were in accordance with each other, i.e. guidelines were 
based on the review evidence. However, there were some areas where evidence 
and guidance were lacking, and these will be discussed in Section 3.4.3.2. 
All high-quality reviews and guidelines were consistent in recommending offering 
behavioural intervention delivered by primary care professionals (irrespective of 
provider type) to adult smokers (or tobacco users) or alcohol drinkers, following 
an assessment of a patient’s tobacco use status or alcohol levels, for effective 
behaviour change (tobacco cessation and reducing alcohol consumption). 
Furthermore, review evidence and guideline recommendations were synchronous 
with regards to assessing and recording a patient’s alcohol use status. It was 
reported in both reviews and guidelines that validated screening tools (for 
example, AUDIT, AUDIT-C, CAGE, FAST) should be used for assessing alcohol risk 
levels (or dependence), to recognise the high-risk drinkers who are at higher risk 
of developing oral cancer or other chronic diseases. However, there were 
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differences with regards to assessment of a patient’s smoking status (discussed 
in Section 3.4.3.2). 
The lack of precise reporting of duration and number of sessions of behavioural 
interventions for both tobacco and alcohol (for example, brief intervention 
described as 5-20 minutes; quite a wide range), somewhat limited the inferences 
(regarding duration of sessions) that can be drawn from the overview findings. 
The overall conclusions drawn from the systematic review evidence and clinical 
guideline recommendations for smoking cessation interventions were similar: it 
was recommended to offer in-person brief motivational (and tailored) 
interventions to all smokers (or tobacco users) to increase quit rates (RR 1.66, 
95% CI 1.42 to 1.94) (SR 8). It was reported that although longer interventions 
(10-20 minutes) were more effective in increasing quit rates, even very brief 
interventions of as little as 2-3 minutes have also been shown to be effective. 
There was a small additional benefit of intensive interventions (more than 20 
minutes) compared to brief interventions (RR 1.37, 95% CI 1.20 to 1.56) (SR 8). 
Evidence-base reviews and guidelines on reducing alcohol consumption were also 
similar. These were drawn largely from the medical practice setting (there were 
no dental alcohol systematic reviews). A brief motivational (10-15 minutes), 
multi-contact (two or more follow-up visits) tailored intervention, following risk 
assessment, was most effective for helping alcohol users to reduce consumption 
(decreased by 3.6 drinks per week from baseline; 95% CI, 2.4 to 4.8 drinks/wk) 
(SR 11); interventions of 5 minutes duration were also reported to be effective 
(mean difference: -38 grams/week, 95% CI: -54 to -23) (SR 17). The reported 
effect rates (where compared) were smaller for intensive and very brief 
interventions compared to brief interventions (5-8% increased abstinence in very 
brief versus 7-12% in brief intervention) (SR 11). 
The high-quality guidelines (dental and medical) went beyond the review 
evidence, and recommended more practical advice (i.e. very brief - for couple 
of minutes) based on some descriptive studies, and expert papers or opinions. 
Moreover, it was recommended in high-quality dental practice guideline that 
dental professionals were not expected to provide intensive interventions for 
tobacco and alcohol, instead they should refer patients to a trained counsellor. 
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The lack of trial evidence for smoking and alcohol referrals (in systematic 
reviews) will be discussed in Section 3.4.3.2. 
3.4.3.2 Areas where evidence-base is weak 
The majority of the included trials/studies in the high-quality systematic reviews 
did not provide information on how they assessed high-risk smokers (or tobacco 
users). The high-quality reviews mentioned about asking and recording a 
patient’s tobacco use status in the clinical records. The high-quality dental 
review further reported recording findings from a patient’s oral examination and 
relating it to their tobacco use. None of the high-quality reviews reported how a 
patient’s self-reported tobacco use status was confirmed. In addition, details of 
a tobacco risk assessment, including that of nicotine dependency, were not 
provided in the review evidence (for example, duration, frequency, or type 
(cigarette, cigar, pipe)). On the other hand, clinical guidelines (medical 
practice) went beyond the review evidence and were clearer in their 
recommendations for a smoking (or tobacco) risk assessment. It was strongly 
recommended to systematically ask and record every patient’s tobacco use 
status at every opportunity in clinical records as a “vital sign”. Guidelines 
further recommended assessment of nicotine dependence by asking about the 
time to first cigarette, number of cigarettes smoked a day, and withdrawal 
symptoms (if the patient previously attempted to quit). Although the strength of 
this recommendation was judged to be strong, the source of these 
recommendations was not clear in terms of any trial or review evidence. In 
addition, there were no validated screening tools reported for assessing a 
patient’s tobacco use status in all high-quality reviews and guidelines. This has 
implications for the use of tobacco risk assessment tools in a primary care 
practice. 
Although very brief interventions (less than 5 minutes) were reported to be 
effective in promoting smoking cessation, there was limited trial evidence, 
reported in both systematic reviews and clinical guidelines, compared to brief or 
intensive interventions for increasing tobacco abstinence rates. The clinical 
guidelines (dental and medical practice) considered this very brief advice as a 
more pragmatic/practical approach, that is easier to implement in a dental 
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practice setting (for both smoking and alcohol). Thus, considering the large 
number of trials supporting relatively longer intervention sessions, more trials 
would be helpful to study the effectiveness of very brief advice in a dental 
practice setting. 
Furthermore, high-quality reviews and guidelines in the dental practice setting 
were lacking with regard to evidence of effectiveness of interventions for 
reducing alcohol consumption. All the high-quality advice for alcohol came from 
the primary care medical practice settings. Thus, there is a need for more 
studies to evaluate the effectiveness of behavioural alcohol interventions in a 
primary care dental practice setting. In addition, there was a lack of studies 
evaluating combined interventions for smoking and alcohol (only isolated 
interventions were reported). 
Patient referrals to cessation services were an important part of the brief 
interventions recommended in all high-quality reviews and guidelines. However, 
the high-quality systematic reviews (dental and medical) reported a lack of 
evidence (no effect sizes) for the effectiveness of smoking (or tobacco use) 
cessation referrals. Guidelines on the other hand, seem to have much stronger 
recommendations regarding referral to cessation services than came through 
from systematic reviews in this overview study. Based on some trial evidence (in 
the medical practice) and expert papers, it was strongly recommended to refer 
or signpost all tobacco users (who agree to quit following brief advice) to quit-
lines services (proactive support). While for high risk drinkers (alcohol 
dependence), referral to a general medical practitioner or to specialist alcohol 
treatment services was recommended in high-quality guidelines, there was, 
however, no evidence reported to support alcohol referrals in this overview. 
Thus, there is a need for more trial evidence reporting the effectiveness of local 
referral pathways for both tobacco and alcohol in primary care dental practices. 
Both systematic reviews and clinical guidelines stressed the importance of the 
training of healthcare professionals to deliver behavioural interventions (for 
tobacco and alcohol). It was noteworthy that most of the effective behavioural 
interventions (for tobacco and alcohol) in the majority high-quality reviews were 
delivered by a trained primary care provider (for example: dentists, clinicians, 
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nurses, pharmacists, health educators); clinical guidelines also recommended 
training primary care professionals to deliver behavioural interventions. 
However, effect sizes were not reported (in both reviews and guidelines) to 
compare effectiveness of interventions delivered by professionals ‘with’ versus 
‘without’ training. Thus, making it difficult to make any conclusions regarding 
effectiveness of offering training to primary care professionals to deliver 
behavioural interventions. Moreover, reviews and guidelines failed to describe 
the nature of the provider training that would be sufficient to deliver an 
effective intervention, including duration and number of training sessions. 
Although some high-quality reviews reported training duration, it was quite 
varied and difficult to make a conclusion. Thus, there is a need for more 
evidence and recommendations in this regard, although it is recognised that the 
content and duration of any training programme will be related to the type of 
intervention planned. 
Moreover, reviews and guidelines were in agreement regarding supporting 
behavioural advice (for tobacco and alcohol) with: educational or self-help 
materials, or online support. However, there was no evidence-base with effect 
sizes regarding effectiveness of interventions delivered ‘with’ versus ‘without’ 
supporting materials. Thus, again, making it difficult to make conclusions 
regarding effectiveness of supporting materials provided along with behavioural 
interventions. 
3.5 Discussion and conclusions  
The present overview study is, to the best of the author's knowledge, the first to 
synthesise the evidence-base from current systematic reviews and clinical 
guidelines, which are relevant to primary care dental professionals, with regard 
to undertaking a patient assessment of the major behavioural risk factors 
associated with oral cancer (tobacco and alcohol), and delivering preventive 
interventions (for example, behavioural advice, signposting/referral to 
preventive services). While the quality appraisal and synthesis methods followed 
validated protocols and frameworks (Section 3.3.8 and 3.3.9), the “higher level” 
synthesis of these two “streams” together in this way was innovative and is 
believed to be a good contribution to knowledge. 
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3.5.1 Comparison with literature 
The findings of this overview are consistent with the implicit theory developed 
as part of the narrative synthesis (Section 3.3.9), i.e. assessing risk factors 
associated with oral cancer (tobacco and alcohol) and providing behavioural 
preventive advice can increase a patient’s knowledge of potential risks, 
motivate them, and eventually lead to behaviour change (i.e. smoking cessation 
and reduction in alcohol consumption). The preventive interventions conducted 
in a primary care setting (dental/medical/pharmacy) were more effective than 
usual care or no intervention for promoting smoking cessation in adult smokers 
and reducing alcohol consumption in high-risk drinkers. 
Current findings were based on a much greater body of research in the primary 
care medical practice setting compared to the limited research undertaken in 
the dental practice setting. Informed by the ADAPTE framework (Collaboration, 
2009), which provides a systematic approach to adapting guideline developed in 
one setting for use in another setting, the high-quality evidence and 
recommendations in the primary care medical/pharmacy setting in this overview 
were adapted to develop recommendations relevant to the dental practice 
setting. 
3.5.1.1 Tobacco cessation interventions 
This overview, based on the findings from the systematic reviews and clinical 
guidelines in medical practice settings, suggested that the same can be 
expected from dental professionals who interact with smokers (or tobacco users) 
in clinical setting. The results from another overview study by Ramseier and 
Suvan (2015), that aimed to improve periodontal health, supported these 
findings and showed the effectiveness of tobacco use cessation interventions in 
the primary care dental practice. The study (Ramseier and Suvan, 2015) included 
five systematic reviews: one of these reviews (Carr and Ebbert, 2012) was 
included in this overview study (only high-quality review in the dental practice 
setting (SR 12)); other four reviews were not included in this overview - due to 
wrong study design (overviews or literature reviews) (Dyer and Robinson, 2006a; 
Nasser, 2011), wrong population (adolescent) (Gao et al., 2014), while other 
review (Needleman et al., 2010) was an update of the older version of Cochrane 
Chapter 3  
 
 
180 
systematic review included in this overview study (SR 12). The effect size 
reported in the study by Ramseier and Suvan (2015) were similar to that 
reported in this overview (OR 2.38; 95% CI 1.70–3.35), to increase the odds of 
quitting tobacco. However, it failed to report the type of intervention, optimal 
length and frequency of interventions for effective tobacco cessation; and 
showed a need for further research in this field (Ramseier and Suvan, 2015). A 
similar lack of dental evidence was reported in reviews and guidelines included 
in this overview study, i.e. insufficient number of studies to determine the 
specific support measures delivered by dental professionals to provide an 
increased effectiveness beyond brief advice (Carr and Ebbert, 2012; SDCEP, 
2014). 
The current clinical guidelines in this overview study reported that an offer of 
assistance/support (referral to cessation services) to quit smoking was more 
motivating than simple advice to do so; i.e. a very brief intervention adopting 
“ask, assess and assist” approach (with lack of trial evidence). This has been 
supported by findings from another overview by Aveyard and co-workers (2012), 
which reviewed trials included in four Cochrane reviews of physician advice and 
pharmacotherapy for smoking cessation. It reported strong statistical evidence 
that offering assistance (referral or pharmacotherapy) for smoking cessation 
motivates an additional 40–60% smokers to attempt cessation compared to being 
advised to quit on medical grounds (Aveyard et al., 2012). The interventions 
were based in a range of healthcare settings (including primary care, hospital 
settings). However, it is worth noting that offering assistance in the included 
interventions was confined to offering pharmacotherapy (nicotine replacement 
therapy) along with a brief advice to quit, and effects for referral to quit-line or 
local support services were not reported. Thus, findings were in line with this 
overview study, showing a lack of evidence for effectiveness of referral services. 
Pharmacotherapy or medical interventions delivered along with behavioural 
preventive interventions have been shown to be effective in this overview study 
and a number of other studies for promoting tobacco use cessation, particularly 
in case of dependence (Kottke et al., 1988; Stead and Lancaster, 2012; Cahill et 
al., 2013). 
Chapter 3  
 
 
181 
Moreover, as was found in this overview study, a more “proactive” approach to 
quit-line support or telephone call-back counselling services was recommended 
by high-quality guidelines (medical practice) and were reported to be more 
effective than signposting or expecting patients to contact these services. 
However, there was a lack of systematic review or trial evidence reported in this 
overview study. A recent large smoking cessation trial (42,277 patients) 
conducted in ten family practice clinics in the United States further reinforced 
this guideline recommendation (Vidrine et al., 2013). This trial compared the 
“Ask-Advise-Connect” and “Ask-Advise-Refer” approaches, and reported that 
there was a 13-fold increase in the cessation treatment enrolment when smokers 
were directly connected to quit-line services (telephone call-back), compared to 
the nationally recommended method of referrals to the quit-line (i.e. providing 
referral cards rather than connections) (Vidrine et al., 2013). There is a need for 
trials to study the effectiveness of connecting and referring approaches in a 
dental practice setting. 
Some of the high-quality guidelines in this overview study recommended a 
similar approach to the “Ask-Advise-Connect”, to be delivered as a very brief 
opportunistic intervention of 30 seconds to a couple of minutes for reducing 
tobacco use (CG 12, 14). However, review or trial evidence was relatively 
lacking for this very brief advice. The very brief approach has, however, been 
recently reported to have a dramatic impact for motivating weight loss by 
primary care physicians in England (Aveyard et al., 2016). This prospective 
randomised trial showed that patients who received a 30-seconds physician-
delivered opportunistic intervention (behaviourally-informed advice and support) 
had 1.43 kg more weight loss compared to those who received simple advice 
(Aveyard et al., 2016). The procedures in this trial drew on the findings of the 
smoking cessation trial reported in the previous paragraph (Vidrine et al., 2013). 
The applicability of this very brief approach (30 seconds chat) for smoking 
cessation in the primary care settings, particularly dental practice settings, is 
therefore worthy of further consideration. 
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3.5.1.2 Alcohol reduction interventions 
As discussed in the introduction (Chapter 1), dental professionals are in an ideal 
position to provide brief alcohol advice to their patients. Despite, this 
opportunity, there is a lack of studies developing and evaluating alcohol brief 
interventions in a dental practice setting. Moreover, studies have reported 
various barriers to the successful implementation of these brief interventions in 
a dental practice, some of the barriers reported in previous feasibility studies 
being: lack of knowledge, skills, confidence, and time, and even doubts about 
the effectiveness of counselling (Macpherson et al., 2003; Shepherd et al., 2010; 
Amemori et al., 2011; Yusuf et al., 2015). 
None of the systematic reviews in this overview reported alcohol reduction 
interventions in the primary care dental practice setting. The dental guideline 
(CG 11) also lacked detailed recommendations regarding the required content of 
the brief intervention. This lack of evidence supporting the effectiveness of brief 
alcohol reduction interventions in primary care dental practices, in comparison 
to other primary care medical practice settings, has been reported in other 
existing literature (Dyer and Robinson, 2006a; McAuley et al., 2011; Ramseier 
and Suvan, 2015). Another overview study by Ramseier and Suvan (2015), agreed 
with these findings, showing insufficient evidence to make conclusions about the 
effectiveness of interventions to reduce alcohol consumption in a dental 
practice setting, aiming to improve periodontal health. As reported in this 
overview, the dental guideline recommended that dental professionals should 
provide very brief tailored advice of a couple of minutes (weak trial evidence) to 
motivate alcohol users to reduce consumption. The medical guidelines and 
systematic reviews, however, recommended providing a brief intervention 
lasting 10-15 minutes (strong trial evidence) with follow-up sessions in a primary 
care setting to reduce alcohol consumption. These results (10-15 minutes 
advice) were in agreement with two other overviews in a medical practice 
setting, which supported the effectiveness of brief alcohol interventions 
(O'donnell et al., 2013; Alvarez-Bueno et al., 2015). The overview conducted by 
Alvarez-Bueno and co-workers (2015) reported similar findings (for example, 
duration and number of sessions) to those reported in the majority of reviews 
and guidelines in this overview, i.e. 5-15-minutes intervention with follow-up 
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sessions had more effectiveness than intensive interventions or usual care. The 
study by O'donnell and co-workers (2013), on the other hand, failed to report 
the components of an effective brief intervention required to maintain longer-
term effects, for example, optimum length and frequency. There is a need for 
further research to find out whether the 10-15 minutes advice could be applied 
to alcohol interventions delivered in a dental practice setting. Moreover, 
considering the comparable effectiveness of shorter 5 minutes advice and 
feasibility, this need to be tested in a dental practice setting. The feasibility 
issues of implementing brief alcohol interventions in dental practice settings, 
i.e. transferability of findings or recommendations from medical to dental 
practice setting will be explored in the next chapters in this thesis (Chapter 4 
and 5). 
Similar to smoking cessation interventions, some of the high-quality guidelines in 
this overview study recommended very brief opportunistic intervention of 30 
seconds to a couple of minutes for reducing alcohol consumption. However, the 
strength of the recommendations was weak, due to lack of reviews or trial 
evidence for this very brief alcohol advice. Thus, there is a need for further 
research to find whether the very brief approach could be applied to 
opportunistic alcohol interventions in primary care, including the dental 
practice. 
3.5.1.3 Combined interventions (for tobacco and alcohol) 
As discussed earlier in the introduction (Chapter 1), multiple risk factors need to 
be considered for oral cancer prevention, as tobacco and alcohol in combination 
magnifies the risk for oral cancer. However, combined interventions were almost 
completely lacking in this overview. Other existing reviews and guidelines have 
also reported a similar lack of evidence focusing on the most effective approach 
to deal with multiple behaviours (for example, if someone smokes, and 
consumes alcohol above recommended limits) (Goldstein et al., 2004; NICE, 
2014). The question thus remains: whether these behaviours should be 
approached in sequence or in combination, and how this should be decided? 
Hence, further investigation is needed to address this large gap in knowledge 
about the effectiveness of multifactorial or combined interventions, 
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incorporating both smoking and alcohol advice in a primary care setting, 
including dental practice. 
3.5.2 Strengths and limitations 
3.5.2.1 Strengths 
This study was novel in synthesising evidence from both systematic reviews and 
clinical guidelines. After conventional synthesis of each stream, a robust 
framework was developed for evidence synthesis (narrative ‘thematic’ synthesis) 
across these information sources, addressing review/guideline quality, recency 
and duplication. A detailed methodology was provided in Section 3.3, which was 
registered with PROSPERO, and published in the journal BMC Systematic Reviews 
(Mathur et al., 2015). 
One of the major strengths of this overview study was the extensive, systematic 
literature search; i.e. international literature, with no language restriction, and 
involving the grey literature search (for clinical guidelines). The systematic 
search was not limited to “oral cancer”, thus the overview did not rule out good 
guidelines and/or evidence on how to assess risk and deliver prevention for the 
risk factors (tobacco and alcohol) that may be aimed at another oral condition 
(for example, periodontal disease) (SDCEP, 2014). Furthermore, the systematic 
search was not limited to the dental practice setting. Preventive interventions 
delivered in all primary care settings (dental/medical/pharmacy) were included 
in this overview, in order to again not rule out any good guidelines and/or 
evidence on how to assess risk and deliver prevention for the risk factors 
(smoking and alcohol) that may be aimed at another clinical/medical condition 
(for example, cardiovascular disease, lung cancer) (Fiore et al., 2008; NICE, 
2010). Thus, despite a lack of reviews and guidelines in dental practice settings, 
best practice was developed (Section 3.4.3 and summarised in Section 3.5.3) 
from synthesising and drawing from the best evidence and recommendations 
from other primary care (medical/pharmacy) settings, which could be adapted / 
adopted to dental practice. Moreover, a number of referenced reviews in the 
high-quality guidelines (on which recommendations were based) were also 
included in this overview study, for example, SR: 1, 6, 8, 11, 12, 16, 17, 22, 27; 
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thus, showing that a comprehensive search strategy was followed in this 
overview to include all relevant systematic reviews and clinical guidelines.  
This overview was carried out in accordance with the PRISMA statement (Moher 
et al., 2009) (Appendix 1), and using the well-established quality instruments 
(AMSTAR, ROBIS, and AGREE II) to evaluate the quality of the included reviews 
and guidelines. As the overview aimed to synthesise the best practice or high-
quality evidence and recommendations, a robust quality appraisal was carried 
out to assess the methodological quality of included systematic reviews (AMSTAR 
and ROBIS instruments), and clinical guidelines (AGREE II instrument). Moreover, 
the quality was assessed independently by two reviewers, and discrepancies 
discussed with the wider team. This helped to ensure the rigour of findings. 
The duplication of trials in all included systematic reviews, and duplication of 
guidelines and reviews within all included clinical guidelines was addressed, i.e. 
none of the findings were synthesised twice, thus strengthening the robustness 
of the overview synthesis. Moreover, as the individual trials from included 
systematic reviews have been isolated (to address duplication; Appendix 6), it 
might be possible to conduct a meta-analysis in future, subject to statistical 
requirements. 
3.5.2.2 Limitations 
One of the main limitations of this study concerned the limited number of 
systematic reviews in the dental practice setting relating to smoking advice 
(only one high-quality review) and the fact that there were no systematic 
reviews regarding providing alcohol advice in a dental practice setting. This 
resulted in restrictions and in extrapolating findings from other settings 
(medical/pharmacy) to the dental practice setting.  
The heterogeneity or sources of variability among study populations, settings 
and outcomes were explored as an integral part of data synthesis, but as this 
work was not meta-analytic, a narrative synthesis approach was used to address 
the applicability of findings across, professional groups and/or patient 
behaviours. Moreover, there was heterogeneity among the reviews and 
guidelines included in terms of the preventive interventions covered: type, 
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duration, number of sessions, methods employed (for example: simple advice, 
motivational interviewing, feedback, follow-ups, and use of educational 
materials). This again influenced the decision to undertake a narrative review 
rather than a meta-analysis. 
Another limitation was related to the fact that there was no consensus about the 
use of the terminologies in terms of the definitions of “brief, very brief, and 
intensive interventions” – which led to a difficulty in interpreting these 
terminologies. Additionally, there was limited information provided on many 
occasions regarding details of interventions covered. Furthermore, there was 
very limited evidence available in terms of effect sizes for some interventions 
that both the systematic reviews and clinical guidelines were to some extent 
recommending. This included referral to specialist services and the use of 
patient educational materials such as posters and leaflets. Thus, this 
heterogeneity (and limited information) constrained the ability to make 
conclusive recommendations regarding which components of behavioural 
preventive interventions should be incorporated into primary care practices. 
Another limitation could be the synthesis of only high-quality systematic reviews 
and clinical guidelines. Initial synthesis from data extraction of all findings 
(including medium- and low-quality), however, did not report any meaningful or 
definitive results. Therefore, after careful consideration of all the included 
reviews and guidelines, it was decided to use the current framework 
(synthesising high-quality reviews), particularly as the aim of this overview was 
to synthesise the “best practice evidence-base”. 
3.5.3 Chapter conclusions 
In conclusion, this overview study adopted a novel robust framework to 
synthesise best practice evidence from both systematic reviews and clinical 
guidelines for undertaking a risk factor assessment and delivering preventive 
interventions for major behavioural risk factors associated with oral cancer 
(tobacco and alcohol). The overview went beyond the review and trial evidence, 
and contributed to the knowledge by suggesting interventions based on an 
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integrated or combined synthesis of current high-quality systematic reviews and 
clinical guidelines. 
Overall, the findings from this overview identified that risk factor assessment is 
an important first step in any prevention intervention (i.e. questions must be 
asked to assess the risk levels or dependence). Regarding tobacco cessation 
intervention, it was found that an appropriate intervention would be to offer an 
in-person brief motivational, tailored intervention, delivered by dental 
professionals, in a single session, following an assessment of a patient’s tobacco 
use status (risk levels) and incorporating an oral examination component. 
Although longer (10-20 minutes) and intensive (more than 20 minutes, with 
follow-up visits) interventions have shown to be effective in increasing quit rates 
compared to shorter interventions, very brief (less than 5 minutes) interventions 
also showed comparable effectiveness to the longer brief or intensive 
interventions. For alcohol drinkers, after assessing the patient’s alcohol use or 
dependence (using validated screening tools), a brief motivational, tailored 
intervention, delivered by dental professionals, could be offered to motivate 
alcohol users to reduce consumption in a dental practice setting. A brief 10-15 
minutes multi-contact intervention was the best recommended intervention in 
medical practice reviews and guidelines for helping alcohol users to reduce 
consumption; brief interventions of 5 minutes duration were also reported to be 
equally effective. Thus, very brief (less than 5 minutes) or brief advice (of up to 
5 minutes), should be trialled for tobacco and alcohol respectively in a dental 
practice setting (considering feasibility and effectiveness as reported in reviews 
and guidelines), tailored to patient motivational status. 
The next step was to investigate the feasibility of implementing these 
techniques in the primary care dental practice, and to make recommendations 
for pilot trials of such implementation (Chapter 4 and 5). 
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Chapter 4 A theoretically-informed exploration 
of dental teams’ views on implementing best 
practice oral cancer prevention in primary care 
dental practices in Scotland 
This chapter focuses on gauging the dental teams’ views on the practical 
barriers and facilitators to implementing behaviour change interventions in NHS 
primary care dental practices (in Scotland). 
4.1 Introduction 
Implementation research (Section 1.4.3) focuses effort on the factors (barriers 
or facilitators) that inhibit or promote the systematic uptake of evidence-based 
practice, by healthcare professionals in routine clinical and organisational 
settings (Eccles and Mittman, 2006; Bauer et al., 2015). The field has developed 
due to a number of recognised issues, involving staff, patient, and organisational 
aspects, which affect the reliable adoption of evidence-based practices (Bauer 
et al., 2015). Exploring such issues is a vital and necessary step in supporting 
healthcare teams and systems in implementation (Bauer et al., 2015). 
The introduction (Section 1.4.3) discussed previous studies of general barriers, 
both personal and organisational, affecting the adoption of tobacco and alcohol-
related interventions in dental practice. For example, some of the barriers 
reported were lack of knowledge, skills, confidence, and time, and there are 
reported doubts about the effectiveness of counselling (Macpherson et al., 2003; 
Shepherd et al., 2010; Amemori et al., 2011; Yusuf et al., 2015). 
Importantly, the Behaviour Change Wheel methodology employed in this study 
(detailed in Section 4.3.9), is based on the theory of enhancing opportunities, 
capabilities and motivation, and advantages identified in particular settings 
(termed ‘facilitators’), as well as identifying and overcoming barriers (Michie et 
al., 2011). For example, it has been argued that dental professionals are in a key 
position to identify patients at high risk for developing oral cancer because 
patients visit for routine preventive appointments where they may not be aware 
of any health problems or symptoms (Petersen, 2008; Shepherd et al., 2010; 
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Amemori et al., 2011; SDCEP, 2014). There may be opportunities for 
implementation of interventions associated with the prevention of oral cancer 
due to the fact that aspects of the dental “check-up” consultation are already 
orientated towards risk factors, for example routine use of patient history 
questionnaires. Additionally, preventive advice can be linked to the clinical 
examination (for example, where this shows periodontal disease, tooth 
discoloration, halitosis, soft tissue changes) (Edwards et al., 2006; Petersen, 
2008; Shepherd et al., 2010; Amemori et al., 2011; SDCEP, 2014).  
Further opportunities may exist because tobacco and alcohol form common risk 
factors not just for oral cancer but for a range of other health conditions, and is 
in line with moves to an integrated oral and wider public health agenda 
(Sheiham and Watt, 2000). The policy context also comes with opportunity 
regarding enhancing the role of the dental team (Steele, 2014; WHO, 2016b; 
Scottish Government, 2018b). For example, “Scotland’s Oral Health 
Improvement Plan” focuses on introducing a preventive care pathway and an 
oral health risk assessment for all adult patients on a regular basis, followed by 
a personalized care plan based on the assessment of the risk level to their oral 
health (Scottish Government, 2018b). It also focuses on increasing the role and 
nature of preventive interventions within the primary care dental contract 
(Scottish Government, 2018b). Moreover, the “WHO’s Global strategy for 
prevention and control of non-communicable diseases” integrates the common 
risk factor approach into global policy for oral diseases (Petersen, 2008; WHO, 
2016b). 
This study now takes this implementation landscape for oral cancer prevention 
further by: a) focusing quite specifically on individual components of behaviour 
change interventions (some of which are evidenced from other settings such as 
primary care medical practice); and b) employing a dedicated implementation 
framework (the Behaviour Change Wheel) which allows for the exploring 
different types of barriers and facilitators with a view of identifying optimal 
targets for further implementation / feasibility testing. 
Finally, the more general risks associated with tobacco and alcohol mean that 
risk prediction tools, available from other health contexts, could be adopted and 
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adapted (Usher-Smith et al., 2015). These risk prediction tools are used in 
primary care medical practice in asymptomatic individuals who are at higher risk 
of developing disease, and might help facilitate effective history taking, 
communication of risk, and adherence to advice, as well as supporting clinical 
decision making, thus improving patient outcomes. There are tools specifically 
for primary care use relating to breast, lung, prostate, and colorectal cancer, 
and for cardiovascular disease (Usher-Smith et al., 2015). However, there is a 
lack of such a personalised risk tool, with potential to guide opportunistic 
assessment and behavioural interventions specifically targeted at oral cancer 
reduction. 
In summary, conducting high quality studies, and producing clear clinical 
guidelines and recommendations for professionals, is a necessary first step but 
not in itself sufficient to ensure patients receive the best possible preventive 
care. Implementation can be inhibited or enhanced by a range of factors, and 
targeted interventions, based on sound behavioural and organisational theory, 
are necessary to support improvement. This study now proceeds to apply such 
theory in a rigorous fashion to the international evidential synthesis produced in 
Chapter 3. 
4.2 Aims and research questions 
The main aims of this study were:  
a) to identify barriers and facilitators to implementation of the synthesised best 
practice evidence for oral cancer risk factor assessment and prevention in 
primary care dental practice in Scotland; 
b) to make recommendations for developing and testing interventions to support 
evidence-based oral cancer prevention in primary care dental practice in 
Scotland and beyond. 
A supplementary aim was to explore the views of dental professionals on the 
specific merits/demerits of oral cancer risk prediction tools in primary care 
dental practice. 
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Specific objectives were to: 
§ Recruit members of the dental team to participate in an interview 
§ Develop a theory-based, semi-structured interview schedule 
§ Explore dental professionals’ history, knowledge and awareness of oral 
cancer risk factor assessment and prevention 
§ Gather views on the feasibility (barriers and facilitators) of implementing 
the synthesised evidence-base, and on potential interventions to support 
dental professionals 
§ Gather views on risk prediction tools 
These objectives were developed in order to address the following broad 
research questions for this study: 
a) What are the current barriers and/or facilitators to oral cancer risk factor 
assessment and prevention in primary care dental practices in Scotland? 
b) What aspects of best practice/evidence-based risk factor assessment and 
preventive advice, taken from medical and pharmacy settings, are transferrable 
to primary care dental practices in Scotland? 
c) What are the recommendations for conducting a pilot intervention in primary 
care dental practices in Scotland? 
d) What are the views of the dental team on utilising an oral cancer risk 
prediction tool in primary care dental practices in Scotland? 
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4.3  Methods 
4.3.1 Choice of method 
A qualitative cross-sectional study, using semi-structured interviews, was 
undertaken to explore the views of dental professionals. 
Qualitative methodology was considered most appropriate as the aims of this 
study were to explore the perceptions, understandings and preferences of the 
individuals (Ritchie et al., 2013). As described in Chapter 2, a pragmatic 
approach was adopted for this thesis. This approach does not start from a 
“disinterested” position, i.e. is not fully exploratory, but nor does it test a 
specific hypothesis and thus prescribe exactly what the response set should be 
(Creswell and Creswell, 2017). Rather, a flexible semi-structured method is 
employed which is directly linked to research questions or aims in order to 
understand the problem, but allows for some freedom of expression of related 
views (Creswell and Creswell, 2017). A phenomenological approach was not 
deemed appropriate for this study, as this focuses primarily on experience, i.e. 
the essence of dental professionals’ experiences of the topic and how they 
reflect on them (Moustakas, 1994; Creswell and Creswell, 2017). Similarly, a 
grounded theory approach was not embraced as the aim of this study was not to 
develop a general, conceptual theory of implementation of oral cancer risk 
factor assessment and prevention grounded in the views of dental professionals 
(Glaser and Strauss, 1967). Instead, the aim was to gather a rich description of 
dental professionals’ views on the practical application of the identified best 
practice evidence (from Chapter 3) on oral cancer risk factor assessment and 
prevention. This was deemed amenable to a pragmatic approach which combines 
an ‘a priori’ framework of specific questions (with a dedicated practical 
purpose) with full exploration of views and inductive coding of responses. 
An in-depth, semi-structured interview approach was the method used for data 
collection in this exploratory qualitative study (Longhurst, 2009). This is a 
structured research process in which a well-trained interviewer/researcher asks 
a set of semi-structured probing questions, establishes good rapport, listens and 
records the responses, in order to obtain particular information from individuals 
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(Hennink et al., 2010; Ritchie et al., 2013; Silverman, 2013). In-depth interviews 
are usually conducted in a face-to-face setting, to allow the researcher to 
respond better to non-verbal cues, which may lead to specific prompts. These 
interviews allow for an in-depth exploration of meaning and language, and as 
these interviews are interactive, flexible and generative in nature, the face-to-
face encounter is an essential context of these interviews (Ritchie et al., 2013). 
Therefore, face-to-face, individual interviews were conducted with dental 
professionals, in order to explore and gain detailed insight. 
4.3.2 Ethical approval 
4.3.2.1 NHS 
Formal confirmation was received from the West of Scotland Research Ethics 
Service (WOSRES) that no NHS Research Ethics Committee (REC) approval was 
required for this study, as the project involved only NHS staff and dental 
practitioners in their professional capacity. The advice was received on March 
20th, 2015 (Appendix 7). 
4.3.2.2 University of Glasgow 
Ethical approval was sought from the College of Medicine, Veterinary and Life 
Sciences ethics committee at the University of Glasgow. Initial approval was 
received on June 12th, 2015. Further approval was obtained on June 16th, 2016 
due to a change to the interview method and removal of a survey component 
from the study (Appendix 8).  
A study proposal form was also submitted to the Glasgow Dental Hospital and 
School Research Management Committee at the University of Glasgow. Approval 
from this committee was received on February 11th, 2015. 
4.3.3 Ethical considerations 
No conflicts of interest were identified in relation to this study. The information 
gathered was obtained, processed and retained in keeping with the Community 
Oral Health (COH) Section Data Security Protocol. The unit’s Data Security 
Protocol is in keeping with the University of Glasgow’s Data Protection and 
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Records Management Policies and was recently audited by the University. The 
principal researcher and supervisors with access to data were required to sign 
the Research Data Security and Confidentiality Agreement. 
4.3.4 Sampling and participant recruitment 
Sampling 
This study involved a non-probabilistic, purposive sample with participants 
chosen based on their ability to inform the aims of the research, i.e. to allow 
exploration of barriers and facilitators to a comprehensive preventive approach 
in practice. Purposive (non-probabilistic) stratified sampling, as is common in 
qualitative research, is a trade-off between efficiency (recruiting people who 
can provide great detail of interest) and thoroughness (obtaining representation 
from those with different length of experience, professional roles etc.) (Oliver 
and Jupp, 2006). 
The choice was both pragmatic (target staff who can respond in time and to 
subject matter) and analytic (those providing routine care tend to be the ones 
who best reflect the system under observation). It has been argued that for 
small sample sizes (typically in studies using intensive qualitative methods), the 
bias from sampling based on selected criteria is less dangerous than the lack of 
precision introduced by probability samples (Deville, 1991). 
Selection criteria 
The research focused on NHS dental practitioners and professionals in their 
professional capacity across Scotland. The dental professionals were recruited 
from a range of dental practices, in order to cover different geographical 
locations. Stratification ensured a mix of participants to give a range of 
responses across: 
a) General dental practitioners and other dental care professionals in the team 
(dental hygienists/therapists) providing preventive care 
b) Range of socioeconomic backgrounds (Scottish Index of Multiple Deprivation - 
SIMD quintile) of the location of their dental practice 
c) Years of experience (experienced dental professionals to current dental 
trainees) 
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Recruitment 
A list of accessible dental practices (based on selection criteria) was drawn up in 
consultation with specialists in Dental Public Health at the University of Glasgow 
Dental School. These practices were also who had either previously participated 
in research projects or had expressed an interest in participating. All potential 
participants (dental professionals) were approached by sending an invitation 
email, and participants were asked to give approval to be contacted for the 
semi-structured interview by replying to that email. The information sheet 
outlining the aims and objectives of the study was sent along with the invitation 
email and an opportunity was given to the potential participants to discuss the 
project verbally prior to taking part in the study, to ensure that they were fully 
informed about the study. A reminder email was sent after two weeks to those 
who did not reply to the first email. The potential participants were not 
contacted again if they did not respond to the second email. For participants 
who gave approval to be contacted, face-to-face interview appointments were 
arranged at a mutually convenient time. 
The target was to recruit and conduct 12 interviews in this study, but the 
planned number of interviews undertaken was open to change in relation to the 
research questions (Guest et al., 2006). As is common in qualitative work, the 
final set was determined under principles of data saturation. Here, a point is 
reached when no new themes emerge from analysis, and exhaustiveness in 
relation to the research questions can be assumed (Sandelowski, 2001; Fusch and 
Ness, 2015). Many qualitative researchers in their studies have showed that 7 to 
12 interviews are usually enough to achieve a desired research objective, 
however, this may not be the case with a relatively heterogenous study group 
(Guest et al., 2006; Fusch and Ness, 2015; Hennink et al., 2017). For this study, 
as the aim was to understand common perceptions and experiences among 
dental professionals in Scotland (a group of relatively homogeneous individuals), 
it was believed that 12 interviews would suffice. In total 13 dental professionals 
agreed to participate, so they were all interviewed (n=13) as part of this study, 
and data saturation was achieved after seven interviews (data saturation 
detailed in Section 4.3.8). 
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4.3.5 Topic guide preparation  
A semi-structured topic guide addressing the study aims and objectives was 
developed (Appendix 9). The questions were based on practical application of 
the best practice evidence identified from the systematic overview of primary 
care prevention in Chapter 3. The topic guide or interview schedule was 
developed based on initial synthesis of the overview findings, however, the 
detailed overview synthesis continued even after the dental professional 
interviews were conducted. This somewhat restricted further in-depth 
exploration of dental professional views based on the findings from robust 
overview synthesis (discussed in Section 4.5.3.2). 
Interviews followed the topic guide, but discussions were revised in situ to 
follow emerging topics of interest, thus not restricting interviews completely to 
pre-determined questions. For example, some dental professionals talked about 
differences between private and NHS dental practices - this topic was then 
explored in following interviews. During data collection the topic guide was 
modified further to address topics of interest that emerged during earlier 
interviews. 
4.3.6 Data collection 
The data were collected between August and October 2016. The interviews were 
carried out at dental practices or offices at participants’ discretion within office 
hours. Prior to beginning the interview, participants were assured that their 
participation was entirely voluntary, and they were free to withdraw from the 
study at any time without giving any reason. The participants were also assured 
that the interview data would be anonymised and all the information which 
could identify the participants would be removed from the transcripts. 
Participants were assigned a unique code identifier at the onset of the 
interviews that was logged on a contact information sheet and stored 
separately. Participants were reassured that all personal information would be 
destroyed at the end of the study, and records would not be retained for longer 
than necessary (retained until completion of the study and submission of the 
thesis). 
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At the start of the interview, participants were told about the purpose of the 
study, and participants were provided with a paper copy of the participant 
information sheet and the consent form and were allowed to ask any questions 
about them (Appendix 10 and 11). When a participant agreed to participate in 
the study, he/she was asked to sign the written consent form prior to interview. 
Participant’s permission (written consent) was also taken to audio record the 
interviews.  
The interviews were conducted in English. During the interview, a supportive 
environment was created, so that participants could express their views freely. 
Discussions were facilitated by asking for more information or explanations 
where needed on topics, by trying to direct the discussions back on topic and 
also by managing the pace of the discussions. An opportunity was given to 
participants at the end of the interview to add or discuss any additional points 
or issues, and participants were also asked to offer any feedback about the 
interview. 
Written field notes were made immediately after each interview covering the 
main points that emerged during interviews, for example, general impression or 
personal reflections on the interview process; any inferences for future 
interviews or analysis; and what it added to the body of the data. 
4.3.7 Pilot interviews 
Practice interviews (and training) were conducted with two supervisors (AJR and 
DIC) in order to get feedback on the interview process, and iterate the topic 
guide in response to any difficulties or omissions. A pilot interview was then 
conducted, with an experienced dental practitioner (not directly involved in the 
research study) taking the role of participant, prior to commencement of the 
fieldwork. The author of this thesis (principal researcher) had previous 
experience in conducting qualitative research (from master’s research project); 
thus, the main purpose was for the author to gain experience of this particular 
topic guide / piece of work, and gain further valuable interview experience. One 
of the supervisors (AJR) observed the pilot interview and gave feedback. 
Subsequent reflections and feedback from the dental practitioner and supervisor 
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guided some valuable changes to the topic guide for succeeding interviews. 
Moreover, feedback from the dental practitioner was that the questions would 
be acceptable, and were relevant to dental professionals working in Scotland. 
4.3.8 Data analysis 
4.3.8.1 Implementation analysis 
An advantage of the dedicated ‘Implementation Science’ approach employed in 
this study is that it allows the researcher doing empirical qualitative work to go 
beyond a set or list of generic themes (Creswell and Creswell, 2017) by imposing 
a structure to examine barriers and facilitators (framed in terms of capability, 
opportunity and motivation) to specific practices (termed behaviours) to identify 
specific recommendations for intervention (Boyatzis, 1998; Michie et al., 2011). 
This approach is facilitated by a visual representation of the model called the 
Behaviour Change Wheel (BCW) (Michie et al., 2011). Starting with the 
behaviours in question, the centre of the wheel involves identifying categories of 
determinants which can help or hinder implementation (hence barriers or 
facilitators). Each behaviour is seen as emerging from the interaction of three 
aspects: capability (C), opportunity (O) and motivation (M). Hence the relation 
between these factors and behaviour is called COM-B (Michie et al., 2011). 
Capability has been defined as the “individual’s psychological and physical 
capacity to engage in the activity concerned. It includes having the necessary 
knowledge and skills”. Opportunity is defined as “all the factors that lie outside 
the individual that make the behaviour possible or prompt it” and includes time 
and other resources.  Motivation is defined as “all those brain processes that 
energize and direct behaviour, not just goals and conscious decision-making. It 
includes habitual processes, emotional responding, as well as analytical 
decision-making” (Michie et al., 2011). Figure 4.1 shows the ‘wheel’, with the 
COM-B framework in the centre. 
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Figure 4.1: The Behaviour Change Wheel (Michie et al., 2011) 
 
 
 
It can be seen from Figure 4.1 that the COM-B model is framed by: a) 
intervention functions or possibilities and b) higher level policy categories. The 
present study had a focus on developing intervention recommendations for each 
of a set of evidence-based practices or behaviours. Policy implications are 
included in the final discussion in Chapter 6. 
The method for intervention recommendations is underpinned by previous work 
synthesising approaches to the specific barrier types (to be addressed) or 
facilitator types (to be enhanced and reinforced) identified in relation to the 
target behaviours (Michie et al., 2011). For example, the Behaviour Change 
Wheel had been used to illustrate to Members of the UK Parliament that the 
current UK Government is disregarding important evidence-based interventions 
to change behaviour concerning public health (for example, tobacco control) 
(West and Michie, 2010; Featherstone et al., 2010). As advocated by the popular 
book “Nudge” (Thaler and Sunstein, 2008), to influence behaviour, the UK 
Government focused on environmental restructuring, some incentivisation and 
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subtle persuasion, while eschewing the other important intervention functions 
from the Behaviour Change Wheel that one might use (Michie et al., 2011). 
Table 4.1 below shows the general theory-based interventions that are linked to 
each subcategory under the COM-B framework, i.e. the table can be used to 
identify intervention functions most likely to be effective in changing a 
particular target behaviour (addressing identified COM barriers and facilitators). 
The greyed (shaded) squares highlight where “evidence or consensus suggests 
that a function may be effective for addressing a particular behavioural 
determinant” (Michie et al., 2011; Barker et al., 2016). 
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Table 4.1: Intervention functions from COM-B model and Behaviour Change Wheel (activities designed to change behaviours) (Michie et al., 2011) 
 
  Intervention functions 
  Education Persuasion Incentivisation Coercion Training Restriction Environmental restructuring Modelling Enablement 
COM-B 
components 
Physical 
capability 
         
Psychological 
capability 
         
Physical 
opportunity 
         
Social 
opportunity 
         
Automatic 
motivation 
         
Reflective 
motivation 
         
The greyed (shaded) squares highlight where “evidence or consensus suggests that a function may be effective for addressing a particular behavioural 
determinant” (Michie et al., 2011; Barker et al., 2016). 
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It can be seen from Table 4.1 that some intervention types have potential for 
addressing multiple determinants (COM barriers and facilitators) and all 
determinants can be addressed in various potential ways. The results in this 
chapter are based on: a) identifying the determinants for each component of the 
best practice evidence synthesis and b) discussing these in terms of the 
recommended intervention possibilities. 
Michie et al. (2011) have defined various COM-B components/determinants as: 
Psychological capability The capacity to engage in the necessary 
thought processes, e.g. reasoning, 
comprehension, etc. It can be achieved through 
imparting knowledge or understanding, training 
emotional, cognitive and/or behavioural skills 
or through enabling interventions such as 
medication. 
 
Physical capability It relates to the skill and technique issues. 
 
Physical opportunity Includes time and other resources. These issues 
point to a need for environmental or 
organisational change. 
 
Social opportunity It is afforded by the cultural milieu that dictates 
the way that we think about things (e.g., the 
words and concepts that make up our 
language). Also point to a need for 
environmental or organisational change. 
 
Reflective motivation Involves evaluations and plans, i.e. beliefs 
about what is good and bad, conscious 
intentions, decisions and plans. 
 
Automatic motivation Involves emotions and impulses that arise from 
associative learning and/or innate dispositions. 
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While the various intervention functions from the Behaviour Change Wheel 
(Figure 4.1 and Table 4.1) are defined as (Michie et al., 2011): 
Education  Increasing knowledge or understanding 
 
Persuasion  Using communication to induce positive or negative 
feelings or stimulate action 
 
Incentivization  Creating an expectation of reward 
 
Coercion  Creating an expectation of punishment or cost 
 
Training  Imparting skills 
 
Restriction  Using rules to reduce the opportunity to engage in 
the target behaviour (or to increase the target 
behaviour by reducing the opportunity to engage in 
competing behaviours) 
 
Environmental 
restructuring  
Changing the physical or social context 
Modelling  Providing an example for people to aspire to or 
imitate 
 
Enablement  Increasing means/reducing barriers to increase 
capability (beyond education and training) or 
opportunity (beyond environmental restructuring). 
 
4.3.8.2 Coding the data 
The semi-structured interviews were audio-recorded with consent from all 
participants, transcribed and transferred to computer files (as Microsoft Word 
2016 documents). Two interviews were transcribed first for the purposes of 
familiarisation with the data, and the remaining interviews were transcribed 
using a contracted transcription service. All interviews were transcribed 
verbatim. The transcripts were imported into the Qualitative Analysis Software 
(QSR) NVivo version 11.0 (QSR, 2017) and were read over repetitively and at the 
same time the interview recordings were listened to again, in order to ensure 
accuracy and consistency of all transcripts. This also helped in becoming 
acquainted with the depth of content of the dataset as a whole. 
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The anonymized transcripts of the interviews were then coded and organised 
into an initial set of determinants for evidence-based practice associated with 
the research aims (and topic guide from the systematic overview) using thematic 
analysis techniques (Braun and Clarke, 2006) and facilitated by the NVivo 11.0 
qualitative analysis software (QSR, 2017). This broad initial coding determined 
the final set of interviews (n=13) using the principle of data saturation via 
absence of newly emergent themes/data (Guest et al., 2006). A robust method 
was used to achieve data saturation as described by Constantinou and colleagues 
(2017), which they term “Comparative Method for Themes Saturation 
(CoMeTS)”. This method involves compiling all themes and then reordering the 
sequence of interviews several times for examination in order to confirm new 
interviews have stopped adding to the coverage (Constantinou et al., 2017). 
Reaching data saturation this way ensures the validity and robustness of the 
study results (Fusch and Ness, 2015; Constantinou et al., 2017). 
Determinants were then collated for each of the set of specific synthesised 
evidence-based practices (‘behaviours’), which broadly take the form of a 
chronological consultation flow from ask/assess, through give advice, to refer 
(Chapter 3). The final determinants, targeted at specific aspects of the 
consultation, were then matched to interventions for consideration to improve 
and support implementation. Interpretation was in line with the project aims to 
produce recommendations for implementation of best practice and a future 
intervention to support preventive care. 
All coded determinants were cross checked between two coders and 
disagreements discussed by the author and all supervisors to ensure robust 
categorisation. The verbatim quotations or segments of the coded data from 
interview transcripts were extracted as instances from the data, in order to: 
a) illustrate key points; 
b) provide evidence of identified themes within the data; 
c) express the essence of the point being discussed. 
All quotations were anonymised and any names identifying persons, dental 
practices, and locations were removed. A pause in the conversation was 
indicated in the verbatim quotations as “ellipsis” (three dots ...), while material 
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omitted in the quotations was indicated as “ellipsis” in a square bracket and 
italicized ([...]). 
4.4 Results 
13 individual interviews were conducted with dental professionals from 11 
primary care dental practices within ‘West of Scotland’ between August and 
October 2016. The principal researcher (author) conducted all interviews. 
Participant characteristics 
Table 4.2 provides general information about the participants: gender of the 
participants, professional role, experience in dentistry, socioeconomic status of 
the location of the dental practice, and ID assigned to them for this study. 
  
Chapter 4  
 
 
206 
Table 4.2: General characteristics of the participants (n=13) 
 
ID Gender Dental professional role 
Years or 
months of 
experience 
NHS or 
private or 
mixed dental 
practice 
SIMD16 
Quintile 
(dental 
practice) 
D1 Female Dentist 36 years NHS 1 
D2 Female Dentist 17 years Mixed 5 
D3 Male Dentist 31 years NHS 5 
D4 Male Dentist 18 years Mixed 1 
D5 Male Dentist 33 years Mixed 2 
D6 Female Dentist 23 years Mixed 1 
D7 Female Dentist (VT) 1 month NHS 2 
D8 Female Dentist 33 years NHS 2 
D9 Female Dentist 16 years NHS 2 
D10 Female Dental Hygienist 32 years NHS 3 
D11 Female Hygienist/ Therapist (VT) 2 months NHS 5 
D12 Female Hygienist/ Therapist (VT) 2 months Mixed 2 
D13 Female Dentist 14 years NHS 1 
VT: Vocational Trainees; SIMD16: Scottish Index of Multiple Deprivation 2016 
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The mean duration of the interviews was 37 minutes (range 25-51). It can be 
seen from Table 4.2 that the male: female ratio of participants in interviews was 
3:10 (three male dentists, seven female dentists and rest female 
hygienist/therapist), which showed less involvement of male dental 
professionals in this study. 
Most of the dental professionals participating in this study had an experience of 
over 10 years in dentistry. There were three dental professionals who were 
undergoing their vocational training (VT). The average length of dental 
professional experience was 19.5 years, ranging from 1 month to 36 years. In 
addition, there was a range of SIMD (deprivation score) for locations of dental 
practices in the study, i.e. from least deprived (score of 5) to most deprived 
(score of 1) locations.  
In the following sections, the main findings from the dental professional 
interviews have been presented under various determinants (COM-B barriers and 
facilitators) for each component of the best practice evidence synthesis. 
4.4.1 Tobacco 
4.4.1.1 Risk factor assessment (Ask/ Assess) 
With regards to asking about and assessing the patient’s tobacco use status, 
synthesis of high-quality systematic reviews and clinical guidelines (Chapter 3) 
identified that it is best practice for dental professionals to systematically 
inquire about and record every patient’s smoking (or tobacco use) status in 
clinical records (to be updated regularly). It was further recommended to assess 
the patient’s readiness to change and their interest in receiving further help for 
quitting smoking (or tobacco use). 
The various barriers and facilitators (in terms of capability, opportunity and 
motivation) to implementation of this evidence for oral cancer risk factor 
assessment are presented below. The examples (quotes) of each theme from 
dental professional interviews have been presented in Table 4.3 (at the end of 
section). 
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Psychological capability (knowledge and confidence) 
This section includes data coded under “psychological capability” in the 
Behaviour Change Wheel (Figure 4.1). 
The best practice of inquiring about and recording every patient’s smoking (or 
tobacco use) status in clinical records was done routinely by dental 
professionals. This was underpinned by a facilitator in terms of psychological 
capability - all dental professionals interviewed in this study demonstrated a 
good knowledge of oral cancer risk factors and talked about a range of factors, 
including tobacco use, alcohol misuse, HPV, diet, lifestyle, precancerous lesions, 
and even talked about sociodemographic factors. All professionals believed that 
smoking increased the risk of oral cancer and had an impact on oral health as 
well as general health. Moreover, they acknowledged that smoking combined 
with alcohol increased the risk more, compared to individual factors.  
Regarding risk factor assessment, all professionals mentioned taking patients’ 
social and medical histories (including questions about tobacco use) on a paper 
‘checklist’ or questionnaire which patients self-complete each time they visit for 
a dental check-up. Most professionals mentioned that the completed 
questionnaires were uploaded onto their computer clinical IT record system by a 
dental nurse or receptionist; they checked, compared and contrasted forms 
regularly, and flagged up any changes or issues to dentists for discussion with 
patients. In addition, all professionals reported conducting a thorough oral 
examination in order to look for any changes in the oral cavity relating to 
smoking (for example, tooth discoloration/staining, foul smell, soft tissue 
changes, or periodontal disease). 
There were no barriers reported to dental professional’s psychological capability 
in terms of risk factor assessment for smoking (or other forms of tobacco). 
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Social opportunity (norms/attitudes/culture) 
This section includes data coded under “social opportunity” in the Behaviour 
Change Wheel (Figure 4.1). 
Patient attitudes, adverse behaviour, causing offence and awkwardness were the 
major social barriers, and were reported to some extent in most dental 
professional interviews. When dental professionals were asked specifically about 
verbalising the term “oral cancer” while discussing oral cancer risks with their 
patients, a lack of consensus was observed. Some dental professionals reported 
avoiding the term “cancer” as they believe it “terrifies patients”. They reported 
that using the term is not routine, but can only be justified or appropriate when 
the professional deems the patient to be at high risk. Others said that they do 
not mind using the term, as they believe the people who are at risk (smokers or 
tobacco users) have already heard all the warnings about every other type of 
cancer anyway (albeit they may be ignoring such warnings and be resistant to 
behaviour change). 
Automatic and reflective motivation (professional role, beliefs and 
considered motivation) 
Taking patients’ medical and social histories was deeply embedded in dental 
practice. Thus, asking patients about their smoking behaviours (regardless of 
patient’s age and gender) at regular intervals was seen as something dentists 
were fairly automatically motivated to do. There were no reflective 
motivational factors reported for risk factor assessment for smoking; motivation 
was more reflective in relation to providing behavioural preventive advice for 
smoking cessation, which are now discussed. 
4.4.1.2 Behavioural preventive intervention (Advise/ Arrange) 
The synthesis of high-quality systematic reviews and clinical guidelines (Chapter 
3) identified that offering a brief tailored intervention up to 5-minutes by dental 
professionals was best practice in promoting smoking (or tobacco use) cessation. 
The intervention could be supported with educational materials, feedback from 
the oral examination, pharmacotherapy (where needed), and follow-up visits to 
check success of quit attempts. 
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The various barriers and facilitators (in terms of capability, opportunity and 
motivation) to implementation of this evidence is now presented. The examples 
(quotes) of each theme from dental professional interviews have been presented 
in Table 4.3. 
Psychological capability (knowledge and confidence) 
It was apparent in all dental professional interviews that, unlike assessing risk 
itself, “psychological capability” played an important role in delivering 
behavioural preventive interventions by dental professionals in primary care 
dental practices. Skill and technique (“physical capability”) was less of a factor.   
When asked about providing behavioural advice to patients about smoking (or 
other forms of tobacco) cessation, most professionals reported providing advice 
for smoking cessation in their regular patient appointments. Some also stated 
that they look for smokeless tobacco use in certain communities (for example, 
South Asians), but they reported that this was not commonly seen in their 
practices. Professionals admitted that they were more confident in talking to 
patients about the harmful effects of smoking on their oral health and general 
health, and benefits of quitting, compared to alcohol reduction advice which 
was seen as a major issue by most dental professionals (Section 4.4.2). 
Moreover, it was acknowledged in most interviews (by both senior and younger 
dental professionals) that younger dental professionals (VTs), who recently 
graduated, address smoking (and alcohol) issues really well as they had been 
trained to provide a more preventive service.  
However, regarding smoking cessation interventions in primary care dental 
practices, most professionals (particularly senior professionals) reported that a 
preventive consultation was somewhat limited to asking patients about their 
smoking status and providing them quit-line numbers, rather than other aspects, 
for example, goal setting, tailoring advice, follow-up phone calls, and formal 
referral to cessation services. The structured advice (i.e. motivational 
interviewing or stages-of-change-based counselling) was only reported to be 
delivered by younger professionals, who talked with their patients about harmful 
effects of smoking and the benefits of quitting, gave tailored advice relevant to 
personal needs and then provided quit-line numbers or asked patients to contact 
Chapter 4  
 
 
211 
a local pharmacy as considered appropriate. There was limited structured advice 
provided by senior dental professionals to help patients stop smoking. The main 
reasons reported for not delivering smoking cessation best practice were 
physical opportunity related (i.e. lack of time, and associated funding 
implications), which are discussed next. 
Physical opportunity (time, remuneration, and resources) 
Time and funding available to deliver best practice preventive interventions, 
and lack of formal training to deliver these interventions, are major barriers 
(physical opportunity). Other barriers reported were lack of good quality 
educational materials or posters for oral health promotion in primary care dental 
practices. Among facilitators for physical opportunity were getting remuneration 
for including preventive interventions in primary care dental practices, and 
receiving training to deliver preventive interventions. 
Time, remuneration or funding:  
Dental professionals were asked about the feasibility of providing best practice 
preventive interventions - i.e. brief advice of up to five minutes for smoking 
during regular dental appointments. An important barrier reported by all dental 
professionals was time available to provide such advice, related to lack of 
funding or payment for providing advice. These two factors (time and money) 
were linked to each other in most conversations. Professionals reported that 
compressing more and more things (e.g. preventive advice with dental 
examinations and procedures) into the same time period of regular dental 
check-ups or treatment appointments was not feasible until the funding 
increases. One of the dental professionals mentioned that this could even lead 
to loss of money for their dental practice, as instead of spending time providing 
preventive advice, they would want to see new patients for dental treatment 
(main priority). 
The professionals reported that if they were being paid for providing smoking 
cessation advice and allowed more time for each patient appointment (i.e. see 
less patients in a day), behavioural preventive interventions could be a part of 
regular patient appointments in primary care dental practices. Some 
professionals also added that time was more of an issue in the NHS dental 
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practices compared to private practices, as NHS practices often have strict 
timelines for dental appointments, i.e. 15-20 minutes for each patient, during 
which period dental professionals need to examine patients and perform dental 
procedures as well. Thus, incorporating up to 5 minutes of advice on smoking 
(and alcohol) was not reported as a feasible option in NHS dental practices. 
However, professionals from private practices also reported time being a major 
barrier in providing preventive advice. 
On the other hand, providing very brief advice (1-2 minutes) was seen as a more 
feasible option in primary care (both NHS and private). Providing a very short 
message for a couple of minutes and referring patients to local support groups or 
cessation services was considered a feasible option that could be incorporated in 
all dental practices - i.e. “ask and assist/refer” structure compared to the best 
practice “ask and advise” structure. Furthermore, younger dental professionals 
(receiving their vocational training) reported that even though they had longer 
appointment times compared to senior dental professionals, they would prefer 
to incorporate a very brief advice into their appointments compared to longer 
counselling sessions – i.e. asking patients about their smoking status and 
referring them to cessation services or other trained professionals. 
Some dental professionals also emphasised that these short messages were quite 
effective compared to hour long support or counselling. As mentioned under 
“psychological capability”, most dental professionals were already employing 
this in their practices, i.e. asking patients about their smoking status and 
providing them with quit-line numbers. This very brief advice of 30 seconds to a 
couple of minutes was supported by some high-quality guidelines in the 
systematic overview study (Chapter 3), where they reported that although 
longer interventions were more effective to increase quit rates, even very brief 
interventions had been found to be effective for increasing smoking abstinence 
rates.  
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Resources (training and education materials): 
Another major barrier under “physical opportunity” reported by most dental 
professionals was a lack of training for delivering behavioural preventive 
interventions. Attending training is a resource which is an important factor in 
professional motivation, engagement, and positive morale or confidence; and is 
recommended for delivering effective behavioural preventive interventions (lack 
of trial evidence for effectiveness) (Chapter 3). There was some mention of 
training for smoking advice provision during undergraduate studies and 
continuing professional development courses. One of the dental professionals 
mentioned that there was a lack of training in particular for dentists compared 
to other healthcare professionals (for example, general medical practitioners, 
pharmacists) and training courses available were designed in particular for the 
medical profession. Thus, it was emphasised that training designed specifically 
for dental professionals is required, partially as they are seeing patients much 
more regularly. 
On asking about what duration or intensity of training would be sufficient to 
learn how to counsel or advise patients on smoking, the majority agreed that 
one or two sessions (half days) would be good, which could be repeated after a 
few years (the evidence in equivocal about the specific duration or number of 
training sessions that could be recommended as best practice). Dental 
professionals in this interview study suggested that the first training session 
could include details about various behavioural interventions and encourage 
dental professionals to start including them in regular patient appointments; and 
then the second session could “touch base” to see how professionals got on and 
to reflect upon whether what they did worked, or to find out what further 
barriers and/or facilitators were encountered. For example, if dental 
professionals found difficulties speaking to patients about risks, the specialized 
trainer helping with the counselling could help guide them on how to deal with 
these awkward conversations they have with their patients. 
Besides remuneration and training, having good educational resources (materials 
or posters) in the waiting room in dental practices was seen in all dental 
professional interviews to have a big influence on changing patients’ behaviour. 
This had been recommended in the systematic overview study (Chapter 3), 
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where most behavioural interventions were supported with stop smoking 
educational materials which could be tailored or personalised to patient needs 
(however, there was a lack of trial evidence for effectiveness). Most dental 
professionals in this study reported a lack of posters or leaflets for advising 
patients of oral cancer risks in their dental practices. Some professionals 
mentioned that there needs to be more initiatives to make patients aware of 
oral cancer and associated risk, because they believe people are not aware of 
the risk of oral cancer (or are in denial of the risks). It was emphasised that 
there is a “big hole” in terms of giving people information on oral cancer. 
People get screening for breast, bowel, cervical, prostate and other health 
contexts; thus, there was a reported need to make the same sort of publicity 
and awareness gains for coming to the dentist for oral cancer screening too, and 
it was felt that good posters or leaflets are the best way to make people aware 
of or remind them of such things when they visit their dental professional. 
Social opportunity (norms/attitudes/culture) 
Most dental professionals believed that social influences or attitudes were more 
of an issue while discussing patient’s drinking behaviours (Section 4.4.2) 
compared to raising their smoking habits. However, “social opportunity” issues 
for providing smoking advice were reported to some extent in some dental 
professional interviews. Some dental professionals mentioned that discussing an 
individual patient’s smoking behaviour was quite a “sensitive” topic, and that 
they needed to take care to convey messages in a non-confrontational way. They 
further added that it is important to maintain a good dentist-patient 
relationship. A related barrier cited by some dental professionals was the 
perception that most patients do not consider receiving smoking advice (to some 
extent) to be related to oral health or dental issues. 
Automatic and reflective motivation (professional role, beliefs and 
considered motivation) 
As mentioned earlier in risk factor assessment (Section 4.4.1.1), asking patients 
about their smoking behaviours (regardless of patient’s age and gender) at 
regular intervals was seen as something dental professionals were fairly 
automatically motivated to do. Most dental professionals were clearly motivated 
to address smoking in regular patient visits, and some also reported giving brief 
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advice to patients about their smoking. However, some dental professionals did 
indicate reluctance to include structured behavioural interventions for smoking 
cessation in regular patient appointments in their practice, but more for 
resources reasons. 
As outlined under “social opportunity”, the social aspect of perceived patient 
wishes or needs was another supposed barrier affecting reflective motivation for 
some dental professionals. It was presumed that patients will consider discussing 
smoking (to some extent), irrelevant to dentistry or their oral health. It was 
reported that to ask about such aspects is less than useful sometimes because 
patients may not self-report such behaviours accurately or honestly. 
4.4.1.3 Referral to cessation services (Assist) 
The synthesis of high-quality systematic reviews and clinical guidelines (Chapter 
3) identified that there was a lack of trial evidence in dental practices for the 
effectiveness of offering referral to ‘quit-lines’ or local cessation services along 
with some brief advice to quit. However, a referral to telephone ‘call-back’ 
counselling services or proactive support was recommended in clinical guidelines 
to increase abstinence rates. That is, simply providing quit-line numbers 
(signposting) to patients and expecting them to call these services was not 
recommended; a more proactive support (telephone call-back) was identified 
best practice in guidelines. 
The various barriers and facilitators for referral are presented here. The 
examples (quotes) of each theme from dental professional interviews have been 
presented in Table 4.3. 
Psychological capability (knowledge and confidence) 
A lack of knowledge of local referral pathways for smoking cessation was seen a 
further barrier in terms of psychological capability. However, dental 
professionals acknowledged that referral services would be a good support to 
help patients quit smoking. Most professionals reported providing a card or 
leaflet containing quit-line numbers to smokers. However, professionals were 
Chapter 4  
 
 
216 
unaware whether patients were contacting these services and how helpful these 
services were to patients. 
Most dental professionals recognised their lack of knowledge and showed an 
interest in learning about the routine way of referring patients to cessation 
services and reported a need for more information or guidelines on local referral 
pathways for smoking. This presented a facilitator to participant’s reflective 
motivation, which will be discussed later.  
Physical opportunity (time, remuneration and resources) 
As mentioned earlier under “physical opportunity”, providing a very short 
message for a couple of minutes, and referring patients to local support groups 
or cessation services, was considered a feasible option that could be 
incorporated in all primary care dental practices. Most dental professionals were 
already employing this in their practices, i.e. asking patients about their 
smoking status and providing them with quit-line numbers. 
Automatic and reflective motivation (professional role, beliefs and 
considered motivation) 
As discussed under “psychological capability”, most dental professionals 
recognised their lack of knowledge and showed an interest in learning about the 
routine way of referring patients to cessation services and reported a need for 
more information or guidelines on local referral pathways for smoking. 
Moreover, it was emphasised that formal training, designed specifically for 
dental professionals, is required, particularly as they are seeing patients much 
more regularly than other professional groups.  
Table 4.3 presents examples of each theme, i.e. barriers and facilitators (in 
terms of capability, opportunity and motivation) for delivering smoking cessation 
interventions by presenting quotes from dental professional interviews. The 
various determinants (barriers and facilitators) are then discussed in terms of 
the recommended intervention possibilities (from the Behaviour Change Wheel) 
for smoking cessation evidence-based practices or behaviours - presented in 
Section 4.5.2. 
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Table 4.3: COM-B barriers and facilitators related to delivering smoking cessation interventions 
 
Psychological Capability 
 Barriers (with examples) Facilitators (with examples) 
Ask/Assess None reported Risk factor assessment (social and medical history) 
done routinely 
D1: We have to do social history for every patient and 
we need to ask whether they are doing smoking habits, 
drug using… and also medical histories updated on 
every appointment. So, then we have got background, 
right, and later obviously patient complaints but also it 
is…if it is careful examination which we are doing, 
always while checking soft tissue. 
 
D4: They’re (patients) given a medical history 
questionnaire which includes questions about alcohol 
and smoking… and whether they want help to stop, 
smoking […] there’s a range of questions about whether 
or not their medical history has changed. 
 
Advise/ Arrange Lack of knowledge: structured behavioural interventions 
D2: I mean, we do some smoking cessation here as well but we 
don’t do anything apart from advice, discuss if they’re interested to 
stop smoking and give them leaflets. 
 
D11: If I was to come across a patient with that I probably wouldn’t 
really know what to advise but I would advise to see their GP and 
None reported 
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then maybe we could refer them on to counselling or from there. 
 
Referral (Assist) Lack of knowledge: local referral pathways 
D2: What we do is we get… in the leaflet which has the numbers on 
it, so… we don’t refer to them… just signposting. 
 
D7: I’m not actually completely familiar with the referral pathway 
 
D8: Well, if I knew who they were. I mean, the people that do it, it 
would be much easier. And where they were. I mean, the card we 
have is a phone number. And I tell the people to phone that number. 
But I haven’t phoned that number, I don’t know who’s at the other 
end of that phone [laughing] 
 
D12: I’m not sure what it is, what the smoke line is here in 
Glasgow, so I just advise them to look into it […] but I just need to 
find out who it is I need to refer to. 
 
None reported 
Physical Opportunity 
 Barriers (with examples) Facilitators (with examples) 
Ask/Assess None reported None reported 
Advise/ Arrange Lack of time: delivering preventive interventions in dental 
practices (up to five minutes) 
D1: We have limited time. So, we need to choose. 
Very brief advice (ask and refer) is routine 
D1: We need to send sometimes very short messages… 
what I’m doing…just…I’m giving short message. 
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D7: I don’t think if he (principal dentist) had five minutes of 
smoking… I think that would be kind of too much time spent on it, 
just feasibly […] because you don’t have a lot of time with each 
patient in the NHS dentistry. 
 
D11: well because we're quite strict to appointment 
times…especially it's NHS as well…you probably only maybe three 
minutes for your clerking in […] you would probably have to try 
and cut that appointment down… in some other aspects. I think 
maybe in private practice it would be a lot easier but within NHS 
like scale appointments are only 15 minutes and you don’t know 
what you're going to be faced with. 
 
 
Lack of funding or remuneration: delivering preventive 
interventions in dental practices 
D2: basically, they would need to remunerate for that extra time… 
 
D3: the fee for what we do would have to be increased.  There 
would have to be some kind of, change in the way that we’re 
funding it. 
 
D4: It comes down to time and money. You only get paid so much 
for what you do […] you can set all the guidelines in the world, but 
people won’t do it if there’s no way of funding it… that’s the 
biggest issue. 
 
D5: Unless you can charge the patient, I don’t know, maybe thirty 
or forty pounds, you don’t have thirty or forty minutes. I’ve got 
 
D5: I think a good deal can be done…general 
practitioners are pretty effective communicators… and 
they can deliver a lot in a minute.  And five minutes is a 
long time to…for me to talk to you about your smoking, 
to be honest.  I mean, if I’ve not delivered the message 
in a minute, then I’m not very effective, I don’t think. 
 
D7: I think similarly smoking, giving them a brief 
outline, written information, support network to phone, 
and maybe writing a referral letter […] a very short kind 
of advice, and then we can refer on to like say there’s 
pharmacy support groups for smoking, so we don’t 
actually sit and provide say an hour long support [...] I 
think that’s probably the best way. 
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twenty minutes and, I lose money. It is actually financial suicide. 
I’ve got a practice that loses money. 
 
D6: I think in the NHS… we get paid very little for an examination.  
In that time… I think I have to address their pain and their 
toothache and things like that… I don’t have time for five minutes 
consultation on smoking and drinking […] Well, the golden thing is 
money. 
 
 
Lack of training: preventive interventions (advice and referral) 
D1: Dentist…we as a profession, as a group, we should also be 
useful to have any, professional, like psychological training how to 
speak to the patient about risks, especially risk of oral cancer […] 
with actors or somebody else, that somebody pretends to be a 
patient or my colleague. 
 
D2: because we’re not formally trained […] There wasn’t really that 
training available. It was more available for the pharmacists and the 
GPs. It wasn’t…didn’t seem to be available for the dentists. 
 
 
Lack of educational materials 
D1: I would like to have any good leaflets because personally I was 
looking for in the Google from long, long time… The only one what 
I could find it is from British Dental Health Foundation. It’s actually 
action is wonderful. The materials are horrible…the graphic is 
unacceptable. 
 
D11: I definitely think information leaflets with graphic pictures 
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would be really good […] sometimes maybe if oral cancer was to 
develop in a patient might not think anything of it, of a lesion, or 
just like it's just something.  Whereas if they’ve (patients) seen these 
information leaflets it might make them more, alert or wary to the 
fact, oh, I've seen that leaflet, what's best, sort of and then get 
themselves in for an appointment to be checked a lot quicker than 
maybe 
 
Referral (Assist) None reported Signposting (ask and refer) is routine 
D7: I think similarly smoking, giving them a brief 
outline, written information, support network to phone, 
and maybe writing a referral letter […] a very short kind 
of advice, and then we can refer on to like say there’s 
pharmacy support groups for smoking or there’s say like 
alcohol organisations, so we don’t actually sit and 
provide say an hour long support [...] I think that’s 
probably the best way. 
 
Social Opportunity 
 Barriers (with examples) Facilitators (with examples) 
Ask/Assess Patient attitudes: using term “oral cancer” 
D7: I think the word cancer scares people a lot… because I find 
patients get a bit nervous the minute you mention those kinds of 
words. 
 
D9: I think a lot of patients prefer you to avoid directly talking 
about the word cancer. It’s not a nice word to a lot of people. 
None reported 
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Advise/ Arrange “Sensitive” topic 
D4: One of the things which is, important is that we don’t lose a 
relationship...from a dental point of view by setting up an 
antagonistic relationship over somebody smoking (or drinking). 
You know, if you push too hard then they may decide that actually 
they don’t want to see you again, and then that’s a detriment to their 
oral health. 
 
D11: I feel that they are quite sensitive subjects (smoking and 
alcohol) because it is personal […] It is a really sensitive when it 
comes to personal things like that, especially with patients it can be 
quite a sensitive subject when they feel you're trying to force 
somebody to do something that they want to do. 
 
 
Patient attitudes 
D4: It depends on the individual. If somebody’s interested, then 
they’ll let you talk. If they’re not interested by and large... they’ll 
tell you pretty quickly. 
 
D6: We just say, you know, yes, see you’re still smoking and most 
people…some people get quite defensive about it. 
 
D7: …they also don’t think it’s a dental issue, so maybe just… 
 
None reported 
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Referral (Assist) None reported 
 
None reported 
 
Automatic and Reflective Motivation 
 Barriers (with examples) Facilitators (with examples) 
Ask/Assess None reported Consider their role/job: ask and assess smoking 
status 
D12: I feel like you have to ask because you know the 
importance of asking. 
 
D13: I feel my role is just there, they already know 
everything, I'm just there to prick their conscience and if 
they seem interested then I'm ready with all the help and 
advice they need to try and stop. 
 
Advise/ Arrange Reluctance to include behavioural interventions (not considered 
their role) 
D3: I’m not sure that it’s a dentist’s job to be then checking up on 
them and calling them back and saying, you know, get them to fill 
in data about how much they smoke and how much they drank [...] 
advice up to five minutes I don’t think is practicable, personally 
[…] I would attend… I mean training to provide advice as to… 
where to go or how to then seek more help but not training to 
provide the smoking cessation itself… and to get involved in the 
follow-up phone calls… and goal setting and things like that. 
 
D5: And then by the time you get to all the end of that (oral 
Consider their role/job: provide advice 
D11: I am comfortable with it to be honest, because at 
the end of the day it's my role to do it and… like doctors 
and dentistry… as well as we would see patients a lot 
more than what those other services would see them.  
Therefore, it's our job to inform them. 
 
 
Considered motivation: always provide behavioural 
advice 
D1: We advise patient... always. If somebody’s a 
smoker, always I advise […] have you ever thought to 
Chapter 4  
 
 
224 
examination and charting), to spend five minutes on alcohol and 
five minutes on smoking is just not going to happen.  It’s not 
realistic… five minutes is a lot […] I probably don’t ask them about 
their sexual habits… I perhaps don’t want to have that discussion 
[laugh] either. 
 
 
Perceived patient wishes and needs 
D1: confidential but in this way… we start to interfere, as in totally 
private life. 
 
D6: I think some people are maybe not expecting to hear that from 
me, I don’t know. I’m old school. 
 
D7: They (patients) also don’t think it’s a dental issue, so maybe 
just… 
 
give up smoking...it is unhealthy for you and... for the 
gums and everything altogether. 
 
D2: We’ll ask them (how much they’re drinking and) 
how much they’re smoking and then we would bring it 
up… I would say that to everybody… everybody would 
be getting the same message […] And I did think that 
we’re seeing the patients so much more regularly…you 
know, and it would make more sense if were doing it… 
 
D12: Every single patient gets it… they all wonder why 
I ask all these questions… but I have to explain, it’s 
important […] I tailor it to each person, so it depends 
what they’re moaning about when they come in […] I 
always mention cancer as one, definitely… 
 
 
Receiving formal training to provide behavioural 
advice would work 
D3: I think it would be interesting to… I would attend 
that kind of thing… I mean training to provide advice as 
where to go or how to then seek more help… 
 
D7: So, I think maybe just a, a short course like a 
morning or something, part of a CPD training, because 
oral cancer obviously is a big issue. 
 
D13: I think we should learn about the research that's 
been done and also be told about the developments for 
healthcare for improved care for cancers and things. So, 
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it would be good to get that once every five years I 
think. 
 
Referral (Assist) None reported More information or guidelines on referral 
D1: Every practitioner should, have any like instruction. 
I think maybe supplied by the health board, exactly 
pathway where to refer the patient… but how to get 
consultant. 
 
D2: Set something up more like Childsmile where there 
was a referral thing. The thing with that is… where we 
were, kind of, connecting with the pharmacists and the 
doctors. 
 
D8: Well, maybe more knowledge of where the 
smoking cessation services are located. That means the 
professional ones are located... 
 
 
Receiving formal training to provide referral would 
work 
D2: if the dentists were trained in that, to be able to 
refer… to be able to prescribe any (intensive counselling 
or pharmacological treatments) 
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4.4.2 Alcohol 
In most of the dental professional interviews smoking and alcohol tended to be 
talked about in combination. Most of the barriers and facilitators reported were 
thus common for both risk factors, but there were some differences. 
The various barriers and facilitators to implementation are presented below. 
The examples (quotes) of each theme from dental professional interviews have 
been presented in Table 4.4 (at the end of section). 
4.4.2.1 Risk factor assessment (Ask/Assess) 
The synthesis of high-quality systematic reviews and clinical guidelines (Chapter 
3) identified that it was a best practice for dental professionals to screen all 
adult patients for alcohol misuse, administer a validated screening tool (for 
example, AUDIT, CAGE, or FAST) for assessing risk levels, and record status in 
clinical records (to be updated regularly). However, some barriers and 
facilitators were apparent, and these are described in the following sections. 
Psychological capability (knowledge and confidence) 
As reported under smoking (Section 4.4.1.1), all dental professionals interviewed 
in this study demonstrated a good knowledge of oral cancer risk factors and 
talked about a range of factors, including alcohol misuse. They emphasised that 
smoking combined with alcohol increased the risk more compared to individual 
factors. Regarding risk factor assessment, all professionals mentioned taking 
patients’ social and medical histories (including questions about alcohol use) on 
a paper checklist questionnaire which patients self-complete each time they 
visit for a dental check-up. Most professionals mentioned that the completed 
questionnaires were uploaded onto the computers by dental nurse or 
receptionist, who checked, compared and contrasted forms regularly, and 
flagged up any changes or issues to dentists for discussion with patients. 
However, none of the professionals reported using any screening tool for 
assessing alcohol misuse and most professionals admitted that they were not 
aware of these tools at all. 
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Automatic and reflective motivation (professional role, beliefs and 
considered motivation) 
As reported under smoking (Section 4.4.1.1), taking patients’ medical and social 
history was deeply embedded in dental practice. Thus, asking patients about 
their drinking behaviours (regardless of patient’s age and gender) at regular 
intervals was seen as something dental professionals were fairly automatically 
motivated to do. There were no reflective motivational factors reported for risk 
factor assessment for alcohol; motivation was more reflective in relation to 
providing behavioural preventive advice for alcohol reduction, which are 
discussed next. 
4.4.2.2 Behavioural preventive intervention (Advise/ Arrange) 
The synthesis of high-quality systematic reviews and clinical guidelines (Chapter 
3) identified that offering a brief tailored intervention of up to 5 minutes by 
dental professionals could be considered best practice in reducing alcohol 
consumption, with this intervention to be supported with educational materials, 
and feedback from the oral examination. A brief (10-15-minutes) multi-contact 
intervention is, however, recommended as best practice in medical practice 
guidelines (strong trial evidence) for helping alcohol users to reduce 
consumption. The various barriers and facilitators to this synthesised evidence 
are now discussed. 
Psychological capability (knowledge and confidence) 
As reported under smoking (Section 4.4.1.1), dental professionals admitted that 
they were more confident in talking to patients about the harmful effects of 
smoking on their oral health and general health, and the benefits of quitting, 
compared to alcohol reduction advice which was seen as a major issue by most 
dental professionals. They showed a lack of knowledge and confidence in 
providing alcohol advice, and also regarding referrals (Section 4.4.2.3). 
However, younger dental professionals (VTs) felt more comfortable and 
confident talking to patients about their drinking behaviours compared to senior 
professionals. One of the senior professionals even acknowledged that younger 
dentists, who recently graduated, address these issues really well as they had 
been trained to provide advice for both smoking and alcohol. 
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Physical opportunity (time, remuneration and resources) 
Once again, time and funding available to deliver best practice preventive 
interventions, and lack of formal training to deliver alcohol interventions were 
the major barriers (“physical opportunity”) in most dental professional 
interviews. Other barriers reported were lack of good quality educational 
materials or posters for oral health promotion. Among facilitators for physical 
opportunity were getting remuneration for including preventive interventions in 
primary care dental practices, experience delivering very brief interventions, 
and receiving training to deliver preventive interventions. 
Dental professionals reported that incorporating 5 minutes or more of advice on 
alcohol was not a feasible option in their dental practices, as they have got 
strict timelines for dental appointments, i.e. 15-20 minutes for each patient, 
during which period dental professionals need to examine patients and perform 
dental procedures as well. As reported under smoking (Section 4.4.1.1), dental 
professionals were motivated to provide a very short message to all smokers to 
quit and considered it as a more feasible option to be included in their regular 
patient appointments (most dental professionals were already employing this in 
their practices). However, none of them reported asking about alcohol. Some 
professionals were happy to include very brief advice (couple of minutes) for 
alcohol along with smoking, while other professionals reported barriers to asking 
about alcohol, which will be discussed under “social opportunity”.  
Another major barrier was a lack of training for delivering behavioural 
interventions for alcohol misuse. As mentioned earlier under “psychological 
capability”, dental professionals reported lack of confidence in providing 
behavioural advice (in particular for alcohol misuse). This was linked in most 
interviews to a lack of training on delivering behavioural interventions. Thus, it 
can be seen here that factors in COM-B affect each other, especially capabilities 
and opportunities go hand in hand. Moreover, it was emphasised that training 
designed specifically for dental professionals is required. 
Again, similar to smoking, a lack of posters or leaflets for advising patients of 
oral cancer risks was reported. It was pointed out that there were some 
materials available addressing smoking cessation, while there were very few 
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advising on alcohol drinking or other oral cancer risk factors. Some participants 
mentioned that there needs to be more initiatives to make patients aware of 
oral cancer and associated risk, because they believe people are not aware of 
the risk of oral cancer (or are in denial of the risks). 
Social opportunity (norms/attitudes/culture) 
Patient attitudes, adverse behaviour, causing offence and awkwardness were the 
major social barriers, and were reported to some extent in most dental 
professional interviews; an important finding is that professionals believed that 
social influences or attitudes were more of an issue while discussing patient’s 
drinking behaviours compared to smoking. 
Dental professionals mentioned that discussing an individual patient’s drinking 
behaviours was quite a “sensitive” topic, and that they needed to take care 
while talking to patients and ensure they conveyed messages in a non-
confrontational way. They further added that it is important to maintain a good 
dentist-patient relationship. Some professionals called it an “awkward” topic, as 
they felt in a sense as if they were “prying”. However, they also acknowledged 
that when professionals practise asking patients about their drinking habits, they 
get used to it and it just becomes part of the routine check-up. 
A related barrier cited by most dental professionals was the perception that 
most patients don’t consider receiving alcohol advice to be related to oral 
health or dental issues. Dental professionals mentioned patients were not 
comfortable discussing their drinking behaviour and some professionals felt it 
would offend or upset their patients. Professionals reported that they would 
provide alcohol advice only if a patient admits their excessive drinking to the 
health professional and are ready to talk about it. A further barrier was that 
some dental professionals mentioned that they would not ask about alcohol to 
patients from certain ethnic or religious groups, because they think that people 
might get offended. 
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Automatic and reflective motivation (professional role, beliefs and 
considered motivation) 
Motivation to discuss alcohol was more reflective, for the social reasons 
discussed above. Some younger professionals cited discussing a patient’s drinking 
behaviours on a regular basis and considered providing behavioural advice to 
reduce alcohol consumption as their job/role. They mentioned they considered 
it to be their responsibility to inform the patients about various risks and if 
patients make the decision against it, then it’s their choice, but at least patients 
have got the right information. However, most dental professionals did not 
consider providing alcohol advice as part of their role, as they consider it to be 
interfering in a patient’s personal life. 
As outlined under “social opportunity”, the social aspect of perceived patient 
wishes or needs was another supposed barrier affecting reflective motivation for 
some dental professionals. It was presumed that patients will consider discussing 
drinking behaviours irrelevant to dentistry or their oral health. It was reported 
that to ask about such aspects is less than useful sometimes because patients 
may not self-report such behaviours accurately or honestly. 
4.4.2.3 Referral to cessation services (Assist) 
The synthesis of high-quality systematic reviews and clinical guidelines (Chapter 
3) identified a lack of evidence for the effectiveness of alcohol referrals, 
however, guidelines recommended making referral for patients with alcohol 
dependence to a general medical practitioner or a specialist alcohol treatment 
service. The various barriers and facilitators for referral are now discussed. 
Psychological capability (knowledge and confidence) 
A lack of knowledge of local referral pathways for alcohol is the main capability 
barrier. All dental professionals admitted that they have no knowledge about 
referring patients to any specialist alcohol services, but some professionals 
admitted that they would simply think about referring a patient with alcohol 
dependence to their general practitioner (which was recommended in guidelines 
in the overview study). They mentioned that most training and educational 
materials available target smoking rather than alcohol (discussed under 
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“physical opportunity” in Section 4.4.2.2). However, dental professionals 
acknowledged that referral services would be a good support to help patients 
address moderate alcohol consumption or alcohol dependence. 
Most dental professionals recognised their lack of knowledge and showed an 
interest in learning about the routine way of referring patients to cessation 
services and reported a need for more information or guidelines on local referral 
pathways for alcohol. 
Physical opportunity (time, remuneration and resources) 
As mentioned earlier under “physical opportunity” to delivering behavioural 
preventive interventions (Section 4.4.2.2), providing a very short message for 
alcohol (couple of minutes) similar to smoking advice, and referring patients to 
local support groups or specialist services, was considered a feasible option that 
could be incorporated in all primary care dental practices. Longer interventions 
where not deemed feasible in time and resource terms, thus there is a real need 
to consider how best to facilitate advice (see discussion). 
Automatic and reflective motivation (professional role, beliefs and 
considered motivation) 
As discussed under “psychological capability”, most dental professionals 
recognised their lack of knowledge and showed an interest in learning about the 
routine way of referring patients to cessation services and reported a need for 
more information or guidelines on local referral pathways for alcohol. Moreover, 
it was emphasised that formal training designed specifically for dental 
professionals is required, partially as they are seeing patients much more 
regularly. This reflection offers possibilities of such training being effective. 
Table 4.4 presents examples of each theme, i.e. barriers and facilitators (in 
terms of capability, opportunity and motivation) for delivering interventions for 
reducing alcohol consumption by presenting quotes from dental professional 
interviews. The various determinants (barriers and facilitators) are then 
discussed in terms of the recommended intervention possibilities (from the 
Behaviour Change Wheel) for alcohol reduction evidence-based practices or 
behaviours - presented in Section 4.5.2. 
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Table 4.4: COM-B barriers and facilitators related to delivering alcohol reduction interventions 
 
Psychological Capability 
 Barriers (with examples) Facilitators (with examples) 
Ask/Assess Lack of knowledge: risk assessment tools 
D2: No, I’ve not used this (AUDIT/CAGE tools) 
 
D13: No, we just use the medical history form and ask them about 
their drinking habit. 
 
 
Risk factor assessment (social and medical history) 
done routinely 
D1: We have to do social history for every patient and 
we need to ask whether they are doing smoking habits, 
drug, using alcohol… and also medical histories updated 
on every appointment. So, then we have got 
background, right, and later obviously patient 
complaints but also it is…if it is careful examination 
which we are doing, always while checking soft tissue. 
 
D4: They’re (patients) given a medical history 
questionnaire which includes questions about alcohol 
and smoking… and whether they want help to stop […] 
there’s a range of questions about whether or not their 
medical history has changed. 
 
Advise/ Arrange Lack of knowledge: structured behavioural interventions 
D11: If I was to come across a patient with that I probably wouldn’t 
really know what to advise but I would advise to see their GP and 
then maybe we could refer them on to counselling or from there. 
 
 
 
Younger professionals: more confident to provide 
alcohol advice 
D6: I know the younger dentists do and I’ve had a few 
VTs who have addressed it (alcohol advice) quite well. 
 
D7: We’ve just come from uni. so, I feel quite 
comfortable talking about it, but maybe people who’ve 
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Lack of knowledge: alcohol advice 
D2: I wouldn’t know how to deal with somebody who you thought 
had an alcohol problem […] advice on how to reduce their intake, I 
wouldn’t know where to start with that one, to be quite honest.  I 
would just advise, you know, you’re at risk. 
 
D12: Because I just started this, so I’m not sure who it is, but 
definitely, I think some people need it, I think that’s the only way 
that they can quit and cut down and things, with that support, I think 
it’s important. 
 
 
Lack of confidence: alcohol advice 
D9: I wouldn’t feel trained enough to and it wouldn’t be possibly 
appropriate to... start challenging someone and saying, oh, I actually 
think you drink twice as much as you’re admitting [laugh]. I don’t 
think I’d feel comfortable with that, no.  
   
D12: I would feel comfortable, if I knew who it was and knew who 
to refer to… 
 
been out of university for a long time maybe don’t know 
how to approach it as much because we’ve just had 
fresh teaching of it. 
 
Referral (Assist) Lack of knowledge: local referral pathways for alcohol 
D7: I’m not actually completely familiar with the referral pathway 
 
D8: Well, if I knew who they were. I mean, the people that do it, it 
would be much easier. And where they were. 
 
D12: That’s the other thing, I don’t know who it (alcohol referral 
services) is here in this area, but I think it’s important to, definitely, 
just because they need support sometimes. 
None reported 
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Physical Opportunity 
 Barriers (with examples) Facilitators (with examples) 
Ask/Assess None reported None reported 
Advise/ Arrange Lack of time: delivering preventive interventions in primary 
care dental practices (five minutes or more) 
D1: We have limited time. So, we need to choose. 
 
D7: I don’t think if he (principal dentist) had five minutes of 
smoking, five minutes alcohol… I think that would be kind of too 
much time spent on it, just feasibly […] because you don’t have a 
lot of time with each patient in the NHS dentistry. 
 
D11: well because we're quite strict to appointment 
times…especially it's NHS as well…you probably only maybe three 
minutes for your clerking in […] you would probably have to try 
and cut that appointment down… in some other aspects. I think 
maybe in private practice it would be a lot easier but within NHS 
like scale appointments are only 15 minutes and you don’t know 
what you're going to be faced with. 
 
 
Lack of funding or remuneration: delivering preventive 
interventions in primary care dental practices 
D2: basically, they would need to remunerate for that extra time… 
 
Very brief advice (ask and refer) could be routine 
D1: We need to send sometimes very short messages… 
what I’m doing…just…I’m giving short message. 
 
D7: giving them a brief outline, written information, 
support network to phone, and maybe writing a referral 
letter […] a very short kind of advice, and then we can 
refer on to like… there’s say like alcohol organisations, 
so we don’t actually sit and provide say an hour long 
support [...] I think that’s probably the best way. 
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D3: the fee for what we do would have to be increased.  There 
would have to be some kind of, change in the way that we’re 
funding it. 
 
D4: It comes down to time and money. You only get paid so much 
for what you do […] you can set all the guidelines in the world, but 
people won’t do it if there’s no way of funding it… that’s the 
biggest issue. 
 
D5: Unless you can charge the patient, I don’t know, maybe thirty 
or forty pounds, you don’t have thirty or forty minutes. I’ve got 
twenty minutes and, I lose money. It is actually financial suicide. 
I’ve got a practice that loses money. 
 
D6: I think in the NHS… we get paid very little for an examination.  
In that time… I think I have to address their pain and their 
toothache and things like that… I don’t have time for five minutes 
consultation on smoking and drinking […] Well, the golden thing is 
money. 
 
 
Lack of training: preventive interventions (advice and referral) 
D1: Dentist…we as a profession, as a group, we should also be 
useful to have any, professional, like psychological training how to 
speak to the patient about risks, especially risk of oral cancer […] 
with actors or somebody else, that somebody pretends to be a 
patient or my colleague. 
 
D2: It’s a bit of the training (for alcohol) would be more… if that 
could be incorporated with smoking […] because we’re not 
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formally trained […] There wasn’t really that training available. It 
was more available for the pharmacists and the GPs. It 
wasn’t…didn’t seem to be available for the dentists. 
 
D9: Well, we’re trained to do a certain level of smoking cessation 
advice […] I wouldn’t feel trained enough to and it wouldn’t be 
possibly appropriate to start challenging someone and saying, oh, I 
actually think you drink twice as much as you’re admitting. 
 
 
Lack of educational materials (in particular for alcohol) 
D1: I would like to have any good leaflets because personally I was 
looking for in the Google from long, long time… The only one what 
I could find it is from British Dental Health Foundation. It’s actually 
action is wonderful. The materials are horrible…the graphic is 
unacceptable. 
 
D13: Well, need more posters. We need posters like the smoking 
ones. The posters for stop smoking is everywhere and the advice 
and helplines are up and about. But they don't the same kind of 
posters for drinking alcohol. It's the same going into my local GP 
surgery. I don't see any posters about alcoholism on the walls. But 
you see loads of smoking things […] it would be good to have 
posters up like on oral cancer health week or whatever. 
 
Referral (Assist) None reported “Ask/Assess and Refer” could be routine 
D7: a very short kind of advice, and then we can refer 
on to like there’s say like alcohol organisations, so we 
don’t actually sit and provide say an hour long support 
[...] I think that’s probably the best way. 
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Social Opportunity 
 Barriers (with examples) Facilitators (with examples) 
Ask/Assess Patient attitudes: using term “oral cancer” 
D7: I think the word cancer scares people a lot… because I find 
patients get a bit nervous the minute you mention those kinds of 
words. 
 
D9: I think a lot of patients prefer you to avoid directly talking 
about the word cancer. It’s not a nice word to a lot of people. 
 
None reported 
Advise/ Arrange “Sensitive” topic 
D4: One of the things which is, important is that we don’t lose a 
relationship...from a dental point of view by setting up an 
antagonistic relationship over somebody drinking. You know, if you 
push too hard then they may decide that actually they don’t want to 
see you again, and then that’s a detriment to their oral health. 
 
D11: I feel that they are quite sensitive subjects (smoking and 
alcohol) because it is personal […] It is a really sensitive when it 
comes to personal things like that, especially with patients it can be 
quite a sensitive subject when they feel you're trying to force 
somebody to do something that they want to do. 
 
 
“Awkward” topic: alcohol advice 
D7: It’s always a bit of an awkward topic asking about someone’s 
drinking… 
None reported 
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D9: There seems to be more of a stigma putting a high alcohol 
intake down than a high smoking… it’s difficult to question that 
without, you know, seeming to be, making the patient 
uncomfortable and almost accusatory then [laugh].  So, in my 
experience I wouldn’t feel comfortable to challenge the patient 
about it. 
 
D12: Because I think some people feel awkward going to talk about 
it and things […] Smoking was fine, it was more the alcohol that I 
felt awkward asking about. 
 
D13: There's more of a stigma attached to alcoholism than there is 
smoking, because smoking has been talked about so much; it's in 
adverts, it's in posters… But alcohol's a bit different because you're 
allowed to drink a little bit, and everybody's idea of how much is a 
little bit is different. 
 
 
Patient attitudes: alcohol advice 
D4: It depends on the individual. If somebody’s interested, then 
they’ll let you talk. If they’re not interested by and large... they’ll 
tell you pretty quickly. 
 
D7: …they also don’t think it’s a dental issue, so maybe just… 
 
D13: Some are in denial of the risks […] and some people don't 
want to discuss their alcoholism. I mean I have quite a lot of 
patients who I know are functioning alcoholics. You can smell it on 
their breath… and they've got the red oral mucosa and stuff like 
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that. And they don't talk about it or bring it up and I just feel… I just 
wouldn't like to upset them by mentioning they smell of booze. 
 
Referral (Assist) None reported None reported 
Automatic and Reflective Motivation 
 Barriers (with examples) Facilitators (with examples) 
Ask/Assess None reported Consider their role/job: ask and assess alcohol 
consumption 
D12: I feel like you have to ask because you know the 
importance of asking. 
 
D13: I feel my role is just there, they already know 
everything, I'm just there to prick their conscience and if 
they seem interested then I'm ready with all the help and 
advice they need to try and stop. 
 
Advise/ Arrange Reluctance to include behavioural interventions (not considered 
their role) 
D1: Drinking habits actually… as a dentist I don’t think that it is my 
role. I think it is coming too far, because it just looks like that I 
judge somebody […] I don’t think that it is my position to tell him 
what he’s doing, because the next step will be how many partners 
you have got and what are you doing after eight o’clock? 
 
D3: I’m not sure that it’s a dentist’s job to be then checking up on 
Consider their role/job: provide advice 
D11: I am comfortable with it to be honest, because at 
the end of the day it's my role to do it and… like doctors 
and dentistry… as well as we would see patients a lot 
more than what those other services would see them.  
Therefore, it's our job to inform them. 
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them and calling them back and saying, you know, get them to fill 
in data about how much they smoke and how much they drank [...] 
advice up to five minutes I don’t think is practicable, personally. 
D5: And then by the time you get to all the end of that (oral 
examination and charting), to spend five minutes on alcohol and 
five minutes on smoking is just not going to happen.  It’s not 
realistic… five minutes is a lot […] I probably don’t ask them about 
their sexual habits… I perhaps don’t want to have that discussion 
[laugh] either. 
 
D8: Usually it’s just smoking. I would think. I don’t ask them 
(hygienists) to provide alcohol advice.  
 
 
Perceived patient wishes and needs 
D1: confidential but in this way… we start to interfere, as in totally 
private life. 
 
D6: I think some people are maybe not expecting to hear that from 
me, I don’t know. I’m old school. 
 
D7: They (patients) also don’t think it’s a dental issue, so maybe 
just… 
 
D9: I think it’s (alcohol) something that people like to keep 
hidden... and if they’re not going to admit it to the health 
professional then it’s quite hard. 
 
 
 
Considered motivation: always provide behavioural 
advice 
D2: We’ll ask them how much they’re drinking and how 
much they’re smoking and then we would bring it up… 
I would say that to everybody… everybody would be 
getting the same message […] And I did think that 
we’re seeing the patients so much more regularly…you 
know, and it would make more sense if were doing it… 
 
D12: Every single patient gets it… they all wonder why 
I ask all these questions… but I have to explain, it’s 
important […] I tailor it to each person, so it depends 
what they’re moaning about when they come in […] I 
always mention cancer as one, definitely… 
 
 
Receiving formal training to provide behavioural 
advice would work 
D3: I think it would be interesting to… I would attend 
that kind of thing… I mean training to provide advice as 
where to go or how to then seek more help… 
 
D7: So I think maybe just a, a short course like a 
morning or something, part of a CPD training, because 
oral cancer obviously is a big issue. 
 
D13: I think we should learn about the research that's 
been done and also be told about the developments for 
healthcare for improved care for cancers and things. So 
it would be good to get that once every five years I 
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Perceived lack of benefit 
D8: I would need some proof that it actually did any good. I mean, 
I’m not convinced that if I said to somebody to stop drinking 
alcohol, it would make a lot of difference to them...if they wanted to 
drink alcohol.  
 
think. 
 
Referral (Assist) None reported 
 
More information or guidelines on referral 
D1: Every practitioner should, have any like instruction. 
I think maybe supplied by the health board, exactly 
pathway where to refer the patient… but how to get 
consultant. 
 
D2: Set something up more like Childsmile where there 
was a referral thing. The thing with that is… where we 
were, kind of, connecting with the pharmacists and the 
doctors. 
 
D8: Well, maybe more knowledge of where the alcohol 
cessation is in. That means the professional ones are 
located... 
 
 
Receiving formal training to provide referral would 
work 
D2: if the dentists were trained in that, to be able to 
refer… to be able to prescribe any (intensive counselling 
or pharmacological treatments) 
 
 
Chapter 4  
 
 
242 
4.4.3 Risk prediction tool 
A supplementary aim of this study was to explore dental professionals’ views on 
having a dedicated oral cancer risk prediction tool in primary care dental 
practices, to help facilitate the best practice behaviours and processes discussed 
above and in the previous chapter. Some dental professionals were not sure if 
having such tools would have any additional benefit in their clinical practice, as 
they believe the medical and social history forms in use in their practice already 
cover most of the questions to identify individuals’ characteristics and 
behaviours. Dental professionals also said they were following a similar process, 
albeit calculating risk “in their head” via thorough oral examination/screening 
along with patient history. In terms of affecting change to patient behaviours 
and/or lifestyle, mixed responses were observed. Some professionals believed 
there would be no effect, while others considered that having such a risk tool 
would be beneficial for a) identifying a high-risk patient and b) tailoring specific 
advice for them. In other words, it was felt that such a risk tool would help 
facilitate the best practice of providing a tailored intervention to high-risk 
individuals. 
As outlined earlier under “physical opportunity”, the major opportunity barriers 
to prevention were time and money, and these same barriers were reported in 
most interviews for having a risk tool in primary care dental practices. 
Professionals emphasised that unless funding increases, they cannot allow more 
time for using new tools in their practice. They have limited time slots, and they 
cannot compress more and more things into that same time slot. Another major 
barrier cited for having such a risk tool (online or paper version) was concern 
over data storage and data protection; one of the professionals even called this 
record keeping a “storage nightmare” for the dental practices. 
One of the possible benefits reported was that patients would know, through the 
derivation of an outcome score, if they are at either high or low risk and thus 
this might facilitate them being amenable to professional intervention. 
However, it was also acknowledged that low risk does not mean patients are not 
going to get disease. Another benefit reported for having such a risk tool was for 
professionals who have less confidence in dealing with these issues, such a tool 
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could help those professionals to discuss these risks more efficiently, thus 
addressing barriers to dental professional’s “psychological capability” and also 
“social opportunity” by making discussions less awkward and more comfortable. 
Training to implement a risk tool 
Some stated that for such risk tools there needs to be more information and 
training sessions for implementation with a wider range of practices, so all 
professionals are doing similar types of things. In particular, professionals should 
be trained to advise those patients who got a high-risk score without frightening 
them (i.e. effective risk communication). Professionals should also be prepared 
to answer questions like: how this risk score is going to affect their patient?; 
where patients go from there?; what they do with that written score?, etc. One 
of the professionals further added that such a tool should be implemented with 
professional help and counselling, and there should be a “before and after” 
session to assess effectiveness. 
Practicable approaches to implement a risk tool 
Professionals were asked about the best way such tools would work in the dental 
practice, for example: self-completion in waiting room by patients; dental 
professionals administer to patients during an oral health assessment; filled in as 
an online tool or as a mobile application (app.); or as a paper questionnaire. 
Self-completion by patients on computers or tablets in waiting room was 
considered the best option by most dental professionals, the reason being 
patients should not feel under pressure in the dental practice with the dentist 
looking at what they are answering, or prompting them when completing fields.  
Patients were thought to feel more comfortable providing such information 
confidentially. Another option suggested was a mobile ‘app.’ where patients can 
check their score themselves; information of this app. could be put on posters in 
the waiting areas in dental practices. Some professionals suggested 
implementation through including a few more questions in the current patient 
history form/ questionnaire in the practice, as most of the lifestyle and 
sociodemographic questions are already included in these forms. Primarily, 
there was agreement that the way in which such a tool is implemented should 
be easy, quick and convenient, and should be incorporated into the practice 
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management system in order to save dental professionals time - addressing 
“physical opportunity” barriers. 
Team effort 
Some dental professionals suggested that for such tools to be effective, not only 
dental professionals, but medical professionals, pharmacists or other providers 
(e.g. retail, advice centres etc.) should be involved in this. One of the 
professionals even called it a “multi-directed action”, where dentists perform 
standard examination for detecting any suspicious lesions and provide advice for 
high risk patients. An idea put forward was that such advice could be reinforced 
or repeated by a general medical practitioner, general nurse, or social worker, 
so patients receive consistent and coherent reminders. If the patients agree, 
dentists could co-operate with pharmacies or cessation services for further 
support. This supports the evidence-based best practice (Chapter 3) where team 
effort was considered more effective in achieving desired behaviour change 
among high-risk individuals. Moreover, one of the dental professionals suggested 
that all information should be made available for patients on the mobile app, so 
it becomes a “do it yourself tool kit”. 
Table 4.5 presents examples of each theme, under the question of acceptability 
of a risk prediction tool, by presenting quotes from dental professional 
interviews. 
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Table 4.5: Barriers and facilitators related to having risk prediction tool in primary care 
dental practices 
 
Barriers (with examples) Facilitators (with examples) 
Perceived lack of benefits of having oral 
cancer risk prediction tool 
D4: From my point of view I don’t know 
that it’s going to change the...what I do 
particularly and... make me look differently 
at anybody. 
 
D5: Not sure. But, I mean, well you didn’t 
need a computer to tell you that.  I’m sitting 
right here and you’re a doctor, you could 
have told me that [laugh] without the 
computer.  I think…you’ve got the brains to 
tell me that. 
 
D6: I don’t think it’s going to help people to 
say I think you’re at high risk of oral cancer. 
I don’t think so [laughing]. I think it might 
frighten them. 
 
D7: I mean, we tend to do that anyway, but 
it’s not…it’s more in your head, like you 
think, okay, this person’s over a certain age, 
they could have had something in the past, 
medication they’re on or if they’re smoking, 
if their alcohol…that kind of thing, so you 
do have that calculate a risk in your head. 
 
D13: I don't think it would help my clinical 
practice any… The only benefit from this is 
the patient knowing they're either high or 
low risk. 
 
Lack of funding for risk tool 
D2: I think the practices need to be 
remunerated for their time, you know… if 
everything’s put in then it just becomes part 
of it… we try to encompass everything and 
we do everything here, but it’s tough to do it 
all. 
 
D4: if somebody is willing to fund us to 
have, you know, a couple of hundred tablets 
so that... but I think that the feasibility of 
that is quite low […] and constantly every 
time something else comes out you’re 
adding onto it, but funding doesn’t increase 
in any way, shape or form. So, if you’ve got 
Perceived benefits for communicating 
oral cancer risks 
D2: I think that if you were using a tool like 
this, it definitely highlights in the patient, 
why are they (dentists) talking about this 
(smoking and alcohol)?  You know, this is 
obviously important. 
 
D9: That might be useful and you could 
then…receive that information and have 
their classification and discuss it further with 
them. They’re asked how much they smoke 
and drink and they’re maybe not aware of 
why they’re being asked that and they don’t 
really want to answer it, whereas if they 
knew, you know, if it’s explained it was part 
of a way of assessing how much at risk they 
were of oral cancers…to help dentists 
detect, that might encourage them to be 
more truthful and raise their awareness and 
care of their oral cavity basically. 
 
D12: I think people would use it and find it 
beneficial, because then at least you know 
you’re not missing anything. I think that’s 
the benefit of it, you’re not missing 
anything, it keeps you on top of things like 
that 
 
Self-completion as an online tool/ an app 
D1: It could be mobile app, like, are you risk 
of cancer, check yourself […] Could be 
poster, do you want to check, if…are you 
under risk of a cancer, go to the apps and 
then…nice, very, very colourful picture, not 
to be frightened. 
 
D11: Like if we had like a practice iPad, or 
something like that, that they could 
complete it on themselves […] Something 
online would be good. 
 
D13: I think it would be better giving them 
an iPad and allow them to do it in their own 
quiet space while they're sitting in the 
waiting room or whatever. 
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an admin process and a clinical process how 
do you pay for that? 
 
Lack of time 
D4: how do you allot the time… that’s the 
biggest issue is... that you’re compressing 
more and more things into the same time, 
and if the funding doesn’t increase then you 
can’t allow more time. 
 
D7: I think the main thing with dentistry 
is… it needs to be kind of easy to access… 
because you don’t have a lot of time with 
each patient in the NHS dentistry. 
 
D8: That is the sort of thing that you 
probably need to increase your appointment 
time for, isn’t it? Because it already takes 
them five or six minutes to fill up the 
medical questionnaire. 
 
 
Data or record storage and protection 
D4: then again you’re talking about how that 
(paper or online tool) interacts with patient 
management software […] then where do 
you store the record?  How do you store it 
safely, look at it from a data protection point 
of view?  That then becomes very difficult.  
And if you’re talking about paper where do 
you store the paper? 
 
 
 
Incorporated with patient history forms 
D2: Possibly incorporated in to the end of 
the medical history.  That would be okay 
[…] I think here…again very similar to the 
Childsmile, if it was incorporated in to the 
computer system we’re doing, it was picking 
all of this up for you, you know, that was 
doing that automatically for you…then that 
would be very helpful […] we were doing a 
social and medical history, we could be 
clicking that through while the patient talks 
and then at the end of it, I suppose we could 
be delivering the verdict. 
 
D7: I think that would be… because they fill 
out forms anyway, fill in medical history, so 
I think having that included…maybe just a 
wee… 
 
 
Implemented as a team approach 
D1: I think it must be multi-directed action. 
So everybody from every site […] 
information from every corner, from dental 
professional, medical professional, from 
society, apps, as much as possible. 
 
D13: I would be more comfortable doing it 
in an audit with a wider range of practices 
within [area name] so we're all doing similar 
types of things. 
 
 
4.4.4 Summary of findings 
The main themes developing from this study using in-depth dental professional 
interviews were developed according to a dedicated framework in terms of 
capability, opportunity and motivation to reveal barriers and facilitators faced 
by dental professionals in primary care dental practices to delivering evidence-
based best practice oral cancer risk factor assessment and prevention in 
Scotland. The main findings can be summarised as follows: 
Chapter 4  
 
 
247 
§ All dental professionals reported good knowledge of oral cancer risk 
factors and identified smoking and alcohol as the major risk factors for 
oral cancer and other chronic diseases. It was reported that all patients 
were asked about their smoking and alcohol habits in the patient history 
forms or questionnaires, irrespective of patient’s age and gender. 
§ However, there was a lack of knowledge of formal risk assessment tools 
for alcohol, for example, AUDIT or CAGE tools. 
§ Advice and prevention related to smoking was more common compared to 
alcohol with patients in primary care dental practice. However, this was 
mainly limited to simply asking smokers about their willingness to stop 
smoking, and “signposting” such as providing them with quit-line numbers 
or leaflets. 
§ There was a lack of knowledge of local referral pathways for smoking 
cessation services, which was seen a barrier to their psychological 
capability. 
§ Providing behavioural interventions for reducing alcohol consumption was 
seen as a problematic issue by most dental professionals. They reported a 
lack of knowledge and confidence in providing alcohol advice. In most 
conversations, alcohol came out as the topic/issue which was least talked 
about in primary care dental practices. 
§ None of the professionals reported signposting or referring patients to 
specialist alcohol services, and all were unaware of local alcohol referral 
pathways. 
§ Opportunities – both physical (resource centred) and social (e.g. cultural 
or normative) were raised as major themes/issues for implementing 
evidence-based best practice for oral cancer behavioural preventive 
interventions in almost all dental professional interviews. Lack of time 
and funding were the resource (physical) barriers reported by most dental 
professionals for providing behavioural interventions in primary care 
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dental practice. Incorporating 5 minutes of advice on smoking and alcohol 
was not reported as a feasible option in primary care dental practice until 
professionals were remunerated for this. 
§ Providing very brief advice for less than 2-minutes and referring patients 
to local support groups or cessation services (i.e. simply “ask and refer”) 
was seen as feasible in physical opportunity terms and was therefore 
considered a possible option that could be incorporated in all primary 
care dental practices - and including the brief interventions if resourced. 
§ Among other facilitators to physical opportunity reported were: receiving 
training to deliver behavioural interventions (advice and referral) and 
having good education materials or posters in the waiting room in primary 
care dental practice. 
§ Social opportunity and reflective motivation of dental professionals 
created a further major barrier to delivering preventive interventions in 
primary care dental practice; most dental professionals do not see 
providing alcohol advice as their role and cited this as an “awkward” 
topic to discuss. 
§ Younger dental professionals reported more confidence in discussing 
patients’ smoking and drinking behaviours compared to more senior 
professionals, and were more likely to see it as part of their core role. 
§ Patient attitude was perceived to be the major barrier reported in terms 
of social opportunity; in particular patients were not seen as happy for 
dental professionals to discuss alcohol drinking behaviours (as most 
patients were thought not to consider this to be related to oral health or 
dental issues). This in turn affects dental motivation to engage in these 
discussions. Patients’ viewpoints were further explored as part of this 
thesis, in order to examine if their perspectives match those of dental 
professionals (Chapter 5). 
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§ Furthermore, discussing an individual’s smoking or drinking behaviours 
was considered quite a “sensitive” topic, and it was recognised that 
professionals need to convey messages in a way that maintains a good 
dentist-patient relationship. 
§ Mixed responses were received regarding having an oral cancer risk 
prediction tool. Some dental professionals considered having such a risk 
tool to be beneficial for identifying a high-risk patient and tailoring advice 
for them. However, once more, time and funding were the major barriers 
to implementing such a tool in primary care dental practices. 
4.5  Discussion and conclusions 
There now follows a short discussion of the main findings from the dental 
professional interviews, in the context of existing literature. The strengths and 
limitations of this study will also be discussed, and suggestions for implementing 
these findings in practice by using various intervention functions from the 
Behaviour Change Wheel framework will be provided. 
4.5.1 Comparison with literature 
This qualitative study with theoretically-based thematic analysis explored 
current views on delivering evidence-based behavioural preventive interventions 
for oral cancer risk factors (smoking and alcohol) in a primary care dental 
practice. This is the first study, to the best of author’s knowledge, to 
systematically isolate synthesis of best practice via a systematic overview, then 
assess theory-based barriers and facilitators to each component of the evidence-
base, and to take this approach specifically in relation to oral cancer. 
As reported in the results, there was a less involvement of male dental 
professionals in this interview study. Similar gender differences or male non-
participation has been reported in many other studies in a range of health 
contexts (Markanday et al., 2013; Techau et al., 2014; Slauson-Blevins and 
Johnson, 2016). Reasons for non-participation in these studies varied depending 
on the research areas or topics. A few common reasons reported by men were 
time constraints, inability to understand or cope with the study, and an 
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uncertainty over health examinations/studies. There was no particular study (to 
the best of the author's knowledge) reporting gender differences for non-
participation among dental professional studies. 
4.5.1.1 Oral cancer risk factor assessment and preventive interventions 
As behaviour change is essential for the prevention of a disease and health 
promotion, the Behaviour Change Wheel’s COM-B model is significant to all 
healthcare professionals. This model was used in this study to identify barriers 
(and facilitators) to implementing best practice preventive intervention in 
dental practices. The reliability of the Behaviour Change Wheel was examined 
by Michie et al. (2011) in two important public health domains of behaviour 
change: tobacco control and obesity. This was tested to describe interventions 
within the English Department of Health’s 2010 tobacco control strategy (DoH, 
2010) and the National Institute of Health and Clinical Excellence’s guidance on 
reducing obesity (NICE, 2006b). Another study by Cane et al. (2012) refined and 
tested the validity of the “Theoretical Domains Framework” and provided a 
system for theoretically assessing implementation problems, along with other 
health-related behaviours in order to inform intervention development. The 14 
theoretical domains were independently mapped against the COM-B components 
in order to assist intervention designers in designing effective behaviour change 
interventions (Cane et al., 2012). In this study, the Behaviour Change Wheel was 
used systematically to determine intervention functions necessary to best 
overcome existing barriers (Michie et al., 2011; Cane et al., 2012) (Section 
4.5.2). 
The findings from this study are that there are fewer barriers in giving smoking 
(or tobacco use) advice relative to alcohol advice. This concurs with previous 
studies where advice against tobacco use was considered appropriate in a dental 
setting, while dental professionals were reluctant to enquire about alcohol use 
and give advice on alcohol moderation (Warnakulasuriya and Johnson, 1999; 
Cruz et al., 2005; Shepherd et al., 2010; McAuley et al., 2011). 
Lack of knowledge or confidence for providing face-to-face behavioural 
preventive interventions for reducing alcohol consumption was reported by most 
dental professionals in this study. This finding is consistent with other studies, 
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which also reported a lack of knowledge regarding best approaches (advice and 
referral) to help patients reduce heavy drinking (Dyer and Robinson, 2006b; Neff 
et al., 2013), and lack of confidence when discussing alcohol (Dyer and 
Robinson, 2006b; Shepherd et al., 2010). These studies also reported insufficient 
personal skills in delivering alcohol interventions by dental professionals in 
primary care dental practices. 
The results from this study confirm the link between knowledge or confidence to 
inadequate training, perception of poor efficiency, disruption of the dentist-
patient relationship, and awkwardness or perceived problems with relevance to 
the clinical situation (Macpherson et al., 2003; Dyer and Robinson, 2006b; 
Shepherd et al., 2010; McAuley et al., 2011). However, regarding smoking 
cessation, a lack of knowledge of local referral system and low perceived 
efficacy has been reported in few studies (Edwards et al., 2006). 
Younger dental professionals in this study were more confident in discussing 
patients’ smoking and drinking behaviours compared to more senior 
professionals and even recognised it as their job or role. However, again a lack 
of knowledge was reported regarding local referral pathways (for both smoking 
and alcohol). These findings have been supported elsewhere, where newer 
dental graduates reported recording patients' smoking status more routinely and 
believed that clinicians' advice and NRT were effective in promoting smoking 
cessation (John et al., 1997). A further study reported that undergraduate 
dental students felt that they had sufficient knowledge regarding oral cancer 
prevention and early detection, and that they reported providing advice to 
patients regarding oral cancer risk factors after graduation (Carter and Ogden, 
2007). 
Physical (resource) opportunity was raised as a major issue in all dental 
professional interviews in delivering preventive interventions in primary care 
dental practices. The results are in agreement with several other studies, where 
lack of time and lack of incentive/remuneration were reported as important 
barriers to providing preventive advice in dental practices. Lack of time was an 
important concern regarding implementation of preventive interventions in 
primary care dental practice that has been reported in many studies 
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(Macpherson et al., 2003; Dyer and Robinson, 2006b; McAuley et al., 2011; Neff 
et al., 2013). Lack of proper reimbursement or funding to offer these services 
has been an important issue reported in several dental studies (Cruz et al., 
2005; Dyer and Robinson, 2006b; McAuley et al., 2011). 
The findings from this study suggested that lack of time was more of an issue in 
NHS dental practices compared to private practices. Similar findings had been 
reported in another study by Csikar et al. (2009), which explored the differences 
in the health promotion and smoking cessation activities between NHS-
orientated and more privately-orientated dental practices. They reported that 
dental practitioners from the NHS-orientated practices were more likely to cite 
'lack of time', 'no incentive' and 'lack of expertise' as potential barriers to 
providing health promotion advice (Csikar et al., 2009). However, results in this 
study differed in terms of lack of incentive/funding and lack of training, which 
were cited as potential barriers by both NHS and private practice dental 
professionals. Moreover, remuneration to include preventive interventions was 
more of an issue reported by private practitioners, and lack of training to deliver 
preventive interventions was reported by both NHS and private practice 
practitioners. 
Lack of training to assist patients in quitting tobacco use (smoking and smokeless 
tobacco) has been reported by dental professionals in various studies in the last 
two to three decades (Schroeder and Heisel, 1992; Hastreiter et al., 1994; 
Warnakulasuriya and Johnson, 1999; Macpherson et al., 2003; Cruz et al., 2005). 
Again, lack of training was the main barrier limiting dental professionals’ 
involvement in providing alcohol advice which has been reported in number of 
studies (Warnakulasuriya and Johnson, 1999; Macpherson et al., 2003; Cruz et 
al., 2005; Shepherd et al., 2010; McAuley et al., 2011). As reported in findings 
from this study, most dental professionals were motivated towards receiving 
training to provide preventive interventions (brief advice and referral) for 
smoking cessation and reducing alcohol consumption in patients attending 
primary care dental practices. Studies have shown the effectiveness of training 
dental professionals to deliver effective smoking cessation interventions (Wood 
et al., 1997; Gould et al., 1998; Binnie et al., 2007). These studies showed that 
after receiving training a significant increase was reported in the number of 
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dental professionals who started assisting patients with stopping tobacco use. In 
addition, dental professionals also reported a significant improvement in their 
confidence after training. Similar positive impact of training dental professionals 
had been reported in a pilot study by Awojobi et al. (2016), by reducing 
perceived barriers, increasing self-efficacy, and increasing oral cancer 
discussions between dentists and patients (Awojobi et al., 2016). 
Regarding training to deliver alcohol interventions in primary care dental 
practices, Ntouva and colleagues (2018) recently assessed a brief alcohol advice 
training programme designed and tailored specifically to the needs of NHS 
general dental practitioners. The programme comprised of two half-day (a total 
of 8 hour) highly interactive sessions, including exercises, role-plays, training 
manuals and other resources for use in the practice. The results were 
encouraging, showing a significant improvement in knowledge, attitudes and 
confidence of NHS dentists towards alcohol screening and delivering brief 
advice. The study established that dental professionals can be trained with the 
relevant knowledge, attitudes and confidence needed to deliver alcohol 
screening and brief advice to patients (Ntouva et al., 2018). However, future 
research is needed to evaluate its effectiveness and cost-effectiveness. This 
training programme was part of a feasibility randomised controlled trial (Dental 
Alcohol Reduction Trial – DART) which aimed to “assess the acceptability and 
practicality of an alcohol brief advice intervention delivered in primary dental 
practices across North London, UK” (Ntouva et al., 2015). The trial was 
successfully completed, though results are yet to be published (Cato, 2016). 
Moreover, a study by Roked and colleagues (2014) suggested replacing the 
alcohol units question on the medical history form in a dental setting with a 
single item screening instrument - Modified-Single Alcohol Screening Question 
(M-SASQ): “How often do you have eight or more standard drinks if male, or six 
or more standard drinks if female, on one occasion?” This screening instrument 
has demonstrated to be an effective, reliable and valid tool that could be used 
quickly in busy healthcare settings (Roked et al., 2014). 
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4.5.1.2 Oral cancer risk prediction tool 
Risk prediction tools are available to predict risk of future cancer incidence for a 
range of cancer sites (for example: breast, lung, prostate, colorectal cancer, 
etc.), for effective risk communication, and to identify asymptomatic individuals 
who are at higher risk of developing cancer (Usher-Smith et al., 2015). The 
development of cancer risk assessment tools (RATs) is one of the initiatives in 
England that aims to support primary care professionals to identify and quantify 
the risk of cancer in primary care patients (Green et al., 2014). The tool is 
currently available for fifteen cancer sites (common cancers that are presented 
to primary care). The RATs were perceived as beneficial by general medical 
practitioners in a study by Green et al. (2014), exploring their views for 
incorporating the RATs for lung and bowel cancers into their clinical practice. 
The tools were perceived by general practitioners as additive to their skills sets 
and appreciated as an instructive tool, but not to supersede their clinical 
judgement. Moreover, offering adequate training and support packages was 
highlighted as a key factor for successful implementation of the RATs (Green et 
al., 2014). This thesis, albeit a small study with dental professionals and patients 
(Chapter 5), explored the barriers/facilitators and feasible options for having an 
oral cancer risk assessment/prediction tool in primary care dental practice and 
found these not insurmountable; future research is needed to establish an 
intervention/tool adapting suggestions from dental professional interviews, and 
further research to assess its effectiveness and cost-effectiveness. 
4.5.2 Implications for practice 
Table 4.6 shows how the identification of specific barriers and facilitators is 
theoretically mapped to a set of intervention functions to explore each target 
behaviour (based on general theory-based intervention - Table 4.1 in the Section 
4.3.8). For example, what needs to be addressed or changed (barriers) and what 
needs to be enhanced or reinforced (facilitators) at the personal level and/or in 
the environment to attain the desired change in behaviour. 
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Table 4.6: Identifying intervention functions from COM-B Model and Behaviour Change Wheel (activities designed to change behaviours) 
 
  Intervention functions 
  Education Persuasion Incentivisation Coercion Training Restriction Environmental restructuring Modelling Enablement 
COM-B 
components 
Physical 
capability 
         
Psychological 
capability 
         
Physical 
opportunity 
         
Social 
opportunity 
         
Automatic 
motivation 
         
Reflective 
motivation 
         
The greyed (shaded) squares highlight where “evidence or consensus suggests that a function may be effective for addressing a particular behavioural 
determinant” (Michie et al., 2011; Barker et al., 2016). 
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From the dental professional interviews, it was identified that: physical 
opportunity, social opportunity, and reflective motivation were raised as having 
most potential for addressing in order to implement best practice for oral cancer 
risk factor assessment and prevention. The intervention functions which are 
potentially relevant in bringing about the desired behaviour change based on 
issues identified by dental professionals are greyed (or shaded) in Table 4.6 and 
are: 
§ Incentivisation in the form of CPD credits or “Quality and Outcomes 
Framework” payments (Leech, 2009) linked to “good practice” in 
delivering preventive interventions in dental practices. This would 
address the most fundamental issue, i.e. resources, and in turn dental 
professional motivation. The “Quality and Outcomes Framework” was a 
general practitioner payment model for delivering interventions such as 
smoking. It was criticised in general medical practice as being more 
process than outcome driven and has since been changed (Gillam, 2010; 
Gillam et al., 2012). But this model might work better in a dental practice 
setting which is more driven by activity (DoH, 2016). 
§ Educate dental professionals by providing more information on the best 
approaches of brief advice (in particular motivational or structured brief 
interventions for alcohol) and referrals (local referral pathways for both 
smoking and alcohol services). This would help to increase capability and 
overcome barriers in dental professionals’ knowledge and understanding. 
§ Training dental professionals in delivering brief interventions for smoking 
and alcohol and overcoming social barriers. Training is recommended in 
evidence; modelling, for example, using actors to roleplay and showing 
examples of good practice could also be incorporated in training. 
§ Change the environment or context in which the preventive interventions 
are delivered, for example, assessing risk factors in the waiting room; 
considering which staff could deliver; use of online or e-assessment tools. 
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§ Enablement strategies might include providing clear materials for 
enhancing referrals. 
4.5.3 Strengths and limitations 
4.5.3.1 Strengths 
This study was based on a rigorous overview of the best practice evidence 
synthesised from systematic reviews and clinical guidelines (Chapter 3). 
Interview topic guides were created based on systematic overview findings. The 
study results will be valuable in informing and improving further the current 
practice on oral cancer risk factor assessment and prevention among dental 
professionals in primary care dental practices in Scotland and beyond. This 
would further help to design a pilot/trial to inform the development of an oral 
cancer prevention intervention package delivered by dental professionals in a 
primary care dental practice. 
In-depth, semi-structured interviews used for data collection in this exploratory 
qualitative study, are interactive and tend to be flexible in nature, thus allowing 
for questions to be asked in an order most suited to the respondent, permitting 
responses to be fully explored and allowing the researcher to be receptive to 
significant issues raised spontaneously by the respondent (Ritchie et al., 2013). 
However, in-depth interviews are difficult to replicate and there are chances of 
interviews being subjective, i.e. there are concerns about impact of 
researcher’s views and close relationship with respondents. Thus, 
researcher/interviewer needs to be skilled in order to avoid any influence on 
topic/data collection, as researcher is the main instrument of data collection 
(Kvale and Brinkmann, 2009). The principal researcher (author) in this study, 
had prior experience of conducting qualitative interviews, and received further 
training, conducted pilot interviews (Section 4.3.7) to gain valuable interview 
experience for succeeding dental professional interviews.  
The principal researcher was able to reflect on each interview, as the data were 
collected over a period of time. A semi-structured topic guide was used, so 
interviews were guided by the principal researcher in real time and were not 
restricted to specific questions, and were quickly revised as new information 
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emerged. The principal researcher spent time after each interview reflecting on 
how well they have been conducted; personal reflections on the process; what it 
added to the body of the data; and any implications for future discussions, 
interviews, or analysis. 
In-depth semi-structured interviews explored views of dental professionals from 
a range of dental practices. A range of views were obtained from: dental team 
members including dentists, dental hygienists/therapists, VTs; with a wide range 
of years of experience (younger and more experienced professionals); and range 
of socioeconomic status (SIMD) of the location of their dental practice. Thus, the 
knowledge generated might be transferable to other professionals or other 
settings, for example, findings replicable to primary care medical practice 
addressing these common risk factors (smoking and alcohol) for other major non-
communicable diseases. 
The coded data were double checked by one of the supervisors (AJR) and any 
coding discrepancies identified were solved by discussion among the principal 
researcher and supervisors. This ensured that a robust coding frame was 
developed in order to enrich qualitative analysis in this study, further ensuring 
accuracy, reliability and consistency of analysis. Moreover, reaching data 
saturation after seven interviews using a novel method (as described in Section 
4.3.8.2) ensured the validity and robustness of study results. 
4.5.3.2 Limitations 
One of the key limitations of this study was that the topic guide was developed 
based on initial synthesis of the overview findings, however, the detailed 
overview synthesis continued even after the dental professional interviews were 
conducted. The interviews were conducted after initial overview synthesis due 
to the time constraints, considering this was a PhD project. This somewhat 
restricted further in-depth exploration of dental professional views based on the 
findings from robust overview synthesis. For example, assessing feasibility of 
longer brief or intensive interventions for smoking cessation in case of patients 
with tobacco dependence or for those patients who were not willing to go to 
cessation services. Future work would thus involve incorporating the in-depth 
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overview findings and exploring these in detail, again using the Behaviour 
Change Wheel. 
Selection bias was another limitation, only professionals who agreed to 
participate in the interview and who could inform the aims of the research had a 
chance of being included in this study. The dental professionals included were 
only from the dental practices in the West of Scotland - due to the time and 
financial constraints it was not possible to spread across different locations in 
Scotland (out with West of Scotland). Moreover, dental nurses could have been 
included in the study, considering ‘Extended Duty Dental Nurses’ are taking 
important prevention role in patient care, for example in Childsmile (a national 
oral health improvement programme for children in Scotland) (O'Keefe, 2015). 
Although, as discussed earlier (Section 4.3.4), for small sample sizes (typically in 
studies using intensive qualitative methods), the bias from sampling based on 
selected criteria is less dangerous than the lack of precision introduced by 
probability samples (Deville, 1991). 
This was a cross-sectional study, thus views expressed by dental professional 
were on that particular day. Thus, revisiting professionals at different time point 
to see if they express the same views would significantly strengthen the internal 
validity of the findings. Secondly, the participants were mostly experienced 
dental professionals (more than ten years of experience) and also there was a 
female domination (gender issues). Whilst this is not uncommon in studies of this 
type, it may limit the generalizability of the findings. 
4.5.4 Chapter conclusions 
Dental professional perspectives on barriers and facilitator in relation to 
implementing tobacco and alcohol behaviour change interventions in primary 
care were captured. The implementation barriers include lack of time and 
funding/remuneration for providing behavioural preventive interventions in 
primary care dental practice setting. The facilitators reported included: defining 
and specifying the content and approach of very brief / brief interventions, 
receiving training to deliver behavioural interventions, and having good 
supportive information resources. The dental team reported that patient 
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attitudes, the perception of causing offence, and awkwardness / 
embarrassment, and relevance to topic were more of an issue while discussing 
alcohol drinking behaviour rather than smoking. Although this qualitative study 
focused on Scotland, the arguments made, and principles described can be 
applied to other parts of the UK and beyond. 
In addition to these dental professional perspectives, the patient views are 
required to more fully understand the implementation and feasibility challenges. 
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Chapter 5 Patient views on implementation of 
best practice oral cancer prevention in primary 
care dental practices in Scotland 
 
5.1 Introduction 
A short qualitative survey, utilising both open and closed questions, was 
conducted with patients attending primary care dental practices in Scotland, 
with the aim of exploring patient’s views on the acceptability of receiving oral 
cancer preventive interventions (including risk factor assessment, advice, and/or 
referral) delivered by dental professionals, and comparing / contrasting views 
with the dental professionals’ responses. 
The burden of treatment costs means that preventive measures, including 
primary prevention, are likely to be of considerable global interest going 
forward (D’souza and Addepalli, 2018). Involving patient perspectives is vital; it 
is known for example that there are barriers in terms of the connections 
patients make between smoking, cancer and health, and up to a third of 
patients smoke even after a head and neck cancer diagnosis (Abdelrahim et al., 
2018). Prior studies have explored patient/public knowledge and awareness of 
oral cancer, including its causes, early signs, screening or examinations 
(Warnakulasuriya et al., 1999; Humphris and Field, 2004; West et al., 2006; 
Awojobi et al., 2012). These studies reported a general lack of awareness about 
oral cancer, associated risks and early signs of oral cancer. Awareness was found 
to be even lower in individuals who were at higher risk as a result of their 
behaviour (for example, smokers and those with excessive alcohol consumption) 
(Humphris and Field, 2004; West et al., 2006). However, none of the studies, to 
the best of the author's knowledge, have explored patient perceptions, 
attitudes, and experiences in relation to preventive interventions (including 
assessment, advice, and/or referral) in a primary care dental practice setting. 
Thus, this study aimed to address this issue by ensuring the patient perspective 
is considered in any future evidence-based preventive intervention. 
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5.2 Aims and research questions 
The main aims of this study were: 
a) to examine the views of patients attending primary care dental practices in 
Scotland on the acceptability of oral cancer risk factor assessment and 
subsequent behavioural preventive interventions delivered by dental 
professionals in practice;  
b) to compare and contrast the views of patients and dental professionals 
(Chapter 4) in relation to implementing oral cancer risk factor assessment and 
prevention in primary care dental practice in Scotland; and 
c) to make recommendations to inform the development of an evidence-based 
oral cancer prevention intervention delivered by dental professionals in primary 
care dental practice. 
As with the dental professional interview study (Chapter 4), a supplementary 
aim under the above was to explore the views of patients on the specific 
merits/demerits of oral cancer risk prediction tools. 
Specific objectives were to: 
§ Recruit patients attending primary care dental practices to participate in 
an interview 
§ Develop a theory-based, survey instrument (incorporating open-ended and 
closed-ended (scale) questions) 
§ Explore patients’ history, knowledge and awareness of oral cancer risk 
factor assessment and prevention 
§ Gather views on the feasibility (barriers and facilitators) of implementing 
the synthesised evidence-base, and on potential interventions to support 
patient care 
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§ Compare and contrast views reported by patients and dental professionals 
§ Gather views on risk prediction tools 
These objectives were developed in order to address the following broad 
research questions for this study: 
a) What are patients’ experiences of previous and current practices in relation 
to oral cancer risk factor assessment and behavioural prevention (advice and/or 
referrals) in primary care dental practices in Scotland? 
b) What are patients’ level of knowledge and understanding in relation to oral 
cancer risks and prevention? 
c) What are the patient-related barriers and facilitators (for example: views, 
attitudes, expectations, motivations, practical concerns) to implementing oral 
cancer risk factor assessment and prevention in primary care dental practices? 
d) What are the differences and similarities in barriers/ facilitators to 
implementing oral cancer risk factor assessment and prevention reported by 
patients and dental professionals? 
e) What are the suggestions/recommendations from patients to inform the 
development of prevention interventions for oral cancer to be delivered by 
dental professionals in primary care? 
f) What are patients’ preferences in regard to having an oral cancer risk 
prediction tool in primary care dental practices? 
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5.3 Methods 
5.3.1 Choice of method 
This study was a short qualitative survey of patients, undertaken to further 
explore the feasibility of translating the best practice evidence on oral cancer 
risk factor assessment to applied preventive interventions. The study design was 
exploratory and cross-sectional. 
A short mixed survey method, incorporating fixed response and open ended 
questions, was deemed appropriate for this study as it allows for a) collection of 
broad information to get an overview about people’s knowledge, attitudes, 
beliefs, and behaviour (Boynton and Greenhalgh, 2004) and b) exploration of 
views in a little more detail where necessary to further the aims and answer the 
research questions. Thus, a flexible, in-depth mode of interviewing (semi-
structured face-to-face individual interview) was adopted alongside collection of 
structured data as in a more traditional questionnaire (Johnson and Turner, 
2003; Kelley et al., 2003); the survey instrument contained both open-ended and 
closed-ended or scale questions (Appendix 12). Studies have shown that 
collecting quantitative data alongside qualitative responses is feasible and 
acceptable. Various studies have referred to this approach as “qualitative 
survey”, “mixed methods data collection” or “mixed methods interview study” 
(Johnson and Turner, 2003; Teddlie and Tashakkori, 2009; Frels and 
Onwuegbuzie, 2013)(Jansen 2010). A study by Brannen (2005) provided several 
examples of research found in the literature and demonstrated how researchers 
developed, utilized and enhanced the different aspects of the research process 
(e.g. research plan; data collection; and data interpretation and 
contextualization) by incorporating such a multiple or mixed-method strategy. 
This mixed-method interviewing design provides pragmatic benefits when 
exploring complex research questions. For example, the qualitative responses 
help to explain or justify any contradictions in the structured survey responses 
and provide a check on understanding of the topic, while the aggregated or 
quantified overview indicates the general pattern of responses (Brannen, 2005). 
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An important practical consideration in this study was the sampling strategy and 
setting (see Section 5.3.4). Patients were recruited at the time of attendance at 
primary care dental practice. This meant that the window of opportunity for 
eliciting views was relatively short. In-depth interviewing would have meant a 
(smaller) group of patients being recruited and separate interview dates / 
locations being drawn up. It was decided that a slightly bigger sample, giving 
brief information open to some exploration, was optimal given tight financial 
and time restraints. It has been argued that this mixed-method design is most 
appropriate for studies that do not require either comprehensive/extensive 
analysis of qualitative data or multivariate analysis of quantitative data 
(Brannen, 2005; Driscoll et al., 2007). 
5.3.2 Survey instrument 
A mixed-methods survey instrument or topic guide was developed for conducting 
interviews with patients attending primary care dental practices in Scotland. 
There were no existing validated instruments that could have been employed 
directly for this study, so the instrument was developed (Appendix 12), guided 
by the research questions, and incorporating open-ended and closed-ended 
(scale) response items pragmatically (Johnson and Turner, 2003; Boynton and 
Greenhalgh, 2004). Fixed response answers were collated, and free-range 
responses were transcribed and coded after the fact. Both sets were then 
described in a narrative (thematic) analysis. The survey instrument was 
developed in consultation with experts in the field of behavioural science, 
dental public health and oral medicine, and the instrument was pilot tested 
before starting fieldwork. Oral cancer was referred to as “mouth cancer” in all 
patient interviews to facilitate lay understanding. 
As established earlier in this thesis, tobacco and alcohol are the major risk 
factors for oral cancer (and also for other non-communicable diseases), and 
these two risk factors characterise the target population of the evidence-based 
interventions. Thus, patients were asked questions regarding preventive 
interventions under these two major headings (tobacco and alcohol). 
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5.3.3 Ethical approval 
5.3.3.1 NHS 
Full ethical approval was obtained from the National Health Service (NHS) 
Research Ethics Committee (REC) and the NHS Greater Glasgow & Clyde 
Research & Development (R&D) department for conducting patient interviews in 
Scotland. 
Research Ethics Committee (REC) approval 
The NHS REC application form, research protocol and supporting documentation 
were submitted for review through the Integrated Research Application System 
(IRAS). The Proportionate Review Sub-committee of the South Central - 
Berkshire B Research Ethics Committee reviewed the application and gave a 
favourable ethical opinion of the research on January 24th, 2017 (Appendix 13). 
Research & Development (R&D) approval 
NHS Research & Development (R&D) approval was also obtained from the 
Greater Glasgow & Clyde (GG&C) Health Board for conducting patient interviews 
in Scotland. It was decided that other health board approvals would be obtained 
if sufficient participants were not recruited from GG&C health board. R&D 
Management approval was obtained on January 26th, 2017, and the approval 
letter is appended in Appendix 14. 
Site Setup workshop/training was received by the principal researcher on 
November 14th, 2017. This was required by NHS GG&C for researchers to 
maintain a study file for the research study requiring ethical and board approval. 
All the study documents were organised in a Site Setup Folder: soft copies in a 
“e-Site Setup Folder” on the University of Glasgow J drive, while all hard copies 
were kept in a secure filing drawer in the university office. It was agreed that all 
data would be stored anonymously, any identifiable data would not be stored on 
a laptop and all data would be stored for 10 years and then destroyed. 
  
Chapter 5  
 
 
267 
Research Passport 
A site-specific form was also submitted to obtain “Letter of Access for 
Research”, this was required as patient interviews were taking place on NHS 
premises. This was obtained on January 26th, 2017 (Appendix 15). 
5.3.3.2 University of Glasgow 
In addition to NHS REC and R&D approval, approvals were obtained from: 
University of Glasgow College of Medicine, Veterinary and Life Sciences ethics 
committee on January 25th, 2017 (Appendix 16), and Glasgow Dental Hospital 
and School Research Management Committee on February 2nd, 2017. 
5.3.3.3 Ethical considerations 
No conflicts of interest were identified in relation to this study. Data access and 
storage processes were as previously outlined in Section 4.3.3. 
5.3.4 Sampling and participant recruitment 
Sampling 
This study was an exploratory study and involved a non-probabilistic, purposive 
sample with participants chosen based on their ability to inform the aims of the 
research, i.e. to allow barriers and facilitators to be explored to a 
comprehensive preventive approach in practice. The purposive sampling 
technique applied at the dental practice level was convenience sampling, while 
at the patient level opportunistic sampling was employed (Kemper et al., 2003; 
Palinkas et al., 2015). 
Purposive (non-probabilistic) stratified sampling, as is common when qualitative 
methods (e.g. interviews) are used for data collection, is a trade-off between 
efficiency (recruiting people who can provide great detail of interest) and 
thoroughness (obtaining representation from those with different experiences, 
cultural backgrounds etc.) (Kelley et al., 2003). The convenience sampling to 
recruit dental practices (from where patients were accessed) helped to collect 
information from a range of settings that were easily accessible by the principal 
researcher. Patients from these dental practices were then recruited 
Chapter 5  
 
 
268 
opportunistically, a formal approach which takes advantage of circumstances, 
events and opportunities for data collection as they arise (Kemper et al., 2003; 
Palinkas et al., 2015). 
Selection criteria (inclusion / exclusion) 
All dental practices were NHS dental practices (two from the Public Dental 
Service and two from the General Dental Service) within the NHS GG&C health 
board area in Scotland. Inclusion criteria were: adult patients (18 years and 
above) attending dental practice; ability to understand information relevant to 
making an informed, voluntary decision to participate in research (i.e. provide 
written informed consent to take part in the interview on the same day of their 
dental appointment). Patients who could not speak or understand English, and 
those with significant oral disease (i.e. dental emergency appointment for pain, 
trauma, bleeding, etc.) or incapacity issues were not included in this study. One 
single included patient could not speak and understand English but was 
accompanied by her son who agreed to translate the discussion and thus 
facilitate the interview. 
Patients were recruited opportunistically, but via a stratification frame to cover 
a range of participant characteristics (where possible) via screening of patient 
lists in the dental practices and/or asking screening questions (including asking if 
patients were happy to answer questions about tobacco and alcohol) to ascertain 
eligibility for the study: 
a) Age- 18-60 years, and 60 and above (60+ years) 
b) Gender- Male/Female 
c) Range of tobacco/alcohol users 
d) Range of area-based socioeconomic deprivation (SIMD) of the location of their 
dental practice 
e) Range of patients’ socioeconomic circumstances, i.e. SIMD of the location of 
their home residence. 
Recruitment 
Patients were approached through the practices of the dental professionals 
interviewed as part of the second study in this thesis (Chapter 4). Four dental 
practices were included in the NHS GG&C area in Scotland (which were located 
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across the range of SIMDs) and the aim was to interview 5-6 patients in each 
dental practice. Thus, in total 20-24 patient interviews were aimed for, to 
ensure a mix of participants in the final cohort, whilst being flexible in relation 
to the research questions under principles of data saturation. Here, a point is 
reached when no new themes emerge from analysis, and exhaustiveness in 
relation to the research questions can be assumed (Sandelowski, 2001; Guest et 
al., 2006). As the survey adopted a broadly qualitative mode of interviewing 
(i.e. using open-ended questions), the sample size needed was smaller than for a 
standard survey method with fixed responses. Sample size considerations did not 
apply as the aim was not to determine statistically significant differences, for 
example, between smokers and non-smokers; only descriptive statistics were 
collated to describe in narrative terms the participants pattern of scale 
responses (Section 5.3.7) (Kelley et al., 2003). 
The dental practices were recruited where there was a separate private room 
available to interview patients. Dental teams were provided with the patient 
selection criteria, and were asked to screen lists of patients who had 
appointments on a selected day. Once patients met the selection criteria and 
agreed to be approached, staff introduced patients to the principal researcher in 
the waiting area. 
All eligible patients were then approached and advised about the study and 
provided with the study information sheet outlining the aims and objectives of 
the study (Appendix 17). Patients were given 10 minutes to read the information 
sheet (this amount of time was decided in consultation with experts in the field 
and referring to previous approved projects with similar time to make a 
decision) and ask questions / discuss the project prior to taking part to ensure 
that they were fully informed about the study. Only the patient’s approval to 
participate in the study was discussed in the waiting area, no other sensitive 
information was discussed here. 
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5.3.5 Data collection 
The data were collected between February and March 2017. The study involved 
15-20 minute semi-structured face-to-face individual interviews, with a number 
of closed-ended (scale) questions for descriptive purposes. All interviews were 
carried out before or after each patient’s dental appointment time, in a 
separate private room at their dental practice. Participant’s permission (written 
consent; Appendix 18) was taken to audio record the interviews. Participants 
recorded their responses for the closed-ended (scale) questions on a paper copy 
of the survey instrument. 
Prior to beginning the interview, participants were assured by the principal 
researcher that their participation was entirely voluntary, and they were free to 
withdraw from the study at any time without giving any reason. Participants 
were informed that their responses would be confidential, and would not be 
shared with their dentist or any other health care professionals. The participants 
were also assured that the interview data would be anonymised and all the 
information which could identify the participants would be removed from the 
transcripts and survey instruments. Participants were assigned a unique code 
identifier at the onset of the interviews that was stored on a separate 
participant log. Participants were reassured that all personal information would 
be destroyed at the end of the study, and records would not be retained for 
longer than necessary. 
During the interview, a supportive environment was created, so that participants 
could express their views freely. Interviews followed the survey instrument to 
ensure all the topics of interest were covered. Further questioning and 
discussions of emerging topics raised by patients was also employed where 
applicable. Discussions were facilitated by following the schedule, prompting for 
clarity or to facilitate understanding, directing responses back on topic, and by 
managing the pace of the discussions to fit the timescale. All patients had the 
opportunity at the end of the interview to add or discuss any additional points or 
issues not covered and participants were also asked to offer feedback about the 
interview. The principal researcher made written field notes immediately after 
each interview covering the main points that emerged during interviews, e.g. 
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general impression or personal reflections on the interview process; any 
inferences for future interviews or analysis; and what it added to the body of 
the data. 
5.3.6 Pilot interviews 
Practice interviews (and training) were conducted with two supervisors (AJR and 
DIC) in order to get feedback on the interview process, and to further 
develop/fine-tune the topic guide in response to any difficulties or omissions. 
Two pilot interviews were conducted prior to commencement of the fieldwork 
with: a) an experienced staff member working at the University of Glasgow 
Dental School; and with b) a dental student at the University of Glasgow Dental 
School (both of whom were registered as patients with a NHS General Dental 
Practitioner in Scotland). One of the participants was a ‘smoker and regular 
alcohol drinker’, while the other was a ‘non-smoker and occasional alcohol 
drinker’; one of the participants was 50-60 years old, and the second between 
20-30 years. The aim was to get feedback on the questions asked and to test the 
survey instrument. Subsequent reflections and feedback from the pilot 
participants and supervisor further guided some valuable changes to the survey 
instrument for succeeding interviews. For example, the sequence or order of 
questions asked was changed based on suggestions from the participants, who 
generally felt that the questions were acceptable, and were relevant to patients 
attending dental practices in Scotland. 
5.3.7 Data analysis 
The semi-structured interviews were audio-recorded, transcribed verbatim and 
transferred to computer files (as Microsoft Word 2016 documents) where they 
were dis-identified. The anonymized transcripts of the responses to the open-
ended questions were then coded and organised into broad themes using 
thematic analysis techniques (Braun and Clarke, 2006) and facilitated by 
Qualitative Analysis Software NVivo version 11.0 (QSR, 2017). The responses to 
closed-ended (scale) questions were coded and added onto a Microsoft Excel 
2016 workbook. Descriptive statistics (frequencies of responses), along with the 
simple graphics (bar charts/graphs) were used to present and describe the basic 
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features of the data. This included describing the sample, their knowledge, and 
their views and experiences of current/previous dental visits. 
The transcripts were imported into the NVivo 11 software and were read over 
repetitively and at the same time the interview recordings were listened to 
again, in order to ensure accuracy and consistency of all transcripts. This also 
helped in becoming acquainted with the depth of the entire content in the data.  
Tabulated responses to scale items are appended (Appendix 19). These are 
useful for illustration of patterned responses but due to small numbers should 
not be interpreted as conventional survey data. Results below are in thematic 
narrative form, drawing for illustration from either description of scale 
responses and/or quotations from the coded text data. 
These themes were developed from the research questions and following 
analysis of the dental professional interviews, as well as allowing for emergent, 
data-driven themes which appeared inductively through the data (Braun and 
Clarke, 2006). As with the dental professional interviews, verbatim quotations 
were extracted and are included in the results as instances from the data, in 
order to: 
a) illustrate key points; 
b) provide evidence of identified themes within the data; 
c) express the essence of the point being discussed. 
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5.4 Results 
24 individual patient interviews were conducted across GG&C health board in 
Scotland between February and March 2017. The duration of the interviews 
ranged from 8 minutes to 22 minutes, with a mean duration of 14 minutes 
(which is slightly less than the 15-20-minute time that was proposed in the study 
protocol – Section 5.3.5). 
5.4.1 Participant characteristics 
Table 5.1 provides general information about the participants: age, gender, 
Scottish Index of Multiple Deprivation (SIMD) quintile of the location of their 
dental practice and of their home residence, occupation, ethnicity, 
tobacco/alcohol use and ID assigned to them for this study.
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Table 5.1: Characteristics of study participants and coding used (n=24) 
 
ID Gender Age (years) 
SIMD16 
Quintile 
(dental 
practice) 
SIMD16 
Quintile 
(patient 
residence) 
Occupation 
(manual/  
non-manual) 
Ethnicity Tobacco use Alcohol use 
P1 Male 27 1 1 manual White Scottish current smoker drinker 
P2 Female 36 1 2 not working Asian Other (Arab) non-smoker non-drinker 
P3 Male 41 1 2 not working Asian Other (Arab) non-smoker non-drinker 
P4 Male 37 1 5 non-manual Asian Indian ex-smoker non-drinker 
P5 Male 57 1 1 manual White Scottish ex-smoker drinker 
P6 Female 56 1 1 manual White Other (Czech) current smoker non-drinker 
P7 Female 72 1 1 not working White Scottish ex-smoker non-drinker 
P8 Female 27 1 1 manual White Scottish non-smoker drinker 
P9 Male 46 1 4 manual White Scottish ex-smoker drinker 
P10 Female 40 1 1 not working Black Other (Italian) ex-smoker drinker 
P11 Female 28 1 1 not working White Scottish current smoker drinker 
P12 Male 54 1 4 manual White Scottish ex-smoker drinker 
P13 Female 67 1 2 not working White Scottish current smoker non-drinker 
P14 Male 67 1 2 not working White Scottish ex-smoker drinker 
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P15 Female 65 1 1 not working White Irish non-smoker drinker 
P16 Male 69 1 3 not working White Scottish non-smoker non-drinker 
P17 Female 44 5 3 not working White Scottish non-smoker drinker 
P18 Female 44 5 5 non-manual White Other (Dutch) non-smoker drinker 
P19 Male 34 5 5 non-manual White Scottish non-smoker drinker 
P20 Female 32 5 1 non-manual African British non-smoker non-drinker 
P21 Female 72 5 1 not working White Scottish non-smoker non-drinker 
P22 Female 32 5 2 non-manual White Scottish non-smoker non-drinker 
P23 Female 49 5 1 non-manual White British ex-smoker drinker 
P24 Female 65 5 4 not working White Scottish current smoker drinker 
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It can be seen from the Table 5.1 that there was a mix of participants in this 
study, with a range of socio-demographic and behavioural characteristics. The 
male: female ratio of participants in this study was 3:5, while the ratio of 
participants based on age groups (18-60 years and 60+ years) was 17:7. 
Number of visits to dental practices in the last five years 
Most patients were regular attenders, reporting visiting dental practices at least 
twice a year in the last five years (specific responses are appended in Appendix 
19). 
Females reported visiting dental practices more often compared to male 
patients. All patients aged 60+ years reported visiting dental practices twice a 
year or more, while the number of visits for patients aged 18-60 years was more 
variable. The main reasons reported for visiting dental practice were: receiving 
basic dental services such as check-up; pain or emergency; scaling/polishing; 
cavity fillings; tooth extractions; and follow-up appointments. Some patients 
also reported visiting dental practice for major dental services such as root canal 
treatment and dental implants. 
5.4.2 Patient awareness and knowledge of oral cancer and its 
causes 
The main theme that emerged with regards to the background knowledge and 
awareness of the sample is that patients are aware of oral cancer, but do not 
generally consider themselves knowledgeable on the topic. 
Almost all patients (22/24; 92%) said that they had heard (or were aware) of oral 
cancer, while only two patients (2/24; 8%) stated that they had not heard of it 
at all (Appendix 19). When asked how much knowledge they had about oral 
cancer and its causes, the majority of the patients (20/24; 83%) reported having 
a “slight/little” or “some knowledge”. Only two patients (2/24; 8%) reported 
having a “good knowledge” of the causes for oral cancer (one male and one 
female; both aged 18-60 years), while, on the other hand, two patients (2/24; 
8%) reported having “no knowledge” at all (both female; 18-60 years; see 
Appendix 19). There was little difference in the knowledge levels reported 
across gender and age groups. 
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With respect to causes, coded responses showed smoking had a much higher 
profile than other risk factors:  
“Would it be smoking that would be something to do with it? But, that’s all, 
that’s all I would know” (P15) 
“Smoking, maybe” (P16) 
“Well I thought a risk, you know, was smoking.” (P18) 
Beyond smoking, there was a tendency to be uncertain: 
“Is it basically just your oral hygiene, I'm guessing maybe, or part of that?  
I'm not too sure, to be honest” (P8)  
Importantly, none of the patients reported that their dental team had ever 
spoken to them about oral cancer or mentioned it in any of their conversations: 
“No I've never, I don’t think so not that I can recall.” (P1) 
The general awareness seems to stem from exposure to media sources (for 
example: newspapers, television, magazines) and friends/family members 
having the disease: 
“Two people I know have, somebody had it on their tongue and somebody 
had it at the back of their throat” (P15) 
“Just probably social media, I suppose; the newspapers” (P16) 
“Media… well usually famous actors who died from it […] And a neighbour a 
few doors down recently died of throat cancer.” (P18) 
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5.4.3 Patient views and experiences of oral cancer risk factor 
assessment and preventive interventions 
The main aim of this study was to gather information from patients on primary 
prevention in practice, with research questions targeting their previous 
experiences, barriers and enablers to engagement with prevention, concordance 
with dental professional views, and suggestions for implementation of the 
evidence-base.  
Four major thematic narratives emerged from this patient survey after analysis: 
1) Patients are open to being asked questions, and to exploring ways to give 
information to dental professionals using various assessment tools, times and 
locations, which may potentially overcome some resource barriers to the 
preventive consultation in practice   
2) Patients are generally happier to receive advice on risk factors than 
professionals may assume; this applies in particular to alcohol assessment and 
advice where professionals felt a strong socially normative barrier  
3) Advice must be tailored to patient need and motivational stage, as is 
recognised in evidence; professionals are not necessarily trained and confident 
in this regard  
4) Patients on the whole are happy to discuss risk specifically in relation to oral 
cancer; again this offers a perspective on professional interviews, where using 
direct cancer terminology was deemed more problematic 
5) Patients reported very little experience of referral or signposting to other 
services. 
5.4.3.1 Asking and assessing risk  
Dental professionals (Chapter 4) saw smoking and alcohol questions as equally 
embedded in the medical/social history forms that patients self-complete at the 
time of their first visit to the dental practice. Some patients outlined this: 
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“Just from the medical history, so that mentions about it” (P4) 
“Yeah, again, it was more when I first registered… they just asked me, how 
often and how many units would you drink each time” (P8) 
Most patients (19/24; 79%) recalled being asked about their smoking status by 
the dental team. Patients said they were asked questions about their smoking in 
the medical/social history form they filled in at the time of their first visit to 
the dental practice (which is best practice - Chapter 3; and also reported by 
dental professionals to be done routinely - Chapter 4). However, on being asked 
if the dental team ever asked patients about their alcohol drinking, only half of 
the patients (12/24; 50%) reported being asked questions about their drinking 
habit in the medical/social history form they filled in at the time of their first 
visit to the dental practice.  
As previously outlined, one aim of this study was to explore patients’ views on 
having a dedicated oral cancer risk prediction tool in primary care that would 
make the combined risk of smoking and alcohol explicit (the details of such 
scoring have been presented in Chapter 4 together with views of dental 
professionals; Section 4.4.3). 
On being asked for their views on having a risk score / categorisation for 
predicting oral cancer risk, based on their personal information (for example: 
smoking, alcohol, age, years of education, family history) - most patients 
thought this might be helpful in increasing awareness among people and helping 
people at high-risk to take early steps to prevent the condition. On a happiness 
scale (Appendix 19), the majority of patients (20/24; 83%) were happy (or very 
happy) to receive such a score. The remainder said: 
“I wouldn’t say that I would be happy, but I wouldn’t be like not happy. I 
wouldn’t be over sure either because it is a good thing. I would say in 
between not sure and happy.” (P1) 
“I don’t want to know so I am not happy about it.” (P6) 
Some of the barriers reported to receiving an oral cancer risk score (as high, 
medium or low) were: they did not want to receive any “bad news”; did not 
Chapter 5  
 
 
280 
want their insurance companies to know about their risk scores; or uncertainty 
as to what would be done with that risk score. 
“Oh no… if they say I may (high risk), then I don't want any bad news.” (P10) 
“Well, yeah, risk scores, I would want to know if it’s just for your 
awareness, but I wouldn’t want the insurance companies to know. What gets 
done with this information if you get the risk score and it gets written down 
in your…does that mean that…?” (P18) 
Similar ambiguity had been raised by some dental professionals, where they 
suggested that they would require formal training to answer questions like: how 
this risk score is going to affect their patient?; where patients go from there?; 
what they do with that written score? Dental professionals also cited that they 
need to be prepared (or trained) to advise those patients who got a high-risk 
score “without frightening them” (Section 4.4.3). 
Patients were asked for their preferences for how they might provide the 
personal information to calculate the oral cancer risk score. Examples included: 
self-completion in waiting room, dental professionals going over with patients 
during their oral health assessment, an online tool or as a mobile application 
(app.), or as a paper questionnaire. Mixed responses were received. Some 
patients were happy for their dental professionals to ask these details, as they 
were “fed up” with filling out forms or questionnaires: 
“Yeah, just the dental team to ask it, yeah… Well, you fill forms out for 
everything. People get fed up with it.” (P24) 
“It’s probably dentist. It would be easier and quicker for me than…’cause 
I’ve got little time as it is.” (P12) 
But most patients were happy to self-complete on computer or a paper form in 
the waiting room, or were happy both ways: 
“I think I'd be alright doing it myself […] you can be more honest when you're 
sitting writing yourself. You’ve not got anyone watching you.” (P1) 
“Yes, that’s better (self-completion), because I can read it two times or 
three times and understand everything” (P3) 
“I'm open to both of them, no preference.” (P4) 
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Self-completing information was desirable for some because they would feel 
under pressure if the dental team was watching them; having a personal space 
to provide information would help them to understand questions properly and 
provide “honest” answers. This finding coincides with dental professional 
interviews (Section 4.4.3), where self-completion of information by patients was 
considered the best option by most professionals, and perhaps surprisingly 
almost identical reasons were reported by dental professionals as well, i.e. 
patients feeling under pressure with the dentist looking at what they were 
answering or more comfortable providing such information confidentially. 
When patients were further asked about their preference on the mode of 
presentation of a risk score, for example: traffic light (red/amber/green) or 
high/medium/low or as a number or percentage score - again mixed responses 
were received. There was a slight preference (10/24; 42%) towards receiving a 
risk score as “high, medium and low”; the reason reported was that it was much 
easier to understand compared to a number or percentage or traffic light 
system: 
“I think high, medium low is better, I think that’s (number/percentage) 
more difficult to calculate.” (P4) 
“I would think high, medium or low would be better. I think it’s simplified.  
You’re either high, medium or you’re low based on this… as well but that’s 
the way I’d prefer it I think.” (P12) 
“if they give you a red card…I don’t know if I’m getting the traffic light, but 
I understand high, medium and low.” (P18) 
Some patients (8/24; 33%) preferred to receive the score as a number or 
percentage, as it would provide an “accurate view” of how close people are to 
developing a condition or how serious their present situation is: 
“I'd say the number… Aye because high, medium and low that’s just three 
options it's not giving you an accurate view of how close you are but if they 
give you a number say you have sixteen percent chance or something.” (P1) 
“It is better giving me percentage... Because sometimes maybe by using red, 
yellow, you will not understand exactly what is really there.” (P10) 
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While the remaining patients (6/24; 25%) preferred to receive risk score as a 
traffic light (red/amber/green): 
“Traffic lights, aye. I don’t know, just it's easier.” (P11) 
“The traffic light is better probably. It just, it’s in your face, you can see 
it.” (P15)  
Overall, as with dental professional responses (Section 4.4.3), there was 
agreement that the way in which any such risk score is provided should be easy 
to understand by the patients and quick to calculate in order to save patients 
time. Finally, both professionals and patients mentioned accuracy/ reliability of 
behavioural risk factor reporting or assessment. Research would be needed as to 
whether a more formal scoring type tool might help in this regard.  
5.4.3.2 Advising and referring 
Smoking 
In terms of smoking advice, current and ex-smokers (n=13) were prompted as to 
whether their dental team ever offered advice/counselling on quitting smoking 
(including context, for example, mouth cancer, gum disease, staining, or other). 
In a perhaps surprisingly low level, about a third (4/13; 31%) of patients said 
that their dental team had encouraged quitting and/or talked about the harmful 
effects of smoking on their oral health. Advice was said to be brief (lasted a 
couple of minutes): 
“Aye we spoke about it while they were doing the work. They told me that 
my gums were due to the smoking as well as the Irn Bru.” (P1) 
“It was just basically to stop smoking, that it’s not good for you, type thing… 
just general advice […] it was only a couple of minutes. When he was doing 
the check-up he basically said, you know, I need to stop smoking.” (P12) 
“because I smoke, and they’re (dentists) always on your back…to stop 
smoking.” (P24) 
This finding that most current smokers did not report receiving brief advice, 
contrasts with the dental professional interviews (Section 4.4.1) where most 
dental professionals reported asking smokers about their willingness to stop 
smoking and undertook “signposting”, such as providing them with quit-line 
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numbers. The very fact that this picture is inconsistent (patient did not recall 
advice and signposting), might be indicative of the somewhat variable approach 
to oral cancer prevention in practice.  
Patients were further asked for their views in terms of how happy they would be 
receiving brief advice (up to 5 minutes duration) from their dental team about 
quitting smoking (Appendix 19). Mixed responses were received from the small 
number of current smokers, making it difficult to come to any firm conclusion. 
Three out of five were happy to receive advice from their dental team, and 
reported no barrier to this advice: 
“I would say as part of the consultation and it saves you going somewhere 
else… Well they're (dental team) doing everything else to your teeth why not 
that as well.” (P1) 
“I would be happy with that… I just think anything…like, a professional 
person giving you advice, you should listen to it, no matter if it’s a dentist or 
a doctor or whatever. If they’re going to give you the advice, you should 
listen.” (P12) 
“’cause obviously if it’s affecting your mouth they (dentist) should be telling 
you” (P13). 
The other two current smokers were either not sure or not happy to receive such 
advice from their dental team: 
“Not happy at all, no… And I would consider it disturbing because I know the 
risks of smoking, but I am not going to give up.” (P6) 
“Not sure… Well, I prefer my GP, to talk to my GP about it.” (P24) 
Patients in general showed slightly more inclination towards receiving smoking 
advice from their general medical practitioner or pharmacist compared to from 
the dental team (Appendix 19). Trust emerged as an issue - one patient said that 
as they had known their general medical practitioner or pharmacist for a long 
time, they would be more comfortable sharing personal information with them:  
“My GP or pharmacist… Well, I prefer my GP […] I’ve known him for years, 
and I trust him” (P24) 
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These patients reported more regular visits to medical practices and pharmacies 
compared to dental check-up frequencies: 
“Chemist… I don’t know, because I'm usually at the chemist back and 
forward for my gran, medication and that, aye, health […] and I just feel as 
if, I don’t know, I don’t wait as long” (P11) 
A related finding was reported in some dental professional interviews (Section 
4.4.1), where it was presumed that patients will consider discussing smoking (to 
some extent) irrelevant to dentistry or their oral health, and thus prefer 
discussing it with their general medical practitioner or pharmacists. However, 
patients were happy to receive advice from their dental team as well; they 
acknowledged that if smoking is affecting their oral health then the dental team 
should be advising about it. 
Patients were generally sceptical about the effect brief intervention could have. 
The evidence-base is that they do work, but patients took an individualistic, 
self-motivational view:  
“It's up to yourself if you're going to stop or not and nobody else can make 
you, it's all to do with you.” (P1) 
“It's up to the person themselves, do you know what I mean?  It's a lot of 
willpower, you know, it's your own willpower […] So you’ve got to be 
determined, you’ve got to want to do it.” (P7) 
“I decided it's because my first daughter was born 2005, so before she was 
born I decided to stop and I stopped myself, nobody advised.” (P10) 
“No, when I stopped smoking I did it myself.” (P14) 
This probably reflects a societal discourse that views smoking in particular as an 
addiction and persistent relapse as inevitable:  
“I have quit quite a few times. I stopped for six months once and then I just 
walked by somebody smoking and the smell got to me and that was it, I was 
smoking again.” (P1) 
Again, discussing patients’ smoking was considered quite a “sensitive” topic by 
most dental professionals, but this was not echoed by patients. The thematic 
narrative in this study was more that patients already had knowledge of smoking 
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being undesirable (risk of continuing, benefit of stopping) and that dental 
professionals couldn’t add much to this: 
“Well I already know the benefits and all that and you see it everywhere.” 
(P1) 
“I probably know it all anyway, ‘cause you see it on the TV all the time.” 
(P5) 
“I know the risks of smoking…” (P6) 
In terms of adjunct materials and referrals, patients as might be expected, were 
favourably disposed to receiving informational or educational materials such as 
posters or leaflets. These are evidenced weak (no effect sizes reported) as 
adjunctive to brief tailored advice/ counselling. There does not appear to be 
any downside to this, however, one smoker mentioned not fully engaging with 
the material: 
“Oh aye, not last week but the week before I ended up walking out with a 
book full of stuff on stopping smoking, the effects of pH that stuff through 
water and all that. There was quite a few things, I didn't actually read 
through it all to be honest.” (P1) 
None of this small group of patients had any experience of being referred to 
specialist services via their dental team regarding smoking cessation. Dental 
teams, on the other hand, did mention “signposting” via quit-line numbers - it 
may simply be that the small number of patients in this study with smoking 
experience do not see this as “being referred”. 
Alcohol 
Current alcohol drinkers were further probed by being asked if their dental team 
ever offered advice/counselling on reducing alcohol consumption (including 
context, for example, mouth cancer, gum disease, trauma, or other). This 
finding was clearer - no patients (one patient was ‘not sure’) reported that they 
were ever offered any advice (or referral) on alcohol by their dental team.  
“No, they just asked, do you drink?” (P1)  
“No… they didn’t ask anything” (P3) 
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“No, not really.” (P12) 
These findings synchronize with the dental professional interviews where 
providing preventive interventions (advice and referral) for reducing alcohol 
consumption was seen as a problematic issue by most dental professionals 
(Section 4.4.2). 
Most patients said they were happy to receive brief advice of up to 5 minutes 
from their dental team about reducing alcohol consumption. In fact, the overall 
impression from most patients was that they were happy to receive advice from 
any healthcare professional, and especially if drinking more than recommended 
levels and advice helps to improve their health. Patients were further probed on 
a happiness scale to assess their acceptance for receiving brief alcohol advice 
(up to 5 minutes duration) from the dental team (Appendix 19). Most current 
drinkers (11/14; 79%) were happy (or very happy) to receive brief advice up to 5 
minutes from their dental team about reducing alcohol consumption: 
“I would say as part of the consultation (dental) and it saves you going 
somewhere else… Well they're doing everything else to your teeth why not 
that as well.” (P1) 
“Aye, I wouldn’t have a problem with that… I’d be happy” (P5) 
“I've not got a problem with the dental team.” (P9) 
“I prefer anyone that can give me good advice for my health is okay by me.” 
(P10) 
This contrasts with the dental professional view that patients are less happy or 
comfortable overall in discussing their drinking behaviour with the dental team 
(Section 4.4.2). This acceptance of the norm by patients seems, in part, to be 
due to exposure to safe drinking messages: 
“Well I already know the benefits and all that and you see it everywhere.” 
(P1) 
“I probably know it all anyway, ‘cause you see it on the TV all the time.  So 
many units you’re allowed each day…sorry, each week, a man or a woman or 
whatever.” (P5) 
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However, the barriers that dentists alluded to were certainly present. Dental 
professionals felt that patients would consider discussing alcohol to be irrelevant 
in the context of oral health, and thus might prefer discussing it with their 
general medical practitioner or pharmacists. Some patients seemed to echo the 
dentists’ concern about whether this was part of their professional role:  
 “I don’t know if that sounds silly but with your dentist you just think your 
teeth, you don’t think alcohol and things like that.” (P8) 
“I wouldn’t personally go and speak to a dentist about any problems I had, 
kind of, thing.” (P5) 
Again, as with smoking, there was slightly more patient inclination (8/14; 57%) 
towards receiving alcohol advice from their general medical practitioner or 
pharmacists compared to the dental team. When asked the reason for their 
preference for receiving advice from a medical practitioner, as with smoking, 
patients said that they were more comfortable talking about such personal 
topics with their general medical practitioner. Some patients also mentioned 
that they don’t relate discussing alcohol with their dental or oral health. 
“Probably your GP would probably…the best person to tell you more or less, 
not the dentist I think… it’s more a personal thing. Not your dentist, kind of 
thing. ‘Cause you can go to your GP and tell them things.” (P5) 
“I don’t know if that sounds silly but with your dentist you just think your 
teeth, you don’t think alcohol and things like that.” (P8) 
Dental professionals were also aware of the sensitivity of discussing patients’ 
behaviours on common risk factors and the effect it may have on the dentist-
patient relationship. Patients independently talked about this rapport, and how 
it could be damaged, especially with generally “responsible” patients: 
“You know, because certain sections of society, they need to be told over 
and over and over again. But… within people who are more responsible, if 
it’s at a manageable level, there’s…I don’t think there’s any point. I think 
they would lose the rapport with the patient. They could damage that even 
if they were to impress it too much […] it doesn’t sound like the dentist 
cares. It would more sound like they’re just having to read it because it’s 
part of their job.” (P19) 
Chapter 5  
 
 
288 
Cultural barriers were reported to a lesser extent. One patient (self-reported 
Arab ethnicity) reported not being asked questions about alcohol, because the 
dental team understands that alcohol is “forbidden” in their country.  
“No, they don’t ask this (alcohol) question, because it is forbidden… in our 
country.” (P2) 
This cultural sensitivity needs to be incorporated in any generic guidance 
(Chapter 6). 
In general, patient views endorse the evidence-based principle that advice 
should be ‘tailored’ to individuals and their needs and/or motivational stages. 
Patients are unlikely to accept advice, for example, until their self-perception is 
that they are at risk (a more formal assessment tool may help in this regard): 
 “I don’t really drink that much to tell you the truth” (P12) 
5.4.3.3 Making oral cancer the focus   
Importantly, patients were happy for their dental professionals to discuss oral 
cancer risks with them, in particular, verbalising or using the term “oral cancer” 
in discussions. There was a motivation to learn about oral cancer risks and 
signs/symptoms (see above section on risk prediction); this can be contrasted 
with how most dental professionals reported avoiding the term “cancer” due to 
the view that this ‘scares’ patients: 
“No it wouldn’t scare me I would just think that at least they are double 
checking for you and making sure that you're alright. It wouldn’t scare me, 
no.” (P1) 
“I’d be happy with it […] I’m open to, I’d rather know as not know what’s 
going on in my body.” (P15) 
“It wouldn’t terrify me […] I am happy… If there were any signs that they 
would…of it, they would make me aware of it.” (P18) 
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5.4.4 Summary of the thematic comparison between patient and 
dental professional views 
The main findings from the patient interviews regarding receiving preventive 
interventions (including risk factor assessment, advice, and/or referral) in 
primary care dental practice setting and comparison with the dental professional 
interviews (i.e. where their views matched or were different) are summarised in 
Table 5.2. 
Table 5.2: Comparison of views of patients attending primary care dental practice with 
dental professional views (from Chapter 4) 
 
Thematic 
narrative Sub-theme 
Dental 
professional view 
Patient view 
(concurring with 
professionals; 
contrasting; mixed) 
Implication 
Patient 
openness to 
assessment 
 
Alcohol 
assessment 
Alcohol (as well as 
smoking) routinely 
asked about/ 
assessed as part of 
medical/social 
history forms or 
questionnaires 
 
Contrasting: only 
50% reported being 
asked about their 
drinking by the 
dental team in the 
medical/social 
history form. 
 
Alcohol risk/ 
history taking 
visibility to be 
increased 
Formal risk 
tool 
Open to exploring 
a formal risk 
assessment tool for 
oral cancer 
 
Concurring: also 
open to exploring if 
no extra time/ cost 
Best tool to be 
feasibility 
tested 
Self-
completion 
of 
assessment 
tool 
Desirable to give 
patients privacy 
and save time in 
consultation 
 
Concurring: also felt 
less pressure if 
completing score 
alone 
Form of tool 
administration 
to be tested 
Patient 
reception of 
advice 
 
Smoking 
advice 
Structurally 
inhibited to very 
brief plus referral 
leaflets 
Mixed:  did not all 
recall such advice; 
were happy to 
receive brief advice; 
sceptical of effect 
 
Explore 
optimal level 
of brief/very 
brief advice re 
evidence base 
Alcohol 
advice 
Socially inhibited 
regarding 
sensitivity, cultural 
norms, professional 
role etc. 
Mixed: most less 
inhibited than 
expected; some 
cultural sensitivity 
Explore 
optimal level 
of brief/very 
brief advice re 
evidence base; 
incorporate 
cultural 
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diversity 
 
Provider of 
advice 
Feeling not 
professional role; 
some risk to 
relationship 
 
Mixed: some felt 
general medical 
practitioner or 
pharmacist more 
suited 
 
Explore multi-
disciplinary 
cohesion 
Tailoring Generally, a 
universal advice 
model 
Contrasting: highly 
sensitive to 
individual 
motivation 
Explore best 
way of 
tailored, 
motivationally 
nuanced 
advice 
 
Adjuncts Barrier was lack of 
good supporting 
materials 
 
Concurring: 
materials seen as 
welcome 
Design best 
supporting 
materials 
Focus on 
oral cancer 
Using the 
term 
Barrier was 
avoidance of the 
term due to 
perceived effect on 
patients. 
Contrasting: most 
patients happy for 
dental team 
specifically 
verbalising the term 
“oral cancer” while 
discussing oral 
cancer risks. 
 
Ask, advise, 
refer re major 
risk factors 
specifically in 
relation to 
cancer risk 
(see formal 
risk tool 
above) 
 
 
5.4.5 Summary of findings 
In summary, patients were successfully and ethically recruited to ascertain their 
views, in line with the study aims to produce recommendations for 
implementation of best practice and future interventions supporting preventive 
care. It could be seen from patient interviews that awareness of oral cancer in 
patients was high, but knowledge was reportedly low. Overall, patients were 
happy to talk specifically about oral cancer, and to be asked about the risk 
factors prior to receiving support and/or referral from their dental team (and/or 
general medical practitioner/pharmacists). Formal risk assessment was generally 
supported. However, they were still sceptical about the effect on some patients 
due to individual factors, perhaps because an evidence-based preventive 
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consultation, involving targeted assessment, tailored brief advice, adjunct 
materials, and referral, has not been their experience. 
5.5 Discussion and conclusions 
There now follows a short discussion of the main findings from the patient 
interviews, in the context of existing literature. The strengths and limitations of 
this study will also be discussed, and brief suggestions for implementing these 
findings in practice (see also Chapter 6). 
5.5.1 Comparison with literature 
This exploration of themes from 24 interviews with patients attending primary 
care dental practices in Scotland, examining their views and experiences on the 
acceptability of oral cancer preventive interventions (risk factor assessment, 
behavioural advice, and referral) delivered by dental professionals in primary 
care dental practices, would appear to be the most in-depth study to take this 
approach, specifically in relation to oral cancer prevention for both tobacco and 
alcohol. There is a plethora of evidence exploring patient awareness and 
knowledge levels in relation to oral cancer, early signs/symptoms and associated 
risk factors. However, only a few studies have reported the patient perspective 
towards receiving tobacco cessation or alcohol moderation advice in a primary 
care dental practice setting. 
5.5.1.1 Knowledge and awareness of oral cancer 
The findings from this study highlighted that, overall, patients were aware of 
oral cancer; however, knowledge of its risk factors was reportedly low. The level 
of awareness of oral cancer in this study is in agreement with the existing 
literature in the UK (and other countries) over the past two decades (Tomar and 
Logan, 2005; West et al., 2006; Choi et al., 2008; Amarasinghe et al., 2010; 
Awojobi et al., 2012). This increased awareness had been mainly linked to the 
mass media promotions or campaigns, for example, oral cancer awareness week. 
Prior studies have shown the importance of media campaigns along with 
messages from healthcare professionals (dentists or general medical 
practitioner) to be an important source to inform public about oral cancer and 
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its risks (Warnakulasuriya et al., 1999; West et al., 2006). Here, media (for 
example, newspapers, television, radio, magazines) was reported to be a major 
source for knowing about oral cancer and its causes. However, only one patient 
recalled their dentist or medical practitioner having mentioned oral cancer. This 
matches evidence from other studies in the UK and other countries (for 
example: United States, India) where mass media was cited as the most common 
source of information about oral cancer, and the contribution of dentists and 
other healthcare professionals to awareness levels was considered to be very low 
(West et al., 2006; Srikanth Reddy et al., 2012; Babiker et al., 2017). 
Moreover, findings had been comparable in all prior studies (older and more 
recent) with respect to lower level of knowledge of risk factors associated with 
oral cancer. While smoking was recognized as a major risk by some patients in 
this study, the association between alcohol (and other factors) and oral cancer 
was known to only a few. Remarkably similar results have been reported in other 
studies in the UK (Bhatti et al., 1995; Warnakulasuriya et al., 1999; West et al., 
2006; Awojobi et al., 2012), as well as studies conducted in other countries (for 
example: United States, India, Germany, Poland) where smoking was recognised 
by most patients as a risk factor for oral cancer (Horowitz et al., 1995; 
Raczkowska et al., 1997; Patton et al., 2004; Choi et al., 2008; Hertrampf et al., 
2012; Srikanth Reddy et al., 2012; Formosa et al., 2015; Hassona et al., 2015; 
Shimpi et al., 2018). For example, West et al. (2006) reported that 84.7% of 
participants identified smoking as a risk factor, with the corresponding value for 
alcohol being 19.4%. Additionally the values reported by Hertrampf et al. (2012) 
were 75% for smoking and 40% for alcohol. This general lack of knowledge of 
alcohol as a risk factor in this thesis study and most other studies shows a clear 
need to engage directly with patients in: a) assessing risk; b) tying advice 
specifically to oral cancer; and c) providing good adjunctive materials (in 
particular for alcohol which was less associated with cancer than smoking). 
5.5.1.2 Acceptability of oral cancer risk factor assessment and preventive 
interventions 
The findings from this study showed that, patients were acceptable to learning 
about the role of smoking and alcohol as risk factors for oral cancer and were 
open to support from their dental team to reduce their risk of developing oral 
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cancer. However, patients were sceptical regarding the effectiveness of brief 
interventions due to individual differences, i.e. they did not expect intervention 
to be equally successful for all patients. This is not surprising, and may part 
explain why reported effect sizes (Chapter 3) are variable even when more 
intensive interventions are used, i.e. interventions only work for some patients. 
Moreover, the view from patients can be explained by the Stages-of-Change 
model (Chapter 1; Section 1.4.1.1), which recognises patients’ individual factors 
and their readiness to make changes in lifestyle as important mediators 
(Prochaska and DiClemente, 1983; Walsh and Sanson-Fisher, 2001). This 
approach encourages dental professionals to provide targeted and tailored 
advice to meet individual needs and/or motivational stages, which is evidence-
based and also endorsed by patients. Therefore, the views from patients in this 
study, drawing from a small sample, fit with literature and are considered 
broadly in line with the population perspective. 
In this study, patients did not recall use of the phrase “oral cancer” by dentists 
or other members of the dental team in any of their conversations during dental 
visits. However, they were generally amenable to this. Similar findings have 
been reported in a study by West et al. (2006), where only 7.1% reported that 
their dentist or general practitioner had spoken to them about oral cancer. 
Comparable findings were reported in other studies where less than 15% of 
patients reported having received oral cancer advice/counselling by a dentist or 
a general medical practitioner (Villa et al., 2011; Srikanth Reddy et al., 2012). 
Although such activity is perceived to be infrequent, patients in principle appear 
to be in favour of discussing oral cancer with their dental team (West et al., 
2006; Awojobi et al., 2012; Srikanth Reddy et al., 2012; Babiker et al., 2017). 
Tobacco 
There was only one previous study (Campbell et al., 1999) found which reported 
on patients’ perspectives and attitudes towards receiving tobacco cessation 
advice from dental professionals. Most studies have focussed on the viewpoint of 
dental professionals toward cessation interventions. This warrants a need for 
further studies exploring the views of patients regarding receiving tobacco 
cessation advice from dental professionals. 
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Most patients in this study reported being asked about their smoking status in 
the medical/social history form they filled in at the time of their first visit to 
the dental practice. However, only a few current smokers reported that they 
were offered advice to quit smoking by their dental team in previous dental 
visits, which included talking about the harmful effects of smoking on a patient’s 
oral health and lasted a couple of minutes (Section 5.4.3.2). Whilst giving 
smoking cessation advice was considered acceptable by most dental 
professionals, mixed responses were received from patients (few current 
smokers in this study) regarding receiving advice for smoking cessation from the 
dental team. Most patients were open to receiving brief smoking advice from 
their dental team, however, they reported low estimates of efficacy. 
In this study, discussing such issues was still viewed as more normalised in the 
primary care medical setting. A related finding had been reported from focus 
group discussions among US adults where participants were more comfortable 
discussing oral cancer with their physicians than with their dentists (Horowitz et 
al., 2002); this focus group study did not further explore participants views or 
attitudes towards receiving smoking cessation advice or referral from their 
dentists. The large study by Campbell et al. (1999) reported that most patients 
(58.5%) believed that dental professionals should provide tobacco cessation 
services to patients. However, most dental professionals (61.5%) believed 
patients did not expect tobacco cessation services (Campbell et al., 1999). 
Having good adjunctive materials was reported by both dental professionals and 
patients in this study as a way to inform patients. Humphris and Field (2004) 
conducted two randomized controlled trials in primary care practices (medical 
and dental) in the UK, to investigate whether smokers gained greater benefits 
(increased knowledge levels) on receiving an oral cancer brief patient 
information leaflet than non-smokers. Findings showed that smokers who did not 
read the patient information leaflet reported less knowledge about oral cancer 
compared to non-smokers, while knowledge levels were similar for those having 
read the information leaflet (Humphris and Field, 2004). 
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Alcohol 
As with smoking, there was limited existing literature which reported patient 
perspectives and attitudes towards receiving alcohol moderation advice from 
dental professionals in a primary care dental practice (Miller et al., 2006; 
Goodall and McAuley, 2012). As seen in Chapter 4 (Section 4.4.2), dental 
professionals were reportedly reluctant to enquire about patients’ alcohol use 
and give advice on alcohol moderation and reported a range of barriers, which 
was persistent in some existing studies (Warnakulasuriya and Johnson, 1999; 
Cruz et al., 2005; Shepherd et al., 2010; McAuley et al., 2011). Conversely, most 
patients in this study specified that they were supportive of their dental team 
asking about their alcohol drinking and, where appropriate, advising them to 
reduce their consumption. However, there was some cultural sensitivity 
reported to receiving alcohol advice. 
This further concurs with previous studies where advice against alcohol 
moderation was considered appropriate in a dental practice setting (Miller et 
al., 2006; McAuley et al., 2011; Goodall and McAuley, 2012). A survey study by 
Miller et al. (2006) in the United States, reported that a majority of dental 
patients (more than 75%) were in support of being screened for alcohol use by 
their dentists with regards to oral cancer (use of AUDIT-C, a three-item alcohol 
screening test). Furthermore, regardless of their age, sex or drinking status, 
patients were in approval of dentists’ providing them with alcohol 
advice/counselling (Miller et al., 2006). 
5.5.1.3 Oral cancer risk score/categorization 
As discussed in Chapter 4 (Section 4.5.1.2), there is a lack of tools to predict risk 
of future oral cancer incidence (Green et al., 2014; Usher-Smith et al., 2015). 
Risk prediction tools are currently available for fifteen cancer sites (for 
example: breast, lung, prostate, colorectal, and other common cancers that are 
presented to primary care), not including oral cancer, suggesting a need for 
development. This thesis, albeit a small study with patients (and dental 
professionals; Chapter 4), explored the barriers/facilitators and feasible options 
for having an oral cancer risk assessment/prediction tool in a primary care 
dental practice setting. In general, both patients and professionals reacted fairly 
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favourably to the possibilities. Future research is needed to explore this further 
with the potential to develop an intervention/tool, in part informed by 
responses from patient and dental professional interviews. Further research is 
also required to assess the effectiveness and cost-effectiveness of such tools. 
5.5.2 Implications for practice 
The results from this patient interview study and other existing studies (Section 
5.5.1), showed that most patients would accept a formal risk assessment, 
framing using cancer terms, and brief advice for smoking and alcohol specifically 
in relation to oral cancer from their dental team. This may have implications for 
this intervention in practice (final discussion Chapter 6). 
5.5.3 Strengths and limitations 
5.5.3.1 Strengths 
This was a short survey but nevertheless was based on theory, ethically approved 
and targeted at illuminating patients views on both the best practice evidence 
synthesised from systematic reviews and clinical guidelines (Chapter 3) and 
barriers and facilitators reported by dental professionals in primary care dental 
practices (Chapter 4). The qualitative survey instrument was created based on 
findings from these previous studies in this thesis so that patient interviews were 
directed to specific aspects which might be important for applied interventions 
in practice. Results will be valuable in informing and improving further the 
current practice on oral cancer risk factor assessment and prevention among 
dental professionals in primary care dental practices in Scotland and beyond, for 
example by helping to design a pilot/trial to inform the development of an oral 
cancer prevention intervention package for primary care. 
A pragmatic approach to suit study purposes was adopted to develop a mixed-
methods qualitative survey instrument (containing both open-ended and closed-
ended questions); this approach endeavoured to resolve the breadth versus 
depth trade-off between traditional quantitative survey and qualitative 
interviews respectively. 
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Interviews were guided by the principal researcher in real time and were not 
restricted to specific questions, and were quickly revised as new information 
emerged. The principal researcher spent time after each interview reflecting on 
how well they had been conducted; personal reflections on the process; what it 
added to the body of the data; and any implications for future discussions, 
interviews or analysis. 
Coded data were cross checked to develop narrative themes, and any coding 
discrepancies identified were solved by discussion among the principal 
researcher and supervisors. This ensured that a robust coding frame was 
developed in order to enrich data analysis in this study, ensuring consensus in 
themes reported. 
5.5.3.2 Limitations 
Selection bias or sampling error might be a limitation (Kelley et al., 2003). The 
participant group (patients) included in this study were regular attenders at 
practice. This study targeted patients in waiting rooms in primary care dental 
practices in the largest health board in Scotland. The principal researcher did 
not go to individual households to select participants for this study. Studies have 
shown that individuals with oral cancer risks (smokers and excessive alcohol 
drinkers) usually do not turn up for these preventive consultations in primary 
care dental practice setting (Purkayastha et al., 2018). One recent paper 
(Purkayastha et al., 2018) showed that less than 50% of those diagnosed with 
cancer had attended anytime in the last five years. So, this study had in part a 
lower risk group. This might lead to reduced opportunities for providing 
preventive advice to those at high-risk (target population for preventive 
interventions in a primary care dental practice setting). Though this sampling 
error could not be disregarded entirely, the selection criteria endeavoured to 
recruit a mix of participant characteristics (Section 5.3.4). 
Another limitation was that there was no patient and public involvement (PPI) in 
the design of this study. Patients were included in this study as participants, i.e. 
patients were interviewed, but were not actively involved in setting the terms of 
the research. Studies have reported that patient and public involvement at all 
stages of the research process can help to improve the research quality, make 
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positive impact and enhance the appropriateness of research, as patients/lay 
people can often bring to a research study their unique insights and expertise 
that adds-on to those of researchers and health care professionals. Moreover, 
patient and public involvement is believed to improve the way the research is 
recognised, prioritised, designed, commissioned, disseminated and implemented 
(WHO, 1978; Entwistle et al., 1998; Mockford et al., 2011; Brett et al., 2014; 
INVOLVE, 2018). Thus, future research should include patient and public 
involvement so that patient input contributes to the research development, such 
as setting questions. 
The relatively small sample size (n=24) is a limitation for scaled items but less so 
for coded data or for a survey where no inferential test is involved (Kelley et al., 
2003). For “qualitative survey” studies using individual interviews, like this 
study, the sample size required would usually be smaller. Moreover, the sample 
size was determined pragmatically based on: the aims of the study, resources 
available, and statistical analysis needed (only descriptive statistics) (Kelley et 
al., 2003). 
This was a cross-sectional study, gathering views expressed by patients on a 
particular day. Thus, revisiting patients at different time point to see if they 
express the same views would significantly strengthen the internal validity of 
the findings. 
5.5.4 Chapter conclusions 
In conclusion, this chapter studied the views of patients attending primary care 
dental practices in Scotland on evidence-based oral cancer prevention and 
compared them with the dental professional perspective. Some identified 
barriers, as reported by patients and dental professionals, would need to be 
addressed before successful implementation of preventive intervention 
programmes for oral cancer risk factors (tobacco and alcohol). However, a 
number of ways forward are suggested in the next synthesis chapter. Patients in 
general are: open to being asked questions, and to exploring ways to give 
information to dental professionals using various assessment tools; happy to 
Chapter 5  
 
 
299 
receive alcohol advice if culturally appropriate; need advice tailored to their 
motivational profile; and are happy to frame discussions in terms of oral cancer. 
As reported, there was a lack of previous evidence on this patient perspective on 
receiving preventive interventions for oral cancer from dental professionals. 
Thus, this study will be a good contribution to the knowledge. Although this 
short survey study focused on Scotland, the arguments made, and principles 
described can be applied to other parts of the UK and beyond. The next stage 
would be to actively involve patients/public in the planning and implementation 
of an evidence-based preventive intervention delivered in primary care dental 
practices to improve outcomes for patients. 
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Chapter 6 Discussion and conclusions 
This chapter highlights the collective findings of the research in the context of 
the overarching aims of this thesis; describes the contribution to the literature 
by comparing the thesis findings to existing work, and provides possible 
explanations for the findings drawing on existing literature. It then identifies 
some of the methodological strengths and limitations of the thesis. 
Recommendations for practice and policy are made, and finally the chapter 
discusses some of the future work that can be undertaken. 
6.1 Summary of thesis findings 
This thesis integrates three studies (Chapters 3, 4, and 5) which constitute a 
comprehensive approach. First the evidence-base on best practice for 
undertaking an assessment of major behavioural risk factors associated with oral 
cancer (tobacco and alcohol) and delivering effective behaviour change 
preventive interventions by dental professionals in a primary care dental 
practice was synthesised. Then the feasibility (barriers and facilitators) to 
implementation and acceptability of the synthesised evidence-base relevant to a 
dental practice setting was investigated from both the professional and patient 
perspectives using a theory-based approach (as postulated by the ‘Behaviour 
Change Wheel’). This helped to make recommendations to inform the 
development and implementation of interventions to support evidence-based 
(and feasible) oral cancer prevention delivery. 
The systematic overview study found that there was a limited evidence-base 
directly from dental practice relating to delivering tobacco cessation and alcohol 
reduction interventions. However, best practice was developed from 
synthesising and drawing from the best evidence and recommendations from 
other primary care (medical/ pharmacy) settings, which could be adapted / 
adopted to dental practice setting. Combining the review evidence and guideline 
recommendations (following a novel robust synthesis framework), overall, the 
findings recognised that risk factor assessment is an important first step in any 
preventive intervention (i.e. questions must be asked to assess the risk levels or 
dependence). Regarding tobacco cessation and alcohol reduction interventions, 
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it was found that an appropriate intervention would be to offer an in-person 
brief motivational, tailored intervention, delivered by dental professionals, 
following an assessment of a patient’s tobacco and alcohol use status (risk 
levels) and incorporating an oral examination component. For tobacco users, 
although longer interventions (10-20 minutes) were more effective in increasing 
quit rates, even very brief interventions (less than 5 minutes) have also shown 
comparable effectiveness. It is also acknowledged that there was a small 
additional benefit of intensive interventions (more than 20 minutes, with follow-
up visits) compared to brief interventions. The guidelines also recommended 
making a referral to a telephone “quit-line” service for further help (proactive 
support) if the patient is willing to quit, however, this did not reflect in the 
systematic reviews in this overview – thus further consideration is required for 
including referral along with a brief intervention. For alcohol users, a brief 10-15 
minutes multi-contact intervention was the “best recommended” intervention in 
medical practice reviews and guidelines for helping alcohol users to reduce 
consumption; even 5 minutes advice was also found to be equally effective. 
Thus, very brief (less than 5 minutes) or brief advice (of up to 5 minutes), should 
be trialled for tobacco and alcohol respectively in a dental practice setting 
(considering feasibility and effectiveness as reported in reviews and guidelines), 
tailored to patient motivational status. 
The lack of precise reporting of duration (and number) of sessions of behavioural 
interventions for both tobacco and alcohol, somewhat limited the inferences 
regarding effective components that can be drawn from the findings. The 
clinical guidelines (dental and medical practice) went beyond the review 
evidence, and recommended offering a more pragmatic/practical approach, i.e. 
very brief advice for a couple of minutes, that is easier to implement in a dental 
practice setting. However, more trials would be helpful to study the 
effectiveness of very brief advice in a dental practice setting. Overall, 
behavioural preventive interventions were effective, irrespective of the primary 
care provider (for example, general practice physicians or practice nurses). In 
addition, there is a read across to primary care dental practices such that 
members of the dental team – hygienists, nurses, as well as dentists could be 
involved in delivering these prevention interventions. 
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On exploring the feasibility of implementation of the synthesised evidence-base 
via dental professional interviews, it was identified that it was more common for 
dentists to deliver smoking preventive interventions compared to alcohol 
interventions to their patients in primary care dental practice. Lack of time and 
funding/remuneration were the major resource (physical) barriers reported by 
most dental professionals. Providing very brief advice for less than 2-minutes 
and referring patients to local support groups or cessation services (i.e. simply 
“ask and refer”) was seen as feasible in physical opportunity terms and was 
therefore considered a possible option that could be incorporated in all primary 
care dental practices, and including the brief interventions (up to 5 minutes) if 
resourced. Other feasible opportunities were: receiving training to deliver 
behavioural interventions (advice and referral) and having good education 
materials or posters in the waiting room in primary care dental practices 
(although the evidence-base does not support these). Dental professionals 
reported that patient attitudes, causing offence and awkwardness were the 
major social barriers to implementing preventive interventions. These barriers 
were more of an issue while discussing patients’ drinking behaviours compared 
to smoking. The proposal of having an oral cancer risk prediction tool was 
considered to be somewhat beneficial for assessing behavioural risk factors - 
identifying a high-risk patient and tailoring advice for them. However, once 
more, time and funding were the major barriers to implementing such a tool in 
primary care dental practices, and receiving appropriate training was seen as a 
feasible opportunity so that professionals knew how to use information gained 
from such a tool. 
On exploring the views of patients attending primary care dental practices, 
smoking was identified as the major risk factor by most patients, and alcohol 
was recognised as a risk factor less often. Media (for example, newspapers, 
television, magazines) was cited as the major source for knowing about oral 
cancer and its causes. None of the patients reported learning about oral cancer 
and associated risks from their dental team. Overall, patients were happy to 
learn about the risk factors associated with oral cancer and were open to 
receiving support from their dental team (as well as medical/pharmacy 
professionals) to reduce their risk of developing oral cancer. However, patient 
readiness for change (denial/unwillingness) were seen as a barrier to quitting 
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smoking and reducing alcohol consumption in some patient interviews, even 
among those aware of the risks associated with smoking and alcohol 
consumption, and the benefits of quitting. Receiving a risk score/ categorisation 
was considered to be beneficial in a) increasing awareness and b) framing risk 
directly in relation to oral cancer terminology. Some concern was raised as to 
what would be done with that risk information. 
6.2 Contributions to the literature 
The findings from the studies outlined in this thesis are important because they 
highlight the potential for delivering tobacco and alcohol behavioural preventive 
interventions in the primary care dental practice setting. The findings will be 
valuable in informing and improving further the current practice on oral cancer 
prevention in Scotland and beyond - contributing to some of the existing 
literature on cancer control and prevention. 
As discussed in Chapter 1, the World Health Organization’s International Agency 
for Research on Cancer (WHO IARC) is promoting international collaboration in 
research for cancer prevention in three important areas in order to reduce the 
cancer burden worldwide (Stewart and Wild, 2014). These areas are: “describing 
the occurrence of cancer; identifying / understanding the causes of cancer; 
and evaluating preventive interventions and their implementation” (Stewart and 
Wild, 2014). Addressing each of these areas is described by the WHO IARC as “a 
vital contribution to the spectrum of cancer prevention”. In addition, the 
prevention module of the World Health Organisation’s (WHO) “Cancer Control: 
Knowledge into Action, WHO Guide for Effective Programs” was developed to 
help “implement effective cancer prevention by controlling major avoidable 
cancer risk factors” (WHO, 2007a). This WHO Cancer Control guide further 
suggested three key planning steps followed by policy implementation steps to 
help develop an effective cancer prevention program, which are: 1) “where are 
we now?; 2) where do we want to be?; and 3) how do we get there?” This guide 
helps to provide practical advice for policy-makers and programme managers to 
make recommendations with regard to taking actions that could help accomplish 
these steps (WHO, 2007a). The relevant issues recommended by the WHO are: 
firstly, to systematically assess cancer risk factors at the country and individual 
Chapter 6  
 
 
304 
levels, in order to set priorities for evidence-based actions to prevent cancer; 
secondly, to focus interventions on the individuals most likely to benefit from 
them because they are at highest risk; thirdly, to acquire knowledge about the 
effectiveness of interventions, considering the acceptability of the interventions 
at the social, cultural or political levels. The guide gives practical advice, taking 
into account available financial resources and other potential barriers and 
constraints for the planning and implementation of the interventions. A 
combination of individual and population-based approaches were recommended 
for tobacco cessation and to reduce alcohol consumption in this guide (WHO, 
2007a). The population level approaches are included in various policy 
documentations, for example, the “WHO Framework Convention on Tobacco 
Control” (WHO, 2004) and the “World Health Assembly’s Public-health problems 
caused by harmful use of alcohol” (WHO, 2005b). This thesis is focused on 
downstream, individual level clinical prevention delivered in healthcare settings. 
However, to deliver this – some upstream / policy changes are required, for 
example, a change to the primary care contract (Section 6.5.2). 
The findings reported in the systematic overview study (Chapter 3) contribute to 
the key research areas highlighted by the WHO IARC and the planning phases 
suggested by WHO’s Cancer Control guide by presenting the best practice 
evidence for “individual level” approaches, i.e. to identify individuals at high-
risk of developing oral cancer and delivering effective evidence-based 
behavioural preventive interventions. The overview went beyond the review and 
trial evidence, and contributed to the knowledge by suggesting interventions 
based on an integrated or combined synthesis (using a novel robust framework) 
of current high-quality reviews and guidelines. The thesis further contributed by 
identifying the immediately feasible options, based on professional and patient 
views, for delivering effective tobacco cessation and alcohol reduction 
interventions in primary care dental practices, which would have the greatest 
impact on patients’ oral health. Moreover, the findings are significant in that 
preventive interventions delivered by dental professionals can contribute to the 
improvement of not only oral health, but also general health, as tobacco and 
alcohol are the common risk factors. Reducing these common risk factors is a 
major strategic priority for the “WHO’s Global action plan for the prevention 
and control of non-communicable diseases (NCDs) 2013-2020” (WHO, 2016b). 
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This action plan has a specific mention of oral diseases including oral cancer, 
and states that an effective oral cancer prevention strategy may have benefits 
that are not limited to this particular condition alone (Sheiham and Watt, 2000; 
Watt, 2005; WHO, 2016b). 
The “Implementation Guide and Toolkit for Making Every Contact Count 
(MECC)” recognizes MECC as the first stage of the Behaviour Change Pathway 
that individuals might take in order for them to make and maintain a behaviour 
change (for example, stop smoking and drink alcohol within the recommended 
daily limits) (Varley and Murfin, 2014). Three core components for the effective 
implementation of MECC are: “organizational readiness, staff readiness, and 
enabling and empowering the public” (Varley and Murfin, 2014). This public 
health policy in the UK, requires healthcare professionals to deliver 
opportunistic health behaviour change interventions to patients during routine 
medical consultations (Varley and Murfin, 2014). Keyworth and co-workers 
(2018), in a recent cross-sectional national survey with NHS staff in the UK, 
reported that these opportunities are often missed during routine clinical 
interactions; some of the implementation barriers being lack of training, lack of 
time, workload, organisational barriers, and healthcare professionals’ 
beliefs/viewpoints about patient motivation to change their behaviour 
(Keyworth et al., 2018). The barriers reported by dental professionals in this 
thesis (Chapter 4) were in agreement with these barriers. The findings from this 
thesis further contributed to the knowledge by recommending implementation 
strategies which draw upon recognized behaviour change theory (the ‘Behaviour 
Change Wheel’), aimed at enhancing dental professionals’ capability, 
opportunities and motivation to deliver behaviour change interventions (Michie 
et al., 2011; Varley and Murfin, 2014; Keyworth et al., 2018). The dental 
professional interview study identified the intervention functions and policy 
categories (Section 6.5) from the ‘Behaviour Change Wheel’ to support changes 
in dental professional behaviour and increase implementation of public health 
policies by translating evidence into practice (Michie et al., 2011; Keyworth et 
al., 2018). 
There is a lack of literature examining the patient perspective and attitudes 
towards receiving opportunistic health behaviour change interventions (for 
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tobacco and alcohol) in a primary care setting. Keyworth and co-workers (2018) 
have highlighted a need for further research to examine patients’ perspectives 
in relation to MECC, and particularly their views regarding receiving behaviour 
change interventions during routine consultations. This thesis contributes to the 
knowledge in this area, by presenting patient views and specific barriers (and 
some facilitators) in relation to translating the evidence-base to practice 
(Chapter 5). Moreover, this thesis compared and contrasted the views of 
patients and dental professionals, in order to capture the most relevant barriers 
and facilitators to dental practice. Addressing these barriers/facilitators will be 
an important step towards prevention and control of oral cancer (and other 
chronic conditions). Triangulation (Table 5.2) showed patients in general were 
amenable to most evidence-based approaches; opportunity barriers on the 
professional side are stronger. However, it is recognised that these were 
patients attending practice regularly. 
Previous studies in the UK, using data from large national surveys, reported that 
the probability of regular dental attendance was low among individuals who are 
at higher risk of developing oral cancer (i.e. smokers and heavy drinkers) 
compared to those who are at lower risk (Netuveli et al., 2006; Yusof et al., 
2006). Thus, opportunities are reduced for both screening and providing 
preventive advice to those at high-risk. This suggests a need to have 
interventions targeted at practice and at policy levels for services to reach out 
to those communities at highest risk, in order to encourage high-risk individuals 
to take preventive actions, such as regular dental visiting (Netuveli et al., 2006; 
Yusof et al., 2006). Moreover, despite this low attendance of high-risk 
individuals, dental professionals should continue assessing all patients and 
deliver preventive interventions as needed, which could contribute to 
prevention of oral cancer as well as other oral diseases and non-communicable 
diseases (via common risk factors). 
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6.3 Explanation of findings 
There is emerging policy proposals for delivering tobacco and alcohol 
interventions in dental practice settings (WHO, 2007b; Scottish Government, 
2018b). With reference to ethical principles (Tannahill, 2008), the common risk 
factor approach (Sheiham and Watt, 2000), and WHO’s Global Action Plan for 
the prevention and control of non-communicable diseases (WHO, 2016b) - 
tobacco and alcohol brief interventions can not only improve oral health, but 
can improve health in general. The tobacco and alcohol preventive 
interventions, as identified from the findings of this thesis, are reasonable in 
that every dental patient who attends can be assessed for risk behaviours and 
offered a brief intervention. They are sustainable because of their quick 
delivery, and low implementation costs after initial training is completed 
(although practitioners would need payment to deliver brief intervention; 
Section 6.5.2), and they also have the potential to impact on inequalities in oral 
health (McAuley et al., 2011; NICE, 2014; Varley and Murfin, 2014; WHO, 2016b). 
The findings from the overview study showed that there was a lack of systematic 
reviews and trials regarding delivering tobacco cessation interventions (only one 
review) and there were no reviews reporting alcohol reduction interventions in a 
dental practice setting. Moreover, the dental review concluded that there were 
differences between the studies that limit the ability to make conclusive 
recommendations regarding the intervention components that should be 
incorporated into the dental practice setting. These results were in line with a 
recent systematic review by Kay and co-workers (2016), which included 44 
studies (including randomised controlled trials, surveys, qualitative or mixed-
method studies) to answer the research question: “Is oral health promotion 
within dental practice effective and how can its effects be optimized?”. The 
review concluded that the evidence for promoting good oral health in adult 
patients (or adolescent), in a dental practice setting, is heterogeneous, 
moreover, the quality of reporting was variable. Similar to the findings of this 
thesis, the review by Kay and co-workers (2016) showed that oral health 
promotion (including oral hygiene, plaque control, diet, fluoride use), based on 
behaviour change theoretical models, was effective in significantly improving 
oral health. Moreover, verbal advice from a dental professional had a positive 
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effect on a patient’s knowledge, behaviour and for improving oral health, while 
written advice only promoted oral health knowledge. The review by Kay and co-
workers (2016), was published after the systematic search was conducted for 
this thesis (including reviews published between 1995 and 2015). However, this 
review did not report interventions specifically for tobacco and alcohol 
reduction in a dental practice setting (Kay et al., 2016). The interventions 
reported were for oral health promotion in general, and there was no evidence 
demonstrating the components of effective interventions to be delivered in a 
dental practice setting. Therefore, inclusion of this review would not have 
changed the overall findings of the thesis. 
The synthesised finding is that offering an assisted or theory-based intervention, 
i.e. brief tailored/structured advice (based on motivational interviewing in the 
majority of included reviews/guidelines) following an assessment of a patient’s 
risk levels and supported by an oral examination component or written materials 
or pharmacotherapy (where needed), is effective. The text book “Theory of 
addiction” by West and Brown (2013) describes motivation as being highly 
dependent on circumstances or contexts and, thus, offering an assistance or 
support (rather than simple advice) might “increase confidence in success, 
create a more positive image of the quitting process or trigger a positive 
response out of a motivation to reciprocate” (Aveyard et al., 2012). This has 
been further described by Michie and co-workers (2010; 2013), who identified 
the specific behaviour change techniques for improved outcomes for smoking 
cessation, and identified four important functions for individual behavioural 
support: “addressing motivation, maximizing self-regulatory capacity and skills, 
adjuvant activities, and general aspects of the interaction (for example, 
communication techniques)”. The study further suggests that the healthcare 
professionals’ communication skills affect patient satisfaction and motivation, 
which could be improved by providing training to practitioners. The work by 
Michie and co-workers (2010; 2013), forms the basis of research carried out by 
the “National Health Service Centre for Smoking Cessation and Training 
(NCSCT)”.  This aims to establish the best practice for the management of 
smoking cessation and develop learning outcomes for training all practitioners to 
deliver brief advice for smokers, aimed at motivating them to make a quit 
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attempt (NCSCT, 2014). Thus, the results of the existing literature, described 
above, further justifies the findings from this thesis. 
There remains a gap around the “active ingredients” for delivering a preventive 
intervention in a dental practice setting (in particular for alcohol interventions). 
Overall, the findings recognised that risk factor assessment is an important first 
step in any prevention intervention (i.e. ask a question to assess the risk levels 
or dependence and readiness to change), followed by brief advice to quit. 
Although there remains a knowledge gap for direct evidence in dental practice, 
it must be acknowledged that there are some important developments in the 
field of alcohol brief interventions (efficiently using wealth of evidence from 
other settings), some of which are not yet reflected in current systematic 
reviews, that could be adopted in a dental practice setting. For example, Michie 
et al. (2012; 2013), aimed to identify specific behaviour change techniques to 
reduce excessive alcohol consumption (not to treat alcohol dependence). They 
identified greater effect sizes from alcohol brief interventions that promoted 
“self-monitoring”, i.e. self-recording of alcohol intake. However, they 
recommended that further research should be undertaken to identify the effects 
of other behaviour change techniques and to extend this approach for more 
intensive interventions. 
6.4 Strengths and limitations 
This section presents the strengths and limitations of the thesis in its entirety, 
mainly in relation to the methodologies employed. The strengths and limitations 
of individual studies have already been detailed and explained in the discussion 
sections of the relevant chapters (3, 4, and 5). 
6.4.1 Strengths 
This thesis adopted a comprehensive pragmatic approach, i.e. each method 
(systematic overview, qualitative interview, and qualitative survey) was chosen 
to fit particular research questions. This helped to avoid any inherent bias in 
traditional literature reviews, and in particular belief systems, such as 
constructivism (qualitative/ inductive) or positivism (quantitative/ deductive) 
(Teddlie and Tashakkori, 2009; Creswell and Creswell, 2017). The thesis first 
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conducted an extensive systematic overview, which included a) systematic 
search of multiple databases and grey literature for relevant systematic reviews 
and international clinical guidelines; b) quality appraisal using standardised 
tools; and c) narrative synthesis with novel methods developed for synthesising 
across systematic reviews and clinical guidelines). Secondly, qualitative in-depth 
interviews with primary care dental professionals investigated barriers and 
facilitators to implementing oral cancer behaviour change interventions. Thirdly, 
patient views and perspectives on receiving these interventions and how these 
compared and contrasted with the dental professional perspectives were 
examined in a mixed-methods qualitative survey.  
The systematic overview was the first study to develop a novel robust framework 
to synthesise best practice evidence from both systematic reviews and clinical 
guidelines. Whilst the appraisal and synthesis methods followed validated 
protocols and frameworks, the “higher level” synthesis of these two “streams” 
together (i.e. integrated or combined synthesis of current high-quality reviews 
and guidelines) was innovative and could be used in other areas of healthcare.  
The theoretically-based assessment of barriers and facilitators (using the 
‘Behaviour Change Wheel’) in translating each component of the synthesised 
evidence-base to practice was thorough. This thesis contributes to the literature 
in this area, by presenting both dental professional and patient views, and by 
comparing and contrasting their views in order to capture the most relevant 
barriers and facilitators to a dental practice setting. Collecting data from one 
source (dental professionals) and comparing them with another source 
(patients), in order to validate or confirm the findings and determine the 
“extent to which different sources provided similar or discrepant data” – has 
been referred to as data (person) or methodological triangulation of research 
studies (Adami and Kiger, 2005; Baxter and Jack, 2008). Adopting these different 
approaches in three research studies helped to achieve a complete picture of 
the topic being explored, i.e. achieving confirmation and completeness of 
findings (Adami and Kiger, 2005). 
Furthermore, the systematic search was not limited to the dental practice 
setting, which is a strength. Preventive interventions delivered in all primary 
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care settings (dental/medical/pharmacy) were included in this overview, in 
order to not rule out any good guidelines and/or evidence on how to assess risk 
and deliver prevention for the risk factors (tobacco and alcohol) that may be 
aimed at another clinical/medical condition (Fiore et al., 2008; NICE, 2010; 
SDCEP, 2014). 
6.4.2 Limitations 
The limitations of individual studies have already been detailed in the discussion 
sections of the relevant chapters (3, 4, and 5). This section particularly 
considers - what could have been done differently. 
As discussed previously in Chapter 3 (Section 3.4.1.2), trial duplication within 
the systematic reviews was addressed effectively in the overview study, by 
extracting a list of all included original trials (Appendix 6) within 31 included 
systematic reviews. This avoided counting findings more than once if repeated in 
multiple systematic reviews, which would falsely inflate the effect or weight of 
findings. Nevertheless, there was inevitable overlap in the source trials within 
the systematic reviews. Conducting a meta-analysis with these original trials was 
considered during this study; but the work was beyond the scope of this thesis. 
However, future work could involve a meta-analysis synthesis, given the detailed 
work done thus far to extract all original trials in this research. In such a meta-
analysis, careful consideration would need to be given to pooling trials with 
different methodology / study designs and contexts - given the high levels of 
heterogeneity. Furthermore, clinical heterogeneity and the somewhat limited 
detailed descriptions of interventions would need to be taken into account 
(Petticrew and Roberts, 2008). 
The interview schedule or topic guide for professional and patient interviews 
was developed based on initial synthesis of the overview findings – this was able 
to capture the key principles of behaviour change interventions. However, the 
detailed overview synthesis, which was able to tease out specific effective 
aspects of the interventions, continued even after the dental professional and 
patient interviews commenced. This was due to the time constraints of the PhD 
timescales.  This somewhat restricted further in-depth exploration of dental 
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professional and patient views based on the final findings from the robust 
overview synthesis. It is unlikely that this more detailed synthesis would have 
changed the main thrust of the findings from the patient and public 
perspectives. Furthermore, there would be an opportunity for further feedback 
from dental professionals and patients if an oral cancer prevention intervention 
package were to be feasibility or pilot tested. 
6.5 Pathways to impact  
6.5.1 Recommendations for practice 
The findings from this thesis, can contribute to recommendations to inform the 
development of interventions to support evidence-based oral cancer prevention 
(tobacco cessation and alcohol reduction interventions) delivered by dental 
professionals in the primary care dental practice in Scotland and beyond. The 
Behaviour Change Wheel (as detailed in Chapter 4), was used in this research to 
identify approaches to the specific barrier types (to be addressed) or facilitator 
types (to be enhanced and reinforced) in relation to the target behaviours 
(Michie et al., 2011). The barriers and facilitators (in terms of capability, 
opportunity and motivation) identified for each component of the best practice 
evidence synthesis (Chapter 3) were discussed in terms of the recommended 
intervention possibilities in Chapter 4 and 5 (Sections 4.5.2 and 5.5.2; Table 
5.2). 
The optimal model of preventive care (from a primary care perspective) could 
involve providing both opportunistic preventive interventions for all patients 
through undertaking a planned assessment of smoking and alcohol risk 
behaviours and the subsequent tailoring of behaviour change interventions. 
Strategies that can be applied to address identified barriers at the dental 
practice level are discussed below. 
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Providing a detailed specified protocol of requirements in including brief 
interventions in the routine clinical dental practice 
The National Centre for Smoking Cessation and Training (NCSCT) has developed 
“a simple form of advice designed to be used opportunistically in less than 30 
seconds in almost any consultation with a tobacco user” (NCSCT, 2014; PHE, 
2014a). This is very brief advice, which involves: 1) establishing and recording 
smoking status (ASK); 2) advising on the personal benefits of quitting (ADVISE); 
and 3) offering help (ACT). The findings from the systematic overview study in 
this thesis reported limited trial evidence (compared to longer interventions) for 
the effectiveness of very brief interventions for smoking cessation, and limited 
to no evidence for alcohol reduction; yet the guidelines did recommend 
delivering very brief interventions (as little as 30 seconds to a couple of minutes) 
in a dental practice setting. However, the definition of “brief intervention” was 
not consistent in all included reviews and guidelines - mostly it was considered 
to be an intervention of 5-20 minutes duration. Dental professionals in the 
interview study considered delivering a very brief intervention (less than 5 
minutes) as a more feasible and effective option than brief advice, that could be 
incorporated in routine patient care. A recent randomised trial further 
supported this pathway by reporting a dramatic impact for motivating weight 
loss by primary care physicians in England, suggesting that a behaviour change 
intervention can be delivered in as little as 30-seconds (Aveyard et al., 2016). 
Thus, there is potential to use the very brief intervention pathway (30-seconds 
chat) in order to increase the chance of a successful quit attempt and reduce 
time of delivery. However, this very brief approach would need to be tested in 
the dental practice setting, considering a lack of evidence for effectiveness of 
very brief interventions. 
Moreover, there is a need to adapt this pathway for reducing alcohol 
consumption in a primary care dental practice setting. In order to “Ask/Assess”, 
i.e. screening patients for alcohol consumption in a primary care setting, a range 
of alcohol screening questionnaires have been developed (for example: AUDIT, 
AUDIT-C, AUDIT-PC, FAST). These questionnaires have been shown to be a 
reliable and valid means of detecting alcohol misuse among individuals. 
However, most of these questionnaires are too long to be incorporated in any 
healthcare setting, for example, AUDIT being the “gold standard” has ten 
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questions. However, the brief version of the AUDIT questionnaire i.e. AUDIT-C, 
takes around 3-minutes to complete, identifies excessive drinking within the last 
year, and offers honest and personalised feedback to the patients. This AUDIT-C 
tool was effectively used as a useful training resource for dental teams in the 
UK, almost two decades ago (Bush et al., 1998). Thus, there is potential for 
implementing these brief questionnaires in a dental practice setting. 
Training and support for dental team in oral cancer prevention 
Dental professional interviews showed a need for further education and training 
interventions to address reflective motivation and psychological capability issues 
(in particular for giving alcohol advice). As in any area of clinical and preventive 
practice, appropriate training is essential to enable dental professionals to 
deliver tobacco cessation and alcohol reduction advice and support. In 2010, the 
National Centre for Smoking Cessation and Training (NCSCT) launched the “first 
nationally recognized accreditation for delivery of smoking cessation for 
practitioners” (NCSCT, 2014), by updating the set of competencies published by 
the Health Development Agency (HDA, 2003) which were required to be present 
in all smoking cessation training courses. The training comprises of a “two-stage 
knowledge and practice assessment and supporting online training modules” 
(NCSCT, 2014). As discussed earlier (Section 6.3), the specific behaviour change 
techniques (BCTs) developed by Michie and co-workers (2010; 2013) form the 
basis for this training, and suggest that healthcare professionals’ communication 
skills affect patient satisfaction and motivation, which could be improved by 
providing training to practitioners. In other words, training could help explore 
best way of providing tailored, motivationally nuanced advice – as implicated 
from dental professional and patient interviews (Table 5.2). 
There is a clear need to support and disseminate this accredited training 
(NCSCT, 2014) for dental teams in order to ensure they are competent to deliver 
very brief interventions for tobacco in a primary care dental practice. The 
training could be delivered in a dental practice setting or could be delivered as 
part of the dental undergraduate, postgraduate, and/or continuing professional 
development programmes. The training should be consistent and in accordance 
with national training standards (NCSCT, 2014; PHE, 2014a). The NCSCT 
recommends “the minimum standard that every dental practice member should 
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achieve is: very brief advice, just 30 seconds to ask, advise and act” (NCSCT, 
2014; PHE, 2014a). Again, there is a need to adapt these training 
recommendations for delivering alcohol reduction interventions in a primary 
care dental practice. Moreover, the provision of training to deliver opportunistic 
alcohol reduction interventions by dental professionals needs to be considered a 
high priority, considering it plays a major role in oral cancer development. 
Lastly, costs for delivering training, including time away from practices needs to 
be considered within the implementation case. 
6.5.2 Recommendations for policy (service organisation level) 
The policy categories from the Behaviour Change Wheel (Chapter 4), i.e. the 
regulatory or authority actions needed to allow the interventions to occur, are 
addressed in this section. The key policy implications needed to bring about the 
desired behaviour change are outlined below. 
Methods of remuneration 
Lack of remuneration or funding issues were reported to be the major barriers in 
delivering tobacco and alcohol interventions by the majority of dental 
professionals in this study. This might remain a problem, as the NHS primary 
care dental contract, i.e. “Statement of Dental Remuneration” (NHS, 2018b), 
does not support the delivery of smoking cessation or alcohol reduction 
interventions, and currently there is no structure to reward dental practitioners 
offering tobacco and alcohol interventions in routine clinical practice 
(Brocklehurst et al., 2016). In Scotland, where dentists are paid in part by a fee-
for-service and capitation remuneration systems (i.e. the volume and type of 
work undertaken), a fee scale for tobacco and alcohol interventions is worthy of 
consideration. This might encourage dental professionals to provide these 
services in day-to-day practice (McAuley et al., 2011; Brocklehurst et al., 2013b; 
Brocklehurst et al., 2016). 
Providing remuneration has been shown to have positive effects on clinician 
behaviours in a range of healthcare services. For example, a recent Cochrane 
review (Brocklehurst et al., 2013b) aimed to determine the impact that various 
remuneration mechanisms (including fee-for-service, fixed salary, capitation and 
Chapter 6  
 
 
316 
blended payments) have upon primary care dentists’ behaviour to impact a 
range of activities. The study found a statistically significant increase in clinical 
activity with the provision of fee-for-service and an educational intervention on 
the placement of fissure sealants (Brocklehurst et al., 2013b). However, further 
research was suggested due to the limited number of trials available, and 
moreover to find impacts on other healthcare services. 
Steps are being taken in this area; the recently published “Scotland's Oral 
Health Improvement Plan” (Scottish Government, 2018b) recommends a “new 
system of enhanced continuing care payments to support the introduction of 
Oral Health Risk Assessments for adult patients”. In addition, it recommends 
developing the potential for wider prevention in the primary care setting. 
However, future evaluation would be needed to determine whether provision of 
payments to deliver tobacco and alcohol interventions in the dental practice 
setting would have an impact on clinician activity. 
Support in implementing guidelines (and quality improvement) 
There is a clear need for clinical guidelines to support dental professionals in 
offering tobacco and in particular alcohol interventions in routine clinical 
practice. The overview in Chapter 3 draws from preventive best practice that 
can help to improve not only oral health but also general health. Linking of 
assessment and advice to wider benefits may enhance acceptability for patients 
and is in line with moves to a more integrated oral and wider public health 
agenda (Sheiham and Watt, 2000). The policy context also comes with 
opportunity regarding enhancing the role of the dental team (Steele, 2014; 
WHO, 2016b; Scottish Government, 2018b). For example, “Scotland’s Oral 
Health Improvement Plan” (Scottish Government, 2018b) focuses on introducing 
a preventive care pathway and an “Oral Health Risk Assessment” for all adult 
patients on a regular basis. Oral health risk assessment includes a full dental or 
oral examination followed by a personalized care plan including a conversation 
between the dentist and patient about the associated risk factors such as 
tobacco and alcohol consumption based on the assessment of the risk level to 
their oral health (Scottish Government, 2018b). Moreover, the “WHO Global 
Strategy for Prevention and Control of Noncommunicable Diseases” is a new 
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policy relevant for managing the prevention and control of oral diseases, 
acknowledging the common risk factor approach (Petersen, 2008; WHO, 2016b).  
Additionally, the cultural sensitivity / diversity issues (as identified from dental 
professional and patient interviews; Table 5.2) needs to be incorporated in any 
generic guidance. 
Despite being a priority area, the absorption of guideline recommendations into 
routine practice requires changes in the attitudes and behaviour of dental 
professionals and a certain adaptation of the structural environment (Edwards et 
al., 2006; Fischer et al., 2016). Given the need for more support in guideline 
implementation, a more active dissemination of guidelines is required to ensure 
a change in routine practice (Fischer et al., 2016). The existing literature 
indicates that structured or multi-faceted implementation strategies (for 
example: educational outreach visits, reminder systems) can improve adherence 
to guidelines (Edwards et al., 2006; Fischer et al., 2016). 
6.6 Future work / research 
The overview study highlighted an overall lack of evidence of effectiveness of 
brief behavioural interventions (for both tobacco and alcohol) directly within a 
dental practice setting, however, there is more evidence available in the wider 
primary care settings. It was further identified that, despite this preponderance 
of evidence in the primary care settings (medical/pharmacy), there was a lack 
of evidence (no effect sizes) for the effectiveness of individual components of 
brief interventions (for example, referral to external services, training primary 
care providers, use of supporting materials), and there was lack of precise 
reporting of duration and number of sessions of a brief intervention. Thus, 
further research is needed to test this evidence deficit in implementation, i.e. 
the acceptability and practicality (feasibility) of an evidence-based preventive 
intervention in a dental practice setting (the adoption and adaption) - some of 
which was explored in the dental professional and patient interviews in this 
research. Moreover, further research is required to explore the optimal level of 
brief / very brief advice, individual components of brief intervention, and to 
explore multi-disciplinary cohesion (i.e. dental team, general medical 
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practitioners, or pharmacist) (Table 5.2). Since the oral adverse effects of 
alcohol excess are largely linked with tobacco use, one way of overcoming a 
potential barrier would be to link tobacco advice with that of alcohol (where 
relevant), i.e. combined interventions (Goldstein et al., 2004). Moreover, as 
notable in the epidemiologic studies (Coups et al., 2004; Fine et al., 2004), a 
majority of individuals are at risk from more than one of the four shared or 
common behavioural risk factors (i.e. tobacco use, unhealthy diet, physical 
inactivity and harmful use of alcohol), that are associated with major non-
communicable diseases (Goldstein et al., 2004; WHO, 2016b). 
Intervention development and feasibility trial 
It is recommended that an oral cancer prevention intervention package should 
be developed, drawing from the evidence-base of the systematic overview study 
(Chapter 3), and adapting suggestions from dental professional and patient 
interviews (Chapter 4 and 5; Table 5.2) for its effective implementation in a 
dental practice setting. The future oral cancer prevention intervention/trial 
could involve testing the implementation and acceptability of the synthesised 
evidence-base in a dental practice setting (tobacco and alcohol interventions), 
demonstrating effectiveness and need for brief tobacco and alcohol 
interventions in routine clinical practice by conducting an initial short feasibility 
trial. For example, testing the feasibility of very brief (less than 5 minutes) or 
brief advice (of up to 5 minutes), for tobacco and alcohol respectively, tailored 
to patient motivational status, in a dental practice setting. In addition, the 
issues with the individual components, such as follow-up visits, referral to 
external services, use of supporting materials, training primary care providers, 
and effectiveness of very brief interventions, would also need to be explored. In 
line with Medical Research Council guidance on the development and evaluation 
of complex interventions, it would be necessary to undertake a feasibility and 
pilot study before conducting a definitive trial/intervention to assess its 
acceptability and practicality to dental professionals and patients (Craig et al., 
2008). 
The potential role and effectiveness of the use of an oral cancer risk prediction 
tool in dental practice settings is not known. In the qualitative studies, a risk 
prediction tool was considered beneficial by most dental professionals and 
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patients attending primary care dental practices - for capturing risk behaviours 
and as a means of communicating risk associated with oral cavity and 
oropharyngeal cancers. However, some concern was raised as to what would be 
done with that risk information. Such a personalised risk prediction tool is 
currently being developed and validated by INHANCE (2018) researchers in the 
United States, specifically targeted at head and neck cancer / oral cancer 
reduction. This anticipated INHANCE risk prediction tool, however, has yet to be 
fully validated and did not materialise in time to be demonstrated and discussed 
in detail with dental professionals and patients in this research, rather risk 
prediction tools in general were discussed. The INHANCE risk prediction tool 
“aims to predict risk of future incident disease in asymptomatic individuals” 
(INHANCE, 2018). This could possibly be used to guide risk factor counselling 
interventions for behaviour modification (i.e., quitting cigarette smoking or 
reducing alcohol drinking). The major risk factors included in this risk prediction 
tool are:  age, gender, socioeconomic status, tobacco smoking, alcohol drinking, 
and family history of head and neck cancer. Thus, based on individuals’ 
characteristics and behaviours, such personalised risk communication could help 
in improving decision making in relation to oral cancer screening and primary 
prevention (Edwards et al., 2013). The INHANCE tool needs further development 
and validation in order to be implemented effectively in a primary care dental 
practice in the UK setting. Moreover, future research is also needed to assess its 
effectiveness and cost-effectiveness. 
Thus, future oral cancer prevention intervention/trials could involve: a) 
assessing the feasibility of recruiting for the study; and how best to deliver the 
intervention; b) designing / testing an appropriate preventive intervention 
drawing from the evidence-base and adapting suggestions from dental 
professional and patient interviews; c) testing the INHANCE risk prediction 
model in Scotland (linked to prevention intervention). 
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6.7 Future prevention considerations 
Besides behavioural preventive interventions, pharmacological interventions (for 
example, nicotine replacement therapy) through stop smoking services have 
been shown to be effective in tobacco cessation (Stead and Lancaster, 2012). 
Moreover, the development of smoking cessation prevention interventions needs 
to consider one of the evolving technologies, i.e. “Electronic Cigarettes” and 
how they fit into current brief interventions (McRobbie et al., 2014). A recent 
Cochrane review examined the effectiveness of electronic cigarettes to help 
smokers quit over the long-term (McRobbie et al., 2014). This review showed a 
reduction in cigarette consumption in electronic cigarette users compared with 
placebo (reported in two trials) and NRT or nicotine patches (reported in one 
trial). However, the small number of effectiveness trials limits the certainty of 
these findings. Electronic cigarette has been a topic of interest among smokers, 
healthcare professionals and policy makers to know if these devices could help 
in smoking harm reduction. The Public Health England’s guidance (NICE, 2013) is 
fully supportive of electronic cigarettes as a harm reduction approach. The 
dental community are possibly more reluctant to support this fully, with 
concerns about unknown impact on oral tissues (Sundar et al., 2016). 
Following their invention in China in 2003, electronic cigarettes became more 
widely available around 2007 (ASH, 2018). Despite unanswered questions about 
their long-term effectiveness, electronic cigarettes are growing in popularity as 
a “relatively safe” alternative to tobacco products and are marketed as a 
healthier alternative to smoking or even to help smokers to quit. As of 2017, 
there were 2.9 million adults in the UK using electronic cigarettes (ASH, 2018). 
In the UK, there are now more ex-smokers (52%) using electronic cigarettes than 
dual users of both cigarettes and electronic cigarettes (45%) (ASH, 2018). The 
sales for electronic cigarettes are rapidly increasing and some analysts have 
even predicted they will surpass cigarettes sales within a decade (Bullen et al., 
2013). A recent study compared data from 45 countries, relating to prices of 
combustible cigarettes, disposable e-cigarettes and rechargeable cigarettes 
(Liber et al., 2017). The study reported that primary care clinicians (general 
practitioners) recognise electronic cigarettes as a low-cost opportunity to reduce 
smoking (especially in deprived groups in society, having higher rates of 
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smoking). The study established that “though start-up costs can be higher, it is 
likely to be less expensive to use an electronic cigarette over time than it is to 
smoke” (Liber et al., 2017; ASH, 2018). 
Thus, further research is needed to confirm their long-term health implications 
as they are relatively new to the market (McRobbie et al., 2014; ASH, 2018). 
6.8 Thesis conclusions 
In conclusion, tobacco and alcohol use are the major risk factors associated with 
oral cancers (oral cavity and oropharyngeal). The principles of prevention for 
oral cancer suggests that risk can reduce when behaviours stop. Despite a lack of 
systematic reviews and clinical guidelines directly within a dental practice 
setting, best practice was developed from synthesising and drawing from the 
best evidence and recommendations from other primary care 
(medical/pharmacy) settings, which could be adapted / adopted to dental 
practice setting. Overall, the thesis showed evidence for the effectiveness of 
brief behavioural interventions for sustained tobacco abstinence and reduced 
alcohol consumption. Dental professionals are in an ideal position to help 
patients quit smoking and reduce alcohol consumption; their role could be 
increased substantially, if the identified barriers to implementation in a dental 
practice setting (from dental professional and patient perspectives) were 
addressed. Further interventions, including feasibility testing in practice, 
targeting these issues could have a potential impact on the prevention of oral 
cancer in the community. 
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Appendices 
Appendix 1: PRISMA-P (Preferred Reporting Items for Systematic review and Meta-Analysis Protocols) 2015 checklist: recommended items 
to address in a systematic review protocol 
Section and topic Item No Checklist item 
ADMINISTRATIVE INFORMATION 
Title:   
 Identification 1a Identify the report as a protocol of a systematic review 
 Update 1b If the protocol is for an update of a previous systematic review, identify as such 
Registration 2 If registered, provide the name of the registry (such as PROSPERO) and registration number 
Authors:   
 Contact 3a Provide name, institutional affiliation, e-mail address of all protocol authors; provide physical mailing address of 
corresponding author 
 Contributions 3b Describe contributions of protocol authors and identify the guarantor of the review 
Amendments 4 If the protocol represents an amendment of a previously completed or published protocol, identify as such and list changes; 
otherwise, state plan for documenting important protocol amendments 
Support:   
 Sources 5a Indicate sources of financial or other support for the review 
 Sponsor 5b Provide name for the review funder and/or sponsor 
 Role of sponsor or 
funder 
5c Describe roles of funder(s), sponsor(s), and/or institution(s), if any, in developing the protocol 
INTRODUCTION 
Rationale 6 Describe the rationale for the review in the context of what is already known 
Objectives 7 Provide an explicit statement of the question(s) the review will address with reference to participants, interventions, 
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comparators, and outcomes (PICO) 
METHODS 
Eligibility criteria 8 Specify the study characteristics (such as PICO, study design, setting, time frame) and report characteristics (such as years 
considered, language, publication status) to be used as criteria for eligibility for the review 
Information sources 9 Describe all intended information sources (such as electronic databases, contact with study authors, trial registers or other 
grey literature sources) with planned dates of coverage 
Search strategy 10 Present draft of search strategy to be used for at least one electronic database, including planned limits, such that it could be 
repeated 
Study records:   
 Data management 11a Describe the mechanism(s) that will be used to manage records and data throughout the review 
 Selection process 11b State the process that will be used for selecting studies (such as two independent reviewers) through each phase of the review 
(that is, screening, eligibility and inclusion in meta-analysis) 
 Data collection 
process 
11c Describe planned method of extracting data from reports (such as piloting forms, done independently, in duplicate), any 
processes for obtaining and confirming data from investigators 
Data items 12 List and define all variables for which data will be sought (such as PICO items, funding sources), any pre-planned data 
assumptions and simplifications 
Outcomes and 
prioritization 
13 List and define all outcomes for which data will be sought, including prioritization of main and additional outcomes, with 
rationale 
Risk of bias in 
individual studies 
14 Describe anticipated methods for assessing risk of bias of individual studies, including whether this will be done at the 
outcome or study level, or both; state how this information will be used in data synthesis 
Data synthesis 15a Describe criteria under which study data will be quantitatively synthesised 
15b If data are appropriate for quantitative synthesis, describe planned summary measures, methods of handling data and 
methods of combining data from studies, including any planned exploration of consistency (such as I2, Kendall’s τ) 
15c Describe any proposed additional analyses (such as sensitivity or subgroup analyses, meta-regression) 
15d If quantitative synthesis is not appropriate, describe the type of summary planned 
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Meta-bias(es) 16 Specify any planned assessment of meta-bias(es) (such as publication bias across studies, selective reporting within studies) 
Confidence in 
cumulative 
evidence 
17 Describe how the strength of the body of evidence will be assessed (such as GRADE) 
 
From: Shamseer L, Moher D, Clarke M, Ghersi D, Liberati A, Petticrew M, Shekelle P, Stewart L, PRISMA-P Group. Preferred reporting items for 
systematic review and meta-analysis protocols (PRISMA-P) 2015: elaboration and explanation. BMJ. 2015 Jan 2;349(jan02 1):g7647. 
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Appendix 2: List of organizations/databases for searching clinical guidelines 
 Organizations/Databases Website 
1 British Dental Association http://www.bda.org/ 
2 British Society for Oral Medicine http://www.bsom.org.uk/ 
3 British Association of Head & Neck 
Oncologists 
http://www.bahno.org.uk/ 
4 National Institute for Health and Care 
Excellence 
http://www.nice.org.uk/ 
5 General Dental Council http://www.gdc-uk.org/ 
6 Scottish Intercollegiate Guidelines Network http://www.sign.ac.uk/ 
7 Cancer Research UK http://www.cancerresearchuk.org/ 
8 Health Technology Assessment http://www.hta.ac.uk/ 
9 European Association of Oral Medicine http://www.eaom.eu/ 
10 Mouth cancer foundation http://www.mouthcancerfoundation.org/ 
11 Centers for Disease Control and Prevention http://www.cdc.gov/ 
12 College of Dietitians of British Columbia http://www.collegeofdietitiansofbc.org/ 
13 American cancer society http://www.cancer.org/ 
14 US Preventive Services Task Force http:// 
www.uspreventiveservicestaskforce.org/ 
15 World Health Organization http://www.who.int/ 
16 EUROPA - European Union website http://europa.eu/ 
17 New Zealand Guidelines Group http://www.health.govt.nz/about-
ministry/ministry-health-websites/new-
zealand-guidelines-group 
18 Agency for Healthcare Research and 
Quality (AHRQ) 
www.ahrq.gov/professionals/clinicians-
providers 
19 American College of Physicians Clinical 
Practice Guidelines 
www.acponline.org/clinical_information
/guidelines/guidelines/ 
20 ADA Center of Evidence-Based Dentistry www.ebd.ada.org 
21 Australian National Health and Medical 
Research Council 
https://www.clinicalguidelines.gov.au/ 
22 Institute for Clinical Systems improvement https://www.icsi.org/guidelines__more/ 
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Appendix 3: MEDLINE search strategy 
1.  (primary adj3 prevention*).mp. 
2.  Primary Prevention/ or "primary prevention*".mp. 
3.  Counseling/ or Patient Education as Topic/ or advice*.mp. 
4.  "Tobacco Use Cessation"/ or cessation*.mp. or Smoking Cessation/ 
5.  Harm Reduction/ or "harm reduction*".mp. 
6.  (harm adj3 reduction*).mp. 
7.  Psychotherapy, Brief/ or "brief intervention*".mp. 
8.  (brief adj3 intervention*).mp. 
9.  Early Medical Intervention/ or intervention*.mp. 
10.  "early intervention*".mp. 
11.  "minimal intervention*".mp. 
12.  "general pract* intervention*".mp. 
13.  "brief counsel?ing".mp. 
14.  (brief adj3 counsel?ing).mp. 
15.  "behavio?r* counsel?ing".mp. 
16.  (behavio?r* adj3 counsel?ing).mp. 
17.  Sex Counseling/ or "sex* counsel*".mp. 
18.  Communication/ or Motivational Interviewing/ or "brief communication".mp. 
19.  "alcohol reduction*".mp. 
20.  "control* drink*".mp. 
21.  "health promotion".mp. or Health Promotion/ 
22.  Risk Assessment/ or "risk assess*".mp. 
23.  "patient recall".mp. 
24.  referral.mp. or "Referral and Consultation"/ 
25.  signpost*.mp. 
26.  1 or 2 or 3 or 4 or 5 or 6 or 7 or 8 or 9 or 10 or 11 or 12 or 13 or 14 or 15 or 16 or 17 
or 18 or 19 or 20 or 21 or 22 or 23 or 24 or 25 
27.  Primary Health Care/ or "primary care*".mp. 
28.  (primary adj3 care*).mp. 
29.  General Practice/ or Family Practice/ or "general practice*".mp. 
30.  (general adj3 practice*).mp. 
31.  "medical practice*".mp. 
32.  General Practice, Dental/ or Dental Care/ or "dental practice*".mp. 
33.  Dental Clinics/ or "dental clinic*".mp. 
34.  "dental setting*".mp. 
35.  Dental Offices/ or "dental office*".mp. 
36.  "community care*".mp. or Community Health Services/ 
37.  Patient Care/ or "patient care*".mp. 
38.  "shared care*".mp. 
39.  "clinical care".mp. 
40.  27 or 28 or 29 or 30 or 31 or 32 or 33 or 34 or 35 or 36 or 37 or 38 or 39 
41.  Alcohol Drinking/ or alcohol*.mp. 
42.  "Tobacco Use"/ or Tobacco/ or Tobacco, Smokeless/ or tobacco*.mp. or Tobacco 
Products/ 
43.  Smoking/ or smok*.mp. 
44.  cigar*.mp. 
45.  Areca/ or quid*.mp. 
46.  snuff*.mp. 
47.  HPV.mp. or Human papillomavirus 16/ or Papillomavirus Infections/ 
48.  "wart* virus*".mp. 
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49.  41 or 42 or 43 or 44 or 45 or 46 or 47 or 48 
50.  26 and 40 and 49 
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Appendix 4: Search filters to identify systematic reviews and clinical guidelines 
1) SIGN search filters to identify systematic reviews or meta-analyses 
MEDLINE EMBASE 
1.  Meta-Analysis as Topic/ 
2.  meta analy$.tw. 
3.  metaanaly$.tw. 
4.  Meta-Analysis/ 
5.  (systematic adj (review$1 or 
overview$1)).tw. 
6.  exp Review Literature as Topic/ 
7.  or/1-6 
8.  cochrane.ab. 
9.  embase.ab. 
10.  (psychlit or psyclit).ab. 
11.  (psychinfo or psycinfo).ab. 
12.  (cinahl or cinhal).ab. 
13.  science citation index.ab. 
14.  bids.ab. 
15.  cancerlit.ab. 
16.  or/8-15 
17.  reference list$.ab. 
18.  bibliograph$.ab. 
19.  hand-search$.ab. 
20.  relevant journals.ab. 
21.  manual search$.ab. 
22.  or/17-21 
23.  selection criteria.ab. 
24.  data extraction.ab. 
25.  23 or 24 
26.  Review/ 
27.  25 and 26 
28.  Comment/ 
29.  Letter/ 
30.  Editorial/ 
31.  animal/ 
32.  human/ 
33.  31 not (31 and 32) 
34.  or/28-30,33 
35.  7 or 16 or 22 or 27 
36.  35 not 34 
1.  exp Meta Analysis/ 
2.  ((meta adj analy$) or 
metaanalys$).tw. 
3.  (systematic adj (review$1 or 
overview$1)).tw. 
4.  or/1-3 
5.  cancerlit.ab. 
6.  cochrane.ab. 
7.  embase.ab. 
8.  (psychlit or psyclit).ab. 
9.  (psychinfo or psycinfo).ab. 
10.  (cinahl or cinhal).ab. 
11.  science citation index.ab. 
12.  bids.ab. 
13.  or/5-12 
14.  reference lists.ab. 
15.  bibliograph$.ab. 
16.  hand-search$.ab. 
17.  manual search$.ab. 
18.  relevant journals.ab. 
19.  or/14-18 
20.  data extraction.ab. 
21.  selection criteria.ab. 
22.  20 or 21 
23.  review.pt. 
24.  22 and 23 
25.  letter.pt. 
26.  editorial.pt. 
27.  animal/ 
28.  human/ 
29.  27 not (27 and 28) 
30.  or/25-26,29 
31.  4 or 13 or 19 or 24 
32.  31 not 30 
 
 
2) University of Texas School of Public Health search filters to identify 
guidelines/recommendations 
MEDLINE 
practice guideline/ or Health Planning Guidelines/ or guideline*.ti. or (practice adj3 
parameter*).ti,ab. or clinical protocols/ or guidance.ti,ab. or care pathway*.ti,ab. or critical 
pathway/ or (clinical adj3 pathway*).ti,ab. or algorithms/ or consensus development 
conference.pt. or consensus development conference nih.pt. 
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Appendix 5: List of excluded studies at the full-text screening stage with reasons 
for exclusion 
Systematic Reviews 
 
Study Reason for exclusion 
Alvarez-Bueno, C.; Rodriguez-Martin, B.; Garcia-Ortiz, L.; 
Gomez-Marcos, M. A.; Martinez-Vizcaino, V. (2015). 
Effectiveness of brief interventions in primary health care settings 
to decrease alcohol consumption by adult non-dependent drinkers: 
a systematic review of systematic reviews. Preventive 
Medicine.76; S33-8 
 
Review of reviews 
Asfar, Taghrid; Ebbert, Jon O.; Klesges, Robert C.; Relyea, 
George E. (2011). Do smoking reduction interventions promote 
cessation in smokers not ready to quit? Addictive Behaviors. 
36(7):764-768 
 
Wrong setting 
Aveyard, Paul; Begh, Rachna; Parsons, Amanda; West, Robert 
(2012). Brief opportunistic smoking cessation interventions: A 
systematic review and meta‐analysis to compare advice to quit and 
offer of assistance. Addiction.107(6):1066-1073 
 
Wrong study design 
Bauld, L.; Bell, K.; McCullough, L.; Richardson, L.; Greaves, L. 
(2010). The effectiveness of NHS smoking cessation services: a 
systematic review. Journal of Public Health. 32(1):71-82 
 
Wrong setting 
Boyle, R.; Solberg, L.; Fiore, M. (2014). Use of electronic health 
records to support smoking cessation. Cochrane Database of 
Systematic Reviews. (12):34 
 
Wrong intervention 
Bridle, C.; Riemsma, R. P.; Pattenden, J.; Sowden, A. J.; Mather, 
L.; Watt, I. S.; Walker, A (2005). Systematic review of the 
effectiveness of health behavior interventions based on the 
transtheoretical model. Psychology & Health. 20(3):283-301 
 
Wrong setting 
Chen, D.; Wu, L. T. (2015). Smoking cessation interventions for 
adults aged 50 or older: A systematic review and meta-analysis. 
Drug and Alcohol Dependence 01. 154:14-24 
 
Wrong setting 
Christakis, D. A.; Garrison, M. M.; Ebel, B. E.; Wiehe, S. E.; 
Rivara, F. P. (2003). Pediatric smoking prevention interventions 
delivered by care providers: a systematic review. American 
Journal of Preventive Medicine. 25(4): 358-362. 
 
Wrong population 
Coulton, S. (2011). Alcohol misuse. Clinical Evidence 
 
Review of reviews 
Crouch, R.; Wilson, A.; Newbury, J. (2011). A systematic review 
of the effectiveness of primary health education or intervention 
Wrong intervention 
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programs in improving rural women's knowledge of heart disease 
risk factors and changing lifestyle behaviours. International 
Journal of Evidence-Based Healthcare. 9:236-45 
 
Dennis, S.; Williams, A.; Taggart, J.; Newall, A.; Denney-Wilson, 
E.; Zwar, N.; Shortus, T.; Harris, M. F. (2012). Which providers 
can bridge the health literacy gap in lifestyle risk factor 
modification education: a systematic review and narrative 
synthesis. BMC Family Practice.13; 44 
 
Wrong outcomes 
Ebbert, J.; Montori, V. M.; Erwin, P. J.; Stead, L. F. (2011). 
Interventions for smokeless tobacco use cessation. Cochrane 
Database Syst Rev. (2):Cd004306 
 
Wrong intervention 
Ebbert, J. O.; Rowland, L. C.; Montori, V. M.; Vickers, K. S.; 
Erwin, P. J.; Dale, L. C. (2003). Treatments for spit tobacco use: a 
quantitative systematic review. Addiction. 98(5):569-583 
 
Wrong setting 
Ebrahim, S.; Smith, G. D. (1997). Systematic review of 
randomised controlled trials of multiple risk factor interventions 
for preventing coronary heart disease. BMJ. 314(7095):1666-74 
 
Wrong setting 
Gao, X.; Lo, E. C.; Kot, S. C.; Chan, K. C. (2014). Motivational 
interviewing in improving oral health: a systematic review of 
randomized controlled trials. Journal of Periodontology 85(3): 
426-437 
 
Wrong population 
Goldfarb, M.; Slobod, D.; Dufresne, L.; Brophy, J. M.; Sniderman, 
A.; Thanassoulis, G. (2015). Screening Strategies and Primary 
Prevention Interventions in Relatives of People With Coronary 
Artery Disease: A Systematic Review and Meta-analysis. 
Canadian Journal of Cardiology. 31(5):649-657 
 
Wrong setting 
Gordon, A. J. (2006).Screening the drinking: Identifying problem 
alcohol consumption in primary care settings. Advanced Studies in 
Medicine. 6(3):137-147 
 
Wrong intervention 
Green, Amanda C.; Hayman, Laura L.; Cooley, Mary E. (2015). 
Multiple health behavior change in adults with or at risk for 
cancer: A systematic review. American Journal of Health 
Behavior. 39(3):380-394 US American Journal of Health Behavior 
 
Wrong intervention 
Harris, R.; Gamboa, A.; Dailey, Y.; Ashcroft, A. (2012). One-to-
one dietary interventions undertaken in a dental setting to change 
dietary behavior. Cochrane Database of Systematic Reviews. 
3():CD006540 
 
Wrong intervention 
Ketola, E.; Sipila, R.; Makela, M. (2000). Effectiveness of 
individual lifestyle interventions in reducing cardiovascular 
disease and risk factors. Annals of Medicine. 32(4):239-251 
 
Wrong setting 
Kim, S. S.; Chen, W.; Kolodziej, M.; Wang, X.; Wang, V. J.; Wrong setting 
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Ziedonis, D. (2012). A systematic review of smoking cessation 
intervention studies in China. Nicotine Tob Res. 14(8):891-9 
 
Kottke, T. E.; Battista, R. N.; Defriese, G. H. & Brekke, M. L. 
(1988). Attributes of successful smoking cessation interventions in 
medical practice. A meta-analysis of 39 controlled trials. JAMA, 
259, 2883-9 
No separate primary 
care results 
(combined results for 
all hospital settings) 
 
Lancaster, T.; Stead, L. F. (2005). Individual behavioural 
counselling for smoking cessation. Cochrane Database of 
Systematic Reviews. (2):CD001292 
 
Wrong setting 
Law, M.; Tang, J. L. (1995). An analysis of the effectiveness of 
interventions intended to help people stop smoking 
Arch Intern Med. 155(18):1933-41 
 
Wrong setting 
Lundahl, Brad; Moleni, Teena; Burke, Brian L.; Butters, Robert; 
Tollefson, Derrik; Butler, Christopher; Rollnick, Stephen (2013). 
Motivational interviewing in medical care settings: A systematic 
review and meta-analysis of randomized controlled trials. Patient 
Education and Counseling. 93(2):157-168 
 
Wrong setting 
McCambridge, J.; Jenkins, R. J. (2008). Do brief interventions 
which target alcohol consumption also reduce cigarette smoking? 
Systematic review and meta-analysis. Drug Alcohol Depend. 
(3):263-70 
 
Wrong setting 
McCambridge, J.; Kypri, K. (2011). Can simply answering 
research questions change behaviour? Systematic review and meta 
analyses of brief alcohol intervention trials. PLoS One. 
6(10):e23748 
 
Wrong intervention 
Okumura, L. M.; Rotta, I.; Correr, C. J. (2014). Assessment of 
pharmacist-led patient counseling in randomized controlled trials: 
a systematic review. International Journal of Clinical Pharmacy. 
36(5):882-891 
 
Wrong intervention 
Patnode, C. D.; O'Connor, E.; Whitlock, E. P.; Perdue, L. A.; Soh, 
C.; Hollis, J. (2013). "Primary care-relevant interventions for 
tobacco use prevention and cessation in children and adolescents: 
a systematic evidence review for the U.S. Preventive Services 
Task Force." Annals of internal medicine 158(4): 253-260 
 
Wrong population 
Patton, R.; Deluca, P.; Kaner, E.; Newbury-Birch, D.; Phillips, T.; 
Drummond, C. (2014). Alcohol screening and brief intervention 
for adolescents: the how, what and where of reducing alcohol 
consumption and related harm among young people. Alcohol 
Alcohol. 49(2):207-12 
 
Review of reviews 
Ramseier, C. A.; Suvan, J. E. (2015). Behaviour change 
counselling for tobacco use cessation and promotion of healthy 
lifestyles: a systematic review. Journal of Clinical 
Wrong setting 
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Periodontology. 42 Suppl 16():S47-58 
 
Ranney, L.; Melvin, C.; Lux, L.; McClain, E.; Lohr, K. N. (2006). 
Systematic review: Smoking cessation intervention strategies for 
adults and adults in special populations. Annals of Internal 
Medicine. 145(11):845-856 
 
Wrong setting 
Riemsma, R. P.; Pattenden, J.; Bridle, C.; Sowden, A.; Mather, L.; 
Watt, I. S.; Walker, A. (2003). Systematic review of the 
effectiveness of stage based interventions to promote smoking 
cessation. British Medical Journal. 326(7400):1175-1177 
 
Wrong setting 
Rubak, S.; Sandbaek, A.; Lauritzen, T.; Christensen, B.( 2005). 
Motivational interviewing: A systematic review and meta-
analysis. British Journal of General Practice. 55(513):305-312 
 
Wrong setting 
Satur, J. G.; Gussy, M. G.; Morgan, M. V.; Calache, H.; Wright, 
C. (2010). Review of the evidence for oral health promotion 
effectiveness. Health Education Journal. 69(3):257-266 
 
Wrong setting 
Schroer-Gunther, M. A.; Zhou, M.; Gerber, A.; Passon, A. M. 
(2011). Primary tobacco prevention in China--a systematic review. 
Asian Pac J Cancer Prev. 12(11):2973-80 
 
Wrong setting 
Stead, L. F.; Lancaster, T. (2012). Combined pharmacotherapy 
and behavioural interventions for smoking cessation. Cochrane 
Database Syst Rev. 10():Cd008286 
 
Wrong intervention 
Sullivan, L. E.; Tetrault, J. M.; Braithwaite, R. S.; Turner, B. J.; 
Fiellin, D. A. (2011). A meta-analysis of the efficacy of 
nonphysician brief interventions for unhealthy alcohol use: 
implications for the patient-centered medical home. American 
Journal on Addictions. 20(4):343-56 
 
Wrong setting 
Tait, R. J.; Hulse, G. K. (2003). A systematic review of the 
effectiveness of brief interventions with substance using 
adolescents by type of drug. Drug & Alcohol Review. 22(3):337-
46 
 
Wrong setting 
Williams, Emily C.; Johnson, M. Laura; Lapham, Gwen T.; 
Caldeiro, Ryan M.; Chew, Lisa; Fletcher, Grant S.; McCormick, 
Kinsey A.; Weppner, William G.; Bradley, Katharine A. (2011). 
Strategies to implement alcohol screening and brief intervention in 
primary care settings: A structured literature review. Psychology 
of Addictive Behaviors. 25(2):206-214 
 
Wrong intervention 
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Clinical Guidelines 
 
Guideline Reason for exclusion 
AAOM (2014). Clinical Practice Statement: Risk Assessment. 
 
Wrong study design 
AAOM (2013). Clinical Practice Statement: Medical History 
 
Wrong study design 
ENTUK (2011). Head and Neck Cancer: Multidisciplinary 
Management Guidelines, 4th edition. British Association of 
Otorhinolaryngology, Head and Neck Surgery, The Royal 
College of Surgeons of England 
 
Treatment/Management 
CG 
BASHH (2006). UK National guidelines on undertaking 
consultations requiring sexual history taking. British Association 
for Sexual Health and HIV 
 
Wrong setting 
BTA (2008). Reichert, J., de Araújo, A.J., Gonçalves, C.M.C., 
Godoy, I., Chatkin, J.M., Sales, M.D.P.U. and de Almeida 
Santos, S.R.R. Brazilian Thoracic Association (BTA) 
Guidelines. J Bras Pneumol, 34(10), pp.845-88. 
 
Treatment/Management 
CG 
NHS Health Scotland publication “A Guide to Smoking 
Cessation in Scotland 2010” 
Duplicate - higher 
quality and large 
guideline included 
(NICE 2006, 2008) 
 
NICE (2007). Sexually transmitted infections and under-18 
conceptions: prevention. Public health guideline (PH3), 
National Institute for Health and Clinical Excellence 
 
Wrong intervention 
 
NICE (2013). Tobacco: harm-reduction approaches to smoking. 
National Institute for Health and Clinical Excellence - Clinical 
Guidelines 1  
 
Wrong setting 
NGC (2012). Tobacco exposure. In: Expert panel on integrated 
guidelines for cardiovascular health and risk reduction in 
children and adolescents. [National Heart, Lung, and Blood 
Institute (U.S.)] info@guidelines.gov (NGC) 12 
 
Wrong intervention 
(2008). The New South Wales Health drug and alcohol 
psychosocial interventions professional practice guidelines. 
Clinical Practice Guidelines Portal 1 
 
Wrong setting 
AAFP (2009). Summary of recommendations for clinical 
preventive services. American Academy of Family Physicians 7 
 
Summary document 
(included full CG) 
(2014). South Australian lung cancer pathway. Clinical Practice 
Guidelines Portal 2 
 
Treatment/Management 
CG 
(2014). South Australian head and neck cancer pathway. 
Clinical Practice Guidelines Portal 2 
Treatment/Management 
CG 
334 
 
 
 
(2012). Safer Sex. British HIV Association 1 
 
Wrong setting 
(2010). Prevention of cardiovascular disease. National Institute 
for Health and Clinical Excellence - Clinical Guidelines 1  
 
Wrong setting 
(2012). New Zealand primary care handbook 2012. New 
Zealand Guidelines Group 3 
 
Wrong intervention 
(2011). Guidelines for the assessment of absolute cardiovascular 
disease risk. [National Heart Foundation of Australia] 
info@guidelines.gov (NGC) 7 
 
Treatment/Management 
CG 
(2013). Guideline Summary: Risk estimation and the prevention 
of cardiovascular disease. A national clinical guideline. [Scottish 
Intercollegiate Guidelines Network] 
info@guideline.gov (NGC) 2 
 
Wrong setting 
USPSTF (2013). Guideline Summary: Primary care 
interventions to prevent tobacco use in children and adolescents: 
U.S. Preventive Services Task Force recommendation statement. 
[U.S. Preventive Services Task Force]. info@guideline.gov 
(NGC) 12 
 
Wrong intervention 
CDC (2013). Guideline Summary: Human papillomavirus 
(HPV) infection. In: Sexually transmitted diseases treatment 
guidelines, 2010. [Centers for Disease Control and Prevention] 
info@guideline.gov (NGC) 2 
 
Treatment/Management 
CG 
USPSTF ( (2015). Guideline Summary: Behavioral counseling 
interventions to prevent sexually transmitted infections: U.S. 
Preventive Services Task Force recommendation statement. 
[U.S. Preventive Services Task Force] info@guideline.gov 
(NGC) 3 
 
Wrong setting 
MQIC (2013). Guideline Summary: Adolescent health risk 
behavior assessment. [Michigan Quality Improvement 
Consortium] info@guideline.gov (NGC) 4 
 
Wrong setting 
ACCF (2014). Guideline Summary: 2013 ACC/AHA guideline 
on the assessment of cardiovascular risk: a report of the 
American College of Cardiology/American Heart Association 
Task Force on Practice Guidelines. [American College of 
Cardiology Foundation]. info@guideline.gov (NGC) 12 
 
Wrong intervention 
(2012). Facilitating Client Centred Learning. Registered Nurses' 
Association of Ontario 1 
 
Practice/Professional 
focused 
SIGN (2006). Diagnosis and management of head and neck 
cancer. SIGN 11 
 
Treatment/Management 
CG 
NICE (2008). CVD risk assessment and management. NICE Wrong intervention 
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Clinical Knowledge Summaries 1 
 
NICE (2011). Cardiovascular disease: identifying and 
supporting people most at risk of dying early [National Institute 
for Health and Clinical Excellence (NICE)] info@guidelines.gov 
(NGC) 5 
 
Wrong patient 
population 
(2008). Canadian Consensus Guidelines on Human 
Papillomavirus. Society of Obstetricians and Gynaecologists of 
Canada 4 
 
Wrong setting 
NHMRC (2009). Australian Guidelines to Reduce Health Risks 
from Drinking Alcohol. National Health and Medical Research 
Council 1 
 
Wrong setting 
(2014). ARCHIVED (March 2010)- Contraceptive choices for 
young people. Faculty of Sexual & Reproductive Healthcare 8 
 
Wrong setting 
NICE (2010). Alcohol-use disorders: preventing harmful 
drinking. National Institute for Health and Clinical Excellence - 
Clinical Guidelines 1  
 
Wrong setting 
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Appendix 6: Trial duplication in the included Systematic Reviews (SRs) 
The included trials in systematic reviews were labelled as T1-171; red coloured labels 
shows duplicate trials. 
Systematic Reviews (SRs) Trials included 
SR1 (Lindson 2015) T1 
T2 
T3 
T4 
 
SR2 (Bully 2015) T5 
T6 
T7 
T8 
T9 
T10 
T11 
 
SR3 (Angus 2014) T12 
T13 
T14 
T15 
T16 
T17 
T18 
T19 
T20 
T21 
T22 
T23 
T24 
T25 
T26 
T27 
T28 
T29 
T30 
T31 
T32 
T33 
SR4 (Morton 2015) T20 
T34 
T35 
T36 
T37 
T38 
T39 
T40 
T41 
T42 
SR5 (Gebara 2013) T43  
SR6 (Rice 2013) T11 
T44 
T45 
T46 
T47 
T48 
T49 
T50 
T51 
T52 
T53 
T54 
T55 
T56 
T57 
SR7 (VanBuskirk 2013) T2 
T35 
T58 
T59 
T60 
T61 
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SR8 (Stead 2013) T1 
T6 
T7 
T44 
T47 
T62 
T63 
T64 
T65 
T66 
T67 
T68 
T69 
T70 
T71 
T72 
T73 
T74 
T75 
T76 
T77 
T78 
T79 
T80 
T81 
T82 
T83 
T84 
T85 
T86 
T87 
T88 
T89 
SR9 (Noordmanz 2012) T11 
T34 
T35 
T37 
T39 
T43 
T49 
T52 
T56 
T60 
T90 
T91 
T92 
T93 
T94 
T95 
SR10 (Willis 2012) T96 
T97 
T98 
T99 
T100 
SR11 (Jonas 2012) T20 
T23 
T25 
T36 
T38 
T39 
T40 
T41 
T60 
T95 
T101 
T102 
T103 
T104 
T105 
T106 
T107 
T108 
T109 
T110 
T111 
SR12 (Carr 2012) T112 
T113 
T114 
T115 
T116 
T117 
T118 
T119 
T120 
T121 
T122 
T123 
T124 
T125 
SR13 (Taggart 2012) T1 
T52 
T126 
T127 
T128 
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SR14 (Brown 2012) T129 
T130 
T131 
T132 
T133 
T134 
T135 
SR15 (Zbikowski 2011) T47 
T54 
T72 
T136 
 
SR16 (Cahill 2010) T6 
T7 
T137 
T138 
 
SR17 (Kaner 2009) T20 
T23 
T25 
T34 
T38 
T40 
T41 
T101/107 
T104 
T105 
T108 
T139 
T140 
T141 
T142 
T143 
T144 
T145 
T146 
T147 
T148 
T149 
T150 
SR18 (Halcomb 2007) T11 
T42 
T45 
T47 
T50 
T51 
T52 
T151 
SR19 (Wilhelmsson 2007) T40 
T152 
 
SR20 (Huibers 2007) T41 
T77 
T81 
T147 
 
SR21 (Hyman 2006) T147 
T150 
 
SR22 (Bertholet 2005) T20 
T25 
T34 
T38 
T40 
T41 
T105 
T139 
T141 
T143 
T144 
T145 
T146 
T147 
T149 
T153 
T154 
T155 
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SR23 (Gorin 2004) T49 
T63 
T72 
T74 
T121 
T123 
T156 
T157 
T158 
T159 
T160 
T161 
T162 
T163 
T164 
SR24 (VanSluijs 2004) T1 
T6 
T52 
T137 
T138 
T157 
T165 
T166 
T167 
T168 
SR25 (Whitlock 2004) T20 
T25 
T38 
T40 
T41 
T101 
T102 
T104 
T105 
T107 
T108 
T169 
SR26 (Ballesteros 2004) T20 
T25 
T40 
T41 
T101 
T104 
T105 
T107 
T108 
T139 
T142 
T143 
T144 
SR27 (Sinclair 2004) T129 
T134 
 
SR28 (Blenkinsopp 2003) T129 
T134 
 
SR29 (Poikolainen 1999) T41 
T101 
T105 
T107 
T108 
T144 
T169 
SR30 (Ashenden 1997) T45 
T47 
T49 
T50 
T63 
T66 
T68 
T70 
T75 
T77 
T76 
T79 
T80 
T81 
T82 
T83 
T84 
T85 
T88 
T89 
T101 
T107 
T108 
T144 
T148 
T170 
T171 
SR31 (Kahan 1995) T101 
T107 
T108 
T144 
T148 
T169 
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Appendix 7: Letter from West of Scotland Research Ethics Service (WOSRES) 
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Appendix 8: MVLS ethical approval for part of the project (dental professional 
interview study) 
1st application 
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2nd application 
 
	
 
  
343 
 
 
Appendix 9: Topic guide or interview schedule for dental professional interviews 
 
 
 
Interview Schedule [for oral cancer feasibility interviews in Scotland] 
 
“Oral cancer risk assessment, examination and prevention: dental teams’ views 
and experiences to explore implementation of best practice and clinical guidelines” 
 
 
1. INTRODUCTION 
 
a) Have you read the information sheet and consent form? Do you have any 
questions regarding this? 
b) Aim of these interviews: I would like to know your views on current practice 
and to explore how best practice evidence on oral cancer prevention and early 
detection (from systematic overviews) can be implemented in general 
practices. 
c) There are no right answers; I just want to know your views. 
 
 
2. GENERAL INFO 
 
a) What is your current role/title? (name for tape) 
b) How long have you been practicing? Were you always in GP? 
c) What if any is your background relating to oral cancer? 
i. Any training? CPD? specialty etc.? 
 
 
3. RISK FACTORS 
 
a) What risks of oral cancer do you know about? 
i. Smoking/ alcohol/HPV/sexual behaviours 
ii. Age/gender/socioeconomic status/education/family history 
 
b) How do you find out / identify these risks? 
i. take social history? or as part of medical history? 
ii. Is this as a norm if they have risk factors? or if patients bring it up? 
iii. When do you take social history? Who takes it? 
iv. Do you use any assessment/screening tools? (AUDIT, CAGE, etc.) 
 
c) How many patients have you seen with oral cancer / suspicious 
lesions? 
i. What happened next? 
ii. What about referral, follow up, recall? 
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d) Do you ever discuss oral cancer risks with your patients or bring oral 
cancer term in discussion (or would it terrify patients)? 
i. Is it duty of dental professionals to inform patient about their risk for 
oral cancer? 
 
 
4. ADVICE/ BRIEF INTERVENTION 
 
a) Do you ever give people behavioural advice / counselling on 
smoking? 
i. How? When? 
 
b) SR evidence: Brief face-to-face advice for at least 5 min (range 5-
10min.) 
Would you be comfortable giving brief advice (up to 5 min.) on 
Smoking? 
i. If not, why? What would help? 
ii. When would this be possible/ useful, if at all? (would it fit within 
general oral health assessment or examinations) 
 
c) Do you ever give people behavioural advice on drinking? 
i. How? When? 
 
d) Would you be comfortable giving brief advice (up to 5 min.) on 
Alcohol? 
i. If not, why? What would help? 
ii. When would this be possible/ useful, if at all? 
 
e) Who is the best member of the dental team to give such advice? 
i. Dentist, nurse, hygienist/therapist; why?  
SR evidence: effectiveness of advice by dental team (any member) 
 
f) What should go alongside brief counselling? 
i. Self-help materials, follow-up (phone calls or visits), goal setting 
SR evidence: effectiveness of these 
 
g) SR evidence: effectiveness of attending training to learn how to 
counsel/ advise patients on their behaviours and ½ day is sufficient. 
Would you attend such training? 
i. If not, why? 
ii. How much training would you think is appropriate: 1 session (half a 
day) or 2 sessions (1 day)? Should it be repeated every year or just 
once? 
iii. What about e-learning/ CPD type activity? 
 
 
5. REFERRAL 
 
a) Have you ever referred patients to another service for their smoking/ 
drinking? 
345 
 
 
i. How? What did that involve? cessation /counselling service or 
signpost or provide smoking quit line telephone number, etc.? 
ii. If not- why? 
 
b) SR evidence: effectiveness of referral & follow up by phone calls. 
Would you be comfortable referring patients to specialist services 
based on their risks? (if already referring, would they continue in 
future?) 
i. Cessation services, more intensive counselling, NRT/ 
pharmacological support, self-help or support groups 
ii. or even sign-post (no formal referral) 
 
c) Would you/ could you follow patients up to see if referral/signposting 
worked? 
 
 
6. RISK PREDICTION/ASSESMENT 
 
a) Are you aware of risk assessment tools for breast cancer, 
cardiovascular disease, etc.? 
 
b) Would it help to have a tool for oral cancer that profiled/ quantified 
risk using this type of information? (red, amber or green) 
 
c) How would it work best in practice? 
i. Where? When? Who? 
ii. 2 ways of using this tool: 
1. self-completion in waiting room- when patient come to you 
risk already calculated for you (save your time)? 
2. go over with dental professional- as part of oral health 
assessment (help to break ice and tailor advice)? 
iii. Online tool / as an app / paper questionnaire? 
 
d) Would you/ could you use this as a decision tool? 
i. To guide Oral exams?  Preventive strategies? Recall? Referral? 
ii. How would it help? or what would the difficulties be? 
 
e) Would this tool help to introduce patient with term ‘oral cancer risk’? 
 
f) What about colleagues/ others that you know about/ work with?  
i. What would they think about this type of risk profiling? 
 
 
7. OTHER  
a) Is there anything you think is missing/not working in your practice on 
oral cancer? 
i. What?  
ii. What might improve things? 
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b) Is there anything about oral cancer early detection/ prevention/ 
referral we haven’t covered? 
 
c) Anything else at all you wish to say? 
 
 
Thank you very much. I appreciate the time you took for this interview. 
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Appendix 10: Participant information sheet – for dental professional interviews 
 
 
 
INFORMATION ABOUT THE RESEARCH 
 
 
“Oral cancer risk assessment and prevention: national pre-pilot interviews to 
explore implementation of best practice and clinical guidelines” 
 
 
Introduction 
You are being invited to take part in a research study. Before you decide whether to take part 
in the study, it is important that you understand why the research is being done and what it will 
involve for you. Please take some time to read the following information carefully. Feel free to 
discuss the study with others before you decide. Ask us if there is anything that is not clear or 
if you would like more information. Take time to decide whether or not you wish to take part. 
 
What is the purpose of the study? 
The study is a qualitative study, involving individual interview (one-to-one) to explore the views 
of dental teams in Scotland on oral cancer examination and prevention guidance. We want to 
find out the barriers and facilitators to oral cancer risk assessment, oral examination, 
preventive advice and referral in dental practice.  
 
Why have I been chosen? 
You are being asked to take part in the study because you are working in General Dental 
Practice and can inform us as to the feasibility of translation research evidence and guidelines 
to everyday working environments.  
 
Do I have to take part? 
It is up to you to decide whether or not to take part. If you do decide to take part, please 
remember that you are free to withdraw at any time and without giving a reason. 
 
What will happen to me if I take part? 
We will invite you to participate in a 30-45 minute face-to-face interview. Questions will focus 
on the current barriers and facilitators to oral cancer risk assessment, examination, patient 
recall, advice-giving and referral in dental practice. We would also like to explore which aspect 
of best practice for oral cancer risk assessment, examination and prevention are transferrable 
to dental practice to improve outcomes for patients. 
 
We will make sure that you are happy with being tape-recorded beforehand. 
 
What do I have to do? 
If you are happy to take part, we will contact you to arrange a mutually convenient time for the 
interview. If you do not want to take part, we will not contact you again. 
 
What are the possible disadvantages and risks of taking part? 
There are no identified risks and it is very unlikely that you will come to any harm as a result of 
taking part in the study. However, if you feel uncomfortable or do not wish to continue at any 
time, you can leave the discussion without giving any reason. 
 
What are the possible benefits of taking part? 
We hope the information that will be collected during this study will be useful to support 
implementation and sustained use of oral cancer guidance in risk assessment, prevention and 
referral for the benefit of the public. 
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Will my taking part in this study be kept confidential? 
Your information will be kept strictly confidential and anonymous. You will only be identified by 
an ID number, and any information about you will have your name removed so that you cannot 
be recognized from it. The anonymized interview notes and your records will be held securely 
for at least 10 years at the University of Glasgow (in accordance with Medical Research 
Council best research practice guidelines). We will then destroy them. 
 
What will happen to the results of the research study? 
The results will be used to write a PhD thesis, and will be made available as scientific papers 
in journals and presentations at seminars and/or conferences. We can also send you a short 
summary of the findings if you wish. 
 
Who is organising and funding the research? 
The study is being conducted by the Glasgow Dental Hospital and School at the University of 
Glasgow. The study is funded by NHS Education for Scotland and Glasgow Dental 
Educational Trust. 
 
 
Who has reviewed the study? 
The project has been reviewed by the College of Medicine, Veterinary and Life Sciences 
ethics committee, NHS West of Scotland Research Ethics Service (WoSRES) and NHS R&D 
Management committee. A study proposal has also been submitted to the Glasgow Dental 
Hospital and School Research Management Committee.  
 
Contact for Further Information: 
 
Please contact Dr Sweta Mathur at s.mathur.1@research.gla.ac.uk or +44 777 839 1940; 
 
If you have any concerns about any aspect of this study, please contact Dr Alastair Ross at 
alastair.ross@gla.ac.uk or +44 141 211 9811 
 
 
Thank you for taking the time to read this information. 
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Appendix 11: Participant consent form – for dental professional interviews 
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Appendix 12: Topic guide or survey instrument for patient interviews 
 
 
            
 
“Oral (mouth) cancer risk assessment, examination and prevention: patients’ views 
and experiences to develop an intervention to implement best practice and clinical 
guidelines in general dental practices in Scotland” 
 
TOPIC GUIDE 
 
INTRODUCTION (introduce self) 
§ Have you read the information sheet and consent form? Do you have any 
questions regarding this? 
§ I would like to know your views and experiences of previous and current dental 
practice visits in relation to mouth cancer risk factors/ causes and prevention. 
§ There are no right answers; I just want to know your views. 
 
1) Thinking of the last 5 years, how often have you visited general dental 
practice? 
 
     10+ 
Twice a year  
or more 
      5-4 
About once  
a year 
      2-4 
Less than once a 
year 
      1 
Only this time 
(first visit) 
 
2) Thinking of the last 5 years, what reasons have you had for visiting 
general dental practice? (tick all that apply) 
 
     Check-
up 
      Follow-
up 
      Pain / 
Emergency 
     Scaling/ 
polishing (oral 
hygiene) 
    Other  
Other, specify: ____________________ 
 
 
GENERAL AWARENESS AND RISKS 
 
1) Have you heard of mouth cancer? 
Yes       No 
 
Prompts: Where have you heard? What have you heard? e.g. from the dental 
team, any history- you or in family, social media, or other. 
If mouth cancer patient- what their case is- how and when detected, referral 
and treatment? 
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2) Do you know what causes mouth cancer? 
Overall how much do you know about causes for mouth cancer? 
Prompts: Smoking/ alcohol/ other form of tobacco/ age/ gender/ SES/ family 
history 
Where have you heard? Who told you? e.g. dental team, social media, or other 
 
 
 
 
 
 
 
PREVENTION (ADVICE/ REFERRAL) 
 
a) Smoking or other form of tobacco (views and experiences of current/previous 
visits) 
 
1) May I ask, are you a smoker? 
     Never       Current       Ex-smoker 
 
2) Do you use any other tobacco products? 
Yes       No 
If yes, which ones? E.g. pipe tobacco, cigars, chewing tobacco, E-cigarettes or 
other? 
 
3) Has your dental team ever asked about your smoking status? 
     Yes       No  Not sure 
 
4) If smoker (current), have you ever thought about quitting? 
     Yes       No 
 
Prompts: why or why not? 
 
5) If smoker (current or ex): has your dental team ever offered advice / 
counselling on smoking (or other form of tobacco)? 
     Yes       No  Not sure 
 
Prompts: What did they say? Why you had that conversation? What context- 
mouth cancer, gum disease, staining, or other? 
What advice do you remember? 
§ Harmful effects of smoking or benefits of quitting 
§ Any leaflets or educational materials 
§ Referral: cessation/counselling services or to pharmacist or provided 
smoking quit line number or medicines for quitting (NRT- gum, patches, 
and lozenges), etc. 
§ Did it help? 
§ Any follow-up (by phone calls or next appointment) 
 
     
No 
knowledge 
     
Slight/ little 
knowledge 
      
Some 
knowledge 
     
Good 
knowledge 
 
    
Very good 
knowledge 
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6) If smoker (current), how do you feel about receiving smoking advice 
from: 
□ Dental team within the practice (as part of consultation) 
□ Or dentist referring you to cessation services or GP 
□ Both 
□ None 
 
Prompts: why or why not? 
 
7) If current smoker, how would you feel about receiving brief advice up to 5 
minutes from your dental team about quitting smoking? 
Prompts: why or why not? What would help? 
 
 
 
 
 
 
b) Alcohol (views and experiences of current/previous visits) 
 
1) May I ask, how often do you have a drink containing alcohol? 
 
     Never      Monthly 
or less 
     2–4 times per 
month 
     2–3 times 
per week 
      4+ times 
per week 
 
 
2) Has your dental team ever asked you about drinking? 
     Yes       No 
 
Prompts: If yes, did they use a tool or questionnaire to ask about alcohol? 
 
3) Has your dental team ever offered any advice / counselling on alcohol? 
     Yes       No 
 
Prompts: What did they say? Why you had that conversation? What context- 
mouth cancer, gum disease, trauma, or other? 
What advice do you remember? 
§ Harmful effects of alcohol or benefits of moderating/ quitting 
§ Talked about safe drinking levels 
§ Any leaflets or educational materials 
§ Referral: cessation/counselling services or to pharmacist or provided 
quit line number, etc. 
§ Did it help? 
§ Any follow-up (by phone calls or next appointment) 
 
4) How do you feel about receiving alcohol advice from: 
□ Dental team within the practice (as part of consultation) 
□ Or dentist referring you to cessation services or GP 
 
Prompts: why or why not? 
     
Not happy  
at all 1 
     
Not happy 2 
      
Not sure 3 
     
Happy 4 
 
    
Very happy 5 
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5) How would you feel about receiving brief advice up to 5 minutes from 
your dental team about alcohol? 
Prompts: why or why not? What would help? 
 
 
 
 
 
 
 
POTENTIAL INTERVENTION 
 
1) How would you feel about dentist telling you a risk score as high, medium 
or low for mouth cancer based on your personal information- e.g. 
smoking, alcohol, age, years of education, family history? 
 
Prompts: Which would then lead onto a mouth cancer check and then 
appropriate smoking/alcohol behavioural counselling? 
Do you think people will be happy to provide this information correctly to their 
dental team? 
 
2) How would you feel or how happy would you be about having a risk 
score/ categorisation? 
Prompts: why or why not? 
 
 
 
 
 
3) Would you be happy to enter this information onto a paper form or online 
form or an app at the practice or would you be happy for someone in the 
dental team to ask you these directly? 
Prompts: self-completion in waiting room? Or go over with dental team- as part 
of consultation? 
 
4) Which would you prefer to receive risk categorisation as: 
□ Traffic light - Red (for high), Amber (for medium), Green (for low) 
□ High, medium and low 
□ As a number or percentage score or in times  
e.g. chance of getting cancer in 5 or 10 or 20 years 
 
 
OTHER  
 
1) Is there anything else re mouth cancer check, brief advice and referral you 
wish to say? 
 
 
     
Not happy  
at all 
     
Not happy 
      
Not sure 
     
Happy 
 
    
Very happy 
     
Not happy  
at all 
     
Not happy 
      
Not sure 
     
Happy 
 
    
Very happy 
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GENERAL BACKGROUND INFORMATION (so we cover a range of patients, 
we’ll not disclose any information) 
 
1) What year were you born? _____________________ 
 
2) Gender: 
o Male 
o Female 
 
3) What is your ethnic group? 
 
White Scottish Northern Irish Gypsy/ traveler  
English British Polish 
 Welsh Irish White Other 
Mixed 
 
Asian,  
Asian Scottish  
or Asian British 
Pakistani,  
Pakistani Scottish  
or Pakistani British  
Bangladeshi,  
Bangladeshi Scottish 
or  
Bangladeshi British 
Chinese,  
Chinese Scottish  
or Chinese British 
Indian,  
Indian Scottish  
or Indian British 
 Other 
African, 
Caribbean  
or Black 
African,  
African Scottish  
or African British 
Caribbean,  
Caribbean Scottish  
or Caribbean British 
Black,  
Black Scottish  
or Black British 
  Other 
Any other 
ethnicity  
 
 
4) Are you currently working? 
Yes       No 
If yes, what is your current occupation/job? _________________ 
 
 
5) What is your postcode? __________________ 
(It will not be used to look up your address or to identify you in any way. We are 
asking this so we get people from different parts of Scotland.) 
 
 
Thank you very much. I appreciate the time you took for this interview. 
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Appendix 13: Research Ethics Committee (REC) approval letter 
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Appendix 14: NHS Research & Development (R&D) approval letter 
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Appendix 15: Letter of Access for Research (Research passport) 
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Appendix 16: MVLS ethical approval for part of the project (patient interview study) 
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Appendix 17: Participant information sheet – for patient interviews 
 
           
 
 
PARTICIPANT INFORMATION SHEET 
 
 
Title of Project: 
Oral (mouth) cancer risk assessment and prevention: patients’ views and experiences to 
develop an intervention to implement best practice and clinical guidelines in general dental 
practices in Scotland 
 
Introduction 
You are being invited to take part in a research study. Before you decide whether to take part 
in the study, it is important that you understand why the research is being done and what it will 
involve for you. Please take some time to read the following information carefully. Feel free to 
discuss the study with others before you decide. Ask us if there is anything that is not clear or 
if you would like more information. Take time to decide whether or not you wish to take part. 
 
What is the purpose of the study? 
This study will contribute towards a PhD. The study involves short tape-recorded individual 
interviews (face-to-face) to explore the views and experiences of patients attending general 
dental practices in Scotland on mouth cancer risk assessment, preventive advice and referral. 
We want to find out the barriers and facilitators associated with mouth cancer prevention in 
dental practices, and gather your suggestions to inform the development of a mouth cancer 
prevention intervention package. 
 
Why have I been chosen? 
You are being asked to take part in the study because you are attending general dental 
practice and can inform us as to the feasibility of implementing research evidence and 
guidelines to everyday working environments.  
 
Do I have to take part? 
No, it is up to you to decide whether or not to take part. If you do decide to take part, please 
remember that you are free to withdraw at any time and without giving a reason. 
 
What will happen to me if I take part? 
We will invite you to participate in a 20-25 minute face-to-face interview. Questions will focus 
on the current barriers and facilitators to mouth cancer risk assessment, examination, advice-
giving and referral among patients attending general dental practices. We would also like to 
know your views on previous and current practice in relation to mouth check and preventive 
advice. We will make sure that you are happy with being tape-recorded beforehand. 
 
What do I have to do? 
If you are happy to take part, we will invite you to take part in a 20-25 minute interview during 
this dental practice visit. Interview will be carried out in a separate private space at your dental 
practice. If you do not want to take part, we will not contact you again. We will ask for your 
contact details if you agree to be approached with opportunities to take part in further studies. 
 
What are the possible disadvantages and risks of taking part? 
There are no identified risks and it is very unlikely that you will come to any harm as a result of 
taking part in the study. However, if you feel uncomfortable or do not wish to continue at any 
time, you can leave the discussion without giving any reason. 
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What are the possible benefits of taking part? 
We hope the information that will be collected during this study will be useful to support 
implementation and sustained use of mouth cancer guidance in risk assessment, prevention 
and referral for the benefit of the public. 
 
Will my taking part in this study be kept confidential? 
Your information will be kept strictly confidential and anonymous. You will only be identified by 
an ID number, and any information about you (including direct quotations from interviews) will 
have your name removed so that you cannot be recognized from it. The anonymized interview 
notes and your records will be held securely in keeping with the Data Protection Act (1998) - 
records will be retained for 10 years. We will then destroy them. 
 
What will happen to the results of the research study? 
The results will be used to write a PhD thesis, and will be made available as scientific papers 
in journals and presentations at seminars and/or conferences. If you wish to receive a short 
summary of the findings, we will provide results in a patient accessible format to your dental 
practice. 
 
Who is organising and funding the research? 
The study is being conducted by the Glasgow Dental Hospital and School at the University of 
Glasgow; and sponsored by NHS Greater Glasgow and Clyde. The study is funded by NHS 
Education for Scotland and Glasgow Dental Educational Trust. 
 
Who has reviewed the study? 
The project has been reviewed by an NHS Research Ethics Committee, NHS R&D 
department, and Glasgow Dental Hospital and School Research Management Committee.  
 
Contact for Further Information: 
 
Please contact Ms Sweta Mathur at s.mathur.1@research.gla.ac.uk or +44 777 839 1940 
 
If you have concerns about any of the issues raised during the interview – please discuss with 
your dentist. 
 
If you have any concerns about the research aspects of the study, please contact Dr Alastair 
Ross at alastair.ross@gla.ac.uk or +44 141 211 9811 
 
The usual NHS complaints procedure will also be available to you 
http://www.nhsggc.org.uk/get-in-touch-get-involved/complaints/  
 
 
Thank you for taking the time to read this information. 
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Appendix 18: Participant consent form – for patient interviews 
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Appendix 19: Patient interviews - tabulated responses (descriptive statistics) 
Figure 1: Patient visits to primary care dental practices in the last five years - by 
gender 
 
 
 
 
Figure 2: Patient visits to primary care dental practices in the last five years - by age 
group 
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Table 1: Knowledge and awareness of oral cancer – frequency 
 
Sample Questions Number Percent (%) 
n=24 
(all 
participants) 
Have you heard of mouth (oral) cancer? 
Yes 
No 
Not sure 
 
 
22 
2 
0 
 
 
91.7 
8.3 
0 
n=24 
(all 
participants) 
Overall how much do you know about 
causes for mouth (oral) cancer? 
No knowledge 
Slight/ little knowledge 
Some knowledge 
Good knowledge 
Very good knowledge 
 
 
2 
13 
7 
2 
0 
 
 
8.3 
54.2 
29.2 
8.3 
0 
 
 
Figure 3: Patient knowledge about causes for oral cancer - by gender 
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Figure 4: Patient knowledge about causes for oral cancer – by age group 
 
 
 
 
Table 2: Views and experiences for smoking advice/ referral – frequency 
 
Sample Questions Number Percent (%) 
n=24 
(all 
participants) 
Has your dental team ever asked about your 
smoking status? 
Yes 
No 
Not sure 
 
 
19 
3 
2 
 
 
79.2 
12.5 
8.3 
n=13 
(current or 
ex-smoker) 
If smoker (current or ex): Has your dental 
team ever offered advice/counselling on 
smoking (or other form of tobacco)? 
Yes 
No 
Not sure 
 
 
 
4 
9 
0 
 
 
 
30.8 
69.2 
0 
n=5 
(current 
smoker) 
If smoker (current): Have you ever thought 
about quitting? 
Yes 
No 
 
 
5 
0 
 
 
100 
0 
2
9
4
2
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3
0 0
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No knowledge
Slight/ little knowledge
Some knowledge
Good knowledge
Very good knowledge
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n=5 
(current 
smoker) 
If smoker (current): How do you feel about 
receiving smoking advice from: 
Dental team within the practice (as 
part of consultation) 
Dentist referring you to cessation 
services or GP 
Both 
None 
 
 
1 
 
2 
 
2 
0 
 
 
20.0 
 
40.0 
 
40.0 
0 
 
 
Table 3: Views and experiences for alcohol advice/ referral – frequency 
 
Sample Question Number Percent (%) 
n=24 
(all 
participants) 
How often do you have a drink containing 
alcohol? 
Never 
Monthly or less 
2–4 times per month 
2–3 times per week 
4+ times per week 
 
 
10 
9 
2 
3 
0 
 
 
41.7 
37.5 
8.3 
12.5 
0 
n=24 
(all 
participants) 
Has your dental team ever asked you about 
drinking? 
Yes 
No 
Not sure 
 
 
12 
9 
3 
 
 
50.0 
37.5 
12.5 
n=14 
(alcohol 
drinkers) 
If alcohol drinker: Has your dental team ever 
offered any advice / counselling on alcohol? 
Yes 
No 
Not sure 
 
 
0 
13 
1 
 
 
0 
92.9 
7.1 
n=14 
(alcohol 
drinkers) 
If alcohol drinker: How do you feel about 
receiving alcohol advice from: 
Dental team within the practice (as 
part of consultation) 
Dentist referring you to cessation 
services or GP 
Both 
None 
 
 
5 
 
8 
 
1 
0 
 
 
35.7 
 
57.2 
 
7.1 
0 
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Figure 5: Views about receiving brief smoking advice up to 5 minutes from the dental 
team (n=5) 
 
 
 
 
 
 
Figure 6: Views about receiving brief alcohol advice up to 5 minutes from the dental 
team (n=14) 
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Figure 7: Views on having a risk score/ categorisation (n=24) 
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